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Abstract
Section 1
I have established a PCR based single strand conformation polymorphism (SSCP) 
assay for the detection of polymorphisms in PCR amplified genomic fragments. I have 
used this assay in the analysis of PCR products up to 300 bp in length from putative 3 1 
untranslated regions (3'UTR) of mouse expressed sequence tags (ESTs) and show that
an SSCP difference allowing mapping of ESTs on Mus spretus x C57BL/6 crosses is
found at >90%. These studies report the mapping of 46 new mouse brain expressed 
sequence tags (ESTs) and one anonymous sequence tag to localised regions (> 2 cM) of 
the mouse genetic map. Assignment of these ESTs to chromosomes was carried out by 
SSCP analysis of sets of typed DNAs from animals in several backcross generations of 
a breeding programme that generates consomic lines with particular chromosomes 
deriving from M. spretus (SEG/Pas) on a C57BL/6 background. This allowed specific 
sets of recombinants to be selected from the European Collaborative Interspecific 
Backcross (EUCIB) resource for precise mapping. These experiments establish an 
effective strategy for the genetic mapping of multiple mouse ESTs. The particular EST 
set which I am mapping is enriched for novel and locally expressed genes of the 
substantia nigra, and may prove to be a good source of candidate genes for loci 
involved with neurological disorders. These studies also establish a qualitative RT- 
PCR screen evaluating the presence or absence of an RNA species in a known tissue at 
a specific timepoint. This work constitutes a significant step towards the goal of 
establishing an integrated gene map, combining information on the position of a gene, 
its sequence and its expression pattern.
Abstract
Section 2
A new mouse oligodendrocyte-specific gene was discovered in a differential screen, 
and subsequently found to be the mouse homologue of the recently discovered rat gene 
encoding the myelin-associated oligodendrocytic basic proteins (MOBP); a family of 
related highly basic myelin protein isoforms. MOBP is a new major component of 
CNS myelin. I have used SSCP analysis of a radioactively labelled PCR product from 
the 3'UTR of this gene in an assay to allow rapid genetic mapping. I report that Mobp 
is localised between D9Mit55 and D9MU19 at 63.6 ± lcM distal to the centromere of 
chromosome nine. Three mouse neurological mutations, spinner, tippy and ducky, 
map in this region of the mouse genome. The syntenic region of the human genome is 
3p21-22. I have cloned the mouse gene Mobp in an endeavour to elucidate its genomic 
organisation and regulation. These studies demonstrate that the Mobp gene is a 
complex transcriptional unit. It comprises at eight discrete exons encompassing a 
genomic region in excess of 14 kb. Mobp also contains alternative internal splice 
donor/acceptor sites within at least two of its exons. I have utilised an oligo-capping 
assay in an endeavour to identify the transcription start points (tsp) associated with the 
Mobp gene. These studies have also revealed the presence of a novel transcriptional 
unit within the Mobp gene. In excess of 10 kb of sequence has been generated across 
the genomic region encompassing Mobp. Finally I have generated a gene targeting 
construct, designed to disrupt the Mobp gene, in an endeavour to begin to elucidate the 
function of this novel gene. These studies provide the platform for a more detailed 
analysis of the function of the Mobp gene product and subsequent evaluation of its 
possible involvement in known neuropathies.
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Chapterl Introduction
Section 1
1.1 Mapping expressed genes
1.1.1 Relevance of gene mapping to the Human Genome
High resolution expression maps of the mouse and human genomes are among the most 
immediate needs of the human genome project (Gardiner and Brennan, 1992; 
Hochgeschwander, 1992). It is widely accepted that mapping genes in higher organisms 
e.g. man or mouse, will provide information permitting the elucidation of the higher levels 
of genome organisation (Polymeropoulos et al., 1992). This approach permits the 
generation of data at a number of levels, ranging from the localisation of human genes and 
their rodent orthologues to the characterisation and classification of genes according to 
function and expression. Such a strategy will yield information critical to the 
understanding of gene evolution (Polymeropoulos et al., 1992; Polymeropoulos et al., 
1993).
One goal of the Human Genome Project is the ability to integrate information on the 
genetic and physical position of every gene in the genome with information regarding their 
temporal and spatial expression (Gardiner and Brennan, 1992). This form of integrated 
map will permit elucidation of the organisation of mammalian genomes, particularly gene 
clustering, gene number and the overlap, in sets of expressed sequences, between tissues 
and developmental stages (Levitt, 1991a). The ultimate goal is to subsequently obtain 
structural and functional information for each gene in our genome (Strachan et al., 1997). 
The generation and genetic mapping of large numbers of expressed sequence tags (ESTs) 
is now accepted as a technically feasible way to work towards these important goals 
(Stewart, 1995). ESTs are single-pass sequences from the end of cDNA clones, usually 
from tissue-specific directional libraries (Adams et al., 1991; Hoog, 1991; Wilcox et al., 
1991; Adams etal., 1992; Okubo, 1992).
1.1.2 Selection of the mouse as the species of choice for these studies
Analyses of spatial and temporal expression are more readily performed in the mouse 
(Hochgeschwander, 1992). The mouse presents much fewer of the ethical problems, 
encountered in man, to an investigator wishing to obtain embryonic tissues. For example, 
there are fewer restrictions on gaining access to specific tissues e.g. brain and also for
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making comparative studies of this tissue at different developmental stages when 
generating specific cDNA libraries, and subsequently ESTs. Figure 1.1 illustrates the 
steps taken, in this study, from isolation of tissue from a particular developmental stage, 
through the generation of ESTs to their eventual localisation within the mouse genome. 
Such an approach permits the identification of gene candidates for involvement with 
previously identified pathologies (Levitt, 1991; Wilcox et al., 1991). The utility of 
gene/EST mapping, to this end, is discussed in greater detail in Chapter 1, 1.2.
The mouse is the species of choice for the performance of functional assays of mammalian 
genes (Guenet, 1996). The development of transgenic and gene targeting technologies in 
the mouse, due partially to the high degree of evolutionary conservation between human 
and mouse genes (Guenet, 1996), has provided a useful tool for the Human Genome 
Project. Consequently, in order to utilise these technologies, in the mouse, any gene 
identified in man must also be identified in and subsequently cloned from the mouse 
genome (Guenet, 1996). It is noteworthy that the ESTs used in this study derive from 
subtracted cDNA libraries enriched for genes showing low level expression or localised 
expression in the mouse ventral midbrain (Savioz and Davies, 1995). It is the 
dopaminergic neurons of the substantia nigra pars compacta within the ventral midbrain 
that is specifically degenerated in the pathology of Parkinson’s disease. A number of 
linkage groups, conserved between the mouse and human genomes, have already been 
identified. Elucidation of the full extent of these syntenic regions requires continuous 
refinement of their respective genetic and physical maps (Guenet, 1996). This will further 
aid the exploitation of the mouse for the functional analysis of genes identified in either 
species.
As mentioned above the generation and genetic mapping of large numbers of expressed 
sequence tags (ESTs) is a technically feasible way to work towards obtaining expression 
maps and furthering the Human Genome Project (Stewart, 1995). However, the 
generation of mouse ESTs has progressed more slowly than human EST sequencing, and 
the development of a simple, rapid and efficient approach to mapping ESTs remains of 
particular importance.
Until recently, mapping human cDNAs was only useful in generating low resolution 
physical maps (Polymerpoulos, 1992). The use of human-mouse somatic cell hybrids with 
a limited complement of human chromosomes, that have been fragmented by large doses 
of radiation, have increased thae rate at which genes and other markers can be localised 
within the human genome (Guenet, 1996). These refined hybrid panels have not been 
available for mapping markers in the mouse genome. One reason for this may be the
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rarity of deletions and translocations within somatic cell hybrids for the mouse (Guenet, 
1996). However, it is widely accepted that genetic mapping in the mouse is a very 
powerful tool (Avner et al., 1988; Copeland and Jenkins, 1991; Takahashi and Ko, 1993). 
Any EST marker demonstrating a polymorphism between two mouse strains can be 
localised, and its position in the linear order of markers in that region can be readily 
determined. This may be established by the genetic typing of backcross progeny between 
the strains in question (Takahashi and Ko, 1993).
1.1.3 Selection of sequence from 3' untranslated regions for use in polymorphism
assays
Coding sequences are more frequently conserved during evolution than non-coding 
sequences (Levitt, 1991; Wilcox et al., 1991; Polymeropoulos et al., 1992, 1993; 
Takahashi and Ko, 1993), and as a consequence gene markers are more productively 
sought in untranslated sequences (Levitt, 1991b; Wilcox et al., 1991; Polymeropoulos et 
al., 1992; Beier, 1993; Polymeropoulos et al., 1993; Takahashi and Ko, 1993; Ko et al., 
1994; Beier et al., 1995). Polymorphic variation occurs in non-coding (5' untranslated 
region, 5'UTR; 3' untranslated region, 3'UTR; intronic) sequences as frequently as 1 in 100 
bp, between individuals (Antonarakis et al., 1982). These polymorphisms are suggested 
(Levitt, 1991) to be readily detectable using PCR amplification in combination with 
established electrophoretic techniques (Orita et al., 1989b; Sheffield et al., 1989; White et 
al., 1992).
3' untranslated sequence has been the most commonly used in the generation of gene 
markers for the human and mouse genomes (Levitt, 1991b; Wilcox et al., 1991; 
Polymeropoulos etal., 1992; Beier, 1993; Polymeropoulos etal., 1993; Takahashi and Ko, 
1993; Ko et al., 1994; Beier et al., 1995; McCallion et al., 1996). With respect to mapping 
expressed sequences in the mouse, the use of sequence derived from 3'UTRs provides a 
number of well documented advantages. These include:
• The significant sequence variation between the mouse strains most commonly used 
in genetic mapping (Beier et al., 1992; Beier, 1993; Takahashi and Ko, 1993).
• The availability of sequence that is virtually free of introns (Hawkins, 1988) and 
the consequent ability to predict the fragment size of amplified sequence in 
genomic DNA.
• The use of single-pass sequence information for the generation of oligonucleotides 
for PCR amplification and the subsequent generation of polymorphic gene markers 
(Levitt, 1991b; Podsulo et al., 1991).
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• The use of 3' UTR provides a consistent point of reference for mapping large genes 
e.g. the gene encoding dystrophin.
• 3' UTR sequences are frequently unique even among family members for example 
the gene family encoding actin proteins (Ko, 1990). Thus it permits the generation 
of gene-specific sequence-tagged sites (STS).
It is noteworthy that the use of 3' directed cDNA libraries makes 3' UTR sequence directly 
available.
Thus, the mapping of ESTs automatically generates STSs which can serve to aid the 
construction of physical maps of chromosomes e.g. in the establishment of cosmid, BAC 
and YAC (Burke et al., 1987; McCormick et al., 1989) contigs. The generation of 
sequence information around anonymous DNA markers, for the construction of a physical 
map of chromosomes, is both laborious and expensive (Hochgeschwander, 1992). This 
makes the mapping of ESTs particularly attractive.
1.1.4 The purpose of establishing genetic and physical maps of expressed genes
The ultimate goal of a gene map is to assign a genetic and physical map position to all 
genes, and a tissue-expression profile for all genes, in the mouse genome (Takahashi and 
Ko, 1993). However, a more immediate goal is to obtain a 1 cM resolution linkage map. 
YACs (Burke et al., 1987; McCormick et al., 1989) contain up to 1 Mb of genomic DNA. 
Hence an expression map, with genes positioned at a 1 cM resolution (approximately 1.6 
Mb), may be used to order, and demonstrate overlaps among, YAC clones. A study by 
Copeland and Jenkins (1991) demonstrated that to obtain a 1 cM resolution linkage map at 
the 99% confidence interval, would require 8,000 cDNAs to be mapped on 500 backcross 
progeny. These calculations rely upon the assumption that genes are distributed randomly 
throughout the genome.
EST mapping may be performed at different levels ranging from chromosome assignment 
(50-250 Mb resolution) to the identification of a DNA clone or contig (< 1 Mb resolution) 
containing the sequence in question (Stewart, 1995). The establishment of a complete 
gene map requires the integration of information from different approaches. The result of 
combining sequence, mapping and expression data will prove to be useful in investigating 
biological phenomena and in identifying and cloning gene candidates for genetic disorders 
(Wilcox etal., 1991; Polymeropoulos etal., 1992, 1993; Takahashi and Ko, 1993).
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1.2 Expression maps: Correlation with disease
Most mutations in genes are recognised solely as a consequence of the phenotype they 
cause (Levitt, 1991). It is widely acknowledged that establishing linkage with 
polymorphic markers is a crucial first step in the localisation and cloning of a gene 
associated with a pathological process (Levitt, 1991; Wilcox et al., 1991). High resolution 
expression maps will expedite the process of localising disease genes (Levitt, 1991). The 
ability to detect polymorphisms in eukaryotic gene sequences facilitates their mapping and 
subsequent evaluation as candidate genes for involvement in an identified pathology 
(Levitt, 1991; Wilcox et al., 1991; Takahashi and Ko, 1993). Mapping cDNAs, generated 
from RNAs of known spatial and temporal expression, will provide strong candidates 
genes for scrutiny in connection with genetic disorders.
Most published reports of EST sequencing utilise tissue-specific cDNA libraries derived 
from human tissues (Adams et a l, 1991, 1992; Wilcox et al., 1991; Hoog et al., 1991; 
Okubo et al., 1992). Likewise, the mouse ESTs mapped in this study (Section 1, 1.3) 
derive from subtracted libraries enriched for genes showing low level expression or 
localised expression in the mouse ventral midbrain (Savioz and Davies, 1995). The use of 
subtracted brain libraries as a source of ESTs significantly increases the probability of 
detecting candidate genes for neurological disorders by genetic mapping. A number of 
reports have already recognised the utility of brain-expressed ESTs in the study of 
neurogenetic disease (Wilcox etal., 1991; Polymeropoulos etal., 1992, 1993).
This candidate gene approach has been validated in a number of recent studies in the 
mouse and in man (Deutsch, 1991; Chalepakis et al., 1991; Gibson et al., 1995). Such an 
approach entails the localisation of a gene, known in the form of a mutant allele, on the 
mouse map whilst a cDNA is also known to map to the region. A plausible connection is 
first suspected and then examined. In one such example (Gibson et al., 1995) the murine 
mutant shaker-1 (sha l) was found to be a consequence of a mutation within a gene 
encoding a novel myosin protein. It has also been shown (Chalepakis et al., 1991) that the 
homeobox containing the gene Paxl, found to map to the region of mouse chromosome 2 
previously implicated in the undulated (un) mutation, was indeed the gene mutated in 
affected un animals. The process of mapping and subsequent identification of plausible 
candidate cDNA sequences was performed as outlined above. The result was confirmed 
by a genetic study which demonstrated that the homologous gene in man was responsible 
for Usher syndrome Type IB (Weil etal., 1995).
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1.3 Identification and selection of genes for further study
In combined EST sequencing and genetic mapping projects a number of arbitrary criteria 
must be established in order to permit the identification and selection of gene sequences 
for further study. Such criteria may be based on the correlation of an EST location with a 
locus associated with a known pathology, or on the identification of ESTs corresponding 
to transcripts which are restricted to or preferentially present within a tissue affected by a 
known pathology. ESTs which are identified as satisfying both of these criteria are 
obvious candidate sequences for further study (Hochgeschwander and Brennan, 1993). As 
mentioned above, the mouse ESTs in these studies (Section 1, 1.3, 1.4 and 1.5) derive 
from subtracted libraries enriched for genes exhibiting a low level of expression or 
localised expression in the mouse ventral midbrain (Savioz and Davies, 1995), including in 
particular the Substantia nigra which is involved in movement control and the pathology of 
Parkinson's Disease. Consequently, genes exhibiting low level or localised expression to 
the ventral midbrain in mouse are of primary interest. Genes demonstrating expression 
patterns localised within defined regions of the brain or restricted to CNS tissues are also 
of interest and may be selected for further study. Genes which satisfy the above 
mentioned criteria, in relation to other pathological processes that do not specifically target 
the nervous system, are of secondary interest to these studies.
1.4 Selection of the Mobp gene for detailed analysis
A novel EST, corresponding to an oligodendrocyte-specific cDNA fragment, was isolated 
in the course of a combined differential screening and sequencing programme to discover 
genes expressed preferentially in particular brain regions (Davies et al., 1994; Savioz and 
Davies, 1995). When mouse ventral midbrain and cerebellum cDNA libraries are 
compared, the former are found to be strongly enriched in oligodendrocyte-derived cDNAs 
(Savioz and Davies, 1995). One clone (Ftg; fibre tract gene) demonstrated an mRNA 
distribution, as determined by in situ hybridisation, in which all CNS white matter fibre 
tracts were labelled, exactly as for myelin basic protein (MBP). This contrasts with most 
other myelin proteins which are found to be localised in the oligodendrocyte cell bodies. It 
was initially suggested that this sequence may either correspond to a novel Mbp splice 
variant or that it may represent a novel gene encoding a new protein that is incorporated 
into CNS myelin (Davies, pers. comm.). While this work was in progress, a new 
oligodendrocyte cDNA was discovered in rat spinal cord (Yamamoto et a l, 1994), which 
showed strong sequence similarity to mouse Ftg. The product of this rat gene was shown 
to be abundant in CNS myelin, at a level exceeded only by PLP and MBP, and was named 
myelin-associated oligodendrocytic basic protein (Mobp; Yamamoto et al., 1994). The
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mouse gene Ftg has subsequently been renamed Mobp in accordance with its homologue 
in rat (Yamamoto et al, 1994). Subsequent analysis (Montague et al., 1997) confirmed 
that the Mobp gene is specifically expressed in oligodendrocytes in concert with the 
development of myelination and that its product represented a new major CNS-specific 
myelin component. Myelin-associated oligodendrocytic specific basic protein (MOBP) is 
distributed throughout CNS compact myelin. A decision was taken to select this gene for 
further study rather than to wait for the eventual identification of a gene whose expression 
was restricted to the substantia nigra. In the context of these studies, waiting for the 
identification of such a gene may have resulted in insufficient time for its study. The work 
reported in Section 1 of this thesis represents a series of pilot studies and as such the 
search for a gene demonstrating expression that is restricted to or enhanced within the 
substantia nigra continues.
1.5 Aims of the studies performed in Section 1
The aim of this study was to identify gene candidates for involvement in neuropathies 
affecting man and mouse, specifically genes whose expression was restricted to the 
substantia nigra. I have established that this goal may be achieved by identifying genes 
which demonstrate linkage to a locus associated with a known pathology, whose 
expression is restricted to the tissues affected by a known pathology or which satisfy both 
of these criteria (Chapter 1, 1.1-1.4). I have endeavoured to establish a technically feasible 
and efficient way to assay large numbers of expressed sequences with respect to these 
criteria. In order to satisfy the aim of this study I defined a number of interim goals. 
These include:
• To establish an SSCP assay that will identify polymorphisms in 3'UTR sequences, 
between the mouse species Mus spretus (SEG/Pas and SPR) and Mus domesticus 
(C57BL/6), with a high frequency.
• To utilise this SSCP assay to establish a genetic mapping strategy for genes 
expressed in the central nervous system (CNS) of mouse and subsequently to increase the 
rate at which ESTs were mapped in the mouse genome via increased cooperation between 
the Davies laboratory (University of Glasgow) and the Guenet laboratory (Institut Pasteur, 
Paris).
• To establish a qualitative RT PCR assay of the spatial and temporal expression 
patterns of ESTs selected from the genetic mapping study
Figure 1.1 illustrates the steps taken, in this study, from isolation of tissue from a 
particular developmental stage, through the generation of ESTs to their eventual 
localisation within the mouse genome.
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Tissue E[n]/P[n]
RNA
I
cDNA
I
EST
I
Chromosome allocation
*Genotyping 10-20 EUCIB DNAs
Localisation between anchor markers
I
Synthesis and cloning
Single-pass sequencing
Polymorphism assay (SSCP)
**Genotyping <22 DNAs
‘Genotyping 10 - 200 EUCIB DNAs
Distance between anchor markers
I
I
Correlation with disease loci
Figure 1.1 Schematic representation of the processes involved in the generation 
of ESTs from a particular tissue of mouse and their subsequent localisation within 
the mouse genome. E[n], Embryonic day [n]; P[n], Postnatal day [n]; EST, 
Expressed Sequence Tag; SSCP, Single Strand Conformation Polymorphism;
EUCIB, European Collaborative Interspecific Backcross. *, subset panels of DNAs 
used in localisation of ESTs within the mouse genome. *, Intermediate generations 
of breeding programme established to generate consomic lines.
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Section 2 Introduction
1.6 Myelin
1.6.1 Myelin structure and formation
Myelin is a unique cellular organelle of the central (CNS) and peripheral (PNS) nervous 
systems (Mikoshiba et al., 1991; Lemke, 1992; Nave, 1994; Scherer and Chance, 1995; 
Staugaitis et a l, 1996). It forms a multilamellar membrane that ensheaths nerve axons and 
facilitates saltatory conduction of impulses (Mikoshiba et al., 1991; Lemke, 1992; 
S taugaitis et al., 1996). Myelin's unusual structure is readily recognised both 
macroscopically in the white matter tracts of the brain and spinal cord, and 
microscopically in the spiral rings of membrane that envelope all rapidly conducting axons 
(Lemke, 1992).
Myelin is formed by two specialised types of glia, oligodendrocytes in the CNS and 
myelin forming Schwann cells in the PNS (Jacobson, 1991; Lemke, 1992; Scherer and 
Chance, 1995). Figure 1.2 illustrates the myelination of multiple axons by a single 
oligodendrocyte and the characteristic structure of the myelin sheath. Embryologically, 
oligodendrocytes derive from multipotent progenitor cells of the neural tube. Schwann 
cells derive from the migratory cells of the neural crest, as do their neuronal partners in the 
PNS (Jacobson, 1991; Lemke, 1992). It is noteworthy that these cell types represent only a 
subset of peripheral and central glia (Lemke, 1992).
The mechanics of myelin deposition by oligodendrocytes and myelinating Schwann cells 
appear, at first aproximation, to be the same (Lemke, 1992): each synthesises a large sheet 
of plasma membrane which is spirally wrapped around target axons and subsequently 
tightly compacted (Mikoshiba et al., 1991; Scherer and Chance, 1995; Staugaitis et a l, 
1996). In the PNS this process results in a sheath comprising up to one hundred layers 
(Lemke, 1992). When viewed in cross section, through an electron microscope, the final 
structure of myelin resembles a highly regular array of concentric rings of plasma 
membrane bilayers (Jacobson, 1991; Lemke, 1992; Staugaitis et a l, 1996). This structure 
arises as a consequence of two different membrane appositions. One of these corresponds 
to the apposition of cytoplasmic membrane surfaces. The other corresponds to the 
apposition of extracellular plasma membrane surfaces. These membrane appositions have 
been termed major dense lines (MDL) and intraperiod lines (IPL) relating to the 
apposition of cytoplasmic and extracellular surfaces, respectively, and based on their 
appearance under the electron microscope (Privat, 1980; Lemke, 1992; Staugaitis et a l,
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1996). The distance between adjacent MDL defines one repeat period of the myelin 
sheath. This distance is exceedingly small; approximately 170 Angstroms and 150 
Angstroms in the PNS and CNS respectively. Membrane bilayers are known to be 
approximately 50 Angstroms wide (Lemke, 1992). Each MDL requires the apposition of 
two bilayers, each approximately 50 Angstroms wide. This indicates that there is very 
little cytoplasm in the spirals of compact myelin (Lemke, 1992; Staugaitis et al., 1996).
1.6.2 Myelin function and neural evolution
During the propogation of an action potential very few ions move across axonal 
membranes in regions that are insulated by myelin. Current flow is instead restricted to 
regions of bare axonal membrane (Nodes of Ranvier), regularly spaced between adjacent 
myelin sheaths (Lemke, 1992; Staugaitis et a l, 1996). These Nodes of Ranvier contain a 
high density of voltage sensitive sodium channels, required for impulse conduction 
(Jacobson, 1991; Lemke, 1992), and are exposed to a relatively low resistance 
environment. This geometry compells the current to jump from one node to another in a 
saltatory fashion, a much faster mode of conduction than in unmyelinated axons (Lemke, 
1992; Staugaitis et al., 1986). It should be noted that a myelinated axon of fixed radius 
conducts nerve impulses at a rate 10 times faster than an unmyelinated axon of the same 
radius. As the volume occupied by an axon is directly proportional to the square of it 
radius, myelinated axons occupy on average only 1/100 the volume of an unmyelinated 
axon conducting impulses at the same rate (Lemke, 1992; Staugaitis et a l,  1996). This 
single factor is considered to be the driving force behind the evolution of myelinating cells 
and the appearance of myelin, constituting the last major cellular advance in evolution 
(Lemke, 1992). Phylogenetically, myelin is first observed in elasmobranch fish (Lemke, 
1992). One critical difference between myelination by Schwann cells and myelination by 
oligodendrocytes relates to the number of axons that can be myelinated by any single cell. 
One Schwann cell can only myelinate a single axon, whereas a single oligodendrocyte can 
provide independent myelin sheaths for up to 50 different axons (Jacobson, 1991; Lemke,
1992). This permits a reduction in cell number and consequently affords a considerable 
saving in brain volume dedicated to cell bodies (Lemke, 1992; Staugaitis et a l, 1996). 
The development of a more complex and versatile nervous system may have been the 
driving force behind the transition, in the CNS, from myelination by Schwann cells to 
myelination by oligodendrocytes.
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Figure 1.2 The processes of an oligodendrocyte forming a myelin sheath around an 
axon of the central nervous system. Figure 1.2 A illustrates the characteristic structure of 
myelin as observed microscopically. Figure 1.2 B illustrates the myelination of >1 axon by 
a single oligodendrocyte. Figure 1.2 C illustrates the process of formation of a myelin 
sheath around an axon. Figure adapted from Principles of Neural Science; Kandell, 
Schwartz and Jessell, 1991.
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1.7 Major and minor myelin genes
During their differentiation into myelin producing cells, oligodendrocytes and Schwann 
cells activate expression of a group of myelin specific genes. These genes encode proteins 
that are involved in the mechanics of myelination: induction of myelination, initial contact 
with axons and deposition of the myelin sheath, and the wrapping and compaction of 
myelin about an axon. These proteins, grouped into major and minor sets (refer also to 
Table 1.1) based on their abundance in myelinating cells, have proved relatively straight 
forward targets for molecular cloning. At the time this study was initiated nine of these 
myelin genes had been cloned (Campagnoni, 1988; Lemke, 1988; Mikoshiba et al., 1991; 
Suter etal., 1993; Nave, 1994).
The major component proteins of myelin are listed in Table 1.1 (suffixed by *). These 
include myelin protein zero (PO), peripheral myelin protein 22 (PMP22), proteolipid 
protein (PLP) and myelin basic protein (MBP). PO is exclusively expressed in peripheral 
myelin (Campagnoni, 1988; Lemke, 1988; Lemke, 1992). It is a 30 kD integral membrane 
glycoprotein and accounts for 50% of PNS myelin. PO is is a member of the 
immunoglobulin (Ig) super family (Lemke, 1992) which includes the neural cell adhesion 
molecule (N-CAM). Its extracellular Ig domain appears to function as a homophillic cell 
adhesion molecule and as such promotes the formation of the intraperiod line. PLP is also 
a 30 kD integral membrane protein (Lemke, 1988; Mikoshiba et al., 1991; Lemke, 1992). 
It is the major structural protein of central myelin (Lees and Brostoff, 1984; Mikoshiba et 
al., 1991; Lemke, 1992) accounting for 50% of the protein therein (Lees and Brostoff, 
1984). Another proteolipid protein DM20, which is produced by the same transcriptional 
unit as PLP, demonstrates immunological cross reactivity with the major PLP (Lees and 
Brostoff, 1984). PLP expression is primarily restricted to the oligodendrocytes of the 
CNS. However, it can be detected at low levels in the myelinating Schwann cells of 
higher vertebrates. PLP is believed to be crucial in the compaction and maintenance of the 
intraperiod line of CNS myelin (Duncan et al., 1987; Mikoshiba et al., 1991). It has been 
suggested that PLP may promote the apposition of extracellular surfaces of myelin 
lamellae (Mikoshiba et al., 1991). MBP is actually a family of closely related protein 
isoforms (Lemke, 1992; Staugaitis et al., 1996) and is expressed in both central and 
peripheral myelin. It comprises approximately 30% of protein in central myelin (Omli et 
al., 1982) and 5-15% in the PNS (Lemke, 1992). Unlike P0 and PLP, MBP is not an 
integral membrane protein. It is, in fact, a highly cationic membrane- associated protein 
(Lees and Brostoff, 1984; Mikoshiba et al., 1991) that is believed to interact with the 
negatively charged phospholipids of the cytoplasmic membrane (Mikoshiba et al., 1991).
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MBP is translated on free ribosomes in both oligodendrocytes and Schwann cells 
(Coleman et al., 1982; Griffiths et al., 1989). There are at least four isoforms of MBP in 
rat, and six in the mouse (Lees and Brostoff, 1984; Newman et al., 1987; Nakajima et al.,
1993). They are all translated from mRNAs generated by the alternative splicing of a 
primary transcript from the single Mbp gene. MBP is thought to be involved in the 
maintenance and compaction of the major dense line i.e. the apposition of the cytoplasmic 
surfaces of the membrane (Lees and Brostoff, 1984). PMP22 is a 22 kD glycosylated 
integral membrane protein, which is similar in topology, with four transmembrane (TM) 
domains, to PLP (Suter et al., 1993).
Thus far five minor myelin genes (Table 1.1), encoding the enzyme 2', 3' cyclicnucleotide 
3' phosphodiesterase (CNP), myelin-associated glycoprotein (MAG) Myelin / 
oligodendrocyte glycoprotein (MOG), the fatty acid transport protein (P2) and the 
oligodendrocyte-myelin glycoprotein (OMgp), have been cloned (Lemke, 1992; Suter et 
a l, 1993).
MAG is a heavily glycosylated 100 kD integral membrane protein. It is expressed at low 
levels in both central and peripheral myelin. Like PO, MAG is also a member of the Ig 
super family and related to N-CAM (Salzer et a l,  1987). It mediates adhesion of the 
processes of myelinating cells to their target axons but is finally excluded from compact 
myelin (Salzer et al., 1987; Bartsch, 1996). OMgp is also a large integral membrane 
glycoprotein and has a structure similar to known adhesion molecules (Lemke, 1992). 
CNP catalyses hydrolysis of 2', 3' cyclic nucleotides. Despite being enriched in myelin, 
the role of CNP has not yet been elucidated. P2 is a small (14 kD, Table 1.1) myelin 
specific cytoplasmic protein. It possesses an amino acid sequence that demonstrates 
strong similarity to fatty acid binding and transport proteins (Lemke, 1992). It is thought, 
in some way, to facilitate the exponential increase in the plasma membrane during the 
process of myelination. MOG is a 24-26 kD minor component of CNS myelin. It is 
primarily located on the external surfaces of the peripheral lamellae of CNS myelin 
(Pham-Dinh et al., 1993). Its location on the external membrane surface of compact 
myelin suggest a role for MOG in the latter stages of myelination and maintainance of the 
myelin sheath (Pham-Dinh et al., 1993).
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Myelin protein CNS PNS Molecular 
weight (kD)a
Mouse
chromosome,
mutation
Associated 
neuropathy in 
man
Protein zero* (Po) / >50% 25 1
Pq-A
CMT (Type IB 
and Dejeme 
Sottas)
Proteolipid protein* 
(PLP)
50% < 1% 30
26
X, jimpy 
Pip
CMT (Type 
1A), PMD,XSP
Peripheral myelin 
protein* (PMP-22)
/ ND 22 11, trembler 
Pmp22~/~
HNPP, CMT 
(Type 1A)
Myelin basic protein* 
(MBP)
~ 30% -  10% 14-21
(multiple
forms)
18, shiverer /
Myelin-associated
glycoprotein*(MAG)
1% < 1% 60
64
1
Mag~/~
/
Myelin / 
oligodendrocyte 
glycoprotein* (MOG)
ND ND 24-26 17 /
P2 basic protein* (P2) / variable 14 ND /
2'3'-cyclic nucleotide 
3' phosphdiesterase* 
(CNP)
40% < 1% 48
46
ND /
Oligodendrocyte-
myelin glycoprotein* 
(OMgp)
1% / 46 17 /
Table 1.1 Myelin proteins known prior to the identification of MOBP
aMolecular weights are based on cDNA sequence and do not reflect posttranslational 
modifications such as glycosylation (Po, MAG, OMgp) or phosphorylation (MBP, CNP). 
The major component proteins of myelin are listed above, suffixed by *. The minor 
component proteins of myelin are listed above, suffixed by *.
CMT, Charcot-Marie-Tooth disease; PMD, Pelizaeus-Merzbacher disease; XSP, X-linked
spastic paraplegia; HNPP, hereditary neuropathy with liability to pressure palsies; 
indicates those genes in which null mutations have been generated. ND, No Data (Note 
that this does not indicate that the corresponding protein is absent form the tissue in 
question). MOBP is absent from the PNS but present in the CNS and is estimated to 
comprise up to 20%, of the myelin protein present therein (Montague, pers. comm.)
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1.8 Mutations in myelin genes
Genetic defects of development have provided insight into the possible roles of individual 
genes involved in cellular differentiation and brain function (Nave, 1994). In recent years 
a group of myelin specific proteins, expressed late in glial development, has been 
implicated in a number of mutant phenotypes (Nave, 1994). This has permitted great 
progress to be made in the elucidation of myelin disorders, from mutant gene to the whole 
organism. Most of these phenotypes demonstrate near total dysmyelination (Campagnoni, 
1988; Lemke, 1988; Mikoshiba et al., 1991). Gaps still remain in our understanding of the 
cellular consequences of some mutations within myelin genes. However the availability 
of a range of mutants, demonstrating perturbation of the same systems, now provides us 
with the ability to ask more precise questions. Rodents demonstrating dysmyelination 
exhibit a characteristic behavioural phenotype, a body tremor beginning around the third 
postnatal week (Nave, 1994). It is noteworthy that all spontaneous mutants were 
originally preselected for study on the basis of their phenotypes. Gene targeting is 
providing and will continue to provide novel mutations in the remaining myelin genes, for 
which no phenotype may be predicted. In a recent review Nave (1994) stated that 
estimation of the modulation and compensation of a phenotype required a detailed 
knowledge of all other proteins pertinent to the function of the cell in question.
Mutations in genes encoding myelin components have been shown to underlie a number of 
human inherited neuropathies, including Charcot-Marie-Tooth 1A (PMP22 mutations) and 
IB (Myelin-PO mutations) and Pelizaeus-Merzbacher disease (PLP mutations). Mutations 
in several mouse genes encoding myelin components have been well characterised 
(Mikoshiba et al., 1991), including MBP (shiverer, myelin-deficient), PLP (jimpy, 
rumpshaker) and PMP22 {trembler), which are useful models of human neuropathies. 
The shiverer mouse was the first dysmyelination mutant to be characterised at the 
molecular genetic level (Roach et al., 1985) and remains the best understood. A review of 
known mutations in genes encoding myelin components is given below and is also listed 
in Table 1.1.
1.8.1 Mutations in the Mbp gene encoding myelin basic protein
i
I
Shiverer (shi) and myelin deficient (shi-mld) are autosomal recessive murine mutants 
deficient in the expression of MBP (Mikoshiba et al., 1991). The shi mutation is the result 
of a 20 kb deletion, caused by a genomic recombination event on mouse chromosome 18, 
of a region encompassing exons 3-7 (Roach et al., 1985). It is noteworthy that these exons
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reside within a larger transcriptional unit, golli-Mbp, which does not encode a myelin 
protein (Campagnoni et al, 1993). None of the six MBP isoforms can be synthesised by 
shiverer mice. Consequently, oligodendrocytes fail to assemble compact myelin, resulting 
in hypomyelination of the CNS (Rosenbluth, 1980). The phenotype and myelination of 
shiverer mice can be rescued by the introduction of a transgene (1.3 kb of Mbp promoter 
sequence and a cDNA fragment encoding the 14 kD isoform of MBP; Kimura et al., 
1989).
S h i v e r e r (myelin deficient) is caused by a duplication of the entire Mbp gene and 
inversion of the region between exon 2 and the 3' end of the gene. The absence of MBP is 
a consequence of the formation of an endogenous antisense RNA which prevents
translation of the Mbp RNA (Fremeau and Popko, 1990). The expression of Shiverer 
MBP is described as being mosaic. That is to say that patches of MBP+ myelin sheath still 
form in the CNS. The amount of MBP in each oligodendrocyte varies widley (Akowitz et 
al., 1987). The mechanism of this mosaicism is not yet fully understood (Mikoshiba et al., 
1991).
Both mutants demonstrate the absence of the MDL (Mikoshiba et al., 1991). MBP is 
suggested to play a role in the maintenance of this structure (Campagnoni, 1988; Lemke, 
1988; Mikoshiba et al., 1991; Nave, 1994). The peripheral myelin of shiverer mice is 
morphologically normal (Mikoshiba et al., 1991). It is believed that another myelin 
component e.g. PO, which has a basic intracellular domain, plays a role in compacting 
PNS myelin (Mikoshiba et al., 1991; Nave, 1994). MBP production is rate limiting in 
CNS myelination. This is exemplified by the results of the above mentioned transgene 
complementation study (Kimura et al., 1989), whereby increasing levels of Mbp transcript
in mutant mice (shiverer, shivererm^ )  restores the degree of myelin assembly and 
formation of the MDL. It has been demonstrated that the single 14 kD MBP isoform is 
sufficient to serve most of the function of the entire MBP family of isoforms (Kimura et 
al., 1989). Analyses of shiverer mice have helped to define the function of MBP in 
compact myelin (Mikoshiba etal., 1991; Nave, 1994).
1.8.2 Mutations in the Pip gene encoding proteolipid protein
Pip has proved difficult to define genetically (Nave, 1994). However, a number of allelic 
mutations, allelic with Pip, are now available. Most information gained about Pip function
33
has been provided by the detailed analysis of rodents (Mikoshiba et al., 1991; Nave, 1994). 
The majority of mutations reported in the Pip gene result in a lethal phenotype. These 
alterations span a range of mutation types, from major alterations of the protein structure 
e.g. in jimpy mice (which lack the PLP C-terminal domain), to conservative substitutions
e.g. in the allele jimpymsd  (for myelin synthesis deficient; Ala 242—»Val) (Nave et al.,
1986; Hudson et al., 1987; Gencic and Hudson, 1990).
jimpy mice lack all functional PLP. The Pip RNA of jimpy mice demonstrates a 74 base
deletion (Nave et al., 1986). The deletion event is a consequence of an A—>G transition
event at the 3' splice site of exon 5 (Pip) and a subsequent failure to utilise exon 5 (Pip). 
The resulting protein contains an altered C-terminal as a consequence of the shift in 
reading frame. In jimpy mice the failure of oligodendrocytes to differentiate is followed 
by premature cell death prior to incorporation of the structural protein into myelin 
(Vermeesch et al., 1990; Mikoshiba et al., 1991). Oligodendrocytes which escape cell 
death may still assemble myelin-like structures which demonstrate slightly reduced 
spacing of the IPL. A report by Duncan (1989) suggests that PLP is not required for the 
adhesion of extracellular membranes but instead acts like a spacer or "strut" in the 
intraperiod line (IPL) of compact myelin (Duncan et al., 1989; Yang and Skoff, 1997).
jimpy rumpshaker {jimpy rsh) mice arise as a consequence of a substitution event (lie
186—>Thr). The result is a marked dysmyelination of the CNS, yet oligodendrocytes are
normal. Many rumpshaker oligodendrocytes generate myelin sheaths which demonstrate 
immunoreactivity with PLP antibodies. It has been suggested that mutations in the Pip 
gene can interfere with oligodendrocyte differentiation and without affecting the 
architecture of the myelin sheath (Schneider et al., 1992).
Aberrant folding of PLP results in it being largely retained within the endoplasmic 
reticulum (ER) and consequently unable to reach the cell surface (Roussel et al., 1987). 
Mutations in the gene encoding PLP result in interference with the differentiation of 
oligodendrocytes prior to myelination (Yang and Skoff, 1997). It has also been suggested 
that proliferating oligodendrocyte precursors, carrying mutations in the Pip gene, 
demonstrate an abnormal cell cycle and have an increased cell number (Knapp and Skoff, 
1987). A number of recent studies (Barres et al., 1992; Lachapelle et a l, 1992) have 
indicated that mutant cell death may be restricted to a specific stage of development and 
that extrinsic forces exist that may overide, at least in part, the lethality of Pip mutations
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(Nave, 1994). However, these extrinsic factors remain to be elucidated.
Myelination is very sensitive to alteration in PLP dosage (Readhead et al., 1994; Griffiths 
et al., 1995). Twofold overexpression of the wildtype Pip gene is in itself lethal, causing 
CNS specific dysmyelination (Readhead et al., 1994; Griffiths et al., 1995). It is 
noteworthy that mice with a targeted disruption of the Pip gene demonstrate remarkably 
mild clinical signs. It has also been suggested that the lethal phenotype associated with 
most mutations in Pip is a complex combination of loss-of-function and gain-of-function 
effects (Griffiths et al., 1995). Oligodendrocyte sensitivity to increased dosage of PLP 
underlies the human neuropathy Pelizaeus-Merzbacher disease (PMD). Mutations in the 
Pip gene have also been demonstrated to be associated with the human neuropathy X- 
linked spastic paraplegia (Griffiths et al., 1995).
1.8.3 Mutations in the PO gene encoding myelin protein zero
PO has been implicated in the compaction of peripheral myelin subsequent to analysis of 
mice carrying a targeted disruption of the PO gene (Martini et al., 1995) and as a
consequence of its membership of the Ig superfamily (Lemke, 1988). PO null (P0~^ ~) 
mutants (Giese et al., 1992; Martini et al., 1995b; Zielasek et al., 1996) demonstrate severe 
PNS specific dysmyelination. This mutation type has been associated with the human 
peripheral neuropathy Charcot-Marie-Tooth disease (CMT) type IB and the more severe 
Dejerne Sottas disease (CMT type 3) (Zielasek et al., 1996). Mice that are heterozygous
(P0+/~) for this mutation are much less affected and the resulting pathology also resembles 
the more common peripheral human neuropathy Charcot-Marie-Tooth disease (CMT) type 
IB. Myelin structure is normal in younger individuals and progressive demyelination 
ensues with age (Martini et al., 1995). This suggests that PO may also demonstrate a gene
dosage effect (Zielasek et al., 1996). In P0+^ ~ mice a characteristic and progressive tremor 
and abnormal gait are observable within 2-3 weeks of birth. The failure of Schwann cells 
to form normal myelin sheaths demonstrates a great degree of heterogeneity among 
individual cells (Martini et al., 1995). These glia may fail to initiate wrapping of myelin 
sheaths around axons or the assembled myelin sheath may lack compaction. It is 
noteworthy that PO function has been demonstrated to be developmentally downstream of 
glia neuron recognition; cells carrying this null mutation do still interact with axons and 
segregate in a 1:1 ratio (Martini et al., 1995). Lack of one myelin component can, 
however, have a marked effect on the distribution of other myelin proteins and recognition 
molecules (Martini et al., 1995). In this instance N-CAM and MAG are no longer
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excluded from compact myelin and PLP, which is normally prevented from entering the 
myelin compartment of Schwann cells, is assembled into the the completed myelin 
structure. A recent report has also implicated a point mutation in the PO gene in the 
peripheral human neuropathy Charcot-Marie-Tooth disease (CMT) type IB (Hayasaka et 
al., 1993).
Axonal degeneration has been reported in P0~!~ null mutant mice(Giese et al., 1992) and 
in transgenic mice with an increased gene dosage (Readhead et al., 1994). In neither case 
has the mechanism responsible been elucidated.
1.8.4 Mutations in the Pmp22 gene encoding peripheral myelin protein 22
In the mouse mutants trem bler and trembler-J, the predicted transmembrane (TM) 
domains of PMP22 are disrupted by a non-conservative substitution. This mutation results 
in a marked peripheral dysmyelination (Suter et al., 1993). The cellular mechanisms 
which underlie this lack of myelin have not yet been elucidated (Nave, 1994). However, 
both of these alleles are semidominant, indicating either that mutant PMP22 behaves in a 
dominant negative manner or that one normal copy of the Pmp22 gene is insufficient for 
myelin assembly (Suter et al., 1993).
Pmp22 has been implicated in the human peripheral neuropathy Charcot-Marie-Tooth 
disease (CMT) type 1A and the more severe Dejerne Sottas disease (CMT type 3) (Scherer 
and Chance, 1995; refer also to Section 2, 2.6) and in the hereditary neuropathy with 
liability to pressure palsies (HNPP) (Scherer and Chance, 1995). The dominant disorder 
CMT 1A is associated with point mutations within the Pmp22 gene or duplication of the 
chromosome (17) region encompassing the gene (Suter et al., 1993).
1.9 The Mobp gene encodes a novel major myelin component
As described in Chapter 1, 1.4 a new oligodendrocyte-specific cDNA clone, corresponding 
to the gene now known as Mobp, was isolated in the course of a combined differential 
screening and sequencing programme to discover genes expressed preferentially in 
particular brain regions (Davies et al., 1994; Savioz and Davies, 1995; Stewart et a l, 
1996). Subsequent analysis (Montague et a l, 1997) confirmed that the Mobp gene is 
specifically expressed in oligodendrocytes in concert with the development of myelination 
and that its product represented a new CNS myelin component. While this work was in
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progress, a new oligodendrocyte cDNA was discovered in rat spinal cord (Yamamoto et 
al., 1994), which showed strong sequence similarity (>90%) to the mouse gene Ftg. The 
product of this rat gene was shown to be abundant in CNS myelin, at a level exceeded only 
by PLP and MBP, and was named myelin-associated oligodendrocyte basic protein 
(MOBP; (Yamamoto et al., 1994)). The mouse gene Ftg has subsequently been renamed 
Mobp in accordance with its homologue in rat. MOBP is distributed throughout CNS 
compact myelin. Five isoforms have been identified (Yamamoto et al., 1994; Holz et al., 
1996) which, in the rat, are 69, 71, 81, 99 and 170 amino acids long respectively. These 
small proline-rich basic proteins have features in common with MBP, and like MBP they 
are likely to be located on the inner surface of the cell membrane and to be involved in 
stabilising and compacting the multilayered structure (Yamamoto et al., 1994; Holz et al., 
1996). A more complete introduction to the identification of this gene and previous 
studies associated with it can be found in Section 2,2.1.
1.10 Aims of the studies performed in Section 2
The aim of this study was to genetically map M obp  gene encoding the novel major 
component of CNS myelin (MOBP); to initiate studies in order to examine its structure 
and function and to evaluate its possible role in known neuropathies. In order to satisfy 
the aim of this study I defined a number of interim goals. These include:
• To genetically map the murine gene (Mobp) encoding myelin-associated 
oligodendrocytic basic protein, using the PCR-SSCP based genetic mapping strategy 
established in Section 1.
• To elucidate the complex splicing events required to generate the variety of splice 
variants produced from the Mobp transcript.
• To isolate the murine Mobp gene, encoding myelin-associated oligodendrocytic 
basic protein, and elucidate its genomic organisation.
• To examine the promoter region and identify the transcriptional start points (tsp) of 
the murine Mobp gene
• To establish a platform for studies examining the function of the Mobp gene 
product via the generation of a targeted disruption of Mobp in embryonic stem (ES) cells.
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Chapter 2 Materials and methods
2.1 Bacteriological materials
2.1.1 Bacterial strains
Strain Description Genotype Reference
TG-1 an EcoK" derivative of JM101 
restriction deficient host for 
plasmids
supE, hsdA5, thi, A (lac-proAB)
F' [traD36, proAB+, lacIQ, 
lacZAM15]
(Gibson,
1984)
TG-2 a recombination deficient 
derivative of TG-1
supE, hsdA5, thi, A (lac-proAB)
A (srl-recA) 306:: TnlO (tetr)
F' [traD36, proAB+, lacIQ, 
lacZAM15]
M. Biggin, 
pers. comm.
Q358 A supE host used for growth 
of bacteriophage X vectors
supE, hsdR (f) 80r (Kam et al., 
1980)
INVa F TA cloning® vector for the 
cloning of PCR products
F'endAl, recAl, hsdR17, (rjc 
mk+), supE44, relAl, thi-1, 
gyrA96, (j)80lacZA M15A
(LacZYA-argF) Y169X~
Invitrogen® 
version B 
150626 
25-0024
BNN
132
a derivative of JM107 
containing a lysogen
(recombinant bacteriophage X,
expressing ere recombinase)
( endAl, gyr96,thi, hsdR17,
supE44,relAl, A (lac-proAB) F'
[traD36, proAB+, lacIQ, lacZA 
M15]
(Elledge et 
al., 1991)
Table 2.1 Escherichia coli strain information. Bacterial strains used in this work are 
listed by name, description, genotype and associated reference. Media for bacterial growth 
were prepared as described in Sambrook et al., (1989).
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2 . 1.2 Commercially available, gifted and engineered vectors
Vector / construct Description Reference
p B S  K S +  n Phagemid derived from pUC (Short et al.,
19 1988)
pCR™ 2.1 TA cloning® vector - permits Invitrogen®
the cloning of dA-tailed PCR version B
products 150626
25-0024
pNT Vector backbone for the Skames pers.
generation of gene disruption 
constructs. Contains the 
bacterial neomycin resistance 
and HSV Thymidine Kinase 
genes.
comm.
Large insert vector which (Nehls et
facilitates rapid mapping and 
targeted disruption of 
mammalian genes
a l, 1994)
X2001 A new selective phage Karn et al.,
cloning vector, lambda 2001, 
with sites for Xba I, Bam HI, 
Hin dill, Eco RI, Sst I and 
Xho I
1984
Mobp KO Derived from pNT; a McCallion,
targeting construct designed 
to disrupt the murine gene 
Mobp
unpublished
Table 2.2 Vector and construct information
Vectors and constructs used in this work are listed by name, description and associated 
reference.
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2.2 Commercial sources of chemicals and enzymes
Chemical / Enzyme Source
General chemicals and solvents BDH, ICN
Biochemicals Sigma, Gibco BRL
Agarose MP Boehringer Mannheim
X-ray film Kodak, Dupont
Restriction enzymes Promega
Modifying enzymes Promega
PCR product purification systems Promega
Acrylamides Applied biosystems (ABI)
Table 2.3 Sources of chemicals and enzymes
General chemicals and enzymes utilised in this study are listed with their commercial 
source. Bacterial growth media were purchased from Media preparation, Division of 
Molecular Genetics, Glasgow University. Solutions and protocol specific chemicals and 
enzymes are defined in the text.
2.3 Molecular biological materials
2.3.1 Sources of genomic and cDNA libraries
2.3.1.1 Genomic DNA libraries
Amplified libraries prepared in the bacteriophage vectors ^2001 (-0.8 x 10^ plaque
forming units, pfu) (Warren et al, 1994) and ^PS (-0.4 x 10^ pfu) (Nehls et al., 1994) 
were supplied by Dr Andrew Smith (University of Edinburgh, Scotland).
2.3.1.2 Subtracted cDNA libraries
Details of the construction of the cDNA libraries utilised in this study have been reported 
previously (Savioz and Davies, 1995). The libraries utilised in this study were enriched 
for rare transcripts by subtractive hybridisation, yielding two subtracted libraries. In both 
cases the target cDNA population was single-stranded (sense) DNA derived from the 
cDNA library. In the case of the first subtracted library, designated A (Savioz and 
Davies, 1995), the driver nucleic acid population was single-stranded first strand
(antisense) cDNA derived from mouse cerebellar polyA+ mRNA. The second library,
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designated B, was constructed using antisense RNA synthesised in vitro from a directional 
mouse cerebellar cDNA library as the driver population. Both libraries were stored as 900 
colony grids on 10 cm nutrient agarose plates, overlaid with Whatman 3 MM paper soaked
in 60% Glycerol in SM (Sambrook et al., 1989) at -70°C. The A library consists of 12905
clones and the B library of 17545 clones.
2.3.2 Sources of ribonucleic acids (RNAs)
2.3.2.1 Source of messenger (poly A+) ribonucleic acids (mRNAs)
Messenger RNAs, from the cerebellum of adult male C57BL/6 mice, were kindly supplied 
by Dr T.A.Glencorse and Mrs A.B.Roberts (University of Glasgow).
2.3.3 Source of first strand cDNAs derived from total ribonucleic acids (RNAs)
RNAs, for RT-PCR assays, from the whole brain (postnatal day 4 [P4], P5, P16, P43); 
spinal cord (PI, P5); sciatic nerve (P15); kidney (P15); spleen (P15); testis (P15) and liver 
(PI5) of adult male C57BL/6 mice, were kindly supplied at 2.5 ng/pl by Dr P. Montague 
(University of Glasgow, Scotland).
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2.4 Methods
2.4.1 Basic molecular biological techniques
The following standard molecular biological techniques were performed as described by 
Sambrook et al. (1989): bacterial growth, isolation of genomic, bacteriophage and 
plasmid DNAs, DNA purification (i.e. phenol extraction, ethanol precipitation etc.), 
restriction enzyme digestion, agarose / polyacrylamide gel electrophoresis and the transfer 
of nucleic acids to nylon membranes via Southern blotting. Details of the above 
procedures, specific to this study, are outlined below.
2.5 Bacterial growth
2.5.1 Growth of bacterial host for bacteriophage lambda
Overnight cultures of E. coli strain Q358 (Kam et a l , 1980) were established in NZCYM 
liquid medium. Maltose was present in the medium at a final concentration of 20% 
weight/volume (w/v).
2.5.2 Growth of bacteria used in molecular cloning strategies
Overnight cultures of E. coli strain BNN 132 (Elledge et al., 1991) were established in LB 
liquid medium. Overnight cultures of E. coli strains TG-1 (Gibson, 1984) and TG-2
(Biggin, pers. comm.) were established in 2 x YT liquid medium.
2.6 Propagation of automatically subcloned plasmids from bacteriophage ^PS
2.6.1 Ctq-IoxP automatic subcloning
10 ml of fresh overnight culture of BNN 132 were centrifuged at 5,000 rpm (JA-20 rotor, 
Beckman J2-21 centrifuge) for 10 minutes, the supernatant aspirated and the pellet 
resuspended gently in 6 ml of 10 mM MgS04. 300 jul aliquots were removed and 
combined with 100 \l\ of each high titre bacteriophage stock (AS; 50, 51, 53, 55, 57, 58 
and 59) in clean 1.5 ml centrifuge tubes. These were incubated at 30°C for one hour 
without agitation. 1 ml of LB was then added to each and the tubes incubated with 
agitation at 30°C for one hour. 200 - 400 |iil of cells from each tube were then spread on 
90 mm LB plates with ampicillin at 50 |ig/ml, 0.1% glucose and incubated overnight at
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37°C. Ampicillin resistant colonies were scraped from these plates into 1.5 ml of LB for 
small scale isolation of plasmid DNA by alkaline lysis and PEG precipitation (Chapter 2, 
2 .8 .2).
2.7 DNA purification
2.7.1 Phenol extraction
Phenol (TE saturated: 10 mM Tris, 1 mM EDTA) was added to each tube in a ratio of 1:1 
(v/v) and mixed vigorously by rapid inversion. The tubes were centrifuged (Heraeus, 
Biofuge; unless otherwise stated) at 15,000 rpm for two minutes and the aqueous phase 
removed to a clean tube.
2.7.2 Chloroform extraction
Chloroform:isoamyl alcohol (24:1) was added to each tube in a ratio of 1:1 (v/v), mixed by 
inversion and then centrifuged at 15,000 rpm for two minutes The upper phase was then 
removed to a clean tube.
2.7.3 Ethanol and Isopropanol precipitation
To each tube 0.1 volumes of 3 M sodium acetate and either 2.5 volumes of ethanol or an 
equal volume of isopropanol were added. The tubes were then mixed by inversion and 
placed on ice for 10 - 120 minutes (protocol dependent) and centrifuged at 15,000 rpm for 
10 -30  minutes (protocol dependent).
2.8 Isolation and purification of nucleic acids
2.8.1 Isolation of bacteriophage lambda DNA
2.8.1.1 Small scale isolation of bacteriophage lambda DNA
Liquid lysates were prepared as described in Chapter 2 (2.13.2). 1.5 ml of lysate was 
added to a 2 ml centrifuge tube. Each lysate was centrifuged at 15,000 rpm for 5 minutes 
and the supernatant removed to a clean tube. 3 |il of DNase (20 mg/ml) and 3 |il RNase 
(20 mg/ml) were added to each tube. The tubes were mixed by inversion and incubated at 
room temperature for 30 minutes. To each tube 375 jllI of PEG solution (26% PEG, 2.6 M 
NaCl ) was added, to aid the precipitation of phage particles. The tubes were mixed by 
inversion, placed on ice for one hour and then centrifuged at 15,000 rpm for 5 minutes.
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The supernatant was aspirated and the remaining pellet resuspended in 200 pi of TE 10,10 
(10 mM Tris pH8, 10 mM EDTA). The tubes were maintained on ice throughout. 50 pi 
of phenol (TE saturated) were added to each and mixed vigorously. The tubes were 
centrifuged at 15,000 rpm for three minutes and 180 pi of each supernatant removed to a 
clean tube. To each tube 20 pi of 3 M sodium acetate and 200 pi of isopropanol were 
added, mixed by inversion and placed at 4°C for 2 hours. The tubes were centrifuged at
15,000 rpm for 15 minutes and the supernatant aspirated. 500 pi of ethanol (70%) was 
added to each tube. The tubes were centrifuged at 15,000 rpm for 2 minutes and the 
supernatant aspirated completely. The pellet was air dried for approximately 10 minutes 
and resuspended in 20 - 40 pi of TE (Tris 10 mM, EDTA 1 mM).
2.8.1.2 Large scale isolation of bacteriophage lambda DNA
Liquid lysates were prepared as described in Chapter 2 (2.13.2). 25 ml of lysate were 
added to a 50 ml polypropylene centrifuge tube. Each lysate was centrifuged at 8,000 rpm 
for 5 minutes (JA-20 rotor, Beckman J2-21) and the supernatant removed to a clean tube. 
25 pi of DNase (20 mg/ml) and 3 pi RNase (20 mg/ml) were added to each tube. The 
tubes were mixed by inversion and incubated at room temperature for 30 minutes. To each 
tube 5 ml of PEG solution (26% PEG, 2.6M N aC l) was added; to aid the precipitation of 
phage particles. The tubes were mixed by inversion and placed on ice for one hour and 
then centrifuged at 15,000 rpm for 20 minutes (JA-20 rotor, Beckman J2-21). The 
supernatant was aspirated and the remaining pellet resuspended in 1.5 ml of phage buffer 
and transferred to a 2 ml centrifuge tube. 375 pi of PEG were added to each tube and the 
tubes mixed by inversion and placed on ice for 30 minutes. The tubes were then 
centrifuged at 15,000 rpm for 10 minutes and supernatant was aspirated completely. The 
remaining pellets were resuspended in 600 pi of TE 10,10 (10 mM Tris pH8, 10 mM 
EDTA). The tubes were maintained on ice. 600 pi of phenol (TE saturated) were added to 
each tube and mixed vigorously. The tubes were centrifuged at 15,000 rpm for three 
minutes and the aqueous phase removed to a clean tube. This phenol extraction was 
repeated a further two times and the aqueous phase once more removed to a clean tube. 
To each tube 60 pi of 3M sodium acetate and 600 pi of isopropanol were added, mixed by 
inversion and placed on ice for 2 hours. The tubes were centrifuged at 15,000 rpm for 15 
minutes and the supernatant aspirated. 500 pi of ethanol (70%) was added to each tube. 
The tubes were centrifuged at 15,000 rpm for 2 minutes and the supernatant aspirated. 
The pellet was air dried for approximately 10 minutes and resuspended in 200 pi of TE (10 
mM Tris, 1 mM EDTA ).
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2.8.2 Small scale isolation of plasmid DNA via alkaline lysis and PEG
precipitation
1.5 ml of fresh overnight culture were placed in a 1.5 ml centrifuge tube and centrifuged at
15,000 rpm for 5 minutes. The supernatants were aspirated and the pellets resuspended in 
200 pi of GET solution (50 mM glucose, 10 mM EDTA pH 8, 25 mM Tris pH 8). 300 pi 
of 200 mM NaOH / 1% SDS (freshly made) were added to each tube and mixed by gentle 
inversion. The solutions were then neutralised by the addition of 300 pi 3M potassium 
acetate and mixed by inversion. The samples were centrifuged at 15,000 rpm for 10 
minutes and the supernatant removed to a clean tube. 2 pi of RNase (20 mg/ml) were 
added to each tube, mixed by inversion and incubated at room temperature for 30 minutes. 
400 pi of chloroform:isoamyl alcohol (24:1) were added to each tube, mixed by inversion 
and then centrifuged at 15,000 rpm for 2 minutes and the upper phase removed to a clean 
tube. This chloroform extraction was repeated and the upper phase once more removed to 
a clean tube. To each tube an equal volume of isopropanol was added, mixed by inversion 
and centrifuged at 15,000 rpm for 10 minutes. The supernatant was aspirated and 500 pi 
of ethanol (70%) were added to each pellet. The tubes were centrifuged at 15,000 rpm for 
2 minutes and the supernatant aspirated completely. The pellets were resuspended in 32 pi 
of sterile water. 42 pi of 13% PEG were then added to each tube, mixed by flicking and 
placed on ice for 20 minutes. The tubes were then centrifuged at 15,000 rpm (4°C) for 20 
minutes and supernatants were aspirated off. 500 pi of ethanol (70%) were added to each 
pellet. The tubes were centrifuged at 15,000 rpm for 2 minutes and the supernatant 
aspirated completely. The pellets were air dried for approximately 10 minutes and 
resuspended in 20 pi of TE (Tris 10 mM, EDTA 1 mM) or sterile water.
2.8.3 Large scale isolation of plasmid DNA for transfection into CGR 8.8
embryonic stem cells
Large scale isolation of Mobp KO DNA from the TG-2 bacterial host was performed using 
the Qiagen Midi prep kit in accordance with the manufacturers instructions.
2.8.4 Isolation of DNA from CGR 8.8 cultured embryonic stem cells
1.5 ml centrifuge tubes containing 0.6 ml of freezing media (refer also to Chapter 2, 2.26), 
with CGR 8.8 embryonic stem (ES) cells were centrifuged at 15,000 rpm for 1 minutes 
and the supernatant aspirated completely. To the cell pellets, 340 pi of reagent B (400 
mM Tris pH 8, 60 mM EDTA, 150 mM NaCl and 1% SDS) were added and the pellet 
resuspended by flicking. 100 pi of 3 M sodium perchlorate were added and the samples
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mixed by vigorous inversion. The tubes were then placed at 65°C for 10 minutes and 
mixed by occasional inversion. 580 |Lil of chloroform:isoamyl alcohol (24:1) were added 
to each tube, mixed by vigorous inversion and the tubes were placed at room temperature 
for 20 minutes. The samples were centrifuged at 15,000 rpm for 5 minutes and 400 j l l I ,  of 
the upper phase, removed to clean tubes. To these, 800 pi of ethanol were added and the 
tubes mixed by inversion. Samples were placed at room temperature for 2 minutes and 
centrifuged at 15,000 rpm for 5 minutes. The supernatants were aspirated and 1 ml of 
ethanol (80%) was added to each pellet. The tubes were centrifuged at 15,000 rpm for 5 
minutes and the supernatant aspirated completely. The pellets were air dried and 
subsequently resuspended in 60 pi of TE (Tris 10 mM, EDTA 1 mM).
2.8.5 Gel extraction of nucleic acids for cloning strategies
Restriction fragments were separated on agarose gels as described in Chapter 2 (2.14) and 
the appropriate DNA fragment isolated using the Qiaex II gel extraction kit in exact 
accordance with the manufacturers instructions.
2.9 Isolation of total RNA from mouse brain
2.9.1 Small scale isolation of RNA from mouse cerebellum
All glassware, pipette tips and tubes were treated by immersion in a 0.1% solution of 
diethyl-pyrocarbonate (DEPC), for at least 16 hours prior to autoclave sterilisation in 
order to prevent contamination with RNase. All reagents were prepared using DEPC 
treated H2 O (DEPC-H2 O). 20-100 mg of tissue from the cerebellum of mouse brain 
(C57BL/6, adult males) was placed in a 1.5 ml centrifuge tube containing 1 ml of Tri- 
reagent™ (Sigma). The tissue was homogenised by vigorous pipetting. The centrifuge 
tubes were placed at room temperature for 5 minutes. 0.2 ml of chloroform:isoamyl 
alcohol (24:1) was added to each tube, mixed by vigorous inversion and then placed at 
room temperature for 10 minutes. The tubes were then centrifuged at 12,000 g (4°C) for 
15 minutes. The upper phase from each tube was removed to a clean tube. To each tube 
500 pi of isopropanol were added, mixed by inversion and then placed at room 
temperature for 10 minutes. The tubes were then centrifuged at 12,000 g (4°C) for 15 
minutes and supernatants were aspirated off. The pellets were washed with cold (4°C) 
75% ethanol and then centrifuged at 9,000 g (4°C) for 5 minutes. The supernatants were 
aspirated off and the pellets were resuspended in 20 pi of DEPC-H2 O.
46
2.9.2 Large scale isolation of RNA from mouse cerebellum
0.55 g of cerebellar tissue was placed in a sterile 50 ml polypropylene centrifuge tube and 
5 ml of Tri-reagent™ (Sigma). The tissue was homogenised using a Polytron™ 
homogeniser. The centrifuge tubes were placed at room temperature for 5 minutes. 1 ml 
of chloroform:isoamyl alcohol (24:1) was added to each tube, mixed by vigorous inversion 
and then placed at room temperature for 15 minutes. The tubes were then centrifuged at
10,000 rpm (JA-20 rotor, Beckman J2-21) at 4°C for 15 minutes. The upper phase from 
each tube was removed to a clean tube. To each tube 2.5 ml of isopropanol were added, 
mixed by inversion and then placed at room temperature for 10 minutes. The tubes were 
then centrifuged at 10,000 rpm (JA-20 rotor, Beckman J2-21) at 4°C for 5 minutes and 
supernatants were aspirated off. The pellets were resuspended in 1 ml off 75% ethanol and 
stored at -70°C.
2.10 Synthesis of first strand cDNA
2.10.1 Synthesis of first strand cDNA for the RT-PCR assay
Reactions were set up in 20 pi volumes and contained: 50% v/v RNA, 40U RNasin, 1 x 
reverse transcription buffer (Promega), 0.1 mg/ml BSA, 200 pM dNTPs, 50 pM {(dT)23- 
dC/dG/dA} and 10 U AMV reverse transcriptase. The reactions were placed at 42°C for 
one hour and subsequently placed at 95°C for 5 minutes in order to heat inactivate the 
enzyme. Subsequently, PCRs were set up as described in Chapter 2 (2.17) in 10-25 |Lil 
volumes and using 0.5-10 jxl of template, dependent upon the efficiency of the RNA 
isolation.
2.10.2 Synthesis of first strand cDNA for the oligo-capping procedure
Reactions were set up in 20 pi volumes and contained: 20% v/v RNA (section 2.25), 40
U RNasin, 1 x Superscript™ II reaction buffer (Gibco BRL), 0.1 mg/ml BSA, 1 mM pM
dNTPs, 50 pM (random hexamers, Gibco BRL) and 200 U Superscript™ II (Gibco BRL). 
The reactions were placed at 23 °C for 10 minutes, 42°C for 45 minutes and then placed at 
95°C for 10 minutes. Subsequently, PCRs were set up as described in Chapter 2 (2.17) in 
10-25 pi volumes using 2 pi of template.
47
2.11 Ligation of nucleic acids
2.11.1 Ligation of plasmid vector and insert DNA
Plasmid (vector) and insert DNAs were prepared as described in Chapter 2 (2.8.2) and 
Chapter 2 (2.8.5) respectively. Typically, 20 - 200 ng of vector and insert DNAs were 
used for ligation. Vector and insert DNA concentrations were estimated by agarose gel 
electrophoresis, along with molecular weight standards of known concentration. A 1:3 
molar ratio of vector:insert DNAs was utilised throughout. Using this vectoninsert ratio, 
10 pi reactions were set up in the presence of the following: T4 DNA ligase 1 U (Weiss
units) and 1 x ligase buffer (final concentration).
2.11.2 Ligation of PCR products using cloning vector pCR™ 2.1
PCR products were cloned using the TA cloning® kit (Invitrogen® version B 150626 25- 
0024) in exact accordance with manufacturers instructions, and DNA sequence determined 
as described in Chapter 2 (2.15) utilising sequencing primers M13/pUC forward and 
reverse (Table 2.3).
2.12 Transformation of DNAs into bacteria
2.12.1 Transformation of XPS derived plasmid DNAs into bacterial cells
1 ml of a fresh overnight culture of TG-2 was added to 100 ml of 2 x YT and incubated 
with agitation for 2 - 3 hours (or until OD600 nm = 0-4 - 0.6). The cultures were then 
added to 40 ml polypropylene centrifuge tubes and centrifuged at 3,000 rpm for 5 minutes. 
The supernatant was then aspirated, the pellet resuspended in 25 ml of chilled (4°C) 50mM 
CaCl2 and the tubes placed on ice for 20 minutes. The tubes were then centrifuged at
3,000 rpm for 5 minutes, the supernatant aspirated and the pellet resuspended in 5 ml of 
chilled (4°C) 50 mM CaCl2- 100 jllI of cell suspension was added to approximately 50 ng 
of each plasmid DNA. The tubes were incubated on ice for 30 minutes, placed at 42°C for
2 minutes and placed on ice. 1 ml of 2 x YT was added to each tube and incubated at 37°C
for 30 minutes. 100-400 |il of cells were then plated on 90 mm LB plates with ampicillin 
at 50 |Lig/ml and incubated overnight at 37°C.
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2.12.2 Transformation of plasmid DNA into bacterial cells
100 pi of a fresh overnight culture of TG-1 or TG-2 was added to 10 ml of 2 x YT and 
incubated with agitation for 2 - 3 hours (or until OD600 nm = 0-4 - 0.6). The cultures were 
then added to 40 ml polypropylene centrifuge tubes and centrifuged at 2,000 rpm for 5 
minutes. The supernatant was then aspirated, the pellet resuspended in 1 ml of chilled 
(4°C) transformation buffer (10 mM MES buffer pH 6.5, 100 mM rubidium chloride, 45 
mM manganese chloride, 10 mM calcium chloride and 3 mM hexaminecobaltic chloride) 
and the tubes placed on ice for 15 minutes. The tubes were maintained on ice. 34 pi of N- 
N dimethyl formamide were then added, mixed by gentle inversion and placed on ice for 5 
minutes. 34 pi of 5% v/v B-mercaptoethanol were then added, mixed by gentle inversion 
and placed on ice for 10 minutes. 34 pi of dimethyl formamide were then added, mixed by 
gentle inversion and placed on ice for 5 minutes. 100-200 pi of cell suspension was added 
to approximately 5-50 ng of each plasmid DNA. The tubes were incubated on ice for 30
minutes, placed at 42°C for 2 minutes and placed back on ice. 1 ml of 2 x YT was added
to each tube and incubated at 37°C for 30 minutes. 100-400 pi of cells were then plated on 
90 mm LB plates with ampicillin at 50 pg/ml and incubated overnight at 37°C.
2.13 Preparation of bacterial cell lysates
2.13.1 Preparation of bacterial cell lysates on solid media
A fresh overnight culture was added to melted NZCYM top agar (< 50°C) to provide a 
final concentration of 75 pl/ml v/v, agitated to mix and poured onto culture plates 
containing NZCYM bottom agar. These plates were allowed to cool to room temperature 
and set. A single plaque forming unit (pfu) of the desired bacteriophage was excised from 
top agar, streaked gently across the plate and incubated overnight at 37 °C
2.13.2 Preparation of bacterial cell lysates in liquid media
2.13.2.1 Lysates for small scale isolation of bacteriophage lambda DNA
200 pi of overnight culture were diluted in 33 ml of phage buffer. To each 20 ml universal
glass bottle, 2 ml of diluted cells were added. Approximately 1 cm^ of top agar from each 
zone of clearing was added to each bottle. These were incubated for 30 minutes at room 
temperature. 8 ml of NZCYM liquid medium were then added to each bottle and the 
bottles incubated in shaking incubator at 37°C, until lysis occurred (six to seven hours).
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2.13.2.2 Lysates for large scale isolation of bacteriophage lambda DNA
300 jxl of overnight culture were diluted in 50 ml of phage buffer. To each 200 ml conical
flask, 10 ml of diluted cells were added. Approximately 2 cm^ of top agar from each 
zone of clearing was added to each bottle. These were incubated for 30 minutes at room 
temperature. 40 ml of NZCYM liquid medium were then added to each bottle and the 
bottles incubated in shaking incubator at 37°C, until lysis occurred (six to seven hours).
2.14 Electrophoresis
2.14.1 Agarose gel electrophoresis
Agarose gels of differing concentrations (0.5-2% w/v) were prepared in 1 x TBE, using
multi purpose agarose MP (Boehringer Mannheim) and incorporated ethidium bromide at 
4 |Lig/ml. Electrophoresis was performed at 50-100 volts for 1-3 hours at room 
temperature. DNA was visualised under ultra violet ligh t.
2.14.2 Acrylamide gel electrophoresis and autoradiography
6% (w/v) acrylamide (19:1 acrylamide:bis-acrylamide; Anachem, supplied at 40%) / 10% 
glycerol non-denaturing gels (Gel: 20 x 56 x 0.04 cm, 0.5 cm lane width) were prepared in
0.5 or 1 x TBE. Electrophoresis was performed at 30 watts, 1500 volts for 5-6 hours at
4°C. In the cases of ESTs W33210, W36179 and W35449; 37.5:1 acrylamide:bis-
acrylamide 6% gels were used. Denaturing gels (Gel: 20 x 56 x 0.04 cm, 0.5 cm lane
width), at a final concentration of 6% (w/v) acrylamide (19:1 acrylamide:bis-acrylamide),
7 M urea were prepared in 1 x TBE. Electrophoresis was performed at 50 watts, 2500
volts for 1-2 hours at room temperature. All acrylamide gels were subsequently dried on 3 
MM Whatman paper and X-ray film (Fuji XR) exposed for 3 hours to overnight at -70°C, 
with intensifying screens.
I
! 2.15 Generation of sequence data
2.15.1 Generation of ESTs and sequencing of cloned Mobp gene fragments
Details of the sequencing procedure utilised in this study have been reported previously
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(Stewart et al., 1997). Briefly, single-pass cDNA sequences were obtained using an ABI 
373 Stretch automatic sequencer. Dye-terminator cycle sequencing with Taq polymerase 
was utilised throughout. Double-stranded plasmid DNA was prepared from 3 ml
overnight cultures, grown in Terrific broth supplemented with 100 mg m l'l ampicillin. 
DNA was purified by either alkaline lysis followed by PEG precipitation (Perkin Elmer 
user bulletin 18) or with AGTC centriflex™ miniprep kits (Advanced Genetic 
Technologies Corporation). Typically, 1/20 of the miniprep DNA was analysed on an
0.8% agarose gel and 250 ng - 1 pg of DNA was used in each sequencing reaction. Clones
were selected for sequencing on the basis of an Mlu I digest. Mlu I releases the entire 
insert from pSPORT (D'Allessio et al., 1990). Fragments were separated by 
electrophoresis in 0.8% ordinary agarose gels as described (Section 2.14; chapter 2). 
Empty clones and those containing non-pSPORT derived plasmid fragments were rejected 
(5% approx.).
The cycle sequencing protocol was exactly as described in the ABI handbook, protocol 
P/N 402078 revision A, August 1995. The main primer used, in the generation of ESTs,
was an extended version of the standard T7/T3a sequencing primer, (Table 2.3).
Oligonucleotide primers utilised in the sequencing of the murine gene M o bp and 
associated intron/exon boundaries are defined in Table 2.3. Oligonucleotide primers were 
used at 3.2 pmol/20 pi reaction. Up to 650 bp of sequence was obtained, per sequencing 
reaction, using the methods above.
Oligonucleotide
identification
Oligonucleotide sequence 5'-3' Orientation
(sense/antisense)
ASM 101 ATG AGT CAA AGT GGC AAA G antisense
ASM 102 AGA TAA TAA GGT TCT ATT CAC sense
ASM 103 CAC AGG AGC CCT GAA TGG sense
ASM 104 AGG ACT GIG TGA ATC AGG CIC sense
ASM 105 GAA GGA GGA GCA GGT CAA CC sense
ASM 106 AGG TGA GGA GOG AGC TCT TC sense
ASM 107 AAC TGT AGG TAA CIT GIG TC sense
ASM 108 TAT GIC TGT GGC AAG GAG AGG sense
ASM 109 CAT CIC TAC ACT TGC TGT GG sense
ASM 110 AAA GCA CAC AGA TAT GGC CAC antisense
ASM 111 ATC TTC TAC CAT AGT CAC AG antisense
ASM 112 TAG GAT GCA CCC ATC CIC G antisense
ASM 113 CAC TTC ATA CAT CCA CAT G sense
ASM 114* ATT AAG CAA AGC ATT GGA GOG antisense
ASM 115 GCC GAA GAG GCA TCT CIG TGC sense
ASM 116 ATC TGG AAA AAC AGA AGC CAC G antisense
ASM 117 TGA AGC CIC AGG TTC CCA CG antisense
ASM 118 ACT ACA CAG ATC TAC CIC CG antisense
ASM 119 CAA AGA GIG ACT GAG AGA AGG antisense
ASM 120 GCT CAC TTA AAC CIT TCT GOG sense
ASM 121 TGA GAG CGC CGC CAG OCA AGC sense
ASM 122* GAC CIC OCT GIC CIA CAT GG sense
ASM 123 CIC CIG TOT TOC CIT GIC TGG sense
ASM 124 CIG TAC TGG GGA GAG GAA sense
ASM 125 CAC CAT GGC GIC CIC ACA GCC sense
ASM 126 TIT GGT TCA GIT TTA TGT CC sense
ASM 127 CAT AGG AAA GCT AAG OGA TGC sense
ASM 128 TGT GIG AAT CAG GCT CAG GC sense
ASM 129 AAA TCA ACA TAT CAG IT T TGC sense
ASM 130 ACA GCT ATG ACC ATG ATT ACG CC universal
ASM 131 TGT AAA AGG ACG GCC AGT universal
ASM 132 AGC GGA TAA CAA T IT CAC ACA GGA universal
ASM 133 AAC ATC AGT CAA GCC CIG AGC antisense
ASM 134 TAG CIC TGC AAT CAC CIT TGC antisense
ASM 135 CAA AGC CCT GIG TGA GGC TGG antisense
ASM
ASM
ASM
ASM
136
137
138
139
CAT CAC ACG CGC ACG OGT ACG antisense
ASM 141 CAG TAA ATG CAG TAT GAC G antisense
ASM
ASM
149
150
ATT TTA TTA CIT GIG ACA AGG antisense
Table 2.4
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Oligonucleotide Oligonucleotide sequence 5'-3' Orientation
identification__________________________________________ (sense/antisense)
ASM 151 CCT CAT AAT TTA TAG GAC CC antisense
ASM 152 ATC ACC TCT GIG GIG AAG TGT CC antisense
ASM 153 ACA GAT GIG CGC AGG GIT GC antisense
ASM 154 TGC TGG GAA CIG AAC TCA GG antisense
ASM 155 GCT CCC ACA CCA TGG GGA CIG antisense
ASM 156
ASM 157
ASM 158
ASM 159
ASM 160 AAT GIT ATA AAC TGC CAT CGG antisense
ASM 161 ATA ACC AAT ACA GGA CIG TGG antisense
ASM
ASM 201 PCR CCA GGC TCT CCA AGA ACC sense
ASM 201 PCR TCA GQC TIG GAG TIG AGG antisense
ASM 202 CAG TGG ATG CIG AAG TGC antisense
ASM 203 TAG TCT TCT GGC AGG CAC AGC antisense
ASM 204 AGC AAC CGC TCT TGC AGA TGC antisense
ASM 215 F TOC TGA GIG CIC GTT TGT CIC C sense
ASM 215 R CCC ATC AGC TTC AAG CAA TCT C antisense
ASM 221 ATC TCT TGC CIT TIG TOC sense
ASM 24 antisense
ASM 241 ATC CTA AGA TIG CIT CIC GC antisense
ASM B667F TCT TGT ACA GAA ATG GAA TIG GC
ASM B667R TCA AGC TAC CAC GCA TGG
r-oligo GGA
7V
UOC UAA ACA AUU AAC ecu CAA sense
TAG 135
A
GAG ACG GAT CCT AAA CAA TTA ACC antisense
CCT AAA
MMSV-1F PCR ATG AGT CAA AAA GIG GCC AAG GAG sense
MMSV-1R ACA ATT TCT AGT GIC T IT GIG TTC antisense
PCR TOC!
FTG-1F TOC TGA GIG CIC GIT TGT CIC C sense
FTG-1R CCC ATC AGC TTC AAG CAA TCT C antisense
T7/T3a ACA GCT ATG ACC ATG ATT AGC C universal
Table 2.4 Oligonucleotides utilised in the study of the murine Mobp gene reported 
Section 2
2.16 Sources of DNA samples utilised in genetic mapping studies
Mouse DNAs for the chromosomal allocation experiments were from one of three panels 
of animals (N2, N4, N6/7). These panels derived from a breeding programme to generate a 
set of consomic lines with one Mus spretus (SEG/Pas) chromosome each on a C57BL/6 
background (J-L Guenet, pers. comm.; refer also to Section 1, 1.1). N2, N4 and N6/N7 
correspond to DNAs obtained from the first, the third and the sixth combined with the 
seventh backcross generations respectively. Each generation has been typed for four to six 
anchor loci per chromosome. The composition of each panel is as follows: DNAs from 
N6/7, 11 DNAs containing one complete M.spretus (SEG/Pas) chromosome on a C57BL/6 
background; N4, 19 DNAs, containing well documented fragments of M.spretus 
(SEG/Pas) chromosomes on a C57BL/6 background; N2, 19 DNAs selected from the 
primary backcross generation. For ESTs shown to be located in that small part of the 
genome not covered by M.spretus DNA in the N4 generation set (chromosome 7 [chr 7], 
15-51 cM; chr 8, 4.6-35 cM; chr 9, 31 cM-telomere; chr 10, 46-64 cM; chr 11, 2-37 cM 
and chr X, centromere-3 cM), chromosomal allocation was finalised using DNAs of 
animals from the N2 backcross generation. Subset panels of DNAs from the European 
Collaborative Interspecific Backcross (EUCIB) were used to localise each EST. All 
DNAs were stored at 20 ng/pl.
2.17 Design of PCR primer pairs and PCR conditions
2.17.1 Polymerase chain reactions used in the mapping of genes expressed in the
mouse ventral midbrain
Fragments ranging in size from 150 to 300 bp were generated by PCR amplification of 
sequence within the putative 3'UTR of ESTs, using primers listed in table 1.3.1 (section 1). 
Primers were designed with the aid of Gene Jockey II (Biosoft, Cambridge) and 
synthesised by Cruachem Ltd and Life Sciences, Gibco BRL. For the PCR, primers were
at a final concentration of 0.5 pmol/pl, with 20 mM deoxyribonucleotides, 2 ng/pl DNA
!
I (mouse genomic) template, 1 mM Mg^+, 1 x buffer (Mg^+ free) supplied with Taq
i
polymerase (Promega), 5% deionised formamide, 1 mCi a32p dCTP, and 0.2 units of Taq 
polymerase in a final volume of 10 p i  Samples were overlaid with oil (Sigma^m) and 
amplified in a Perkin Elmer Cetus MK1 thermocycler. After initial denaturation (94 °C for 
2 min), 25-30 (Table 1.3.1) cycles were performed (denaturation 94°C for 15 sec;
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annealing 52-58°C (Table 1.3.1) for 30 sec; extension 72°C for 30 sec), followed by a final
elongation step of 2 minutes at 72°C. PCR reactions with each primer pair that did not 
involve incorporation of a radioactive deoxyribonucleotide (dNTP) utilised dNTPs at a 
final concentration of 500 pM.
2.17.2 Polymerase chain reaction used in the mapping of Mobp
A 205 bp fragment was generated by PCR amplification of sequence within the 3'UTR of a 
cDNA fragment of the mouse Mobp gene, using primers ASM 215 forward and ASM 215 
reverse (Table 2.3). PCR cycling conditions for primer pair ASM 215 forward and reverse 
are defined in Table 2.4.
2.17.3 Polymerase chain reaction used in the oligo-capping procedure
PCR conditions were as follows: gene specific oligonucleotides [Experiment OC I; ASM 
201 and 202 and Experiment OC II; ASM 203 and 204] utilised in the experiment are
defined in Table 2.4 and were at a final concentration of 0.5 pmol/jiil, with 500 |iM 
deoxyribonucleotides, 1 mM Mg^+, 1 x buffer (Mg^+ free) supplied with Taq polymerase
(Promega) and 0.2 units of Taq polymerase in a final volume of 10 jul. After initial
denaturation (94°C for 2 min), 25 cycles were performed (denaturation 94°C for 15 sec; 
annealing 60°C for 30 sec; extension 72°C for 30 sec), followed by a final elongation step 
of 5 minutes at 72°C. Experiments OC I and OC II are defined in Section 2 (subsection 
2 .6).
2.18 Single-strand conformational polymorphism assay
The SSCP assay was performed based on the procedure of Orita et al. (1989), with 
significant alterations. All PCRs for SSCP assays involved the incorporation of a
radioactive deoxyribonucleotide (ocP^dCTP) and were performed as described in section
2.17 and table 2.3 A 2 pi aliquot of a PCR reaction was diluted with 30 jxl of 0.1% SDS, 
10 mM EDTA. 2 jllI  of diluted PCR reaction was then added to 2 |xl formamide loading 
buffer, heat denatured (90°C, 2 min) and 2 |il loaded onto a 6% acrylamide (19:1 
acrylamide:bis-acrylamide) / 10% glycerol non-denaturing gel (Gel: 20 x 56 x 0.04 cm,
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0.5 cm lane width) in 0.5 x TBE. Electrophoresis was performed as described in Chapter 
2 (2.14).
2.19 Software used for data analysis
The sequence data was edited using Sequence Editor (version 1.0.3, ABI) and analysed 
using Gene Jockey II (Biosoft, Cambridge). Sequence comparisons were performed 
against all entries in the Genbank databases (performed January 5th-Sept 1st 1997) using 
the NIH BLAST facility (Altschul et al, 1990) and the EMBL BLITZ facility (protein 
searches; Sturrock and Collins 1992). Comparisons of the sequences translated in all six 
reading frames were performed using the TBLASTX program. Sequence analysis and 
primer design was performed with the aid of Gene Jockey II (Biosoft, Cambridge). 
Linkage analyses for chromosomal allocation with the N2 consomic generation was 
performed using Genelink software (Montagutelli, 1988). Backcross panel subsets were 
selected using the Mbx database for the European Collaborative Interspecific Backcross 
(EUCIB).
2.20 Radioactive labelling of DNA
2.20.1 Oligonucleotide probes
Synthetic oligonucleotides (oligos) of 18-23 nucleotides in length were radioactively 
labelled by the addition of a y-32p rATP molecule to their 5'-hydroxyl termini. 
Phosphorylation reactions were set up in 10 pi volumes comprising: 5.5 pmol of
oligonucleotide, 1 (il y -^A T P  (3,000 Ci/mmol, 10 mCi/ml), 10 U (Weiss units)
polynucleotide kinase (PNK) and 1 x PNK reaction buffer (final concentration). Reactions
were incubated at 37°C for 1 hour and probes were then purified by passage through G-25
Nick™ (oligos < 20 nt) or G50 (oligos > 20 nt) Sephadex® (Pharmacia Biotech) columns
in accordance with the manufacturers' instructions and the incorporation of radioactivity 
assessed by scintillation counting. All oligo probes utilised in these studies demonstrated
radioactive incorporation in excess of 10^ cpm/(ig.
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2.20.2 Double-stranded DNA probes
DNA fragments for probes were generated by PCR (MMSV-1F/R, ASM 201F/R, 
ASM215F/R and ASM 245/6 [Table 2.4]) or by band isolation from agarose gels using the 
Qiaex II Gel Extract kit, in accordance with manufacturers' instructions. DNA probes 
were labelled using a protocol based that developed by Feinberg and Vogelstein (Feinberg, 
1983), which utilises a mixture of random hexamers in the priming of DNA synthesis.
a-^^dATP (3,000 Ci/mmol, 10 mCi/ml) is incorporated in this synthesis reaction. The
reaction was set up using the Ready to go™ DNA labelling kit (Pharmacia Biotech) and 
was performed in accordance with the manufacturers instructions. Probes were then
purified by passage through G50 Nick™ Sephadex® columns (Pharmacia Biotech) in
accordance with the manufacturers' instructions and the incorporation of radioactivity 
assessed by scintillation counting. All double stranded (DS) DNA probes utilised in these
studies demonstrated radioactive incorporation in excess of 10^ cpm/|ig.
2.21 Transfer of nucleic acids to nylon membranes via Southern blotting
Agarose gels (0.5-1.5%) were prepared for Southern transfer by successive immersion in 
0.5 M NaOH, 1.5 M NaCl (20 minutes); 0.5 M Tris pH 7.5, 1.5 M NaCl (20 minutes) and
20 x SSC for 20 minutes (1 x SSC is 0.15 M NaCl, 0.0015 M sodium citrate). Southern
transfer of DNA onto Magna™ nylon membrane (MSI) was performed overnight by
capillary action, at room temperature and in the presence of 20 x SSC. The membrane was
subsequently rinsed in 6 x SSC and placed at 80°C for 2 hours.
2.22 Screening of genomic libraries
Bacteriophage, plated at a density of ~ 105/t/w/ 15 cm (diameter) plate, were transferred, in 
duplicate, onto Magna™ nylon membrane (MSI). The DNA was fixed to the membranes 
by successive blotting in: 0.5 M NaOH, 1.5 M NaCl (5 min); 0.5 M Tris pH 7.5, 1.5 M
NaCl (5 min) and 2 x SSC for 10 min (1 x SSC is 0.15 M NaCl, 0.0015 M sodium citrate).
A 1.6 kb cDNA fragment was used as a probe to screen the bacteriophage plaques, within
the X 2001 and X PS genomic DNA libraries, for Mobp gene sequences. This cDNA
fragment was generated by RT-PCR utilising a sense primer (MMSV-1F PCR, defined in 
Table 2.4) derived from the 5' region of the rat rOPl cDNA (Yamamoto et al., 1995)
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nucleotides 65-88 and an antisense primer (MMSV-1R PCR, defined in Table 2.4) 
corresponding to nucleotides 1-27 of the cDNA fragment mmsv-1 (Montague et al.,
1997a) and was radioactively labelled (-10^ cpm/jig) as described in section 2.20.
2.23 Nucleic acid hybridisation
2.23.1 Hybridisation of oligonucleotide probes to DNA bound to nylon
membranes
The hybridisation solutions for screening with oligonucleotide probes contained: 5 x
Denhardt's solution, 5 x SSC, 100 pg/ml Salmon sperm DNA (Boehringer Mannheim), 50 
mM sodium phosphate and 1 mM sodium pyrophosphate and 20% v/v formamide. 
Membranes were incubated at 42°C and subsequently washed, at room temperature, with 2
x SSC, 0.1% SDS. Probes were utilised at 10^ cpm/ml (hybridisation solution).
2.23.2 Hybridisation of DS DNA probes to DNA bound to nylon membranes
The hybridisation solutions for screening with DS DNA probes contained: 20% w/v 
dextran sulphate, 5% v/v sarkosyl NL 30 and 10 x SCP buffer (20 x SCP is 2 M NaCl, 0.6 
M Na2HPC>4, 0.02 M EDTA at pH 6.2). Membranes were incubated with DNA probes for 
14-16  hours at 60°C and washed at 60°C with 0.3 x SSC, 0.5% SDS.
2.24 Identification of overlapping genomic fragments by DNA fingerprinting
Overlapping genomic fragments were identified utilising a DNA fingerprinting assay 
based on that of Coulson (Coulson et a l., 1986), with the following alterations: -100 ng of
DNA from each clone was incubated in a 4 |il reaction volume containing; 0.8 U HindTIl, 
0.8 U EcoRl, 0.8 U AMV reverse transcriptase (Promega), 0.1 |ig RNase, 0.01 pCi aP32 
dATP (3,000 Ci/mmol), 2 x One Phor-All buffer and in the absence of any dideoxy- 
nucleotide. The reactions were placed at 37°C for 45 minutes and subsequently placed at 
68°C for 30 minutes in order to inactivate the reverse transcriptase. The reactions were 
then placed on ice. 2 U Sau3Al and 1 x React 4 (Promega) added (final concentration) in
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a 2 pi volume were added. The reactions were placed at 37°C for 2 hours and stopped by
the addition of 4 jllI of formamide loading dye. The samples were then placed at 90°C for
5 minutes and subsequently on ice for 2 minutes. The samples were then loaded onto a 6% 
denaturing acrylamide gel (19:1 acrylamide:bis-acrylamide) and electrophoresed under 
the conditions described in Chapter 2 (2.14). The procedure is outlined in Figure 2.1
2.25 Detection of transcriptional start sites via the oligo-capping procedure
The transcription start points (tsp) of Mobp, were determined using the oligo-capping
method (Maruyama and Sugano, 1994) with the following alterations: Poly (A)+ RNA 
from adult male C57BL6 mice was kindly supplied by Dr T.A.Glencorse and A.B.Roberts 
(University of Glasgow) and gene specific oligonucleotides (ASM 201, 202, 203 and 204) 
utilised in the experiment are defined in Table 2.3. The Bam HI and r-oligos utilised were 
as described by Maruyama and Sugano (1994) and are also defined in Table 2.3. The 
procedure is outlined in Figure 2.2.
2.25.1 Incubation of messenger RNAs with bacterial alkaline phophatase
5-10 |ig of mRNA in a 20 pi volume (DEPC-H2 O) were incubated with 10 U of bacterial 
alkaline phophatase (BAP) in a reaction volume of 100 pi, containing 1 x BAP reaction
buffer and 1U RNasin. The samples were placed at 42°C for 1 hour and then an equal
volume of phenol:chloroform:isoamyl alcohol (25:24:1) was added. The samples were 
mixed by vigorous inversion, placed on ice for 5 minutes and centrifuged at 15,000 rpm 
(4°C) for 5 minutes. The upper phase from each tube was removed to a clean tube. This 
phenol:chloroform extraction was performed three times. Then 1 pi of glycogen (20 
p,g/pl), 10 pi 3 M sodium acetate and 250 pi of ethanol were added to the upper (aqueous)
phase. The samples were placed at -20°C overnight.
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Figure 2.1 Schematic diagram of the DNA fingerprinting procedure. E, Eco RI; H, Hin 
dill sites. *, radioactively labeled DNA fragments and restriction enzyme sites.
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Figure 2.2 Oligo-capping procedure of mRNAs. RNAs are represented as solid bars 
and r-oligos as shaded bars. Poly (A)+ RNA consists of RNA molecules with various 
types of 5' ends as shown at the left margin. Gppp:CAP structure; p:phosphate; OH: 
hydroxyl.
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2.25.2 Incubation of messenger RNAs with tobacco acid pyrophophatase
Samples from section 2.25.1 were centrifuged at 15,000 rpm (room temperature) for 10 
minutes. The pellets were washed with cold (4°C) 75% ethanol and then centrifuged at
12,000 rpm (room temperature) for 5 minutes. The supernatants were aspirated and the 
pellets were resuspended in 270 pi of DEPC-H2 O. This RNA was then incubated with 10
U of tobacco acid pyrophophatase (TAP) in a reaction volume of 300 pi, containing 1 x
TAP reaction buffer and 1 U RNasin. The samples were placed at 37°C for 1 hour and
then an equal volume of phenol:chloroform:isoamyl alcohol (25:24:1). The samples were 
mixed by vigorous inversion, placed on ice for 5 minutes and centrifuged at 15,000 rpm 
(4°C) for 5 minutes. The upper phase from each tube was removed to a clean tube. This 
phenol:chloroform extraction was performed three times in total. Then 1 pi of glycogen 
(20 pg/pl), 30 pi 3 M sodium acetate and 750 pi of ethanol were added to the upper
(aqueous) phase. The samples were then placed at -20°C overnight, centrifuged at 12,000 
g (4°C) for 10 minutes and supernatants were aspirated. The pellets were washed with 
cold (4°C) 75% ethanol and then centrifuged at 9,000 g (4°C) for 5 minutes. The 
supernatants were aspirated and the pellets were resuspended in 20 pi of DEPC -H2 O.
2.25.3 Ligation of the synthetic RNA-oligonucleotide
The synthetic RNA-oligonucleotide (r-oligo) (Table 2.3) was ligated to the 5' termini of 
mRNA species (4 pi from section 2.25.2), in the presence of 1 x T4 DNA ligase reaction
buffer, 200 U of T4 DNA ligase, 25% PEG, 100 U RNasin, 150 pmol r-oligo. The 
reaction was performed in a total volume of 100 pi and placed at 16°C overnight. 200 pi 
of DEPC-H2 O and 300 pi of phenol:chloroform:isoamyl alcohol (25:24:1) were added. 
The samples were mixed by vigorous inversion, placed on ice for 5 minutes and 
centrifuged at 15,000 rpm (4°C) for 5 minutes. The upper phase from each tube was 
removed to a clean tube. This phenol:chloroform extraction was performed three times in 
total. Then 1 pi of glycogen (20 pg/pl), 30 pi 3 M sodium acetate and 750 pi of ethanol
were added to the upper (aqueous) phase. The samples were then placed at -20°C for 1
hour, centrifuged at 12,000 rpm (4°C) for 10 minutes and supernatants were aspirated. 
The pellets were washed with cold (4°C) 75% ethanol and then centrifuged at 12,000 rpm 
(4°C) for 5 minutes. The supernatants were aspirated and the pellets were resuspended in 
100 pi of DEPC-H2 O. 100 pi 5 M ammonium acetate and 500 pi ethanol were added, 
mixed by inversion and placed on ice for 1 hour. The samples were then centrifuged at
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12,000 rpm (4°C) for 10 minutes and supernatants were aspirated. The pellets were 
washed with cold (4°C) 75% ethanol and then centrifuged at 12,000 rpm (4°C) for 2 
minutes. The supernatants were aspirated and the pellets were resuspended in 12 (il of 
DEPC -H2 O.
2.26 Tissue culture
2.26.1 Embryonic stem cells
The embryonic stem (ES) cell line CGR 8.8 was a kind gift of Dr Bill Skarnes (Medical 
Research Council, Centre for Genome Research, Edinburgh).
2.26.2 Preparation of tissue culture flasks and plates
All tissue culture flasks and plates were gelatinised as follows: The growth surface of 
each receptacle was overlaid with a 0.1 % gelatin solution and placed at room temperature 
for at least 15 minutes prior to use. The excess gelatin solution was aspirated immediately 
prior to use.
2.26.3 Cell culture
The medium used for cell culture in this study contained: 1 x minimal essential medium
(MEM), 0.25% sodium bicarbonate, 1 x non-essential amino acids, 1 mM sodium
pyruvate, 2 mM Glutamax™ (Gibco BRL, Life Technologies), 0.77% v/v p- 
m ercaptoethanol, 10% S-serum (Foetal calf serum, Sigma), 100 pg/m l
penicillin/streptomycin and 2 x 10^ U/ml Leukaemia Inhibitory Factor (LIF). 1 ml of 
medium was added to a cryovial containing CGR 8.8 cells, thawed rapidly at 37°C. The
cells were dispersed by gentle pipetting and removed to a gelatinised 5 cm^ tissue culture 
flask. The volume was increased to 5 ml by further addition of medium. The flask was 
then placed at 37°C in the presence of 5% CO2  overnight. The medium was then aspirated 
and replaced with 7.5 ml of fresh medium and placed at 37°C in the presence of 5% CO2
for 24 hours. The medium was then aspirated and the cells washed twice with 7 ml of 1 x
PBS. 1 ml of TVP (0.025% Trypsin, 1% v/v chick serum, 1 mM EDTA and 1 x PBS) was
then added to the flask and the flask agitated until the cells were observed to release from 
the flask (normally 3-4 minutes). 5 ml of medium were added to the flask and the cells
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transferred to a 50 cm^ flask. This cycle of feeding and trypsinising was repeated twice
over the ensuing four day period; the cells being transferred to 75 cm^ and 150 crcfl flasks 
in succession.
2.26.4 Transfection of CGR 8.8 embryonic stem cells with DNA
When the cells were 40-50% confluent, in the 150 cm^ flask, the medium was aspirated
and the cells washed twice with 50 ml of 1 x PBS. 2 ml of TVP was then added to the
flask and the flask agitated as above. 8 ml of medium was then added to the flask and the 
cells transferred to a 15 ml polypropylene centrifuge tube. The cells were then centrifuged
1,000 rpm for 1 minute (Jouan, CR 312), the supernatant aspirated and the cells gently
resuspended in 10 ml of 1 x PBS. This centrifugation and PBS wash was repeated twice. 
The supernatant was aspirated, the cells were gently resuspended in 0.8 ml of 1 x PBS, and
50 p.1 of linearised DNA (pMobp-N/TK; defined in Section 2, 2.6 and illustrated in Figure 
2.6.4) was added. The cells and DNA were transferred to a 0.4 cm electroporation cuvette
(Biorad, Gene Pulser). Electroporation was performed at 0.8 kv, 600 Q; with a time
constant of 0.1. The transfected cells were placed at room temperature for 20 minutes and 
then added to 30 ml of medium contained in a 50 ml polypropylene centrifuge tube and 
mixed by gentle pipetting. 2 ml aliquots were added to each of 15 tissue culture plates (10 
cm diameter) and the volume completed by the addition, to each, of 8 ml of medium. The 
plates were then placed at 37°C, in an atmosphere containing 5% CO2  overnight. The 
medium was then aspirated and replaced by the addition of 10 ml of medium containing 
G418 (0.2 mg/ml) and Gancyclovir (0.55 jig/ml). N.B. one plate was identified as a 
control and was fed a medium lacking Gancyclovir. The medium was replaced with 10 ml 
of fresh medium containing G418 (0.2 mg/ml) and Gancyclovir (0.55 fig/ml) on a daily 
basis, over a period of 14 days. By day eight distinct colonies, resistant to the drugs used 
in this study, could be observed with the naked eye.
2.26.5 Picking drug resistant colonies
The medium was aspirated and the cells washed twice with 10 ml of 1 x PBS. The plates 
were then overlaid with 10 ml of 1 x PBS. Using a pipette tip (2-200 |xl), colonies were
gently agitated and removed from the plates in 100 (il volumes of 1 x PBS and each placed
in 24 well (16 mm) tissue culture plate. The cells were dispersed by gentle pipetting. 100 
j l i I  of TVP were then added to each well and the plate gently agitated. After a period, not
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in excess of 5 minutes, 2 ml of medium was added to each well. The plates were then 
placed at 37°C, in an atmosphere containing 5% CO2  for 48 hours. The medium was then 
aspirated and 1 ml of fresh medium added. This was repeated on a daily basis until the a 
confluent layer of cells was obtained.
2.26.6 Harvesting of selected colonies
The selected colonies were allowed to grow to confluence. Colonies, having reached this 
stage, were treated as follows: 1 ml of fresh medium was added to each colony 1-2 hours 
prior to preparation for freezing. The medium was aspirated and the colony washed twice
with 2 ml of 1 x PBS and the PBS subsequently removed. 100 |il of TVP were then
added to each well and the plate gently agitated. After a period, not in excess of 5 
minutes, 1 ml of freezing medium (9:1 [vohvol] medium:DMSO) was added to each well. 
0.4 ml from each well was placed in a 1.2 ml cryovial for storage under liquid nitrogen. 
The remaining 0.6 ml was placed in a 1.5 ml centrifuge tube for DNA isolation as 
described in Chapter 2 (2.8.4).
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SECTION 1
1.1 Introduction
1.1.1 Choice of the single-strand conformation polymorphism (SSCP)
assay for genetic mapping of mouse ESTs
The importance of efficient and reliable detection of single base substitutions is widely 
accepted within biomedical research. In recent years SSCP has emerged from the range of 
available options as a convenient technique due to its sensitivity and ease of use. I have 
investigated the use of SSCP in generating genetic mapping markers from mouse 
expressed sequence tags (ESTs) which are short sequences generated by single-pass end 
sequencing of cDNAs. In an endeavour to establish a rapid genetic mapping strategy for 
genes expressed in the CNS of mouse I have been concerned to maximise the frequency 
with which SSCPs, based on the limited EST sequence available, are informative i.e. show 
detectable differences between Mus spretus and C57BL/6. SSCP assays are compared 
below with the range of most frequently used techniques.
1.1.1.1 Review of available technologies
Since the establishment of restriction fragment length polymorphism (RFLP) analysis 
(Botstein et al., 1980), the range of available options for detection of single base 
substitutions / mutations has increased dramatically. The range of the most frequently 
used techniques now includes: RFLP analysis (Botstein et al., 1980; Jiang et al., 1989; 
Takahashi and Ko, 1993); allele specific oligonucleotide (ASO) hybridisation (Wallace et 
al., 1981; Conner et al., 1983; Saiki et al., 1988); heteroduplex assays (White et al., 1992); 
mismatch cleavage assays (RNase and chemical cleavage) (Myers et al., 1985; Winter et 
al., 1985; Cotton et al., 1988); sequencing of PCR products (Murray, 1989); denaturing 
gradient gel electrophoresis (DGGE) (Fischer and Lerman, 1980; Myers et al., 1985; 
Lerman and Silverman, 1987; Myers, 1987; Noll and Collins, 1987; Sheffield et al., 1989) 
and single strand conformation polymorphism (SSCP) analysis (Orita et al., 1989a; Orita 
et al., 1989b; Suzuki et al., 1990; Okamato et al., 1991; Spinardi et al., 1991; Beier et al., 
1992; Glavac and Dean, 1993; Hayashi and Yandell, 1993; Kupryjanczyk et al., 1993; 
McCallion et a l, 1996).
RFLP has proved itself to be exceptionally useful in situations where no sequence 
information is available (Jiang et al., 1989; Silver, 1995). RFLPs are detected at high 
frequency between Mus species (Avner et al., 1988). However, the cost of utilising the 
battery of enzymes (Silver, 1995) which may be required to screen many different loci in
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search of polymorphisms can be prohibitive. ASO hybridisation is a sensitive technique 
which detects genetic variation over short lengths (1-20 nt) in PCR products (Wallace et 
al., 1980; Conner et al., 1983; Saiki et al., 1989; Hayashi and Yandell 1993; Silver, 1995) 
but is limited by the short length over which it is effective. Heteroduplex assays (White et 
al., 1992) are based on the difference in electrophoretic mobility of matched and 
unmatched heteroduplexed PCR products. However, few published data were available on 
the sensitivity of the technique (Hayashi and Yandell 1993). Mismatch cleavage is a 
sensitive technique (Winter et al., 1985) which involves the identification and cleavage of 
DNA, at the point of heteroduplex mismatch, by chemical or enzymatic means. However, 
cleavage utilising RNase has demonstrated insensitivity to certain mismatches (Meyers et 
al., 1985) and the more sensitive chemical cleavage techniques require expertise in the 
performance of the biochemical steps involved (Cotton et al., 1988). Sequencing of PCR 
products is exceptionally sensitive but has historically proved to be labour intensive and 
expensive when used to genotype large numbers of DNAs are clearly prohibitive. The 
development of automated sequencing technologies means that this need not necessarily 
be the case. DGGE is based on the fact that the mobility of a partially melted DNA duplex 
is virtually zero and that the site of mismatch tends to melt early (Fischer and Lerman, 
1980; Meyers et al., 1985; Noll and Collins, 1987). DGGE is very sensitive but requires 
special apparatus to control temperature, long primers, frequently entailing the addition of 
a 30-40 nt GC clamp (Sheffield et al., 1989), and is labour intensive (Hayashi and Yandell 
1993). However, the theoretical basis for the detection of polymorphisms with DGGE has 
been reported (Meyers et al., 1987). No such model exists for the 3-dimensional (3-D) 
structure of single strands under given conditions (e.g. in SSCP analysis). Maxam and 
Gilbert (1975) suggested that intramolecular interactions beyond Watson and Crick pairing 
are important determinants of folding. The 3-D structure of single stranded DNA 
molecules is more complex than a simple stem loop or secondary structure as determined
by X-ray crystallography [Rich, 1976 #810]. SSCP does, however, readily lend itself to
empirical optimisation (Hayashi and Yandell 1993), the formation of higher order 
structures being dependent on length, sequence, and physical factors (e.g. temperature and 
ionic strength, Hayashi and Yandell, 1993)
In native gels conformations of single strand DNA molecules are stabilised by intrastrand 
interactions (Orita et al., 1989a’b). Therefore, conformation and mobility are dependent 
on sequence composition; a mobility shift reflects a conformational change. It has also 
been suggested that more than one metastable conformation is available to a single
stranded DNA molecule (Orita et al., 1989a>b; Beier et al, 1992; Glavac and Dean 1993;
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Hayashi and Yandell 1993). It noteworthy, however, that the patterns provided by SSCP 
assays are seldom ambiguous (Beier et al., 1992). The SSCP assay has developed into a
highly sensitive, convenient technology (Orita et al., 1989a’b; Suzuki et al., 1990). It does 
not require restriction enzyme cleavage or hybridisation and lends itself to PCR 
amplification (Orita et al., 1989^) and strand separation on thin polyacrylamide gels (Orita 
et al., 1989a’b; Suzuki et al., 1990; Beier et al., 1992; Beier, 1993; Glavac and Dean 1993; 
Hayashi and Yandell 1993; Beier et al., 1995; McCallion et al., 1996). Dissociated PCR 
fragments up to 600 nt in length can be separated without loss of resolution (Ludeke et al., 
unpublished observations; cited in Hayashi and Yandell, 1993). Detection levels as high 
as 100% have been reported (Michaud et al., 1991).
1.1.1.2 Selection of SSCP as the method of choice for mapping expressed
sequences
Genetic mapping requires the detection of allelic differences between parental DNA 
sequences. In a recent report by Silver (1995), the author cites five criteria for an ideal 
polymorphism detection protocol. These are: (1) detection of any and all basepair variants 
in a DNA region as multiple alleles; (2) no requirement for sequence information from 
each allele; (3) no requirement for synthesis of ASOs; (4) no requirement for special skills 
or equipment; (5) rapidity and ease of result reproduction.
The conformation and mobility of a single stranded DNA molecule in a native gel are 
dependent on sequence composition (Orita et al., 1989a’b). In SSCP analyses a sequence 
polymorphism between single stranded DNA molecules frequently results conformational 
change is reflected in the subsequent detection of a polymorphism. SSCP may be 
combined with PCR amplification and consequently requires sequence from only one 
allele and does not require the generation of ASOs. SSCP assays may be performed using 
standard molecular biology technologies (PCR amplification in combination with 
sequencing type gel electrophoresis) and as such does not require any skills or equipment 
not normally found in molecular biology laboratories. SSCP has been demonstrated to be 
efficient and reproducible (Orita et al., 1989a>b; Suzuki et al., 1990; Beier et al., 1992; 
Beier, 1993; Hunter et al., 1993; Beier et al., 1995; McCallion et al., 1996; McCallion et 
al., in prep.). Silver concludes that all of these criteria are satisfied to a "good degree" in 
the form of SSCP analysis.
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1.1.2 Generation and use of interspecific backcross and consomic panels in the
construction of genetic maps
1.1.2.1 Genetic maps
A genetic map is a representation of the distribution of a set of loci within a genome 
(Silver, 1995). Loci included in a mapping project may be related according to any 
number of parameters e.g. functional or structural homologies, a predetermined 
chromosomal assignment or expressed sequences deriving from a common tissue source or 
developmental timepoint. Mapping of any locus may be accomplished at any one of a 
number of levels of resolution; from chromosomal assignment to ever increasing precision 
in subchromosomal localisation and linkage to known loci and ultimately to mapping loci 
to a DNA sequence. Three types of genetic map may be derived; linkage, chromosomal 
and physical. These maps are distinguished by the methods used for their generation and 
the metric used for establishing distances within them (Silver, 1995).
The linkage (recombination) map was the first to be developed subsequent to the 
rediscovery of Mendel's work early in this century. The construction of a genetic linkage 
map is a fundamental step in the structural and functional characterisation of a mammalian 
genome (Copeland and Jenkins, 1991). This map form may be generated for loci existing 
in two or more allelic (heritable) forms. Thus, monomorphic loci may not be mapped in 
this fashion. Linkage maps are generated by comparing the number of offspring receiving 
a parental or recombinant allele combination from a parent carrying two different alleles at 
two or more loci. Analysis of this type of data permits the establishment of whether or 
not two loci are genetically linked. Chromosomal assignment is normally accomplished 
when a new locus is found to be linked to a previously assigned locus (Copeland and 
Jenkins, 1991; Silver, 1995). The linkage map is the only map based on classical breeding 
analysis. Distances are measured in centimorgans (cM; 1 cM =1%  crossover rate).
Chromosome (cytogenetic) maps are based on karyotype information. All mouse 
chromosomes are cytogenetically defined according to their size and banding pattern. 
Map positions are defined using band names. Chromosome maps may now be generated 
using somatic cell hybrid lines, containing portions of the mouse karyotype in a 
background genome derived from another species. Correlation of the presence or 
expression of a mouse gene with the presence of a mouse chromosome or chromosomal 
region permits chromosomal allocation. Other approaches utilising locus specific probes 
for in situ hybridisation (ISH) or correlation of cytogenetic abnormalities with mutant 
phenotypes are less accurate (Avner et al., 1988; Silver, 1995) and require experience in
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analysing mouse chromosomes. All mouse chromosomes are telocentric and are 
consequently not as readily distinguished from each other, at the cytogenetic level as 
human (Avner et al., 1988; Silver, 1995). The distinction between chromosome and 
linkage maps is now perhaps more historical than real, linkage groups coalesce to 
chromosomes.
The physical map is based on direct analysis of DNA and is measured in base pairs, bp; 
kilobase pairs, kbp and megabase pairs, Mbp. Arbitrary distinction is made between short 
range (< 30 kbp) and long range (> 30 kbp) physical maps. Detection of the same large 
restriction fragment by probes unique for two different loci establishes physical linkage. 
In the future long range physical maps consisting of overlapping clones (Yeast artificial 
chromosome, YACs; PI and Cosmid clones) will be established, covering each 
chromosome in the mouse genome.
This study will primarily restrict itself to the generation of linkage maps but will 
acknowledge the value of correlating map positions on linkage and physical maps (Levitt, 
1991; Polymeropoulos et a l,  1992, 1993; Silver, 1995). The benefit of correlating map 
positions of loci in both linkage and physical map forms, to those undertaking physical 
mapping projects, is quite clear. The ability to correlate an interval (physical or linkage), 
associated with a pathology, with expressed genes provides strong candidate genes for 
further study (Burke et al., 1987; Levitt, 1991; Polymeropoulos et a l, 1993).
1.1.2.2 Generation of backcross mapping panels
Most breeding experiments begin with an outcross; mating two animals or strains 
considered unrelated to each other. For many experiments the unrelated strains are two 
different inbred strains. Inbred strains are considered to be homozygous across their entire
genome. Thus an outcross can be symbolised as Ai_j/Ai_j x ai_j/ai_j (where A and a are
two alleles of the same locus and the number of loci present is in the range i-j), and the 
offspring resulting from such a cross (first filial generation), symbolised by FI.
All FI animals are identical and heterozygote (Ai_j/ai_j) throughout their genomes. The FI 
animals obtained from this cross can then be mated with animals from a parental strain that 
are homozygous (Ai_j/Ai_j or ai_j/ai_j) throughout their respective genomes. Such a cross 
is termed a backcross. The two generation outcross-backcross combination is one of the 
major breeding protocols used in linkage analysis (Avner et a l ,  1988; Copeland and 
Jenkins, 1991; Breen et a l, 1994; Silver, 1995; Section 1.1.2). Mendel's first law predicts
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that offspring from a backcross to a/a will be distributed in roughly equal proportions 
between the two genotypes, at any one locus; 50% A/a and 50% a/a. Until recently genetic 
mapping in mouse has been reliant on the analysis of 2 and 3-point crosses established 
between genetically non-identical laboratory strains or recombinant inbred strains. 
However, these analyses are limited by the degree of allelic difference between laboratory 
strains (Copeland and Jenkins, 1991). These limitations have recently been overcome by 
the use of interspecific crosses, exploiting the genetic diversity inherent among wild 
species (Avner et al., 1988). One of the most distantly related Mus species that may 
interbreed with laboratory strains, and still provide fertile FI hybrid animals, is Mus 
spretus (Avner et al., 1988). Backcrosses between Mus spretus and common laboratory 
strains have become the method of choice in the construction of multilocus linkage maps 
of the mouse genome (Copeland and Jenkins, 1991). C57BL/6 mice are frequently chosen 
as the laboratory strain in a backcross breeding program because they are so well 
genetically characterised (Copeland and Jenkins, 1991). The European Collaborative 
Interspecific Backcross (EUCIB; Breen et al., 1994) was generated in this way; utilising 
Mus spretus (SPR and SEG/Pas) and Mus domesticus (C57BL/6) inbred strains. It has 
established the largest and most precise purpose bred genetic mapping resource, for the 
mouse genome, in the world (Breen et al., 1994). The EUCIB resource was utilised in the 
genetic mapping of ESTs expressed in the ventral midbrain of mouse, reported in these 
studies (Section 1, 1.3-1.4).
This kind of approach is limited by a number of factors. Firstly, laboratory strain x Mus
spretus FI males are sterile (Avner et al., 1988; Copeland and Jenkins, 1991). As a 
consequence only recombination data from FI females can be obtained, and recombination 
in the X-Y pseudoautosomal region cannot be established (Copeland and Jenkins, 1991). 
Secondly, the approach is limited by the amount of DNA available from each animal in the 
cross. This will limit the number of probes or markers that can be localised in a DNA 
panel. However, the advent of PCR based mapping strategies (for example: Orita et al.,
1 9 8 9 a,b; Sheffield et al., 1989; White et al., 1992), means that DNA quantity is no longer 
a major limiting factor.
1.1.2.3 Generation and utility of consomic strains
A consomic strain is one in which one entire chromosome from one strain is transferred 
onto the genetic background of another strain. This is in contrast to congenic strains in 
which only a chromosome region is transferred. The transfer is achieved by iterative 
backcrossing with the strain providing the genetic background (Silver, 1995; Guenet, pers.
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comm.). Consomic strains are normally completed after a minimum of ten backcross 
generations (Silver, 1995; Guenet, pers. comm.). In most studies the chromosome to be 
made consomic is the Y.
However, Guenet (Institut Pasteur) has recently initiated a backcross breeding project to 
transfer each individual chromosome from the Mus spretus (SEG/Pas) genome onto a 
C57BL/6 background. Each generation is screened using a battery of PCR microsatellite 
markers (Guenet, pers. comm.). Genotyping of DNAs from each generation, with a 
battery of molecular markers, has permitted the use of intermediate generations in 
chromosomal allocation (Guenet, pers. comm.; refer also to discussion in Section 1, 1.3). 
In this study (Section 1, 1.3) the first backcross generation (N2), the third backcross 
generation (N4) and the sixth and seventh backcross generations (N7/8) provided 
informative results, permitting the allocation of ESTs to mouse chromosomes. This 
breeding programme also establishes a stable and unlimited resource for the immediate 
chromosomal allocation of new markers (Guenet, pers. comm.). It was envisaged that the 
use of a single panel of DNAs from consomic strains in the allocation of novel markers to 
mouse chromosomes would dramatically reduce the labour involved in chromosome 
allocation utilising whole genome scanning. It is noteworthy that radiation hybrid panels 
for mapping the mouse genome were unavailable at the inception of these studies. This 
study (Section 1) reports the use of both consomic and EUCIB DNA panels in 
combination with a PCR based SSCP assay in the establishment of a rapid genetic 
mapping strategy for mouse ESTs.
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1.2 Establishment of an SSCP assay
1.2.2 Analysis of parameters affecting SSCP sensitivity
A wide range of techniques, for the detection of allelic differences between, DNA 
sequences is available, but single-strand conformation polymorphism (SSCP) analysis of
PCR products (Orita et al., 1989a; Orita et al., 1989^; Suzuki et al., 1990; Beier et al., 
1992; Beier, 1993; Beier et al., 1995; McCallion et al., 1996) has come to be widely used 
because of its rapidity, sensitivity and ease of use (refer also to introduction of Section 1, 
1.1.1). In order to make optimal use of SSCP in the mapping of large numbers of mouse 
ESTs, for which limited sequence exists, it is essential to achieve high sensitivity levels for 
polymorphism detection with the minimum of optimisation work for each EST. A number 
of parameters, including temperature, gel concentration, median pore size and the 
concentration of additives such as glycerol, have been shown to affect the detection of 
known mutations using SSCP (Glavac and Dean 1993; Hayashi and Yandell 1993; 
Spinardi et al., 1993). Most studies have, thus far, reported mutation detection in coding 
regions (Orita et al., 1989a; Orita et al., 1989^; Suzuki et al., 1990; Okumato et al., 1991; 
Beier et al., 1992; Glavac and Dean 1993; Hayashi and Yandell 1993; Kupryjanczyk et al., 
1993; Spinardi et al., 1993). In contrast, the ESTs utilised in this study (Stewart et al., 
1996) derive primarily from the 3'UTRs of transcribed sequences, which are frequently 
more AT rich than coding regions (Stewart et al., 1996). Though the role of sequence
composition in the detection of SSCPs had been acknowledged (Orita et al. 1989a’b; 
Glavac and Dean 1993; Hayashi and Yandell 1993), it was not known how, if at all, the 
sequence bias within 3'UTRs would affect the detection of SSCPs. Neither the utility of 
nor parameters for the detection of SSCPs in 3' directed DNA fragments had been reported 
at the time that this study was initiated.
It was not practicable to adjust all of the previously assessed parameters for each of a large 
number of ESTs. This series of experiments demonstrates that a simple laboratory 
protocol using two gel reaction mixes providing different median pore sizes and otherwise 
standard running conditions allows allelic differences between M.spretus and C57BL/6 
EST sequences to be detected very efficiently. This study compared the utility of gel 
reaction mixes with two different acrylamide:bis-acrylamide ratios (19:1 and 37.5:1), in 
SSCP detection. All results reported are consistent upon repetition.
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1.2.2.1 Comparison of cross linking densities between acrylamides 
SSCP assays
In order to examine the effect, on the frequency of SSCP detection, of altering median 
pore size within a native acrylamide gel, two gel matrices were used (19:1, acrylamide:bis- 
acrylamide and 37.5:1, acrylamide:bis-acrylamide). Thirteen PCR products (150-300 bp) 
from putative 3' untranslated (3'UTR) sequences of thirteen different mouse brain EST 
sequences were chosen at random for this study. EST sequences were obtained by single­
pass sequencing of cDNA clones from a mouse brain-region specific cDNA library 
produced by oligo-dT priming (Davies et al., 1994). DNA sequence from the 3'UTR 
demonstrates a high frequency of base mismatches between the mouse subspecies most 
frequently used in genetic mapping (Takahashi and Ko, 1993). Only eight EST-based 
PCR products gave distinct SSCPs between M.spretus and C57BL/6 in the 19:1, 
acrylamide:bis-acrylamide (19:1), 6 % polyacrylamide gels that are in widespread use 
(Table 1.2.1). However, no fewer than four out of the five that failed to give distinct 
SSCPs did provide resolvable SSCPs in 37.5:1 acrylamide:bis-acrylamide (37.5:1), 6 % 
gels (Figure 1.2.1; Table 1.2.1). Thus the frequency of detecting informative SSCPs can 
be raised significantly by testing systematically with 37.5:1 as well as 19:1. For the eight 
distinct polymorphisms detected on 19:1 gels, running in 37.5:1 acrylamide:bis-acrylamide 
did not improve the clarity of the result, and in two instances (W33249 and W33240) did 
not provide SSCPs. The SSCPs demonstrated, between M.spretus and C57BL/6, by PCR 
amplified sequences from within these ESTs are illustrated in Appendix I. N.B. The 
utility of 60:1 gels was also examined but demonstrated no of further enhancement in 
resolution or frequency of detection of SSCPs, in 3’UTR, between the mouse species 
examined.
1.2.2.2 Comparison of ionic strength of electrophoretic buffer in 
SSCP assays
It is also interesting to note that the SSCP resulting from one pair of PCR primers (EST 
W33210) was dramatically further enhanced in both 19:1 and 37.5:1, 6 % gels, by running
with 1 x TBE buffer compared with running in 0.5 x TBE buffer (Figure 1.2.2). This 
contrasts with previous reports that use of 0.5 x TBE frequently improves resolution (Orita 
et al., 1989). However, I still recommend the use of 0.5 x TBE as a standard running 
buffer; for all other amplified EST sequences used in this study 0.5 x TBE provides an 
equal or enhanced resolution compared with 1 x TBE. All other conditions used (Figure
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EST
identification
Oligonucleotide sequences 
5 ' -3 '
PCR 
product 
size (bp)
SSCP
6 %,
19:1
SSCP
6 %,
37.5:1
W33210 AAC GCA CTG CTG CCA TCT AGT G 
CGT AAG CCC TTA GAA TGC CAG AC
249 +
W36179 GGT CCG TIT CCA CAA TTC AGG ACT 
ACT AAC TAG CAG CGA CCA GAC CTG
184 +
W36203 TTA TCG CTC TGC ATG TGT GGA G 
GGT CCT GTG CAT TC A ATG TG A AC
243 + +
W33249 CAT CCG AGT GAC AAC AGA CAA AAG 
CTT CCC AAA GTC AAA TG A GTC TC
259 +
W36181 GCC TTC AGG ATC TTC TC A CAT GAG 
CCA TTT GTG GGA GCG TTG TC
199 + +
W36200 CCA TGA AGA AAT AGA TAG CAA GGT G 
AAG CCT GGG AAA GAT ACT GGA C
152 + +
W35430 CCA ATT ATT TGT ATC AAT CAG GAC C 
CGG GAA AGA GAG GTA TGG CTA G
259 + +
W39947 CTG AAA CAT TAA ATG GAG GTC CCC 
CCA GTG AGA GAA CAA ATC CTG ACC
160 +
W35449 CAT GGT CTT TCC TTC CAT CAG G 
GAA GC A GAG AGC TAT AAG CCT TCT G
2 2 1 ” +
W33240 TTC TCG CTG TCT ATG ACT TAG CAG G 
TTT GAC CAG GAA TCT GAA ATT AGG AG
291 +
'
W36223 CTG AAA CAT TAA ATG GAG GTC CCC 
CCA GTG AGA GAA CAA ATC CTG ACC
2 0 0 ”
Z36363 TCC TGA GTG CTC GTT TGT CIC CC 
CCC ATC AGC TTC AAG CAA TCTC
205 + “
AA008736 TCG AGA TC A TTG TCT GAA AGT AC A TC 
TCC CGT TTG GAA AAG TTG G
272 + +
Table 1.2.1 Detection of allelic differences by SSCP within PCR products from 
M.spretus C57BL/6 DNAs based on EST sequence data. +, detectable SSCP; no 
detectable SSCP. Appendix I illustrates the most distinct SSCPs obtained, for each of the 
amplified sequences above, in this study.
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Figure 1.2.1 The effect of different acrylamide:bis-acrylamide ratios on electrophoretic 
mobility in the SSCP assay of sequences amplified using PCR primers designed to 
putative 3'UTRs of 3 mouse brain-derived ESTs 1, 2 and 3 (W39947, W35449 and 
W36179 respectively). Templates are defined as follows: S, Mus spretus (substrain 
SEG/Pas) and C, C57BL/6. Running conditions are the following: A, 0.5 x TBE, 4°C, 
10% glycerol and 19:1 acrylamide:bis-acrylamide; B, 0.5 x TBE, 4°C, 10% glycerol and 
37.5:1 acrylamide:bis-acrylamide.
s c
2
s c
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s c
4
s c
: * •
Figure 1.2.2 The effect of different acrylamide:bis-acrylamide ratios and buffer 
concentrations on electrophoretic mobility in the SSCP assay of sequences amplified using 
PCR primers designed to putative 3'UTRs of a mouse brain-derived EST (W33210). 
Templates are defined as follows: S, Mus spretus (substrain SEG/Pas) and C, C57BL/6. 
Running conditions are the following: A, 0.5 x TBE, 4°C, 10% glycerol and 19:1 
acrylamide:bis-acrylamide; B, 0.5 x TBE, 4°C, 10% glycerol and 37.5:1 acrylamide:bis- 
acrylamide; C, 1 x TBE, 4°C, 10% glycerol and 19:1 acrylamide:bis-acrylamide; D, 1 x 
TBE, 4°C, 10% glycerol and 37.5:1 acrylamide:bis-acrylamide.
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r1.2.1) are standard SSCP conditions based on the combined experience of many groups 
(Orita et al., 1989; Suzuki et al., 1990; Beier et al., 1992; Glavac and Dean 1993; Hayashi 
and Yandell 1993; Spinardi et al., 1993).
1.2.3 Discussion
This study reaffirms the suggestion that the ratio of acrylamide:bis-acrylamide plays an 
equal if not more important role than gel concentration in the resolution of SSCPs (Glavac 
and Dean 1993; Hayashi and Yandell 1993). These data would further indicate that simply 
using two levels of crosslinker percentage with otherwise standardised SSCP conditions
(Orita etal., 1989a»b; Suzuki etal., 1990; Beier etal., 1992; Beier, 1993; Glavac and Dean 
1993; Hayashi and Yandell 1993; Beier etal., 1995) allows allelic differences within short 
DNA stretches of M.spretus and C57BL/6 mouse lines to be detected efficiently. Over 
92% of the ESTs gave an informative SSCP with these mouse lines from the first PCR 
product, compared with 62% for a standard SSCP assay utilising a single median pore size. 
This enables the rapid genetic mapping of ESTs using, for example, the available EUCIB 
resource (Breen et al., 1994). This protocol (described in full in Chapter 2) is now 
routinely utilised in a collaborative project, with the Guenet laboratory (Institut Pasteur), 
for the large-scale genetic mapping of mouse ESTs. A pilot study, establishing the 
primary use of this protocol in the genetic mapping of ESTs expressed in the mouse 
ventral midbrain, is reported in Section 1 (1.3).
The experimental stages in the establishment of a PCR-SSCP assay are outlined below.
• Optimisation of PCR conditions
• PCR: amplification of parental DNAs with the incorporation of a radioactive 
nucleotide (refer also to Section 1, 1.3)
• Electrophoresis: separation of DNAs by in native polyacrylamide gels (19:1 and 
37.5:1 acrylamide:bis-acrylamide, 6% polyacrylamide gels)
• Selection of gel matrix providing the more distinct SSCP of the two matrices 
examined
• Use of selected conditions, for individual ESTs, in genetic mapping studies 
(Section 1, 1.3 and 1.4)
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1.3 Establishment of a genetic mapping strategy for genes expressed in
the central nervous system (CNS) of mouse
1.3.1 Establishment of an SSCP assay
An initial series of PCR reactions without incorporation of a radioactive 
deoxyribonucleotide were performed in order to establish optimal amplification conditions 
for primers on mouse genomic DNA (SEG/Pas). All primer pairs were observed to 
provide single products of the expected size as determined by electrophoresis on a 2.5% 
agarose gel under the PCR conditions given in Table 1.3.1. It should also be noted that 
primer pair W36162 provided a second distinct band of higher molecular weight. This 
PCR product was also sequenced (U58912, see Table 1.3.1) and demonstrated no 
significant sequence homology to the expected product (W36162). However, it did 
provide a distinct SSCP permitting its chromosomal allocation (Table 1.3.2). PCR
reactions with incorporation of radioactive a^^P dCTP were then performed on both the
parental strains with which the breeding programme was initiated (C57BL/6 and M. 
spretus SEG/Pas) and M. spretus SPR. The latter was also included because it was used as 
a parent in the breeding programme to generate the EUCIB resource which is used 
subsequently. The products were electrophoresed in a non-denaturing gel for SSCP 
assessment (Chapter 2) and subsequently visualised by autoradiography. SSCP analysis 
identified clear polymorphisms discriminating between these parental strains, for >90% of 
ESTs generated within the putative 3'UTR. This procedure is referred to as PCR*-SSCP 
analysis throughout. It should be noted that the Mus spretus mice utilised by the EUCIB 
originate from 2 subpopulations: SEG/Pas and SPR (Breen et a l, 1994). Of the 15 primer 
pairs for which results are reported in this study, 14 provided SSCP band patterns 
distinguishing between both the M.spretus substrains and the C57BL/6 strain. However, 
in the case of the PCR product for EST W33210 the band patterns provided by the two 
Mus spretus strains were clearly distinct but the band pattern provided by the amplified 
SPR sequence could not be distinguished from that of the C57BL/6 strain.
1.3.1 Chromosomal assignment
Radioactively labelled PCR*-SSCP analyses were performed, for each EST, on panels of 
DNAs deriving from several backcross generations of a breeding programme that 
generates consomic lines (Guenet, pers. comm; refer also to Section 1, 1.1.1) as listed in 
Table 1.3.1 For those ESTs tested on the N2 DNAs (Figure 1.3.1), the resultant typings 
were analysed using Genelink software. These analyses provided a linkage group around
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the corresponding ESTs. For those ESTs tested on the N4 (Figure 1.3.2) or N6/N7 DNAs 
the resultant typings were compared with the tables of known data (Appendix II and 
Appendix III respectively), indicating the expected segregation patterns for any SEG/Pas 
chromosomal fragment flanked by the anchor markers utilised in the breeding programme. 
These analyses indicated on which chromosome each EST was located. Genotyping data, 
permitting the chromosomal assignment of these sequences, are listed in Appendix IV.
1.3.2 Determination of genetic map location
1.3.2.1 Position between anchor markers (EUCIB)
The chromosome allocations were confirmed in each case by studying the genetic typing 
results of EUCIB subset panels (8-20 animals per chromosome), selected from the Mbx 
database (http://www.hgmp.mrc.ac.uk/MBx/MBxHomepage.html) for each putative 
chromosome or regional allocation. The recombination events between anchor markers 
for the animals in these EUCIB panels had been well characterised and subdivided the 
relevant chromosome into 4 or 5 distinct regions. PCR*-SSCP analyses were performed 
on the DNAs from these panels. The segregation pattern observed for each EST 
confirmed the chromosomal allocation and implicated a region between two anchor 
markers or between an anchor marker and the centromere (Table 1.3.2) as a likely 
location. Genotyping data, permitting the confirmation of chromosomal assignment of 
these sequences, are listed in Appendix VI.
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Figure 1.3.1 An example of the genetic linkage analysis, providing chromosomal 
allocation, of a novel EST using intermediate generation of the breeding programme to 
generate a consomic panel. Shown are PCR*-SSCP analyses of a 164 bp fragment within 
the putative 3'UTR of W36213, using as template the parental strain DNAs (M.spretus 
SPR and C57BL/6, lanes 1 and 2 respectively), DNA minus control (Lane 3) and 19 
DNAs, from the N2 generation of the breeding program to generate a set of consomic lines 
with one Mus spretus (SEG/Pas) chromosome each on a C57BL/6 background (Lanes 4- 
22). The clear mobility difference between the parental strains readily allows distinction 
between the homozygote (e.g. lane 6) and heterozygote (e.g. lane 11) patterns.
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Figure 1.3.2 An example of the genetic linkage analysis, providing chromosomal 
allocation, of a novel EST using intermediate generation of the breeding programme to 
generate a consomic panel. Shown are PCR*-SSCP analyses of a 249 bp fragment within 
the putative 3'UTR of W39933, using as template the parental strain DNAs (M.spretus 
SPR and C57BL/6, lanes 1 and 2 respectively), DNA minus control (Lane 22) and 19 
DNAs, from the N4 generation of the breeding program to generate a set of consomic lines 
with one Mus spretus (SEG/Pas) chromosome each on a C57BL/6 background (Lanes 3- 
21). The clear mobility difference between the parental strains readily allows distinction 
between the homozygote (e.g. lane 6) and heterozygote (e.g. lane 9) patterns.
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Clone Oligonucleotide sequences 5' - 3' DNA panel PCR PCR PCR
identification used product Ta  cycle
for size(bp) number
chromosome 
allocation
W36259 CAC
ATC
AAA
TTA
CAT
ACT
CCA
TGG
CCC
TTA
TCC
GCC
N6/N7 179 55°C 25
W36162 CCA GGT GTA TTG TAT CCA GAG C N4 233 52°C 30
GTC TCA TAG CGA ACA ATA CAG C
W33240 TTC
CAG
TCG
G
CTG TCT ATG ACT TAG N4 291 55°C 25
TTT
AGG
GAC
AG
CAG GAA TCT GAA ATT
W36135 AAA ACC TGT GTG AGG CGA GC N4 275 58°C 25
CAT AGA AAG CAC AGA CAA GTG G
W39933 ACT GCT TTT CTC GGA CTA CTG C N4 180 55°C 25
CTT ATC TGA GCA GTG GGA GTG G
W36139 AAA ATG ACC GAG GCG TTA GG N4 100 55°C 25
ACA CTG GCT GTT GAA GAA GC
*77z AGA GGC TTT CCC ATG TGT GTG G N4 172 57°C 30
GGA
TGA
GAC
G
CTT TCC TTC CTT TAT
W33210 AAC GCA CTG CTG CCA TCT AGT G N4 249 57°C 30
CGT AAG CCC TTA GAA TGC CAG AC
W39952 TGA AAT AAG AGG ACT ACT CAA GG N4 143 55°C 25
AAA CAG TCT TGG GTC ATA GG
W39947 CTG
CCC
AAA CAT TAA ATG GAG GTC N4 200 53°C 25
CCA
ACC
GTG AGA GAA CAA ATC CTG
W39956 ATT
ACA
CTA
GGA
ATG
GTC
TGG
TCT
TGA
GCT
CCT
TCC
CC N4 160 58°C 25
Table 1.3.1
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Clone Primer sequences 5' - 3' DNA panel PCR PCR PCR
identification used product t a cycle
for size (bp) number
chromosome
allocation
W36213 T C A C T G T A A C A T T G G G G G G T G G N2 278 55°C 25
T T T T G T C T A T G T C C A A G A G G
W35449 C A T G G T C T T T C C T T C C A T C A G G N4 2 2 1 55°C 25
G A A
T C T
G C A
G
G A G A G C T A T A A G C C T
W36221 C A C T A A C T A A C C T C A T T C T T G G G N6/N7 2 2 1 55°C 25
A C A
G A C
G T T
G
A C T C A G C A C A G T G A A
W36179 G G T
A C T
C C G T T T C C A C A A T T C A G G N2 184 55°C 25
A C T
C T G
A A C T A G C A G C G A C C A G A C
U58912 C C A G G T G T A T T G T A T C C A G A G C N4 360 52°C 30
G T C T C A T A G C G A A C A A T A C A G C
Table 1.3.1 continued Chromosomal allocation of 14 ventral midbrain ESTs and 1 
anonymous DNA sequence. *, 3'UTR sequence from the mouse tyrosine hydroxylase 
gene was used as a control for the mapping procedure. Data for EST PCR primer pairs are 
shown giving their corresponding EST accession number (clone ID), sequence, predicted 
product size annealing temperature (Ta ) and PCR cycle number for these assays.
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Clone
Identification Chromosome Region
Distance from
proximal $ or 
distal* anchor 
marker (cM)
Confidence
interval
(Cl)
W36259 1 Col3al-DlMitl2
-H
- 2.5
W36162 2 D lM itl 1 -D2Nds3 12.19* 5.5
W33240 2 D2Mitl -D2Mitl 1 7.1* 5.7
W36135 4 Trypl -D4Mit52 6.7* 3.4
W39933 5 D5Nds8-D5Nds2 5.65* 4.5
W36139 6 D6Nds4-D6Nds5 3.25* 3.7
Th 7 D7Mit40-D7Mitl 5 r,c r
W33210 9 D9Mit42-D9NdslO r r
W39952 10 D10M it20-Dl 0M it7 2 .1* 1.7
W39947 10 D1 OMitl 6-D10Mit20 13* 6.4
W39956 13 D13Mitl 7-D13Mit61 8.75* 4.3
W36213 17 D17Mit39-D17Mitl23 7.8* 3.5
W35449 18 D18Mit8-D18Mit25 3.4$ 1.7
W36221 18 D18MU20-D18Mit24 0$ < 1.8
W36179 19 D19Ndsl-D19Mitl 6.5$ 4.0
U58912 X PLP-DXHar2 r r
Table 1.3.2 Localisation of 14 ventral midbrain ESTs and 1 anonymous DNA sequence 
Note. Data for EST loci are shown giving their positions as a distance relative to an 
adjacent anchor marker. All confidence intervals (Cl) are at the 95% level. The
recombination frequency was calculated as (rf x 1 0 0 ), where rf = number of recombinant
events between the proximal marker and the EST x (number of DNAs, recombinant within
the region of interest, tested)"!, standard error was calculated as (±SE = (rf(l- 
rf)/total)0-5. All markers generated in this study have been submitted to the Genome 
Database (GDB) for approval of loci names. At this time loci are named according to their 
EST accession number.
cPositive control allocation, *Position is relative to distal marker, ^Position is relative to 
proximal marker, Regional allocation only
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1 .3.2.2 Distance between anchor markers (EUCIB)
A second EUCIB subset panel was then selected from the Mbx database (http://www. 
hgmp.mrc.ac.uk/MBx/MBxHomepage.html), for each EST. These panels included DNAs 
recombinant within the implicated regions of the genome. More than 750 animals had 
already been typed for all regions flanked by anchor markers, providing panels of more 
than 50 DNAs demonstrating recombination events within each region (Breen et al., 
1994). PCR*-SSCP analyses were performed on 22 DNAs from each of these panels of 
recombinants (Figure 1.3.3). At least 19 DNAs provided interpretable results in each 
instance. The distance between an EST locus and the respective proximal marker was 
taken as the fraction of interpretable results demonstrating recombination events between 
the proximal marker and the EST locus, multiplied by the distance between the flanking 
markers. W33210 could not be further localised using the EUCIB DNAs. The 
recombinant DNAs in the region of interest D9Mit42-D9NdslO derived from M.spretus 
SPR/Pas and C57BL/6 parents alone. These parental DNAs do not demonstrate an 
observable SSCP for the amplified sequence within this EST and as such did not permit 
further SSCP genetic typing. It is not surprising to find single-stranded amplification 
products, from SPR and SEG/Pas Mus spretus subpopulations, that demonstrate differing 
mobilities. The report by Breen et al. (1994) notes the occurrence of sequence variants 
between these subpopulations. Genotyping data, permitting the genetic localisation of 
sequences reported in this study, are listed in Appendix VI.
1.3.3 Database sequence comparisons
Sequence comparisons were performed against all entries in the Genbank databases using 
the NIH BLAST (http://www.ncbi.nlm.nih.gov/cgi-bin/BLAST/nph-blast [23rd August 
1997]) facility (Altschul et al., 1990). Comparisons of the sequences translated in all six 
reading frames were performed using the TBLASTX (http://www.ncbi.nlm.nih.gov/cgi- 
bin/BLAST/nph-blast [23rd August 1997]) program. High scoring pairs, those 
demonstrating a high degree (>70%) of identity with data base sequences ESTs in this 
study, are indicated in Table 1.3.5. Those searches yielding no such homology to ESTs in 
this study (W36259 and W36179) are indicated by a backslash (/) symbol.
Seven of the ESTs (W36162, W39933, W33210, W39948, W39956, W36213, and 
W36221) demonstrate homology (>78%) with previously identified gene sequences in 
mouse, rat or man (Table 1.3.3). Amongst these, W36162, W39948, W36213, and 
W36221 demonstrate homology with genes whose expression patterns have been 
characterised and are known to be expressed in the brain (genes encoding: Arrestin-E,
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connexin 43, endothelin receptor type-B [endothelin-B^] and the kinesin heavy chain 
respectively).
Arrestin-E is a member of a family of proteins which act as agonists to the G-protein 
linked receptors involved in the phototransduction cascade permitting colour vision (Craft 
et al., 1994). Connexin 43 is a gap junction protein of the mammalian heart and brain (el 
Aoumari et al., 1990). Expression in the mammalian brain is restricted to glial fibrillary
acidic protein positive (GFAP+) cells (Astrocytes). It is not surprising to find genes with 
glial expression patterns within such a library (Adams et al., 1991; Davies et al., 1994). 
Endothelin-B has been reported to be expressed in the neuronal cells of the hippocampus 
and cerebellum (Zeng et al., 1997). It is also expressed in glial cells, specifically 
astrocytes and microglia; (Rogers et al., 1997) liver and the placenta (Zeng et al., 1997). 
Kinesin is known to be a cytoskeletal motor protein which is involved in cell division and 
axonal transport (Noda et al., 1995). It is noteworthy that EST W33210 demonstrates 95% 
identity to rat glycoproteins gp55 and gp65, and 98% identity to the unidentified ESTs 
D50463 and mr26f07.rl. The sequence D50463 derives from a signal trap experiment to 
detect secreted proteins (Shirozu et al., 1996) which correlates with the fact that 
glycoproteins gp55 and gp65 are major components of synaptic membrane in the forebrain 
(Langnaese et al., 1997). Glycoprotein gp65 is brain specific and gp55 is reported present 
in most tissues examined (Langnaese et al., 1997). Furthermore W39956 demonstrates 
97% identity to the 84 kD mouse heat shock protein.
Four ESTs (W33240, W36135, W36139 and W39953) demonstrate homology (>70%) 
with unidentified rat and mouse cDNA sequences (Table 1.3.5). Three further sequences 
(W36259, W36179 and U58912) demonstrate no homology to any non-self sequence in 
these searches.
It is further noteworthy that the gene encoding deoxycytidine kinase (DCK) has been 
mapped in human to chromosome 4 ql3.3-q21.1 (Stegmann, 1993) which overlaps the 
corresponding region of synteny to the region allocated to EST W39933 (between D5Nds8 
and D5Nds2\ Table 1.3.5).
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Figure 1.3.3 An example of the genetic localisation of a novel EST a subset panel of 
DNAs from the EUCIB resource. Shown are PCR*-SSCP analyses of a 179 bp fragment 
within the putative 3'UTR of W36259, using as template the parental strain DNAs 
(C57BL/6 and M.spretus SPR, lanes 1 and 2 respectively), DNA minus control (Lane 3)
and 22 DNAs, recombinant between the markers Col3al  and D lM it l2 ,  from the
backcross [(C57BL/6 x SPR)Fi x C57BL/6] (Lanes 4-25). The clear mobility difference
between the parental strains readily allows distinction between the homozygote (e.g. lane 
4) and heterozygote (e.g. lane 11) patterns.
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Accession
number
Blastn and Tblastx search results High scoring pairs 
(Identities with data 
base sequences)
W36259 / /
W36162 Blastn:
Locus RRU03630 388 bp mRNA 86% (over 270nt)
Definition Rattus rattus arrestin-E mRNA, partial Minus / plus
cds. orientation
Accession U03630
NID g458208
Source black rat. Rattus rattus
Tblastx:
mp96h09.rl Soares 2NbMT Mus musculus cDNA
clone 577121 5' similar to SW:ARRE_RAT 94%
P37200 arrestin-E
W33240 Tblastx:
mo28e05.rl mouse embryo 13 5dpc Mus musculus 94%
cDNA clone 554912 5'
W36135 Tblastx: 70% (over 60
EST108869 Rattus sp. cDNA 5' end residues)
W39933 Blastn:
Locus MMDEOKI 2812 bp RNA >95% (over 170nt)
D efin ition  M u s . m u s  c u i u s  mRNA for Plus / Plus
Deoxycytidine kinase.
Accession X77731
NID g456676
SOURCE house mouse; Mus musculus
Tblastx:
mi36f09.rl Soares mouse embryo NbME13.5 14.5 100% (over 50
Mus musculus cDNA clone 465641 5' similar to residues)
gb:X77731 M.musculus mRNA for Deoxycytidine
kinase
Table 1.3.3
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Accession
number
Blastn and Tblastx search results High scoring pairs 
(Identities with data 
base sequences)
W36139 Blastn:
Locus HUMD 5A 09 M3 302 bp mRNA 85% (over 80 nt)
Definition Human HepG2 3' region (gene 
signature)
Accession D 17249 
NID g598852 
Source Homo sapiens 
Tblastx:
Plus / Plus
mr28a09.rl Soares mouse 3NbMS Mus musculus 95% (over 90
cDNA clone 598744 5' residues)
W33210 Blastn:
Locus D50463 1900 bp mRNA 98% (over 150 nt)
Definition Mouse SDR1 mRNA 
Accession D50463 
NID g 1747303 
Source Mus musculus
Locus RNGP55 2031 bp and RNGP65
Plus / Plus
200? bp RNA >95% (over 300 nt)
Definition R.norvegicus mRNA for glycoproteins 
55 and 65.
Accession X99337 and X99338 (?)
NID g 1806275 and g
Source Norway rat; Rattus norvegicus
Tblastx:
Plus / Plus
mr26f07.rl Soares mouse 3NbMS Mus musculus 
cDNA clone 598597 5'
98% (over 100 
residues)
W39953 Tblastx:
ve72e09.rl Soares mouse mammary gland 98% (over 90
NbMMG Mus musculus cDNA clone 831784 5' residues)
Table 1.3.3
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Accession
number
Blastn and Tblastx search results High scoring pairs 
(Identities with data 
base sequences)
W39948 Blastn:
Locus MMCOX43 1926 bp DNA 
Definition M.musculus gene for connexin 43. 
Accession X62836 
NID g50522
KEYWORDS connexin43; gap junction protein; 
transmembrane protein.
Source house mouse; Mus musculus 
Tblastx:
96% (over 380 nt)
mn27e07.rl Beddington mouse embryonic region 97% (over 100
Mus musculus cDNA clone 539172 5' similar to 
gb:X61576 M.musculus mRNA for connexin 43
residues)
W35449 Tblastx:
m q82hll.rl stratagene mouse melanoma 96% (over 78
Mus musculus cDNA clone 585285 5' residues) 
91% (over 71
vk50c05.rl stratagene mouse T cell 937311 
Mus musculus cDNA clone 958088 5'
residues)
W39956 Blastn:
Locus S46109 806 bp mRNA 
Definition HSP90=heat shock protein 
Accession S46109 
NID g257730 
SOURCE Mus sp. heart.
Tblastx:
m y22al2.rl Barstead mouse pooled organs 
MPLRB4 Mus musculus cDNA clone 696574 5'
98% (over 248 nt)
similar to gb:M18186 Mouse 84 kD heat shock 97% (over 46
protein mRNA residues)
Table 1.3.3
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Accession
number
Blastn and Tblastx search results High scoring pairs 
(Identities with data 
base sequences)
W36213 Blastn:
Locus HUMHETBR7 2972 bp DNA 
Definition Human gene for endothelin-B receptor 
(hET-BR), exon 7.
Accession D13168 
NID g285924 
SOURCE Homo sapiens 
Tblastx:
vf75g04.rl Soares mouse mammary gland
78% (over 219 nt)
NbMMG Mus musculus cDNA clone 849654 5' 82% (over 84
similar to gb:S57283 endothelin-B receptor 
(Human)
residues)
W36221 Blastn:
Locus MMU86090 3791 bp mRNA 
Definition Mus musculus pancreatic beta-cell 
kinesin heavy chain mRNA,
Accession U86090 
NID g2062606
SOURCE house mouse; Mus musculus 
Tblastx:
98% (over 410 nt)
mz91d01.rl Soares mouse lymph node NbMLN 95% (over 98
Mus musculus cDNA clone 720769 5' similar to 
gb:X65873 kinesin heavy chain (Human)
residues)
W36179 / /
U58912 / /
Table 1.3.3 Data generated by sequence comparisons performed against all entries in 
the Genbank databases using the NIH BLAST (http://www.ncbi.nlm.nih.gov/cgi- 
bin/BLAST/nph-blast, 23rd August 1997) [comparison at the nucleotide level] and 
TBLASTX (http://www.ncbi.nlm.nih. gov/cgi-bin/ BLAST/nph-blast, 23rd August 1997) 
[comparison at the amino acid level] facilities. Searches yielding no homology (>70%) to 
ESTs in this study are indicated by a backslash (/) symbol.
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1.3.4 Association with known neurological mutations in mouse
Three of the ESTs mapped in this study are located close to one or more neurological 
mutations in unidentified genes. These are found on: chromosome 5 (chr5), tilted 
(W39933); chrlO, hesitant (W39948); chrl3, twirler, ataxia and sphingomyelinosis 
(W36221). However, all three sequences demonstrate >95% identity to DNA sequences 
from known genes. EST W39933 is linked to the tilted  locus. However, the EST 
W39933 corresponds to the gene encoding deoxycytidine kinase. Loss of function 
mutation in this gene would result in the failure of DNA replication of a dividing cell and 
subsequent cell death. This must preclude its involvement in a transmissable mutant 
phenotype. EST W39948 is linked to the hesitant locus. The hesitant mouse demonstrates 
ataxia and reduced male fertility (Kapfhamer et al., 1996). The EST W39948 corresponds 
to the gene encoding connexin 43, which is a gap junction protein of the brain and heart (el 
Aoumari et aL, 1990). It is conceivable that proteins involved in cell-cell communication 
in the brain may also play a role in neuropathy. Genotyping of the marker for W39948 on 
the backcross panel utilised in mapping the hesitant locus may prove worthwhile in 
excluding the gene, corresponding to this EST, from a role in the hesitant pathology or 
present it as a candidate gene for further study. EST W36221 is linked to the loci for the 
mutants twirler, ataxia  and sphingomyelinosis. This EST corresponds to the gene 
encoding kinesin. The reported function of this protein, as a cytoskeletal motor protein in 
axonal transport and cell division (Noda et al., 1995), presents it as a good candidate for 
involvement in neuropathy. Thus the marker for W36221 may also be genotyped on the 
respective backcross panels utilised in mapping the twirler, ataxia and sphingomyelinosis 
loci or any neuropathology linked to this region in the future.
1.3.5 Discussion
I have utilised SSCP in the mapping of 14 ventral midbrain expressed ESTs. This 
straightforward and sensitive technique permits the resolution of polymorphisms in short
amplified single stranded sequences differing by a single base (Orita et al., 1989a’b; 
Suzuki et al., 1990; Okamato et al., 1991; Beier et al., 1992; Beier, 1993; Glavac and 
Dean 1993; Hayashi and Yandell 1993; Kupryjanczyk et al., 1993; Spinardi et al., 1993; 
Beier et al., 1995; McCallion et al., 1996). Using single pass sequencing of 3' directed 
cDNAs allows ready access to the highly polymorphic 3'UTR (Ko et al., 1994; Wilcox et 
al., 1991). Each EST has been mapped genetically using the combined resources of 
genetically typed DNAs deriving from several backcross generations of a breeding 
programme that generates consomic lines (refer also to Section 1, 1.1.1; Guenet, pers.
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comm.) and EUCIB DNAs. The map distances and locations have been assigned using the 
linkage analysis programmes provided by the Mbx database (http://www.hgmp.mrc. 
ac.uk/MBx/MBxHomepage.html) and Genelink software. The EUCIB facility is the most 
precise and largest purpose bred mouse mapping resource presently available (Breen et al.,
1994). Discordances are evident between map positions assigned to anchor loci on EUCIB 
and Jackson Laboratory maps (Encyclopedia of the Mouse Genome, release 3, 
http://www.informatics.jax.org.). Such discordances predict that new loci mapped on the 
EUCIB panel can only tentatively be matched with known loci placed on the map 
according to the Jackson Encyclopedia of the mouse genome and vice versa. Subsequent 
correlation of mapping data, generated using the EUCIB and Jackson resources, requires 
approval by the respective chromosome committees.
The consomic line breeding programme was initiated to provide a stable and less limiting 
source of DNA for the immediate chromosomal allocation of new markers within the 
mouse genome. The progressive manner in which each generation is typed, for anchor 
markers, reduces the loss of DNA in screening final generations (section 1.1; Guenet, pers. 
comm.). For those considering the development of such consomic lines in other organisms 
it should be noted that our results show that typed DNA from early backcross generations 
can be used for chromosomal allocation.
This study also raises questions of relevance to researchers utilising SSCP and EUCIB 
DNA in mapping. The differing motility of single-stranded amplification products from 
SPR and SEG/Pas Mus spretus strains is not unexpected. Sequence variants have 
previously been noted between these Mus spretus subpopulations (Breen et a l., 1994). 
Clearly, instances will continue to arise where a marker distinguishes between C57BL/6 
and one of the M. spretus parental subpopulations but not the other. It is not possible at 
present to determine the frequency with which this may occur. Researchers intending to 
use SSCP with the EUCIB DNAs should be aware of this and the resulting possibility of a 
reduction in the available precision in mapping. The extent to which precision may be lost 
is dependent on the number of progeny available, from the informative subspecies, for a 
region of interest.
The sequence homology between certain ESTs (W36162, W39933, W33210, W39948, 
W39956, W36213, and W36221) combined with a knowledge of the source tissue 
provides a greater level of information for those looking for expressed sequences 
corresponding to candidate genes in a region associated with a known pathology. Without 
further investigation no great significance can be laid upon the correlation of any EST 
locations with regions associated with neuropathies. However, the correlation is
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noteworthy and it is expected that further investigation of these and other brain expressed 
ESTs will, in the future, provide gene candidates for known neuropathies. I have 
established a collaborative project with the laboratory of Jean-Louis Guenet (Institut 
Pasteur) with the aim of increasing the numbers of ESTs genetically mapped in the mouse 
genome. The preliminary results of this work are reported in Section 1, 1.4.
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1.4 Collaborative genetic mapping of ESTs expressed in the ventral
midbrain of mouse
1.4.1 Establishment of collaborative studies
The establishment of an integrated map, which includes information regarding the genetic 
and physical location of a sequence as well as its temporal and spatial expression patterns 
requires the mapping of large numbers of ESTs (Takahashi and Ko, 1993; refer also to 
Chapter 1). Such a map will permit elucidation of the organisation of mammalian 
genomes, particularly gene clustering and gene number (Levitt, 1991; refer also to Chapter 
1). I have established a collaborative project with the Guenet laboratory (Institut Pasteur) 
with the aim of genetically mapping expressed sequences in the mouse genome (refer also 
to discussion in Section 1, 1.3), on a larger scale than the study reported in Section 1, 1.3. 
This study reports the preliminary data arising out of this collaborative work. In excess of 
100 primer pairs have been designed to sequence within the putative 3'UTR of these 
cDNA fragments. I report the genetic mapping of the first 32 of these ESTs. These ESTs 
(Stewart et al., 1996) derive from the same cDNA library resource utilised in Section 1,
1.2 and 1.3 (Savioz and Davies, 1995).
A second pilot study has also been established, with the Serikawa laboratory (Kyoto 
University, Japan). The purpose of which was to assess the utility of PCR 
oligonucleotides, designed to sequence within mouse ESTs, as genetic markers within 
the rat genome. Hence preliminary data is also reported, indicating the chromosome 
location of 7 EST loci, genetically mapped in the mouse genome, within the rat 
genome. These studies were performed by Dr Yasushi Kondo (Kyoto University,
Japan) and utilised rat x mouse hybrid DNA panels, constructed within the Serikawa
laboratory (Serikawa, pers. comm.). Mapping genes in mouse and rat will permit 
further definition of the boundaries of syntenic regions between the species (Guenet, 
pers. comm; Serikawa, pers. comm.). ESTs localising near previously identified 
synteny boundaries will be selected for fine mapping in both species, refining the 
regions encompassing the boundaries in question.
1.4 .2 Extant data from the collaborative mapping of expressed sequences
within the mouse genome
All data arising, thus far, from this study are listed in Table 1.4.1. Allocation of ESTs to a 
particular chromosome and their subsequent localisation were performed as described in 
Section 1, 1.3. It is noteworthy that two of the ESTs demonstrated length polymorphism
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between the mouse strains M. spretus (SEG/Pas) and C57BL/6. These amplified products 
could be resolved by electrophoresis in ordinary agarose gels. Consequently the SSCP 
assay was not required to allocate these sequences to mouse chromosomes.
98
EST Mouse
chr
X-over between 
EST and closest 
marker
Confidence
interval
Probability Polymorphism
detection
method
Rat
chr
GP 1.176 ND ND ND ND Agarose ND
GP 1.108 1 0/23 with Col3al 0 .0 0 -1 2 .2 1 2.40E-7 SSCP ND
GP 2.228 16 0/27 with D5MU379 0.00-10.5 1.50E-8 SSCP ND
GP 3.106 ND ND ND ND ND ND
GP 4.145 11 0/31 withDHNdsl9 0.00-9.21 9.30E-10 Agarose ND
GP 4.196 8 0/36 with D8Mitl9 0.00-7.98 2.90E'11 SSCP ND
GP 4.265 1 1/39 with Col3al 0.07-13.48 1.50E-10 SSCP ND
GP 5.9 16 0/27 with Prml 0.00-10.5 1.50E-8 SSCP ND
GP 5.170 14 0/31 with D14Ndsl 0.00-9.21 9.30E-10 SSCP ND
GP 6.15 9 5/36 with D9Mitl9 
(proximal)
4.67-29.5 1.30E-5 SSCP ND
GP 6.236 3 0/28 with D3Mitl9 0.00-10.15 7.50E'10 SSCP ND
GP 7.15 11 0/30 with D llNds9 0.00-9.5 1.90E-9 SSCP ND
GP 7.28 4 0/22 with Mos 0.00-12.73 4.80E’7 SSCP ND
SPMP22.6 11 3/16 with Duf-1 4.05-45.65 0.02127 SSCP ND
GP 2.22 4/11 5/20 with D ll  Pas 1 8.66-49.1 0.04139 SSCP ND
GP 1.25 7 0/19 with sercal 0.00-14.39 3.80E"6 SSCP ND
GP 2.30 1 3/15 with My If and 
Vil
4.33-48.09 0.03516 SSCP 14
GP 3.36 2 2/36 with D2Mitl 
(proximal)
0.68-18.66 1.90E'8 SSCP ND
Table 1.4.1
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EST Mouse
chr
X-over between 
EST and closest 
marker
Confidence
interval
Probability Polymorphism
detection
method
Rat
chr
GP 3.42 16 1/15 with Prml 
(proximal)
0.17-31.95 0.00098 SSCP 11
GP 2.48 4 1/16 with Mos 0.16-30.23 0.00052 SSCP 5
GP 3.54 17/3 ND ND ND SSCP ND
GP 2.61 4 2/26 with Mos 
(proximal)
0.95-25.13 l.OOE"5 SSCP ND
GP 3.64 8 4/29 with Junb 
(proximal)
3.89-31.66 0 .0 0 0 1 SSCP ND
GP 3.71 5 2/14 with D5Pas2 1.78-42.81 0.1294 SSCP ND
GP 2.107 7 3/21 w ithi/ras 
(proximal)
3.05-36.34 0.0149 SSCP ND
GP 2.120 7 ND ND ND SSCP ND
GP 2.129 9 1/17 with Modi 0.15-28.69 0.00027 SSCP 8
GP 2.137 2 1/21 with D2Mit\ 0.12-23.82 2. IE ' 5 SSCP ND
GP 2.138 14 ND ND ND SSCP 15
GP 2.234 5 ND ND ND SSCP 14
GP 2.245 8 /6 ND ND ND SSCP ND
GP 2.271 2/5 ND ND ND SSCP 3
Table 1.4.1 Localisation of ESTs expressed in the ventral midbrain of mouse
Data for EST PCR primer pairs are shown giving their corresponding EST identification 
number (clone ID). Note. Data for EST loci are shown giving their positions as a 
recombination fraction relative to their respective adjacent anchor marker. All locations 
are centromere distal of the nearest marker except where otherwise stated. All confidence 
intervals (Cl) are at the 95% level. Where available, EST chromosome locations 
established within the rat genome are also listed, chr, chromosome; ND, indicates that 
data from a particular stage in the experimentation has not yet been obtained (not done). 
Where two or more chromosomes are provided the location of the EST remains to be 
confirmed.
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1.4 .3 Discussion
This report extends the work performed in Section 1, 1.3. It demonstrates the use of an 
already established strategy (McCallion et a l, 1996; McCallion et al., in prep.) in the 
genetic mapping of mouse ESTs on a larger scale. It has been estimated that mapping 
1 0 0 0  expressed sequences will permit the identification of up to 2 0  genes involved in 
previously identified pathologies (Guenet, pers. comm.) based solely on the correlation of 
EST and disease loci. As discussed in Section 1, 1.3 the correlation of any EST locus with 
a region associated with a neuropathy is noteworthy. Further investigation of these and 
other ESTs will, in the future, provide gene candidates for known pathologies. The 
availability of gene targeting strategies in mouse permits subsequent evaluation of gene 
function (refer also to Chapter 1 and Section 2, 2.6).
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1.5 Qualitative assay of spatial and temporal expression of ESTs selected
from the genetic mapping study
1.5.1 Qualitative-RT PCR assay of the temporal and spatial expression pattern of
selected ESTs
The degree of novelty evident within the EST resource utilised in this study strengthens 
suggestion that it provides a valuable resource in the search for genes with relevance to 
neuropathology (Levitt, 1991; Stewart et al., 1996). However, it is acknowledged that 
selection of particular genes, for further study, based upon sequence information alone 
would be premature (Stewart et al., 1996). It is further suggested (Stewart et al., 1996) 
that little can be said about the interest level of novel sequences without further 
characterisation of their expression patterns or sequence characterisation of their coding 
regions. The report by Savioz and Davies (1995) demonstrates the use of heterologous 
probes from precise regions of the bovine brain in an endeavour to identify genes with 
higher levels of expression in the substantia nigra (SN) than in the total ventral midbrain or 
cerebellum. This type approach can be somewhat laborious (Davies et al., 1994) and, due 
to the physical constraint of how many probes may be manipulated at any one time, only 
provides information concerning a very limited number of tissues. This chapter describes a 
pilot study initiated with the aim of establishing a qualitative screen for the detection of 
gene transcripts corresponding to ESTs produced by the ongoing EST sequencing project 
in the laboratory of R.W. Davies (Davies et al., 1994; Stewart et al., 1996).
Many studies have demonstrated the use of PCR in the quantitation of RNA species 
(Delidow et al., 1989; Wang et al., 1989; Ferre, 1992; Foley et al., 1993; Grassi et al., 
1994; Hamoui et al., 1994). These studies attempt to circumvent a variety of sources of 
quantitative error, inherent in the PCR, including: inconsistencies in the reaction 
efficiencies of individual reverse transcription (RT) (Delidow et al., 1989; Grassi et al.,
1994) and PCR (Delidow et a l, 1989; Wang et al., 1989; Ferre, 1992; Grassi et al., 1994) 
steps; inconsistencies in the reaction concentrations of template molecules (Delidow et al., 
1989); the exponential nature of PCR (Wang et al., 1989; Ferre, 1992; Foley et al., 1993) 
and the reproducibility of results (Ferre, 1992; Foley et al., 1993). It has also been 
acknowledged (Foley et al., 1993; Hamoui et al., 1994) that establishment of a quantitative 
PCR strategy, even for a single primer pair, requires substantial time and effort. This 
approach was considered too labour intensive and expensive to implement for use as a 
large scale expression screen. Consequently, the aim of this pilot study was simply to 
provide information on the presence or absence of any desired RNA species in a tissue of
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interest at a particular postnatal timepoint. The value and effective use of PCR in such 
studies has been acknowledged previously (Delidow et al., 1989). The PCRs were 
maintained at a moderate cycle number (30 cycles) in an attempt to reduce PCR 
anomalies. All results are consistent upon repetition.
1.5.2 Qualitative-RT PCR assay of expression of selected ESTs in tissues of the
central and peripheral nervous systems and in non-brain tissues
In an endeavour to discover if any of the selected ESTs demonstrated brain specific 
expression, PCRs were performed on total cDNA preparations from a number of CNS, 
PNS and non-brain tissues. Template cDNAs from brain (CNS; postnatal day 16), sciatic 
nerve (P I6 ), spleen, kidney, testis and liver were PCR amplified using primer pairs 
designed to putative 3'UTR sequence of selected ESTs (listed in Table 1.5.1; defined in 
Table 1.3.1). The results of these PCRs are listed in Table 1.5.1. Detection levels are 
arbitrarily defined as strong, moderate or weak.
Four of the eleven arbitrarily selected EST primer pairs (W33240, W33210, W36213, 
W36221) detect their corresponding cDNA species, at moderate to strong detection levels, 
in all tissues examined (Table 1.3.1). cDNA corresponding to the EST primer pair 
W39956 is also detected in all tissues examined but is only weakly detected in the brain 
and in kidney (Table 1.3.1). EST primer pairs W36139 and W39953 detect their 
corresponding cDNA species, at moderate to strong detection levels, in all tissues 
examined except kidney (W36139) and spleen (W39953) (Table 1.3.1). cDNAs 
corresponding to the EST primer pairs W36259 and W39933 are detected (at weak to 
moderate levels) in brain, kidney, testis and spleen (W36259 only) but are not detected in 
sciatic nerve or liver. EST primer pair W35449 detects its corresponding cDNA species 
weakly in brain tissue, sciatic nerve and liver. It is noteworthy that EST W33210 
demonstrates the same degree of sequence identity with the two genes encoding the 
glycoproteins gp65 and gp55 respectively; the latter of which demonstrates almost 
ubiquitous expression (Shirozu et al., 1997). Expression of the gene encoding 
glycoprotein 65 is restricted to the brain (Shirozu et al., 1997). W36213 corresponds to 
the endothelin-B receptor type which has been reported to be detected in brain, liver and 
placenta (Noda et al., 1995). There is no evidence to suggest that its expression should be 
restricted to these tissues. PCR primers, designed to amplify sequence from the gene 
encoding cyclophillin were used as a control for invariant transcript levels (Montague et 
al., 1997). Transcript from this gene is readily detected in all tissues under examination 
(Table 1.3.1). Transcript corresponding to the EST W36135 is not detectable in any tissue 
examined in this study. Figure 1.5.1 A-D illustrates the result of RT-PCR assays for four
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of the EST sequences in this study.
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Clone
Identification
Brain Sciatic
nerve
Spleen Kidney Testis Liver Sequence
W36259 ++ - ++ ++ + - unknown
W33240 +++ +++ +++ +++ +++ +++ cDNA
(mouse)
W36135 - - - “ “ “ cDNA
(rat)
W39933 + - - + + - DCK
W36139 ++ +++ +++ - +++ +++ cDNA
(man)
W33210 +++ +++ +++ +++ +++ +++ gp55 & 
gp65
W39953 +++ +++ - +++ ++ ++ cDNA
(mouse)
W39956 + +++ ++ + ++ ++ HSP90
W36213 ++ +++ ++ ++ ++ +++ hET-BR
W35449 + + - - - + cDNA
(rat)
W36221 ++ +++ ++ +++ +++ +++ Kinesin
Cyclophilin +++ +++ +++ +++ +++ +++ /
Table 1.5.1 RT-PCR detection of RNA species, corresponding to EST sequences, in 
brain (P I6 ) and non-brain (PI5) tissues. Detection levels are arbitrarily identified as: 
+++, strong; ++, moderate; +, weak and -, not detected. Corresponding sequences 
(Sequence) are identified as: DCK, Deoxycytidine kinase (mouse); gp55 and gp65, 
glycoproteins 55 (rat) and 65 (rat) respectively; HSP90, 90 kD heat shock protein (mouse); 
hET-BR, endothelin receptor-type B (man); Kinesin, kinesin heavy chain (mouse). PCR 
primers designed to amplify sequence from the gene encoding cyclophilin, were utilised as 
a positive control for expression at all examined tissues.
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Figure 1.5.1 Examples of results from RT-PCR assays performed using 
RNA derived from brain and non-brain tissues (as described in Section 
1.5.1) with oligonucleotides designed to amplify sequence within the EST 
sequences: W33210 (Figure 1.5.1 A), Cyclophilin (Figure 1.5.1 B), 
W36221 (Figure 1.5.1 C) and W39953 (Figure 1.5.1 D). B: brain; S: 
Spinal cord; SP: Spleen; K: Kidney; T: Testis; L: Liver. P[n]: Post 
natal day
1.5.3 Qualitative RT PCR assay of postnatal expression in the CNS
In a subsequent endeavour to asses the temporal expression pattern of these ESTs, within 
CNS tissues; PCRs were performed on cDNAs from spinal cord and brain at a number of 
postnatal timepoints. Template cDNAs from spinal cord (PI, P4) and brain (P4, P5, P16, 
P43) were PCR amplified using primers utilised in 1.5.1 (listed in Table 1.5.2; defined in 
Table 1.3.1). The results of these PCRs are listed in Table 1.5.2.
That nine of the eleven EST sequences examined were detectable in the adult (P43) is not 
surprising; the library from which the ESTs were generated was prepared using 8 week 
old mice (Davies et a l,  1994). Of the six ESTs (W36259, W33240, W36135, W36139, 
W39953, W35449) demonstrating no homology to any previously identified gene 
sequence, transcripts corresponding to two (W33240 and W39953) were detected in the 
spinal cord (PI, P5) but remained undetected in the brain until P16 (Table 1.5.2). The 
amplified cDNA sequence corresponding to EST W35449 was only detected, in this assay, 
at timepoints P16 and P43 (Table 1.5.2). Transcripts, corresponding to ESTs W36259 and 
W36139, were detected at moderate to strong and weak levels respectively, at all 
timepoints examined (Table 1.5.2). Transcript sequence corresponding to EST W36135 
was not detected at any timepoint in this assay, nor was it detected in any tissue. This is 
not surprising; the library from which these ESTs were generated (Savioz and Davies,
1995) is enriched for low expression genes in the ventral midbrain and the brain cDNA 
utilised was prepared from whole brain RNA (Montague et a l, 1997). The cDNA species 
corresponding to EST W36135 may not have been represented amongst the template 
species utilised in the PCR, due to its very low representation amongst whole brain RNA. 
However, it may more simply reflect a failure of the PCR amplification step utilising the 
corresponding primer pair. PCR primers, designed to amplify sequence from the gene 
encoding cyclophillin were used as a control for invariant transcript levels (Montague et 
a l,  1997).
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Clone
Identification
Spinal Spinal 
cord (PI) cord(P5)
Brain
(P4)
Brain
(P5)
Brain 
(PI 6)
Brain
(P43)
Sequence
W36259 +++ +++ ++ ++ +++ +++ unknown
W33240 +++ ++ - - + ++ cDNA
(mouse)
W36135 - - - - - cDNA
(rat)
W39933 - - - - - +++ DCK
W36139 + + + + + + cDNA
(man)
W33210 ++ +++ - - + gp55 & 
gp65
W39953 + + - - +++ +++ cDNA
(mouse)
W39956 - - - - + - HSP90
W36213 +++ ++ ++ + + + hET-BR
W35449 - - - - + +++ cDNA
(rat)
W36221 ++ ++ ++ ++ +++ +++ Kinesin
Cyclophilin +++ +++ +++ +++ +++ +++ /
Table 1.5.2 RT-PCR detection of RNA species, corresponding to EST sequences, in 
CNS tissues of mice at six postnatal timepoints (P, Postnatal day). Detection levels are 
arbitrarily identified as: +++, strong; ++, moderate; +, weak and -, not detected.
Corresponding sequences (Sequence) are identified as: DCK, Deoxycytidine kinase 
(mouse); gp55 and gp65, glycoproteins 55 (rat) and 65 (rat) respectively; HSP90, 90 kD 
heat shock protein (mouse); hET-BR, endothelin receptor-type B (man); Kinesin, kinesin 
heavy chain (mouse). PCR primers designed to amplify sequence from the gene encoding 
cyclophilin, were utilised as a positive control for expression at all examined postnatal 
timepoints.
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W33240 Cyclophilin
W39933 W39952
Figure 1.5.2 Examples of results from RT-PCR assays performed using 
RNA derived from CNS tissues (PI, P4, P5, P I6, P17 and P43; as described 
in Section 1.5.2) with oligonucleotides designed to amplify sequence within 
the EST sequences: W33240 (Figure 1.5.1 A), Cyclophilin (Figure 1.5.1 B), 
W39933 (Figure 1.5.1 C) and W39952 (Figure 1.5.1 D). B: Brain; SC: 
Spinal cord. P/[n]: Post natal day.
1.5.4 Discussion
I have utilised RT-PCR in the detection of cDNA species corresponding to ESTs generated 
by the ongoing sequencing project (Stewart et al., 1996; Stewart et al., unpublished) and 
subsequently used in the establishment of a genetic mapping strategy for mouse ESTs 
(McCallion et al., 1996; McCallion et al., in press). This pilot study provides an initial 
and arbitrary screen. It establishes a sensitive, yet qualitative approach which provides 
information regarding the presence or absence of an RNA species in a tissue at a specific 
timepoint. Transcript corresponding to each EST has been sought in non-brain (spleen, 
kidney, testis and liver), PNS (sciatic nerve) and CNS (spinal cord; PI, P5 and brain; P4, 
P5, P16, P43). Transcript from the gene encoding cyclophilin is utilised throughout as a 
spatially and temporally invariant positive control (Montague et al., 1997).
Identification of transcript species present in all tissues examined is not surprising (Davies 
et al., 1994; Savioz and Davies, 1995). The data reported by Savioz and Davies (1995) 
suggest that only 1.16% of transcripts sought will correspond to genes with expression 
enhanced in the substantia nigra (SN) but not in other brain regions. No indication is 
given, however, with respect to what proportion may be expected to demonstrate brain 
restricted expression. The study further identifies a number of novel sequences that 
remain undetected in some tissues (W36259 and W35449) and in the brain at certain 
postnatal timepoints (W36135, W33240 and W39953).
The data generated by this study would suggest that tentative inferences may be made with 
respect to the library source and the ESTs generated from it. All but two transcript 
sequences sought were detected in the adult brain. This correlates with the use of adult 
mice in the library preparation. It does not, however, suggest that lack of detection equates 
to lack of transcript presence in the tissue. Detection of genes that are expressed, at low 
levels, in a tissue specific manner in the brain may require a more refined approach. For 
the information provided by such a screen to be dramatically enhanced, the utility of RNA 
from regionally dissected tissue e.g. brain; ventral midbrain, hippocampus, cerebellum, 
thalamus, pons etc. must be examined.
The number of EST sequences utilised in this pilot study is far too small to gain any 
insight into how well the expected composition (Savioz and Davies, 1995) of the library 
correlates with the observed. However, this study establishes that such a qualitative assay 
can be utilised to provide an arbitrary means of selection of sequences for further study i.e. 
in situ hybridisation (ISH), isolation and sequencing of full length cDNAs, protein 
prediction or functional study (gene disruption). Detection of a subset of transcripts
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expressed only in the brain, or more precisely only in specific brain regions, will provide 
one such platform for selection of sequences for further study.
I have also established a collaborative project with the laboratory of Dr M. Schalling 
(Karolinska Institute, Sweden) for the performance of ISH with probes designed to 
sequence derived from selected ESTs. This will provide an immediate assay, of spatial 
expression in the mouse brain, for any selected sequence arising out of this or related 
studies (genetic mapping) using this EST resource.
I l l
1.6 Discussion
These studies establish an efficient strategy for the genetic mapping of mouse ESTs. They 
also establish a qualitative RT-PCR screen of the temporal and spatial expression patterns 
of selected ESTs. The combined use of these strategies provides a firm foundation for the 
identification of gene candidates for involvement in known neuropathies, and in particular 
for neuropathies affecting the ventral midbrain e.g. Parkinson's disease.
1.6.1 Correl ation with disease
These studies have also established a number of noteworthy correlations with disease loci 
(refer to Section 1, 1.3). The ability to correlate map positions of expressed sequences 
with disease loci is widely accepted as a crucial step in the identification of a gene 
associated with a pathological process (Levitt, 1991; Wilcox et al., 1991; Polymeropoulos 
et al., 1992, 1993; Takahashi and Ko, 1993; refer also to Section 1,1.1). As described in 
Chapter 1, this form of candidate gene approach has already been validated (Gibson et al.,
1995) by its use in the successful identification of shaker 1 locus in mouse, and the 
subsequent demonstration (Well et a l, 1995) that the homologous gene in man is 
associated with Usher syndrome Type IB. Though the numbers of ESTs mapped in this 
study are small, it is expected that increasing the throughput of the mapping process will 
result in the provision of a significant number of gene sequences as candidates for 
involvement in known pathologies (refer also to Chapter 1; Section 1, 1.3 and Section 2, 
2 . 1-2 .2).
1.6.2 Future studies
1.6.2.1 Increasing the number of ESTs genetically mapped in the mouse
A total of 46 ESTs have been genetically mapped in this series of studies. A further 80 
primer pairs have been designed to sequence within the putative 3'UTRs of ESTs. The 
collaborative group, established during the process of these studies, have undertaken to 
genetically map in excess of 100 ESTs within the next six months. This author 
acknowledges that the availability of radiation hybrid DNA panels, for mapping the mouse 
genome, will in the future permit high throughput genetic mapping in mouse to become a 
reality. When such panels become available they will be utilised in association with 
available automated systems (robot workstations and multiwell plate systems) to increase 
the rate at which new ESTs are mapped. In the future, where possible, expressed 
sequences mapped in mouse will also be mapped in man and rat, aiding the development
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of a comparative gene map and improving access to mutations within all three species.
1.6.2.2 Increasing the information obtained from the qualitative RT-PCR assay of
the temporal and spatial expression patterns of selected ESTs
The establishment of a qualitative PCR screen, providing information regarding the 
presence or absence of an RNA species in a tissue at a specific timepoint, represents a 
distinct contribution to the establishment of an integrated gene map (defined and discussed 
in Chapter 1). This contribution will be further enhanced by the use of region specific 
tissues from the nervous system (refer also to discussion in Section 1, 1.5). Consequently, 
temporal and spatial expression data will be available for each EST, mapped by this 
collaborative unit, in the future.
1.6.3 Conclusion
These studies (Section 1, 1.2-1.5) represent a considerable contribution to the 
establishment of a gene map of the mouse genome. I established a technically feasible and 
efficient way to assay large numbers of expressed sequences with respect to their position 
in the mouse genome, and their temporal and spatial expression patterns. The PCR-SSCP 
assay, developed in this study, is currently being utilised for the genetic mapping of ESTs 
in mouse (Guenet laboratory; Institut Pasteur, Paris) and rat (Serikawa laboratory; Kyoto, 
Japan).
113
Section 2
2.1 Introduction
2.1.1 Identification and study of a gene encoding a novel major myelin
component
The single gene Mobp encodes the novel major myelin component myelin-associated 
oligodendrocytic basic protein (MOBP) (Yamamoto et al., 1994; Holz et al., 1996). As 
described in Chapter 1 a cDNA fragment, corresponding to a portion of 3' UTR within 
Mobp, was first identified among cDNAs derived from substantia nigra and striatum 
(Davies et al., 1994; Savioz and Davies, 1995). Like Mbp, the Mobp gene encodes a 
family of related oligodendrocyte specific basic proteins of 69, 71, 81, 99 and 170 amino 
acids (Yamamoto et al., 1994; Holz et al., 1996; Montague et al., 1997a). These protein 
isoforms correspond to predicted Mr values of 8.2, 8.4, 9.7, 11.7 and 19 kD respectively 
(Yamamoto et al., 1994; Holz et al., 1996). Antibodies raised against the common N- 
terminal (aa 1-68), shared by all previously identified MOBP isoforms, identified bands on 
western blots larger than those predicted from their respective cDNA sequences 
(Yamamoto et al., 1994; Holz et al., 1996). The reason for these discrepancies in Mr 
values has not yet been elucidated but is thought likely to be a consequence of post- 
translational modification of the protein isoforms (Holz et al., 1996; Montague et al., 
1997a). Though all isoforms thus far identified (Yamamoto et al., 1994; Holz et al., 1996; 
Montague et al., 1997a) share in common amino acid residues 1-68, they differ in the 
length and polarity of their respective C-terminal regions (Holz et al., 1996; Montague et 
al., 1997a). The predicted MOBP protein isoforms are, like MBP, basic, hydrophilic and 
positively charged (Yamamoto et al., 1994; Holz et al., 1996). Like MBP, MOBP lacks a 
signal peptide and is predicted to be an extrinsic membrane associated protein (Yamamoto 
et al., 1994; Holz et al., 1996; Montague et al., 1997a). MBP binds the negatively charged 
acidic phospholipids of the cytoplasmic membrane, an interaction known to stabilise the 
structure of myelin (Roach et al., 1985; Mikoshiba et al., 1991). MOBP has been shown 
to localise in the MDL of compact CNS myelin (Yamamoto et al., 1994; Montague et al., 
1997a) in a manner similar to MBP. It has been suggested that MOBP may play a role in 
compacting or stabilising the myelin sheath (Yamamoto et al., 1994; Holz et al., 1996; 
Montague et al., 1997a). A recent study (Montague et al., 1997b), which evaluated MOBP 
expression in the myelin mutant shiverer, has demonstrated that the 20 kD MOBP isoform 
is significantly reduced in the brain of shiverer mice when compared with wild-type 
animals. This suggests that any role that MOBP plays in the compaction of myelin may be 
secondary to or dependant on MBP. This suggestion is strengthened by the results of
115
recent study (Montague et a l, 1997a) which demonstrated that MOBP was barely 
detectable in the jimpy mutant mouse, which exhibits severe hypomyelination. However, 
these studies do not exclude MOBP from a role in stabilising myelin via interactions with 
MBP, cytoskeletal or other membrane molecules. Another recent study (Montague et al., 
1997a) has also demonstrated that MOBP colocalises with the microtubular network of 
oligodendrocytes.
In total the reports by Yamamoto (1994) and Holz (1996) have identified 6  Mobp splice 
variants, in the rat. Published data (Yamamoto et al., 1994; Holz et al., 1996; 
Montague et al., 1997a) indicate that the Mobp transcriptional unit is subject to a 
complex series of alternative splicing events (refer also to discussion in Section 2, 2.3).
In situ hybridisation studies (Montague et a l, 1997) have demonstrated that individual 
splice variants, of the Mobp mRNA, can be detected in the ventral columns of the 
spinal cord around postnatal day 1 (PI). Further evidence supporting the proposed role 
for the Mobp gene product in myelination is found in the fact that the temporal 
occurrence of the Mobp transcript correlates closely with the assembly of myelin 
sheaths (Yamamoto et al., 1994; Holz et al., 1996; Montague et a l, 1997a). 
Furthermore, the caudal to rostral progression of signal, corresponding to the Mobp 
transcript, with respect to time, in the postnatal brain, also parallels the spatial and 
temporal presence of Mbp transcript (Kirstensson et a l, 1986), and the progress of 
myelination.
Two of the reported splice variants {Mobp 81A and Mobp 8 IB; Holz et al., 1996) 
encode the same MOBP isoform. These transcripts differ only in their respective 
3'UTRs. It is noteworthy that these transcripts localise to different parts of the 
oligodendrocyte (Holz et a l, 1996; Montague et a l, 1997) and it has been suggested 
that, as suggested for Mbp RNAs (Brophy et a l, 1993), their respective 3'UTRs may 
contain transport signals (Holz et a l, 1996). The Mobp transcript may be transported 
to the oligodendrocyte processes for translation on free ribosomes (Holz et al., 1996; 
Montague et a l, 1997), in a manner similar to Mbp RNAs (Colman et a l, 1982). It has 
also been suggested that the differential localisation of transcripts may also be 
influenced by oligodendrocyte maturity (Montague et a l, 1997). The report by 
Montague et a l, (1997) also demonstrates that, as with other myelin genes {Pip, Mbp, 
Cnp and Mag), Mobp splice variants are detectable differentially during development.
It is noteworthy that the splice variant encoding MOBP 170 can be detected at 
embryonic day 12 (E l2) (Montague et al., 1997), whereas the other identified splice
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variants are only detectable in the postnatal brain (Montague et al., 1997). This 
suggests that MOBP 170 may have a function alternative or additional to involvement 
in myelination (Montague et al., 1997).
Myelin-associated oligodendrocytic basic protein (MOBP) is a major CNS myelin 
component. Therefore mutations in the gene encoding it might well underlie an 
inherited CNS neuropathy, and/or a known mouse neurological mutation. In order to 
evaluate the possible role of the Mobp gene product in known neuropathies I have 
undertaken the series of studies reported in Section 2 (2.2-2.6). Firstly, I have 
genetically mapped the Mobp gene in the mouse (McCallion et al., 1996). Secondly, in 
order to elucidate the complex splicing events required to generate the known splice 
variants of the Mobp gene transcript and to provide a platform for the functional 
analyses of the Mobp gene product, I have examined the genomic organisation of the 
mouse gene. I have also examined the correlation between the Mobp gene structure 
and the production of the identified splice variants (Yamamoto et al., 1994; Holz et al., 
1996; Montague et al., 1997a). Lastly, I have used the information obtained from these 
studies to pursue a gene disruption strategy in an endeavour to begin to elucidate the 
function of this novel gene.
Multiple sclerosis is a major human demyelinating disease which preferentially affects 
CNS myelin. Multiple sclerosis is generally accepted to be an autoimmune disorder, 
but the autoantigen(s) responsible is not known (Martyn, 1991; Allen and Brankin, 
1993; Steinman, 1996). Oligodendrocyte-specific myelin proteins are particularly 
interesting in this context (Yamamoto et al., 1994; Holz et al., 1996; Montague et al., 
1997a). The Mobp gene product is expressed exclusively in the CNS, and is therefore 
an interesting candidate gene for further study in relation to multiple sclerosis (refer 
also to discussion in Section 2, 2.7).
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2.2 Genetic mapping of the murine gene (Mobp) encoding myelin-
associated oligodendrocytic basic protein
2.2.1 Establishment of an SSCP assay
An initial series of PCRs, that did not involve incorporation of a radioactive 
deoxyribonucleotide (dNTP), were performed to establish optimal amplification conditions 
for primers ASM 215 F/R (defined; Table 2.4, Chapter 2) on mouse genomic DNA (Mus 
spretus; SEG/Pas). These primers were observed to provide a single product of the 
appropriate size (205 bp) as determined by electrophoresis in 2.5% agarose gels under the 
PCR conditions given in Chapter 2. The identity of the PCR product was confirmed by 
sequencing, as described in Chapter 2. A PCR, incorporating the radioactive
deoxyribonucleotide a P ^ d C T P  was then performed on the parental (C57BL/6 and
SEG/Pas) DNA templates. The products were separated by electrophoresis in a non­
denaturing gels for SSCP assessment (as described in Chapter 2) and subsequently 
visualised by autoradiography. SSCP analysis identified a clear polymorphism 
discriminating between parental strains (Figure 2.2.1, lanes 1-3). It should be noted that 
the Mus spretus mice utilised by the EUCIB originate from 2 subpopulations: SEG/Pas 
and SPR (Breen et al., 1994) and provide correspondingly distinct SSCP band patterns. In 
the case of this Mobp PCR product the two Mus spretus strains both differed clearly from 
C57BL/6, and from one another (Figure 2.2.1, lanes 1-3).
2.2.2 Chromosomal assignment
Radioactively labelled PCR and SSCP analysis (PCR-SSCP*) were performed on a panel 
of 21 DNAs. This panel included 19 DNAs from the N4 generation of the consomic 
breeding programme (described in Section 1, 1.1) and both the parental strains with which 
the programme was initiated (C57BL/6 and Mus spretus [SEG/Pas]). No heterozygotes 
were observed amongst the panel of N4 DNAs. This result implicated one of 6  regions 
known to be uninformative amongst this panel, since the corresponding regions of Mus 
spretus (SEG/Pas) DNA were not present in this N4 set: Chromosome (Chr 7) 7, 15-51 
cM; Chr 8 , region 4.6-35 cM; Chr 9, 31 cM-Telomere; Chr 10, 46-64 cM; Chr 11, 2-37 
cM and Chr X centromere - 3 cM. Subsequently, PCR-SSCP* analysis was performed on 
a panel of DNAs including 19 DNAs from the N2 generation and both parental strains. 
The SSCP typing results for amplification of these DNAs with the PCR primers ASM 215 
F/R (defined; Table 2.4, Chapter 2) can be seen in Figure 2.2.1. These data were then 
entered into a Genelink analysis programme (Montagutelli, 1988) containing all of the
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available N2 generation typing data for all anchor loci utilised in the generation of the 
consomic lines. The segregation pattern implicated chromosome 9 alone.
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Figure 2.2.1 An example of the genetic linkage analysis, providing chromosomal 
allocation, of a novel EST using intermediate generation of the breeding programme to 
generate a consomic panel. Shown are PCR*-SSCP analyses of a 205 bp fragment within 
the 3'UTR of Mobp, using as template the parental strain DNAs (M.spretus SEG/Pas, 
SPR and C57BL/6, lanes 1, 2 and 3 respectively), DNA minus control (Lane 4) and 19 
DNAs, from the N2 generation of the breeding program to generate a set of consomic lines 
with one Mus spretus (SEG/Pas) chromosome each on a C57BL/6 background (Lanes 5- 
23). The clear mobility difference between the parental strains readily allows distinction 
between the homozygote (e.g. lane 6) and heterozygote (e.g. lane 12) patterns.
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2.2.3 Determination of genetic map location
A EUCIB subset panel of 8 animals was selected from the Mbx database (http://www. 
hgmp.mrc.ac.uk/MBx/MBxHomepage.html). The recombination events between anchor 
markers for these animals had been well characterised and subdivided chromosome 9 into 
4 regions. PCR-SSCP* analysis was performed on the DNAs from this panel. The 
segregation pattern (Figure 2.2.2) observed for Mobp (ASM 215 F/R; Table 2.3, Chapter 
2), shown in Figure 2.2.2 and listed in Table 2.2.1, implicated the region between 
D9Mit24 and the telomere.
2.2.3.1 Position between anchor loci
A second EUCIB subset panel was then selected from the Mbx database. This panel 
included 17 DNAs non-recombinant between D9Mit24 andD 9M itl9  and 17 DNAs 
(defined by suffix *; Table 2.2.1) demonstrating recombination events within this region. 
These DNAs were selected to establish the position of Mobp relative to D9Mit24 and 
D9Mitl9 , i.e. whether Mobp was situated between these markers or telomeric to D9Mitl9 
(the final EUCIB anchor marker for chromosome 9). The segregation pattern among this 
limited DNA set demonstrated that in animals non-recombinant for the region D9Mit24 to 
D9Mitl9 no recombination events were observed between Mobp and either marker but that 
among animals demonstrating recombination events within this region, several 
recombination events were observed between Mobp and D9Mit24 (Table 2.2.1).
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Figure 2.2.2 Location of Mobp to a subdivision of chromosome 9 using the EUCIB 
panel. Shown are PCR*-SSCP analyses of a 205 bp fragment within the putative 3'UTR 
of Mobp, using as template the parental strain DNAs (M.spretus SEG and C57BL/6) 
lanes 1 and 2 respectively and a subset panel of 9 DNAs from EUCIB resource (Lanes 3- 
11). The clear mobility difference between the parental strains readily allows distinction 
between the homozygote (e.g. lane 6) and heterozygote (e.g. lane 11) patterns. Refer also 
to Table 2.2.1. N.B. Lane 3 corresponds to PCR-SSCP assay performed using DNA from 
the EUCIB resource which used the M. spretus substrain SEG/Pas as the Mus spretus 
parent. Lanes 4-11 correspond to PCR-SSCP assays performed using DNAs from the 
EUCIB resource which used the M. spretus substrain SPR as the Mus spretus parent. The 
difference in electrophoretic mobility between single-stranded DNA molecules deriving 
from these two backcross sources is evidence of a strain difference between Mus spretus 
SEG/Pas and Mus spretus SPR (refer also to Discussion 2.2.6) within the amplified 
sequence.
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DNAs with known recombination events within Chromosome 9
Marker Marker
Location
LS061 LB 118 LB 104 LS348 LB050 LB 165 LB 112 LB 113
D9Mit42 8cM l a 2 2 1 2 1 2 1
D9NdslO 21cM 2a 1 2 1 2 1 2 1
D9Nds8 28cM 2 1 1 2 2 1 2 1
D9Mit24 52cM 2 1 1 2 1 2 2 1
D9Mitl9 66cM 2 1 1 2 1 2 1 2
Mobp - 2 1 1 2 1 2 1 2
Table 2.2.1 Location of Mobp to a subdivision of chromosome 9. The typing data 
displayed above, for 5 EUCIB anchor markers on chromosome 9, clearly subdivide the 
chromosome into 4 regions. The PCR-SSCP alleles of the mouse gene Mobp demonstrate 
the same segregation pattern as marker D9Mitl 9, thus allocating Mobp to the region
between D9Mit24 and the telomere. al and 2 correspond to homozygote and heterozygote 
SSCP patterns respectively.
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2.23.3 Localisation of Mobp within the interval D9Mit24 - D9M itl9
The segregation pattern observed indicated that Mobp is situated between D9Mit24 and 
D9M itl9. The recombination events within this panel more specifically implicated the
region between C ol7al and D 9M itl9. The Mbx database (http://www.hgmp.mrc.
ac.uk/MBx/MBxHomepage.html) indicated that 42 DNAs had been typed for this region,
using C ol7a l, of which 33 demonstrated recombination events in the interval. This was
considered insufficient for accurate localisation. Consequently animals recombinant in the 
region D9Mit24 to D9Mitl9 were chosen.
952 animals had been typed for this region, providing 126 recombinants between D9Mit24
and D9Mitl9, including 33 known recombinants between Col7al and D9M itl9. All 126
samples provided interpretable results. The segregation pattern observed indicated that the 
Mobp gene is situated between D9Mit24 and D9Mitl9. Recombination events between 
D9Mit24 and Mobp indicated that Mobp was located at a distance from D9M it24, 
equivalent to 84.1% (106/126) of that between D 9M it24  and D 9M itl9 , while 
recombination events between D9Mitl9 and Mobp indicated that Mobp was located at a 
distance distance from D9Mitl9, equivalent to 15.9% (20/126) of that between D9Mit24 
and D9Mitl9. These data (Table 2.2.2) place Mobp 2.2 cM (±lcM) proximal to D9Mitl9 
(Figure 2.2.3).
2.2.3.4 Genotyping of a new EUCIB anchor marker D9Mit55
In an endeavour to further refine the map position allocated to Mobp, the marker D9Mit55 
was also mapped relative to D9MU24 and D 9M itl9  using the same DNA panel. 107 
samples provided interpretable results. Recombination events between D9Mit24 and 
D9Mit55 were 42% (45/107) of those observed between D9MU24 and D9Mitl9, while 
recombination events between D 9 M itl9  and D9Mit55 were 58% (62/107) of 
recombination events between D9Mit24 and D9M itl9. These data (Table 2.2.3) place 
D9Mit55 8.1 cM proximal to D9Mitl9, and thus 5.9 cM proximal to Mobp. It should be 
noted that both D9Mit55 and Mobp may now be used as anchor loci on the EUCIB panel 
(Figure 2.2.3) and have been their associated data have been submitted to the Mbx 
database (http://www.hgmp.mrc.ac.uk/MBx/MBxHomepage.html).
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Cen tr o m e r e
8cM - D 9 M H 4 2
2 1 cM ' D 9 N d s l O
2 8cM ' D 9 N d s 8
5 2cM '
5 . 9 c M
11 . 8  cM
5 S c M
6 3 . 8  c M —  < l c M
2 . 2  cM
6 6 c M '
D 9 M it2 4
C ol7-a lphal  ( 5 4 ±  >6cM )
D 9 M it5 5  5 7 . 9  ± < l c M
M o b p
D 9 M i t l  9
Figure 2.2.3 Genetic map of mouse chromosome 9 based on the Mbx database 
(http://www.hgmp.mrc.ac.uk/MBx/MBx Homepage.html) showing the location of the 
Mobp gene encoding myelin-associated oligodendrocytic basic protein. The distances 
given to the left of the map are based on recombination estimates of Mobp and D9Mit55 
loci typed using the EUCIB DNA panel (Table 2.2.2 and Table 2.2.3).
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EUCIB
DNA
Genotype X-over EUCIB
DNA
Genotype X-over EUCIB
DNA
Genotype X-over
LB 112* a l Yes LSI 93 2 Yes LS813 / /
LB113* a 2 Yes LSI 96 2 Yes LS815 2 No
LB 147* a/ / LSI 97 1 Yes LS817 / /
LB 159* / / LS217 2 No LS818 2 Yes
LB 162 / / LS229 1 Yes LS819 1 No
LB 164 Yes LS230 1 Yes LS821 1 No
LB207* 1 Yes LS258 2 Yes LS832 1 Yes
LB211* / LS261 2 Yes LS854 / /
LB234* Yes LS265 2 No LS8 6 8 1 Yes
LB236* / / LS266 2 Yes PB017 2 No
LB245* 1 No LS276 / / PB024 1 No
LB290* Yes LS326 1 Yes PB063 1 Yes
LB303* 1 Yes LS331 2 Yes PB064 1 Yes
LB309 1 Yes LS371 2 Yes PB074 1 Yes
LB350 1 Yes LS404 1 Yes PB075 2 No
LB389* 1 Yes LS448 1 Yes PB080 1 Yes
LB398 Yes LS452 2 Yes PB086 2 Yes
LB409* Yes LS458 2 Yes PB113 / /
LB424* / / LS462 2 Yes PB125 2 Yes
LB443* / / LS470 1 Yes PB130 2 Yes
LB506* 1 Yes LS492 / / PB136 2 Yes
LB509* / / LS552 1 Yes PB144 1 Yes
LB511 / / LS554 2 Yes PB162 2 No
LB514 1 No LS559 1 Yes PB171 2 Yes
LB521 Yes LS569 2 Yes PB194 / /
LB 528 1 Yes LS577 1 No PB195 1 Yes
LB529 Yes LS579 2 No PB201 1 Yes
LB 542 1 No LS583 2 Yes PB202 2 Yes
LB 545 1 No LS586 2 Yes PB223 2 Yes
LB591 2 Yes LS589 1 Yes PB233 1 Yes
LB592 2 No LS704 1 Yes PB238 2 Yes
Table 2.2.2
EUCIB
DNA
Genotype X-over EUCIB
DNA
Genotype X-over EUCIB
DNA
Genotype X-over
LB598 2 Yes LS714 2 Yes PB245 2 Yes
LB613 2 Yes LS726 1 Yes PS 003 / /
LB615 1 No LS728 2 Yes PS 009 1 Yes
LS025 2 Yes LS730 1 Yes PS013 1 Yes
LS094 1 Yes LS731 1 Yes PS017 / /
LS095 / / LS758 1 Yes PS049 1 Yes
LSI 22 2 Yes LS762 1 Yes PS050 2 Yes
LSI 27 1 Yes LS767 Yes PS051 1 Yes
LS151 2 Yes LS776 1 Yes PS056 1 Yes
LSI 54 1 Yes LS777 1 Yes PS061 2 Yes
LS178 2 Yes LS782 1 Yes PS062 1 No
LS191 2 Yes LS808 1 Yes PS066 2 Yes
Table 2.2.2 continued. Localisation of Mobp between EUCIB anchor markers D9Mit24 
and D9M itl9. The data displayed above are for the PCR-SSCP* typing of Mobp (ASM 
215; defined in Table 2.3, Chapter 2) on DNAs demonstrating recombination events in the 
interval D9Mit24 - D9Mitl9. a l, a2 and a/ correspond to homozygote, heterozygote and 
non-informative SSCP patterns respectively. X-over, recombination event.
EUCIB
DNA
Genotype X-over EUCIB
DNA
Genotype X-over EUCIB
DNA
Genotype X-over
LB 112 a l Yes LSI 93 1 No LS813 1 No
LB113 a 2 Yes LS196 2 Yes LS815 / /
LB 147 a/ / LSI 97 2 No LS817 No
LB 159 2 No LS217 2 No LS818 1 No
LB 162 2 / LS229 1 Yes LS819 / /
LB 164 2 Yes LS230 2 No LS821 / /
LB 207 / / LS258 / LS832 No
LB211 / / LS261 / / LS854 / /
LB234 2 Yes LS265 / / LS8 6 8 / /
LB236 / / LS266 / / PB017 No
LB 245 / / LS276 / / PB024 1 No
LB 290 1 No LS326 No PB063 1 Yes
LB303 2 No LS331 1 No PB064 1 Yes
LB 309 1 Yes LS371 1 No PB074 1 Yes
LB350 1 Yes LS404 1 Yes PB075 Yes
LB389 1 Yes LS448 No PB080 No
LB398 2 No LS452 1 No PB086 / /
LB409 2 Yes LS458 Yes PB113 / /
LB 424 / / LS462 / PB125 1 No
LB443 / / LS470 / PB130 / /
LB 506 1 Yes LS492 / PB136 1 No
LB509 2 No LS552 1 Yes PB144 2 No
LB511 1 No LS554 / PB162 2 No
LB514 1 No LS559 / PB171 2 Yes
LB521 2 Yes LS569 Yes PB194 / /
LB528 2 No LS577 / PB195 1 Yes
LB529 1 No LS579 / PB201 1 Yes
LB 542 / / LS583 1 No PB202 1 No
LB 545 / / LS586 2 Yes PB223 2 Yes
LB591 2 Yes LS589 2 No PB233 1 Yes
LB592 2 No LS704 2 No PB238 1 No
Table 2.2.3
EUCIB
DNA
Genotype X-over EUCIB
DNA
Genotype X-over EUCIB
DNA
Genotype X-over
LB598 1 No LS714 2 Yes PB245 2 Yes
LB613 2 Yes LS726 2 No PS003 2 No
LB615 / I LS728 / / PS009 2 No
LS025 / I LS730 1 Yes PS013 1 Yes
LS094 1 Yes LS731 1 Yes PS017 1 No
LS095 / / LS758 / / PS 049 / /
LSI 22 / / LS762 / / PS050 1 No
LSI 27 1 Yes LS767 2 Yes PS051 1 Yes
LS151 2 Yes LS776 1 Yes PS056 1 Yes
LSI 54 1 Yes LS777 1 Yes PS061 1 No
LS178 2 Yes LS782 2 No PS062 1 No
LS191 LS808 2 No PS066 2 Yes
Table 2.2.3 Localisation of D9Mit55 between EUCIB anchor markers D9Mit24 and 
D9Mitl9. The data displayed above are for the PCR typing of a microsatellite sequence 
defined by the marker D9Mit55 (ASM B667 F/R; defined in Table 2.3, Chapter 2) on 
DNAs demonstrating recombination events in the interval D9Mit24 - D9Mitl9. a l, a2 and 
a/ correspond to homozygote, heterozygote and non-informative SSCP patterns 
respectively. X-over, recombination event.
2.2.4 Association with known neurological mutations in mouse and man
These data show that the Mobp gene encoding mouse myelin-associated oligodendrocytic 
basic protein is located centromere-distal on chromosome 9 at 63.8 cM ± <1 cM (Figure 
2.2.3), in a region containing three uncharacterised mouse neurological mutations which 
are located in the corresponding region of the Mouse Genome Chromosome 9 consensus 
map (Encyclopedia of the Mouse Genome, release 3, http://www.informatics.jax.org.). 
These mutations are: tippy (Lane, 1984); spinner (Deol and Robins, 1962) and ducky 
(Snell, 1955), of which ducky is the only mutant for which myelin deficiency has been 
reported as a phenotypic component.
2.2.5 Examination of possible involvement in the neurological mutant ducky (du)
The mouse mutant du has been mapped centromere proximal to the marker D9Mit55 
(Frankel, pers. comm.). The position of D9Mit55, which is not one of the EUCIB anchor 
markers, was previously unknown with respect to Mobp. Thus, genotyping of this marker, 
using the same panel of DNAs as Mobp, permits direct comparison of the loci. These data 
(Tables 2.2.2 and 2.2.3 and Figure 2.2.3) clearly place D9Mit55 and as a consequence the 
du locus, in a position proximal to Mobp and thus excludes the possibility of Mobp 
involvement in the du pathology.
2.2.6 Discussion
I have mapped the gene {Mobp) encoding the mouse homologue of M obp  to distal 
chromosome 9 (Figure 2.2.3). The data locate Mobp at 63.6 cM from the centromere 
(±lcM ). Comparison of data listing known recombination events between marker 
(D9Mit24, D9Mit55 and D9Mitl9) loci, and those data generated by the genotyping of the 
Mobp marker (ASM 215 F/R) indicate that Mobp lies between D9Mit55 and D9MU19. 
The accuracy of the map position provided by the analysis of these data approaches the 
limit of precision afforded, by the EUCIB resource, to this region of the mouse genome at 
this time. The map distances and location of Mobp have been assigned using the linkage 
analysis programs provided by the Mbx database (http://www.hgmp.mrc.ac.uk/MBx/MBx 
Homepage.html) and Genelink software (Montagutelli, 1988). Also, Mobp has been 
placed on the map provided by the Mbx analysis of EUCIB DNAs. This mapping facility 
is the most precise and largest purpose bred mouse mapping resource presently available 
(Breen et al, 1994). Discordances are evident between map positions assigned to anchor 
loci on EUCIB and Jackson Laboratory maps (Encyclopedia of the Mouse Genome,
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release 3, http://www.informatics.jax.org.). Such discordances predict that new loci 
mapped on the EUCIB panel can only tentatively be matched with known loci placed on 
the map according to the Jackson Encyclopedia of the mouse genome and vice versa.
The consomic line breeding programme was initiated to provide a stable and less limiting 
source of DNA for the immediate chromosomal allocation of new markers within the 
mouse genome. The progressive manner in which each generation is typed, for anchor 
markers, reduces the loss of DNA in screening final generations (refer also to Section 1, 
1.1.3; Guenet, pers. comm.). For those considering the development of such consomic 
lines in other organisms it should be noted that our results show that typed DNA from 
early backcross generations can be used for chromosomal allocation.
This study also raises questions of relevance to researchers utilising SSCP and EUCIB 
DNAs in mapping. As discussed in section 1.3, the differing motility of single-stranded 
amplification products from SPR and SEG/Pas Mus spretus subpopulations (Figure 2.2.2) 
is not unexpected; the report by Breen et al. (1994) notes the occurrence of sequence 
variants between these Mus spretus subpopulations. In the case of Mobp, all three parental 
strains differed in band mobility in the SSCP assay. Researchers intending to use SSCP 
with the EUCIB DNAs should be aware of this and the resulting possibility of a reduction 
in the available precision in mapping. The extent to which precision may be lost is 
dependent on the number of progeny available, from the informative subspecies, for a 
region of interest (refer also to the discussion of Section 1.3).
The map position assigned to Mobp by this study (Figure 2.2.3) and its situation between 
D9Mit55 and D9Mitl9 suggests that it is closely linked to 3 known neurological mutations 
in the corresponding region on the Jackson map (Encyclopedia of the Mouse Genome, 
release 3, http://www.informatics.jax.org.). The published genetic mapping data available 
for these mutants was inadequate to allow exclusion of allelism with Mobp and further 
work is required for most. However, the possibility of Mobp involvement in du pathology 
has been excluded by this study. It is also noteworthy that a new insertion mutation with a 
transient dysmyelination phenotype maps to distal chromosome 9 (Orian et al., 1994). The 
corresponding region of synteny to distal mouse chromosome 9 in the human genome 
includes chromosome 3p21-22. The only identified inherited human neurological disorder 
associated with a gene in the 3p21-22 region is gangliosidosis, which has been shown to 
correlate with mutations in the gene encoding beta-galactosidase (Shows et al., 1979). 
However, the human gene encoding Mobp will be a candidate for involvement in CNS 
neuropathies found to be linked with this region in the future.
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2.3 Analysis of Mobp splicing patterns by sequence comparison
2.3.1 Comparison of all published Mobp sequences derived from rat data
Recent reports by Yamamoto et al. (1994) and Holz et al. (1996) have identified six splice 
variants of the Mobp transcript, in rat, generated by the novel gene Mobp encoding myelin- 
associated oligodendrocytic basic protein. Yamamoto et al. (1994) identified 2 messenger 
RNA species (rOPl and rOPRPl) encoding polypeptides of 71 and 170 amino acids 
respectively. Subsequently, Holz et al. (1996) reported a further four splice variants 
(MOBP 69, 81 A, 8 IB and 99) encoding polypeptides of 69, 81 and 99 amino acids 
respectively. The latter study, by Holz et al. (1996), notes that the isolated transcripts have 
their 5' regions in common. This common region encodes amino acids 1-68 of all the 
proteins predicted to be translated from the Mobp splice variants. The aim of this study 
was to assess whether any sequence units, other than that reported (Holz et al., 1996), were 
shared amongst the published transcripts (Yamamoto et al., 1994; Holz et a l, 1996). This 
required the performance of sequence alignments (Figure 2.3.1) comparing all the rat 
Mobp transcript sequences published in the reports of Yamamoto et al. (1994) and Holz et 
al. (1996).
2.3.1.1 Generation of a sequence multi-alignment of published Mobp sequences 
derived from rat
Sequences were imported to the Genejockey software (Cambridge, Biosoft), from the 
database according to their EMBL accession numbers (defined in table 2.3.1) and aligned 
by eye within the Genejockey sequence multialignment feature. Figure 2.3.1 illustrates the 
results of this analysis. Exonic sequence units are arbitrarily defined using the nucleotide 
numbers listed above the sequence and are identified in Table 2.3.2. Though the 
numbering of exonic sequence units (Q-Z) is purely arbitrary and cannot infer the exact 
order or number of exons comprising the Mobp gene, the order of some exonic segments 
may be deduced: R is downstream of Q; V is downstream of T and U; X is downstream 
of W; Y is downstream of V and Z is downstream of Y. Nothing, however, can be 
inferred about the linear relationship between H and I or indeed about the linear 
relationship between S and T-Z. Table 2.3.3 demonstrates that certain sequence units (V, 
X, Y, Z), downstream of B (encoding amino acids 1-68, shared by all MOBP isoforms), 
are shared by two or more of the published transcripts. Exonic segment V is transcribed in 
the generation of Mobp 71 (rOPl; Yamamoto et al., 1994), Mobp 69, Mobp 81A and 
Mobp 8 IB; exonic segment X is transcribed in the generation of Mobp 69 and Mobp 8 IB
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and exonic segment Z is transcribed in the generation of Mobp 71, Mobp 81A and Mobp 
99. This result reinforces the suggestion that the Mobp gene undergoes a complex series 
of splicing events (Holz et al., 1996) in order to generate the variety of protein isoforms 
and 3' UTRs predicted by transcript sequences (Yamamoto et al., 1994 and Holz et al., 
1996).
2.3.1.2 Prediction of exon/exon junctions
The 5' and 3' end sequences of the exonic segments (Q-Z) are defined in Table 2.3.4. It is 
noteworthy that four of the seven exonic segments (Q, R, U and Y), not terminating in 
polyadenylation signals, contain the exonic sequence portion (C/AAGI) of the extended 5' 
splice donor sequence (C/A)AGIGT(G/A)AGT (where the exon/intron boundary is 
denoted by the vertical line). The remaining three exonic segments (T, V and W) contain 
corrupted 5' donor sequences (T/GAGI) though it should be noted that this sequence is not 
highly conserved (Smith et al., 1989). The DNA sequences across these putative 
exon/exon boundaries are defined in Table 2.3.4 and the encoded amino acid sequences 
are indicated in three-letter code. The amino acid sequence is numbered (1-68) from the 
first residue of the isoform MOBP 81 (Holz et al., 1996) and from that point continues in 
accordance with the amino acid sequence of the individual isoform (Table 2.3.4). The 
predictions of exon/exon junctions, made on the basis of sequence comparison, indicate 
that R provides the first two nucleotides of the codon encoding amino acid residue 69, 
which may be Serine or Arginine dependent upon which downstream exonic segment, R is 
subsequently spliced to (Table 2.3.4).
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Contig# 1 TATCCACAGGGAACCTTTCACAGCAGCCAATACCTGCAGGGCAACAAAGAATCAAATGAGAGCGAGACA 
rOPRPl TGAGAGCGAGACA
MOBP69 TATCCACA GGAACCTTTCACAGCAGCCAATACCTGGAGGGCAACAAAGAATCAAATGAGAGCGAGACA 
rOPl TGAGAGCGAGACA
MOBP8 IB AGGGAACCTTTCACAGCAGCCAATACCTGCAGGGCAACAAAGAATCAAATGAGAGCGAGACA
MOBP81A CTTTCACAGCAGCCAATACCTGCAGGGCAACAAAGAATCAAATGAGAGCGAGACA
MOBP99 GCCAATACCTGCAGGGCAACAAAGAATCAAATGAGAGCGAGACA
70 80 90 100 110 120 130
Contig# 1 AGCTGGGAATGAAGTCCTGGTTGCCAGATGGGAGCTTGAAAACACAGTAAGATGAGTCAAAAAGTGGCC 
rOPRPl AGCTGGGAATGAAGTCCTGGTTGCCAGATGGGAGCTTGAAAACACAGTAAGATGAGTCAAAAAGTGGCC
MOBP 6 9 AGCTGGGAATGAAGTCCTGGTTGCCAGATGGGAGCTTGAAAACACAGTAAGATGAGTCAAAAAGTGGCC
rOPl AGCTGGGAATGAAGTCCTGGTTGCCAGATGGGAGCTTGAAAACACAGTAAGATGAGTCAAAAAGTGGCC
MOBP8 IB AGCTGGGAATGAAGTCCTGGTTGCCAGATGGGAGCTTGAAAACACAGTAAGATGAGTCAAAAAGTGGCC
MOBP81A AGCTGGGAATGAAGTCCTGGTTGCCAGATGGGAGCTTGAAAACACAGTAAGATGAGTCAAAAAGTGGCC
MOBP9 9 AGCTGGGAATGAAGTCCTGGTTGCCAGATGGGAGCTTGAAAACACAGTAAGATGAGTCAAAAAGTGGCC
140 150 160 170 180 190 200
Contig# 1 AAGGAGGGCCCCAGGCTCTCCAAGAACCAGAAGTTCTCAGAGCACTTCAGCATCCACTGCTGCCCACCC 
rOPRPl AAGGAGGGCCCCAGGCTCTCCAAGAACCAGAAGTTCTCAGAGCACTTCAGCATCCACTGCTGCCCACCC
MOBP 6 9 AAGGAGGGCCCCAGGCTCTCCAAGAACCAGAAGTTCTCAGAGCACTTCAGCATCCACTGCTGCCCACCC
rOPl AAGGAGGGCCCCAGGCTCTCCAAGAACCAGAAGTTCTCAGAGCACTTCAGCATCCACTGCTGCCCACCC
MOBP8 IB AAGGAGGGCCCCAGGCTCTCCAAGAACCAGAAGTTCTCAGAGCACTTCAGCATCCACTGCTGCCCACCC
MOBP81A AAGGAGGGCCCCAGGCTCTCCAAGAACCAGAAGTTCTCAGAGCACTTCAGCATCCACTGCTGCCCACCC
MOBP9 9 AAGGAGGGCCCCAGGCTCTCCAAGAACCAGAAGTTCTCAGAGCACTTCAGCATCCACTGCTGCCCACCC
210 220 230 240 250 260 270
Contig# 1 TTCACCTTCCTCAACTCCAAGCGTGAGATCGTGGACCGCAAGTACAGCATCTGCAAGAGCGGTTGCTTT 
rOPRPl TTCACCTTCCTCAACTCCAAGCGTGAGATCGTGGACCGCAAGTACAGCATCTGCAAGAGCGGTTGCTTT
MOBP 6 9 TTCACCTTCCTCAACTCCAAGCGTGAGATCGTGGACCGCAAGTACAGCATCTGCAAGAGCGGTTGCTTT
rOPl TTCACCTTCCTCAACTCCAAGCGTGAGATCGTGGACCGCAAGTACAGCATCTGCAAGAGCGGTTGCTTT
MOBP8 IB TTCACCTTCCTCAACTCCAAGCGTGAGATCGTGGACCGCAAGTACAGCATCTGCAAGAGCGGTTGCTTT
MOBP81A TTCACCTTCCTCAACTCCAAGCGTGAGATCGTGGACCGCAAGTACAGCATCTGCAAGAGCGGTTGCTTT
MOBP9 9 TTCACCTTCCTCAACTCCAAGCGTGAGATCGTGGACCGCAAGTACAGCATCTGCAAGAGCGGTTGCTTT
280 290 300 310 320 330 340
Contig# 1 TACCAGAAGAAGGAGGAGGACTGGATCTGCTGTGCCTGCCAGAAGACCAG 
rOPRPl TACCAGAAGAAGGAGGAGGACTGGATCTGCTGTGCCTGCCAGAAGACCAG
MOBP69 TACCAGAAGAAGGAGGAGGACTGGATCTGCTGTGCCTGCCAGAAGACCAG
rOPl TACCAGAAGAAGGAGGAGGACTGGATCTGCTGTGCCTGCCAGAAGACCAG
MOBP8IB TACCAGAAGAAGGAGGAGGACTGGATCTGCTGTGCCTGCCAGAAGACCAG
MOBP81A TACCAGAAGAAGGAGGAGGACTGGATCTGCTGTGCCTGCCAGAAGACCAG
MOBP9 9 TACCAGAAGAAGGAGGAGGACTGGATCTGCTGTGCCTGCCAGAAGACCAG
*** CCGCCGTGC 
*** CCGCCGTGC
350 360 370 380 390 400 410
Contig#
rOPRPl
MOBP69
rOPl
MOBP81B
MOBP81A
MOBP99
1 CACATCCCCTCAGAAGCCCAAGCACCAGCCAGCTGCATCCCCTGTGGTGGTCAGAGCGCCGCCAGCCAA 
CACATCCCCTCAGAAGCCCAAGCACCAGCCAGCTGCATCCCCTGTGGTGGTCAGAGCGCCGCCAGCCAA
420 430 440 450 460 470 480
Contig#
rOPRPl
MOBP69
rOPl
MOBP81B
MOBP81A
MOBP99
1 GCCAAAGTCCCCTCCGAGGCCAGCCAAGCCAAGGTCCCCTCCGATTCCAGCCAAGCCAAGGTCCCCTTC 
GCCAAAGTCCCCTCCGAGGCCAGCCAAGCCAAGGTCCCCTCCGATTCCAGCCAAGCCAAGGTCCCCTTC
Contig# 1 AAGGACTGAGCGCCAGCCGCGTCCCCGCCCAGAGGTCCGACCACCACCAGCCAAGCAGAAGCCCCCTCA 
rOPRPl AAGGACTGAGCGCCAGCCGCGTCCCCGCCCAGAGGTCCGACCACCACCAGCCAAGCAGAAGCCCCCTCA
MOBP69
rOPl
MOBP81B
MOBP81A
MOBP99
560 570 580 590 600 610 620
Contig#
rOPRPl
MOBP69
rOPl
MOBP81B
MOBP81A
MOBP99
Contig#
rOPRPl
MOBP69
rOPl
MOBP81B
MOBP81A
MOBP99
Contig# 
rOPRPl 
MOBP69 
rOPl 
MOBP81B 
MOBP81A 
MOBP99
Contig# 
rOPRPl 
MOBP69 
rOPl 
MOBP81B 
MOBP81A 
MOBP99
Contig#
MOBP69
rOPl
MOBP81B
MOBP81A
MOBP99
Contig# 
MOBP69 
rOPl 
MOBP81B 
MOBP81A 
MOBP99
Contig# 
MOBP69 
rOPl 
MOBP81B 
MOBP81A 
MOBP99
1 GAAGTCTAAACAGCCAGCACGAAGCAGCCCCCTCAGAGGGCCAGGCACCAGCCGCGGGGGGTCTCCCAC 
GAAGTCTAAACAGCCAGCACGAAGCAGCCCCCTCAGAGGGCCAGGCACCAGCCGCGGGGGGTCTCCCAC
630 640 650 660 670 680 690
1 CAGAGCTCCTAGGTTCTGGTAACACCATCTCTTGCCTTTTGTCCCCCCTAGCCTAAGGTCAGTAGCTGC 
CAGAGCTCCTAGGTTCTGGTAACACCATCTCTTGCCTTTTGTCCCCCCTAGCCTAAGGTCAGTAGCTGC
700 710 720 730 740 750
1 TCTCTGCAAGTACTAACATGGGGGATCTCTCCACAGTACCAAGCTGTGTAATCTACTCCTGCATTAAAC 
TCTCTGCAAGTACTAACATGGGGGATCTCTCCACAGTACCAAGCTGTGTAATCTACTCCTGCATTAAAC
760 770
1 CCCCTCTGTTTG * * 
CCCCTCTGTTTG
780 790 800 810 820
I I I I I
ATAATAAGGTTCTATTCACTGTACTGGGGAGAGGAATATGATTTGTGA
ATAATAAGGTTCTATTCACTGTACTGGGGAGAGGAATATGATTTGTGA
830 840 850 860 870 880 890
1 TTCCCGAGGACCAAGAAGAGAGAAGCTGGCCCTGGTGTACACAGTAATCACTCCAATACTGCCGTGCCA 
TTCCCGAGGACCAAGAAGAGAGAAGCTGGCCCTGGTGTACACAGTAATCACTCCAATACTGCCGTGCCA
900 910 920 930 940 950 960
1 GGATGTATGACCAAAGGAGCCCTGAATGGCGATTGTCCAGCTCTGCCATGGGAGCCTGAGGCTTCACAG 
GGATGTATGACCAAAGGAGCCCTGAATGGCGATTGTCCAGCTCTGCCATGGGAGCCTGAGGCTTCACAG
970 980 990 1000 1010 1020 1030
1 AGAAAATTAGGTTGGAGCGGCGTACAGGAGAAGGATAGACAGAGAGGCACTTACCAATCTGCTCTGCCT 
AGAAAATTAGGTTGGAGCGGCGTACAGGAGAAGGATAGACAGAGAGGCACTTACCAATCTGCTCTGCCT
1040
Contig#
MOBP69
rOPl
MOBP81B
MOBP81A
MOBP99
Contig# 
MOBP69 
rOPl 
MOBP8IB 
MOBP81A 
MOBP99
Contig#
MOBP69
rOPl
MOBP81B
MOBP81A
MOBP99
1 TAG 
TAG
★ * *  
★ ★ ★
1050 1060 1070 1080 1090 1100
I I I I I I
GACTGTGTGAATCAGGCTCAGGCAATCTTACACTCATCTCTCTAGAGCCCAGCTCA
GACTGTGTGAATCAGGCTCAGGCAATCTTACACTCATCTCTCTAGAGCCCAGCTCA
1110 1120 1130 1140 1150 1160 1170
I I I I I I I
1 GGGTTTGGCTGACGTCGGCGACTGAATGAGACCAGATAATTTACCTCACAGTCTGACCCAGCAAGAAAG 
GGGTTTGGCTGACGTCGGCGACTGAATGAGACCAGATAATTTACCTCACAGTCTGACCCAGCAAGAAAG
1180
I
TCAG
TCAG
1190 1200 1210 1220 1230 1240
ATTGAGAAGGAGGAGCAGGTCAACCCCAAGAAAAAAGTGACCGAGAAGGGAC
ATTGAGAAGGAGGAGCAGGTCAACCCCAAGAAAAAAGTGACCGAGAAGGGAC
ATTGAGAAGGAGGAGCAGGTCAACCCCAAGAAAAAAGTGACCGAGAAGGGAC
ATTGAGAAGGAGGAGCAGGTCAACCCCAAGAAAAAAGTGACCGAGAAGGGAC
ATTGAGAAGGAGGAGCAGGTCAACCCCAAGAAAAAAGTGACCGAGAAGGGAC
Contig# 
MOBP69 
rOPl 
MOBP81B 
MOBP81A 
MOBP99
Contig# 
MOBP69 
rOPl 
MOBP81B 
MOBP81A 
MOBP99
1250 1260 1270 1280 1290 1300 1310
TTCTCGTGAATGGACAGCCTCTGCTTGTGGATTTACTGCTTCACCGCAACCCATCTGCCCTCAGACTTA
TTCTCGTGAATGGACAGCCTCTGCTTGTGGATTTACTGCTTCACCGCAACCCATCTGCCCTCAGACTTA
TTCTCGTGAATGGACAGCCTCTGCTTGTGGATTTACTGCTTCACCGCAACCCATCTGCCCTCAGACTTA
TTCTCGTGAATGGACAGCCTCTGCTTGTGGATTTACTGCTTCACCGCAACCCATCTGCCCTCAGACTTA
TTCTCGTGAATGGACAGCCTCTGCTTGTGGATTTACTGCTTCACCGCAACCCATCTGCCCTCAGACTTA
1320 1330 1340 1350 1360 1370 1380
TCTGGCCTCGAGTATGACGCAGGGGTGGACACCTGCTGATGTAACAACTACAGATGCCCTCAGTCCCCA
TCTGGCCTCGAGTATGACGCAGGGGTGGACACCTGCTGATGTAACAACTACAGATGCCCTCAGTCCCCA
TCTGGCCTCGAGTATGACGCAGGGGTGGACACCTGCTGATATAACAACTACAGATGCCCTCAGTCCCCA
TCTGGCCTCGAGTATGACGCAGGGGTGGACACCTGCTGATGTAACAACTACAGATGCCCTCAGTCCCCA
TCTGGCCTCGAGTATGACGCAGGGGTGGACACCTGCTGATGTAACAACTACAGATGCCCTCAGTCCCCA
1390 1400 1410
Contig#
MOBP69
rOPl
MOBP81B
MOBP81A
MOBP99
TGGTGTGGGAGCCTTAGGGCAGCCTGCCTGGAG
TGGTGTGGGAGCCTTAGGGCAGCCTGCCTGGAG
TGGTGTGGGAGCCTTAGGGCAGCCTGCCTGGAG
TGGTGTGGGAGCCTTAGGGCAGCCTGCCTGGAG
TGGTGTGGGAGCCTTAGGGCAGCCTGCCTGGAG
1420 1430 1440
I I I
***** GTGAGGAGGGAGCTCTTCATGCCT 
***** GTGAGGAGGGAGCTCTTCATGCCT
1450
Contig#
MOBP69
rOPl
MOBP81B
MOBP81A
MOBP99
Contig# 
MOBP69 
rOPl 
MOBP8IB 
MOBP81A 
MOBP99
1460 1470 1480 1490 1500 1510
1 TACTCTAGCCACAGAGTCCTGGAAGGACCCCTCGGGCTCCAGAGCTCAGGGAATGGGTCTTTTGGTTTC
TACTCTAGCCACAGAGTCCTGGAAGGACCCCTCGGGCTCCAGAGCTCAGGGAATGGGTCTTTTGGTTTC
1520 1530 1540 1550 1560 1570 1580
1 ATCTGGAGCCCTTTTCTCTCTGGCAGGTGCACAGTTCCTCAGGGTCTTTGGCAAAGGTGATTACAGAGT
ATCTGGAGCCCTTTTCTCTCTGGCAGGTGCACAGTTCCTCAGGGTCTTTGGCAAAGGTGATTACAGAGT
136
Contig#
MOBP69
rOPl
MOBP81B
M0BP81A
MOBP99
Contig# 
MOBP69 
rOPl 
MOBP8IB 
MOBP81A
Contig#
MOBP69
rOPl
MOBP81B
MOBP81A
MOBP99
Contig# 
MOBP69 
rOPl 
MOBP8IB 
MOBP81A 
MOBP99
Contig#
MOBP69
rOPl
MOBP81B
MOBP81A
MOBP99
Contig# 
MOBP69 
rOPl 
MOBP81B 
MOBP81A 
MOBP99
Contig# 
MOBP69 
rOPl 
MOBP8IB
1590 1600 1610 1620 1630 1640 1650
I I I I I I I
1 CAATCCACACACATTCCTCCTCCTTCCAATTCCCCTCTCTCCCTGGGTCAGGTTGACAACCTGGCTCTT 
CAATCCACACACATTCCTCCTCCTTCCAATTCCCCTCTCTCCCTGGGTCAGGTTGACAACCTGGCTCTT
1660 1670 1680 1690 1700 1710 1720
1 TTTCCTTTCCTTCCTAATTCTCTGCCTGGCCTCTCTTGATCACGTGACATCTGTCTCCCATTGACCTTC
TTTCCTTTCCTTCCTAATTCTCTGCCTGGCCTCTCTTGATCACGTGACATCTGTCTCCCATTGACCTTC
1730 1740 1750 1760 1770 1780 1790
1 TTAATCAGGAGTGGTCAGAGCCAACGTCCACACTGGTGAAGGCTCAGGTTATTTTTGGAGTAAGATACA
TTAATCAGGAGTGGTCAGAGCCAACGTCCACACTGGTGAAGGCTCAGGTTATTTTTGGAGTAAGATACA
1800 1810 1820 1830 1840 1850 1860
1 GAGTTGCTGTATGATCCTTAAATGCAGCAATGTTCTCATAAGAATGGGATCCCGTTAAATCTTCACGTC
GAGTTGCTGTATGATCCTTAAATGCAGCAATGTTCTCATAAGAATGGGATCCCGTTAAATCTTCACGTC
1870 1880 1890 1900 1910 1920 1930
1 AACTGTAGGTAACTTGTGTCAGAAACAGAGAAAAGGGGGCATCTTCCTCCCTCCCCCTCTGCAGGCCCA
AACTGTAGGTAACTTGTGTCAGAAACAGAGAAAAGGGGGCATCTTCCTCCCTCCCCCTCTGCAGGCCCA
1940 1950 1960 1970 1980 1990 2000
1 GTCTCCAGCGTTACACAGGGCTTTGTGAGCACCAGCTCCTGCCCCAGTCTGGGGATAACAACCCTCTAA
GTCTCCAGCGTTACACAGGGCTTTGTGAGCACCAGCTCCTGCCCCAGTCTGGGGATAACAACCCTCTAA
2010 2020 2030 2040 2050 2060 2070
1 ACACTGACTTTGACTTGTCCCCAGTGCAGTTGGCACTCAGCCTCACAGACTCTCAGTGCAGCTCTGACT
ACACTGACTTTGACTTGTCCCCAGTGCAGTTGGCACTCAGCCTCACAGACTCTCAGTGCAGCTCTGACT
2080 2090 2100 2110 2120 2130
Contig#
MOBP69
rOPl
MOBP81B
MOBP81A
MOBP99
1 GCTCTCAATTATATAATTTAGGAAGGTCATGTGGCTTCAGCCCTGTCCCCCATTCCCCATCACCTCCCT
GCTCTCAATTATATAATTTAGGAAGGTCATGTGGCTTCAGCCCTGTCCCCCATTCCCCATCACCTCCCT
2140
Contig#
MOBP69
rOPl
MOBP81B
MOBP81A
MOBP99
2150 2160 2170 2180 2190 2200
1 TGAGGCATCCTGGACAAGTCCCATGTGCACTTGTATAGGTCTAGAAAGAATGCTTGGAGAGTTTCTGTC
TGAGGCATCCTGGACAAGTCCCATGTGCACTTGTATAGGTCTAGAAAGAATGCTTGGAGAGTTTCTGTC
137
Contig#
MOBP69
rOPl
MOBP81B
M0BP81A
MOBP99
Contig#
MOBP69
rOPl
MOBP81B
MOBP81A
MOBP99
2210 2220 2230 2240 2250 2260 2270
I I I I I I I
1 TCCAGGTCAAAATTCCTCAAATTCCTGGGAAGGGCAGAGGCTTGATGCTCCAGTGTTTTCCGTGGCTGA 
TCCAGGTCAAAATTCCTCAAATTCCTGGGAAGGGCAGAGGCTTGATGCTCCAGTGTTTTCCGTGGCTGA 
2280 2290 2300 2310 2320 2330 2340
I I I I I I I
1 CCCTCCACATCTGGGTCTGTGGTAAGGGAGAAGTCAAGAAAAAGGGGAAAGGAACTTGACTTTCTATAA 
CCCTCCACATCTGGGTCTGTGGTAAGGGAGAAGTCAAGAAAAAGGGGAAAGGAACTTGACTTTCTATAA
Contig#
MOBP69
rOPl
MOBP81B
MOBP81A
Contig#
MOBP69
rOPl
MOBP81B
MOBP81A
MOBP99
Contig#
MOBP69
rOPl
MOBP81B
MOBP81A
MOBP99
Contig#
MOBP69
rOPl
MOBP81B
MOBP81A
MOBP99
Contig#
MOBP69
rOPl
MOBP81B
2350 2360 2370 2380 2390 2400 2410
1 AGGAAGGTAGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTACGTGTGCAC
AGGAAGGTAGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTACGTGTGCAC
2420 2430 2440 2450 2460 2470 2480
1 ATGTGTGTGTTAGAGAGCTAGCAATCCAAGAGTCCTTCCCAGACTAGGAGGCCAATCCATGGTATGAAG
ATGTGTGTGTTAGAGAGCTAGCAATCCAAGAGTCCTTCCCAGACTAGGAGGCCAATCCATGGTATGAAG
2490 2500 2510 2520 2530 2540 2550
1 GAGTTTGTGCTCAACTGTCTATGTGGAGCAGGGTTGGGCTGAGTTTCTGTCTCCTTGCTCTAGTTTGCC
GAGTTTGTGCTCAACTGTCTATGTGGAGCAGGGTTGGGCTGAGTTTCTGTCTCCTTGCTCTAGTTTGCC
2560 2570 2580 2590 2600 2610 2620
1 TCCACGATCTGTAGCTCAGACTCTTGGGAAAGAATGAGCTTCGGTATGGACACTTGTTCTAGACCATAG
TCCACGATCTGTAGCTCAGACTCTTGGGAAAGAATGAGCTTCGGTATGGACACTTGTTCTAGACCATAG
2630 2640 2650 2660 2670 2680 2690
1 GAGCCAACCCTCCCCCATGGCACTTGCTTGTACCTCATCTGCACTCTTGCTGTGAGGACAGAGATTGGG
GAGCCAACCCTCCCCCATGGCACTTGCTTGTACCTCATCTGCACTCTTGCTGTGAGGACAGAGATTGGG
2700 2710 2720 2730 2740 2750 2760
Contig#
MOBP69
rOPl
MOBP81B
MOBP81A
1 CCAGATGTAACCGCCTTGTACTGCCTTGTACTCGTGTGGACTGGCGTGTGGGTGTCGGCGTTGGGATTA
CCAGATGTAACCGCCTTGTACTGCCTTGTACTCGTGTGGACTGGCGTGTGGGTGTCGGCGTTGGGATTA
2770 2780 2790 2800 2810 2820
Contig#
MOBP69
rOPl
MOBP81B
MOBP81A
MOBP99
1 GCTTGGGGAGATATTTGCCAGCTCTCGGTTTTCTTGCCCAAGTGCAGATGCTAGAGAGCCCCTCCAAGT
GCTTGGGGAGATATTTGCCAGCTCTCGGTTTTCTTGCCCAAGTGCAGATGCTAGAGAGCCCCTCCAAGT
138
2830 2840 2850 2860 2870 2880 2890
Contig# 
MOBP69 
rOPl 
MOBP81B 
MOBP81A 
MOBP99
Contig#
MOBP69
rOPl
MOBP81B
MOBP81A
MOBP99
Contig# 
MOBP69 
rOPl 
MOBP8IB 
MOBP81A 
MOBP99
Contig# 
MOBP69 
rOPl 
MOBP8IB 
MOBP81A
Contig# 
MOBP69 
rOPl 
MOBP81B 
MOBP81A 
MOBP99
Contig# 
MOBP69 
rOPl 
MOBP81B 
MOBP81A 
MOBP99
1 CCCAACTTAATTCTTGCCTCCCTGAAGACCTCAACCGTAGAAGGTCATCATGAAAAGGCCACCACTTCA
CCCAACTTAATTCTTGCCTCCCTGAAGACCTCAACCGTAGAAGGTCATCATGAAAAGGCCACCACTTCA
2900 2910 2920 2930 2940 2950 2960
1 GAGTCCTGGCCTAAACTCAGAGTCCACATGCCTTCCCAGCAGGGGCCACAGAGGTGATCCACTTGGGCC
GAGTCCTGGCCTAAACTCAGAGTCCACATGCCTTCCCAGCAGGGGCCACAGAGGTGATCCACTTGGGCC
2970 2980 2990 3000 3010 3020 3030
1 TCTTTCCCCACTCAGCCCAGATGGGTGGGGGTGGAGGGTGGAGGGTGGAAGGAGAGGAGTTGGAGAAAA 
TCTTTCCCCACTCAGCCCAGATGGGTGGGGGTGGAGGGTGGAGGGTGGAAGGAGAGGAGTTGGAGAAAA 
3040 3050 3060 3070 3080 3090 3100
I I I I I I I
1 TCCATGTCTATTCAGGCTCCGTCTGGGTCTGCTGCACAACAACTTCAGCTTGTTTGAGCCCAAACTTAC
TCCATGTCTATTCAGGCTCCGTCTGGGTCTGCTGCACAACAACTTCAGCTTGTTTGAGCCCAAACTTAC 
3110 3120 3130 3140 3150 3160 3170
I I I I I I I
1 ATAAGTTATAATCACAAAGCTGGAACTAGAGAAAGAGAGAAGGACACACACACACACACACACACACAC 
ATAAGTTATAATCACAAAGCTGGAACTAGAGAAAGAGAGAAGGACACACACACACACACACACACACAC 
3180 3190 3200 3210 3220 3230 3240
I I I I I I I
1 ACACACACATACACACACACTCATATATACACATACACACATATACACATATATACACATACACACGCA 
ACACACACATACACACACACTCATATATACACATACACACATATACACATATATACACATACACACGCA
Contig#
MOBP69
rOPl
MOBP81B
MOBP81A
MOBP99
Contig#
MOBP69
rOPl
MOBP81B
MOBP81A
MOBP99
Contig# 
MOBP69 
rOPl 
MOBP81B
3250 3260 3270 3280 3290 3300 3310
1 TACACACATACACACATATACACACATACATAACACACATACACATGCATACACACACTCATATATACA
TACACACATACACACATATACACACATACATAACACACATACACATGCATACACACACTCATATATACA
3320 3330 3340 3350 3360 3370 3380
1 CATACACACATATACACATATATATACGCATACACACATACACACATATACACACATACATAACACACA
CATACACACATATACACATATATATACGCATACACACATACACACATATACACACATACATAACACACA
3390 3400 3410 3420 3430 3440 3450
1 TACACATGCATACACACACACACACACACACACACACACACACACACACACACACCCTCGTCACTCCTC
TACACATGCATACACACACACACACACACACACACACACACACACACACACACACCCTCGTCACTCCTC
139
Contig#
MOBP69
rOPl
MOBP81B
MOBP81A
MOBP99
Contig# 
MOBP69 
rOPl 
MOBP8IB 
MOBP81A 
MOBP99
Contig# 
MOBP69 
rOPl 
MOBP81B 
MOBP81A 
MOBP99
Contig#
MOBP69
rOPl
MOBP81B
MOBP81A
MOBP99
Contig#
MOBP69
rOPl
MOBP81B
MOBP81A
Contig#
MOBP69
rOPl
MOBP81B
MOBP81A
Contig#
MOBP69
rOPl
MOBP81B
MOBP81A
MOBP99
Contig#
MOBP69
rOPl
MOBP81B
MOBP81A
MOBP99
Contig# 
MOBP69 
rOPl 
MOBP81B 
MOBP81A
3460 3470 3480 3490 3500 3510
I I I I I I
1 ATCCCTCCTAACATTTTCTCCTTAGGAGGCTAGTAGAAGGGAAGGAAGCCGTTTCTATTTACAAGGAAG 
ATCCCTCCTAACATTTTCTCCTTAGGAGGCTAGTAGAAGGGAAGGAAGCCGTTTCTATTTACAAGGAAG 
3520 3530 3540 3550 3560 3570 3580
I I I I I I I
1 TCCGGCTCACGGCCCGGGAGATGACTGCCTTGCAGGCATGGGGGATAGAGTTCGGATCCCCGTGACCCA 
TCCGGCTCACGGCCCGGGAGATGACTGCCTTGCAGGCATGGGGGATAGAGTTCGGATCCCCGTGACCCA 
3590 3600 3610 3620 3630 3640 3650
I I I I I I I
1 CGTGAAGGCTGGGTAGGCCTGGCAGTGGACCTCTAAATCCAAACTCAGAAAGTGGAGACAGGAGATGCC 
CGTGAAGGCTGGGTAGGCCTGGCAGTGGACCTCTAAATCCAAACTCAGAAAGTGGAGACAGGAGATGCC 
3660 3670 3680 3690 3700 3710 3720
I I I I I I I
1 AGAGCAAGTCAAGAGGCCATATCCATGAACTCTGGGACTGATGGAGAAACCCTTCCTTCCTCCAGTGAA 
AGAGCAAGTCAAGAGGCCATATCCATGAACTCTGGGACTGATGGAGAAACCCTTCCTTCCTCCAGTGAA 
3730 3740 3750 3760 3770 3780 3790
I I I I I I I
1 TATGATTAGAAGACATAGGCTGACTCCCAGTGTCAAACTCAGGGACTCCATGCACACACACCCCTGCAT
TATGATTAGAAGACATAGGCTGACTCCCAGTGTCAAACTCAGGGACTCCATGCACACACACCCCTGCAT 
3800 3810 3820 3830 3840 3850 3860
I I I I I I I
1 GCTCCTGCACATACACTTGCAAACATGAGCACACACACTTCATACATCCACATGGAAATGGGGGTAAGA
GCTCCTGCACATACACTTGCAAACATGAGCACACACACTTCATACATCCACATGGAAATGGGGGTAAGA 
3870 3880 3890 3900 3910 3920 3930
I I I I I I I
1 GAAACGAGAGAGTACCTGGCTCATGGTTCCTCTAGGATGGGCCCACCCTGCCCAGGACTTAGAAGCCCT 
GAAACGAGAGAGTACCTGGCTCATGGTTCCTCTAGGATGGGCCCACCCTGCCCAGGACTTAGAAGCCCT 
3940 3950 3960 3970 3980 3990 4000
I I I I I I I
1 TTCCACACCTAGCAGGACCACACGATTTCTTCTGCCTGTTCTCTCTCTTGTACGTGTGAACAAACGGGA 
TTCCACACCTAGCAGGACCACACGATTTCTTCTGCCTGTTCTCTCTCTTGTACGTGTGAACAAACGGGA
4010 4020 4030 4040 4050 4060 4070
i I I I I I I
1 TGTGTCATCCACCATGGGGCTGTGTGCGCACTCCTAG *** GGCCTCTTGTGCTCTGACCTCCCTGTC
*** GGCCTCTTGTGCTCTGACCTCCCTGTC
TGTGTCATCCACCATGGGGCTGTGTGCGCACTCCTAG *** GGCCTCTTGTGCTCTGACCTCCCTGTC
140
4080 4090 4100 4110 4120 4130 4140
Contig#
MOBP69
rOPl
MOBP81B
MOBP81A
Contig#
MOBP69
rOPl
MOBP81B
MOBP81A
MOBP99
1 CTACATGGATGCCCTCGGCTCAAATATCACCCCAGAGATTCTTCCACGGTCACCGACTCCGTCATTCTA 
CTACATGGATGCCCTCGGCTCAAATATCACCCCAGAGATTCTTCCACGGTCACCGACTCCGTCATTCTA
CTACATGGATGCCCTCGGCTCAAATATCACCCCAGAGATTCTTCCACGGTCACCGACTCCGTCATTCTA
4150 4160 4170 4180 4190 4200
1 GTTTGTCTTCAGGAATCATCACTCACTTGTTTAATTATTGTTTAATTCTCGCTCCAATGCTTTGCTTAA 
GTTTGTCTTCAGGAATCATCACTCACTTGTTTAATTATTGTTTAATTCTCGCTCCAATGCTTTGCTTAA
GTTTGTCTTCAGGAATCATCACTCACTTGTTTAATTATTGTTTAATTCTCGCTCCAATGCTTTGCTTAA
4210 4220 4230 4240 4250 4260 4270
Contig#
MOBP69
rOPl
MOBP81B
MOBP81A
MOBP99
Contig#
rOPl
MOBP81B
MOBP81A
MOBP99
Contig#
rOPl
MOBP81A
MOBP99
Contig#
rOPl
MOBP81A
MOBP99
1 TGTAAATCCCATGGCTGCCCCTTTGATTTCTCCTGTCTTCCCTTGTCTGGCACTAACAAGACGTCAATA 
TGTAAATCCCATGGCTGCCCCTTT
TGTAAATCCCATGGCTGCCCCTTTGATTTCTCCTGTCTTCCCTTGTCTGGCACTAACAAGACGTCAATA
4320 43304280 4290 4300 4310
I I I I I I
1 AATTCTTGCCGACTGAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA 
AATTCTTGCCGACTGAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA
4350 4360 4370 4380 4390 4400
4340
I
CACTTGGACG
CACTTGGACG
CACTTGGACG
4410
1 ATGCCACTCCATCACCTCCCTCTATAACCGCCGAAGAGGCATCTCTGTCCACCTTCTGACCCTCCATGG 
ATGCCACTCCATCACCTCCCTCTATAACCGCCGAAGAGGCATCTCTGTCCACCTTCTGACCCTCCATGG 
ATGCCACTCCATCACCTCCCTCTATAACCGCCGAAGAGGCATCTCTGTCCACCTTCTGACCCTCCATGG
4420 4430 4440 4450 4460 4470 4480
TTGTTCAGTCTGAAGATTCCTGTGTCTTCAGGGATGTGCAAAACAAGGTCATGGTGTGCGACCATCCAA
TTGTTCAGTCTGAAGATTCCTGTGTCTTCAGGGATGTGCAAAACAAGGTCATGGTGTGCGACCATCCAA
TTGTTCAGTCTGAAGATTCCTGTGTCTTCAGGGATGTGCAAAACAAGGTCATGGTGTGCGACCATCCAA
4490 4500 4510 4520 4530 4540 4550
Contig# 1 
rOPl 
MOBP81A 
MOBP99
ATGGCAAATATAAAAAAGAAATTGTCAAGTGTTGGCGGTGACGCAAGAAAAATCCTAGAAGCCACAGAT
ATGGCAAATATAAAAAAGAAATTGTCAAGTGTTGGCGGTGACGCAAGAAAAATCCTAGAAGCCACAGAT
ATGGCAAATATAAAAAAGAAATTGTCAAGTGTTGGCGGTGACGCAAGAAAAATCCTAGAAGCCACAGAT
4560 4570 4580 4590 4600 4610 4620
Contig# 1 
rOPl 
MOBP81A 
MOBP99
GGGGATTTATACACTGTCGCAACACCGTTGAGATGTACTCTGGGGACACTATCAAGGCAAAGTATCTTA
GGGGATTTATACACTGTCGCAACACCGTTGAGATGTACTCTGGGGACACTATCAAGGCAAAGTATCTTA
GGGGATTTATACACTGTCGCAACACCGTTGAGATGTACTCTGGGGACACTATCAAGGCAAAGTATCTTA
4630 4640 4650 4660 4670 4680 4690
Contig# 1 
rOPl 
MOBP81A 
MOBP99
AAACCTCTAATCAAGCGACTGTAATTTTAGGCATCCATCCTGGGGAAAACTCACACCCTTTTAGAGAAA
AAACCTCTAATCAAGCGACTGTAATTTTAGGCATCCATCCTGGGGAAAACTCACACCCTTTTAGAGAAA
AAACCTCTAATCAAGCGACTGTAATTTTAGGCATCCATCCTGGGGAAAACTCACACCCTTTTAGAGAAA
4700 4710 4720 4730 4740 4750 4760
Contig# 1 
rOPl 
MOBP81A 
MOBP99
GGAGAAATGCCCAAATTTGTTTAAAAGATCGTGGTTTGTAGTTAAGAGAGGTAGAATGAGATTAACCAA
GGAGAAATGCCCAAATTTGTTTAAAAGATCGTGGTTTGTAGTTAAGAGAGGTAGAATGAGATTAACCAA
GGAGAAATGCCCAAATTTGTTTAAAAGATCGTGGTTTGTAGTTAAGAGAGGTAGAATGAGATTAACCAA
141
4770 4780 4790 4800 4810 4820 4830
Contig# 
rOPl 
MOBP81A 
MOBP99
1 AATGTCGGTCCACGGGAGAGCAAGAGAGTCAATCTTGGTATGTCCACAAAGTCCTAAGAGCAGTTAAAA 
AATGTCGGTCCACGGGAGAGCAAGAGAGTCAATCTTGGTATGTCCACAAAGTCCTAAGAGCAGTTAAAA 
AATGTCGGTCCACGGGAGAGCAAGAGAGTCAATCTTGGTATGTCCACAAAGTCCTAAGAGCAGTTAAAA
4840 4850 4860 4870 4880 4890
Contig#
rOPl
MOBP81A
MOBP99
1 GCCAATCTGTCAGACAGACCCATGCCGAGCAGGTAAATCTAGAAAGCAAACCAAGGACTATAAAAGTCA 
GCCAATCTGTCAGACAGACCCATGCCGAGCAGGTAAATCTAGAAAGCAAACCAAGGACTATAAAAGTCA 
GCCAATCTGTCAGACAGACCCATGCCGAGCAGGTAAATCTAGAAAGCAAACCAAGGACTATAAAAGTCA
4900 4910 4920 4930 4940 4950 4960
Contig# 1 AGCACCAGGCAGTAAATCCAG | AATAAGAGCCTATGCATACATATTGACAGCTCACAATCCTGTACTGGT 
rOPl AGCACCAGGCAGTAAATCCAG j AATAAGAGCCTATGCATACATATTGACAGCT ACAATCCTGTACTGGT
MOBP81A AGCACCAGGCAGTAAATCCAG | AATAAGAGCCTATGCATACATATTGACAGCTCACAATCCTGTACTGGT
MOBP9 9 AATAAGAGCCTATGCATACATATTGACAGCTCACAATCCTGTACTGGT
4970 4980 4990 5000 5010 5020 5030
Contig# 1 TATTGCTTACATAAGGAGAAGCCACAGATCTCATTCTTTCTTCTAGAATGCAATAGAATTTAAAAATGA 
rOPl TATTGCTTACATAAGGAGAAGCCACAGATCT ATTCTTTCTTCTAGAATGCAATAGAATTTAAAAATGA
MOBP81A TATTGCTTACATAAGGAGAAGCCACAGATCTCATTCTTTCTTCTAGAATGCAATAGAATTTAAAAATGA
MOBP9 9 TATTGCTTACATAAGGAGAAGCCACAGATCTCATTCTTTCTTCTAGAATGCAATAGAATTTAAAAATGA
5040 5050 5060 5070 5080 5090 5100
Contig# 1 CAGCAGAACAAAAGGACACTAGAAATTATCCTCTCAGAAATAAAAGTATAAGAAATAATTTCTGGCTTG 
rOPl CAGCAGAACAAAAGGACACTAGAAATTATCCTCTCAGAAATAAAAGTATAAGAAATAATTTCTGGCTTG
MOBP81A CAGCAGAACAAAAGGACACTAGAAATTATCCTCTCAGAAATAAAAGTATAAGAAATAATTTCTGGCTTG
MOBP9 9 CAGCAGAACAAAAGGACACTAGAAATTATCCTCTCAGAAATAAAAGTATAAGAAATAATTTCTGGCTTG
5110 5120 5130 5140 5150 5160 5170
Contig# 1 AGGAAATAACCCAGGCTAAAAGCTACACAGGCCTGGCTTAACCATACCAGCAGGGCATACCTTTGTTAG 
rOPl AGGAAATAACCCAGGCTAAAAGCTACACAGGCCTGGCTTAACCATACCAGCAGGGCATACCTTTGTTAG
MOBP81A AGGAAATAACCCAGGCTAAAAGCTACACAGGCCTGGCTTAACCATACCAGCAGGGCATACCTTTGTTAG
MOBP9 9 AGGAAATAACCCAGGCTAAAAGCTACACAGGCCTGGCTTAACCATACCAGCAGGGCATACCTTTGTTAG
5180 5190 5200 5210 5220 5230 5240
Contig# 1 GAGAGGGTCAATTCGAAGTTTGTGAACAGCCTGGGCTGTTTCCGAGGCTGCATAAATCTTAAACACCAA 
rOPl GAGAGGGTCAATTCGAAGTTTGTGAACAGCCTGGGCTGTTTCCGAGGCTGCATAAATCTTAAACACCAA
MOBP 81A GAGAGGGTCAATTCGAAGTTTGTGAACAGCCTGGGCTGTTTCCGAGGCTGCATAAATCTTAAACACCAA
MOBP 9 9 GAGAGGGTCAATTCGAAGTTTGTGAACAGCCTGGGCTGTTTCCGAGGCTGCATAAATCTTAAACACCAA
5250 5260 5270 5280 5290 5300 5310
Contig# 1 AAATGTGTGTTTTGAATTAACTTTGGGTCTGGTCTACAGAGTCCGGCTTGTGATGGCTCCTGACACGGG 
rOPl AAATGTGTGTTTTGAATTAACTTTGGGTCTGGTCTACAGAGTCCGGCTTGTGATGGCTCCTGACACGGG
MOBP81A AAATGTGTGTTTTGAATTAACTTTGGGTCTGGTCTACAGAGTCCGGCTTGTGATGGCTCCTGACACGGG
MOBP9 9 AAATGTGTGTTTTGAATTAACTTTGGGTCTGGTCTACAGAGTCCGGCTTGTGATGGCTCCTGACACGGG
5320 5330 5340 5350 5360 5370 5380
Contig# 1 AGAAAAGGGGATAAGTTAATATAAGGCTCTGGGATTTTCCTTTGAGGAACAGGCAGGTAGGAAAGGACA 
rOPl AGAAAAGGGGATAAGTTAATATAAGGCTCTGGGATTTTCCTTTGAGGAACAGGCAGGTAGGAAAGGACA
MOBP81A AGAAAAGGGGATAAGTTAATATAAGGCTCTGGGATTTTCCTTTGAGGAACAGGCAGGTAGGAAAGGACA
MOBP9 9 AGAAAAGGGGATAAGTTAATATAAGGCTCTGGGATTTTCCTTTGAGGAACAGGCAGGTAGGAAAGGACA
5390 5400 5410 5420 5430 5440 5450
Contig# 1 CTAGAATGTTGGGGAATGTGGAGGGATGTAAAACAGACAGTATTATGATGGGGGGAACTCAGGAAGGAA 
rOPl CTAGAATGTTGGGGAATGTGGAGGGATGTAAAACAGACAGTATTATGATGGGGGGAACTCAGGAAGGAA
MOBP81A CTAGAATGTTGGGGAATGTGGAGGGATGTAAAACAGACAGTATTATGATGGGGGGAACTCAGGAAGGAA
MOBP9 9 CTAGAATGTTGGGGAATGTGGAGGGATGTAAAACAGACAGTATTATGATGGGGGGAACTCAGGAAGGAA
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5460 5470 5480 5490 5500 5510 5520
Contig# 1 CGGTAAGGACACCAGAATGGCCTCGTGCTGGGAGCCAGGGTGGCCAAGCCCAGGCAGATGCACAAAGAC 
rOPl CGGTAAGGACACCAGAATGGCCTCGTGCTGGGAGCCAGGGTGGCCAAGCCCAGGCAGATGCACAAAGAC
MOBP 81A CGGTAAGGACACCAGAATGGCCTCGTGCTGGGAGCCAGGGTGGCCAAGCCCAGGCAGATGCACAAAGAC
MOBP9 9 CGGTAAGGACACCAGAATGGCCTCGTGCTGGGAGCCAGGGTGGCCAAGCCCAGGCAGATGCACAAAGAC
5530 5540 5550 5560 5570 5580
Contig# 1 CCCAAAGGCCACCATTGCCTCACAACCAGACCCAGCAAAGTTCAGATCAAGTGCATAAATGGGGGTCAC 
rOPl CCCAAAGGCCACCATTGCCTCACAACCAGACCCAGCAAAGTTCAGATCAAGTGCATAAATGGGGGTCAC
MOBP81A CCCAAAGGCCACCATTGCCTCACAACCAGACCCAGCAAAGTTCAGATCAAGTGCATAAATGGGGGTCAC
MOBP9 9 CCCAAAGGCCACCATTGCCTCACAACCAGACCCAGCAAAGTTCAGATCAAGTGCATAAATGGGGGTCAC
5590 5600 5610 5620 5630 5640 5650
Contig# 1 GTCAGTGGAAACTGTCCGGAGCATGGAGCAGGGGGTGAGGAAGACAGTCAGAAGGAAGCAAGAGATGGC 
rOPl GTCAGTGGAAACTGTCCGGAGCATGGAGCAGGGGGTGAGGAAGACAGTCAGAAGGAAGCAAGAGATGGC
MOBP 81A GTCAGTGGAAACTGTCCGGAGCATGGAGCAGGGGGTGAGGAAGACAGTCAGAAGGAAGCAAGAGATGGC
MOBP9 9 GTCAGTGGAAACTGTCCGGAGCATGGAGCAGGGGGTGAGGAAGACAGTCAGAAGGAAGCAAGAGATGGC
5660 5670 5680 5690 5700 5710 5720
Contig# 1 TTAGAGTGTTGCATGGCAGCAAGAAGAAGCAGTCCAAATATCATCCCAAGGCAGCCATGGCTTCCTCTC 
rOPl TTAGAGTGTTGCATGGCAGCAAGAAGAAGCAGTCCAAATATCATCCCAAGGCAGCCATGGCTTCCTCTC
MOBP81A TTAGAGTGTTGCATGGCAGCAAGAAGAAGCAGTCCAAATATCATCCCAAGGCAGCCATGGCTTCCTCTC
MOBP9 9 TTAGAGTGTTGCATGGCAGCAAGAAGAAGCAGTCCAAATATCATCCCAAGGCAGCCATGGCTTCCTCTC
5730 5740 5750 5760 5770 5780 5790
Contig# 1 CCGAGGACACTGTGGCCCTGTGGAAGTGCCAAGGCAGAGGCAGAGGAATTTAACCGCACACAAACTACA 
rOPl CCGAGGACACTGTGGCCCTGTGGAAGTGCCAAGGCAGAGGCAGAGGAATTTAACCGCACACAAACTACA
MOBP81A CCGAGGACACTGTGGCCCTGTGGAAGTGCCAAGGCAGAGGCAGAGGAATTTAACCGCACACAAACTACA
MOBP9 9 CCGAGGACACTGTGGCCCTGTGGAAGTGCCAAGGCAGAGGCAGAGGAATTTAACCGCACACAAACTACA
5800 5810 5820 5830 5840 5850 5860
Contig# 1 TGCAGAAACTAAGGTGCTAAATGAACATCTACGTGACAACCTTTCTGAGGACCAGGTTCCAGTGAGCGG 
rOPl TGCAGAAACTAAGGTGCTAAATGAACATCTACGTGACAACCTTTCTGAGGACCAGGTTCCAGTGAGCGG
MOBP81A TGCAGAAACTAAGGTGCTAAATGAACATCTACGTGACAACCTTTCTGAGGACCAGGTTCCAGTGAGCGG
MOBP9 9 TGCAGAAACTAAGGTGCTAAATGAACATCTACGTGACAACCTTTCTGAGGACCAGGTTCCAGTGAGCGG
5870 5880 5890 5900 5910 5920 5930
Contig# 1 CCCAGGGCCGTTATCTTCGCGATGGTAACTGAGCTGAGAAGAATGGGAACCGGATAGGAGCACACAGTA 
rOPl CCCAGGGCCGTTATCTTCGCGATGGTAACTGAGCTGAGAAGAATGGGAACCGGATAGGAGCACACAGTA
MOBP81A CCCAGGGCCGTTATCTTCGCGATGGTAACTGAGCTGAGAAGAATGGGAACCGGATAGGAGCACACAGTA
MOBP9 9 CCCAGGGCCGTTATCTTCGCGATGGTAACTGAGCTGAGAAGAATGGGAACCGGATAGGAGCACACAGTA
5940 5950 5960 5970 5980 5990 6000
Contig# 1 GCCCACTGGTGAGACAAATCCACGGGCGAGCCTCAACCAACCCACTAAGGAAACTTCACGCCTTTTCAT 
rOPl GCCCACTGGTGAGACAAATCCACGGGCGAGCCTCAACCAACCCACTAAGGAAACTTCACGCCTTTTCAT
MOBP81A GCCCACTGGTGAGACAAATCCACGGGCGAGCCTCAACCAACCCACTAAGGAAACTTCACGCCTTTTCAT
MOBP9 9 GCCCACTGGTGAGACAAATCCACGGGCGAGCCTCAACCAACCCACTAAGGAAACTTCACGCCTTTTCAT
6010 6020 6030 6040 6050 6060 6070
Contig# 1 CTAGTTTTCATTTTGGCAAAGCAAAGCCATCCTGAGTGCTTGCTTGTCTCCGCCCTCCACGCCACCCCC 
rOPl CTAGTTTTCATTTTGGCAAAGCAAAGCCATCCTGAGTGCTTGCTTGTCTCCGCCCTCCACGCCACCCCC
MOBP81A CTAGTTTTCATTTTGGCAAAGCAAAGCCATCCTGAGTGCTTGCTTGTCTCCGCCCTCCACGCCACCCCC
MOBP9 9 CTAGTTTTCATTTTGGCAAAGCAAAGCCATCCTGAGTGCTTGCTTGTCTCCGCCCTCCACGCCACCCCC
6080 6090 6100 6110 6120 6130 6140
Contig# 1 GAGACACAGAGCATGCGCATTAACCCAGAGCGCGCTAACACATGCACAGCGTTGGACATTAGCCTATTA 
rOPl GAGACACAGAGCATGCGCATTAACCCAGAGCGCGCTAACACATGCACAGCGTTGGACATTAGCCTATTA
MOBP81A GAGACACAGAGCATGCGCATTAACCCAGAGCGCGCTAACACATGCACAGCGTTGGACATTAGCCTATTA
MOBP9 9 GAGACACAGAGCATGCGCATTAACCCAGAGCGCGCTAACACATGCACAGCGTTGGACATTAGCCTATTA
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6150 6160 6170 6180 6190 6200
I I I I I I
Contig# 1 ATGGGAATAACCAGAAACTACTAAATTTTGTTTGTTGTAGAAATAAAACCTGGGGATGGATCAAAA 
rOPl ATGGGAATAACCAGAAACTACTAAATTTTGTTTGTTGTAGAAATAAAACCTGGGGATGGATC
MOBP81A ATGGGAATAACCAGAAACTACTAAATTTTGTTTGTTGTAGAAATAAAACCTGGGGATGGATCAAAA 
MOBP99 ATGGGAATAACCAGAAACTACTAAATT
Figure 2.3.1 Sequence multi-alignment of published (Yamamoto et al., 1994; Holz et al., 
1996 ) rat splice variants. Putative exon/exon junctions are indicated by I and ***. 
Polyadenylation signals are identified in the sequence as ATTAAA and AATAAA. 
Exonic sequences containing polyadenylation signals are separated from subsequent 
exonic sequence units by **. N.B. Nucleotide numbers, listed above sequence, are purely 
arbitrary and bear no relevance to the genomic organisation of the gene. Contig #1 is an 
arbitrary contiguous sequence, generated by joining the exonic segments Q-Z.
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Transcript identification EMBL accession number Publication
rOPl (Mobp 71) D28110 Yamamoto et al., 1994
rOPRPl (Mobp 170) D28111 Yamamoto et al., 1994
Mobp 69 X90402 Holz et al., 1996
Mobp 81A X87900 Holz etal., 1996
Mobp 8 IB X89637 Holz etal., 1996
Mobp 99 X89638 Holz etal., 1996
Table 2.3.1 Mobp transcript sequences derived from rat tissue defined, according to 
their respective EMBL accession number.
Exonic
sequence
Q R S T U V W X Y Z
Nucleotide 1-117 118- 337- 781- 1049- 1191- 1426- 4039- 4338- 4920-
numbers 326 753 1038 1177 1413 4329 4277 4920 6182
Table 2.3.2 Exonic sequences defined according to arbitrary nucleotide numbers listed 
above sequence multialignment (Figure 2.3.1).
Transcript Q R S T U V w X Y z
Mobp 71 + + - - + + - - + +
Mobp 170 + + + - - - - - - -
Mobp 69 + + - + - + - + - -
Mobp 81A + + - - - + - - + +
Mobp 8 IB + + - - - + + + - -
Mobp 99 + + - - - - - - - +
Table 2.3.3 Identification of sequence units shared between the published transcript 
sequences, based on sequence multialignment (Figure 2.3.1). Q-Z, exonic sequences; +/-, 
presence or absence of exonic sequence.
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Exonic 5' Donor Polyadenylation Intron 3' Acceptor Exonic
sequence signal sequence
Q CAC £G / S ize
unknown
T GAG R
R ACC AG
s e s
Arp
Arg
Arz
/ S ize
unknown
C CGC 
r 69 z\rg 7 0
S
S OCIGC . . .ATTAAA. . . S ize
unknown
A69 TAA 
g  OCH
T
T CITAG / S ize
unknown
G69 ACT70 
g  Thr
U
U GAAAG / S ize
unknown
A69 TTG70 
g  Leu
V
V TQGAG / S ize
unknown
GIGAG W
W CCIAG / S ize
unknown
GGCCT X
X AGGIC . . .AATAAA. . . S ize
unknown
CACTT Y
Y TCCAG A69 ATA70 
g  H e
Z
Z GIAGA . . .AATAAA. . .
Table 2.3.4 Sequences across putative exon/exon boundaries of messenger RNA species 
from the rat Mobp gene (Yamamoto eta l., 1994 and Holz et al., 1996). The DNA 
sequences across putative exon/exon boundaries are shown and the encoded amino acid 
sequences are indicated in three-letter code. The last amino acid residue encoded by Ex 2 
may be Ser or Arg, dependent upon which downstream exonic segment they are 
subsequently spliced to. The downstream exonic segment is indicated, in each case, by the 
subscript letters S, T, U or Z. The amino acid sequence is numbered from the first residue 
of the isoform MOBP 81 (Holz et al., 1996). Polyadenylation signals are indicated by the 
sequence ATT AAA (exon 3) and A AT AAA (exons 8 and 10). Exonic segments 
containing the exonic sequence portion (C/AAG) of the extended 5' splice donor sequence 
[(C/A)AGIGT(G/A)AGT] are underlined.
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2.3.2 Discussion
Sequence from the six transcripts of the novel rat gene Mobp, identified in the studies of 
Yamamoto et al. (1994) and Holz et al. (1996), have been compared. This study confirms 
the conclusion that the transcripts share in common their 5' regions (Yamamoto et al., 
1994 and Holz et al., 1996); encoding amino acids 1-68 of their predicted proteins. The 
report of Holz et a l (1996) further states that each of the predicted proteins has a unique 
C-terminal segment. However, the authors almost completely fail to recognise that the 
exonic segments, encoding the carboxyl termini and providing the respective 3'UTRs of 
the Mobp transcripts, do share sequences to varying degrees. Concession is made in the 
report of Holz et al. (1996) that sequences are shared by rOPl and MOBP 81 A. In fact 6  
of the 1 0  exonic segments identified in this study are shared by two or more of the 
transcripts reported by Yamamoto et al (1994) and Holz (1996). These findings lend 
strength to the suggestion that MOBP isoforms are generated by a complex series of 
alternative splicing events (Holz et al., 1996 and Montague et al., 1997). Exclusive use of 
certain exonic segments does occur. Exonic segments S, T, U and W are used exclusively 
in the transcripts rOPRPl, MOBP 69, rOPl and MOBP 8 IB.
The predictions of exon/exon boundaries are based on sequence comparison and 
identification of putative 5' donor splice site remnants. These predictions are tentative and 
serve only as a model for examination in an endeavour to elucidate the genomic 
organisation of the Mobp gene. Thus, the precise relationships between the alternatively 
spliced mRNA species and the single copy gene remain unknown, at this stage. However, 
examination of the genomic region encompassing Mobp will resolve this (Montague et al., 
1997; McCallion etal., manuscript in preparation; refer also to Section 2, 2.4).
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2.4 Isolation and characterization of the murine gene {Mobp) encoding
myelin-associated oligodendrocytic basic protein
2.4.1 Isolation of the Mobp gene
Two mouse 129/Sv genomic libraries, prepared in X 2001 (Warren et al., 1994) and X PS
(Nehls et al., 1994), were used to isolate the Mobp gene. These libraries were kindly 
donated by Dr Andrew Smith (University of Edinburgh). Screening of the libraries was 
performed, at high stringency, as described in Chapter 2 using as probe a 1.6 kb cDNA 
fragment (defined in Chapter 2). Using this approach forty four independent clones were
obtained; thirty seven from the X 2001 library and seven from the X PS library.
2.4.2 Genomic structure of the murine gene {Mobp) encoding myelin-associated 
oligodendrocytic basic protein
2.4.2.1 DNA fingerprinting of bacteriophage clones containing Mobp sequences
The procedure used for fingerprinting the clones is outlined in Figure 2.1 (Chapter 2) and
was performed (as described in Chapter 2, 2.2.4) utilising all 37 clones isolated from the X
2001 library. Cloned DNA was incubated in the presence of two restriction enzymes with 
6  bp specificities {EcoRl and Hindlll) that leave staggered ends. These ends were 
simultaneously radioactively labeled by end-filling with the inclusion of a radioactive 
dNTP. The enzymes were then heat inactivated and the DNA fragments cleaved again, 
this time with an enzyme with a 4 bp specificity {Sau3Al). The resulting fragments were 
separated in denaturing polyacrylamide (sequencing type) gels. The signals obtained on 
autoradiographs were arbitrarily identified as I-XXXV. All data were compared with 
those derived from AS 18 (arbitrary selection). The number of signals shared between 
AS 18 and any other clone was taken as an indication of the degree of overlap of the cloned 
fragments. This overlap was expressed in arbitrary units. The data arising from this assay 
are shown in Table 2.4.1. The extent of overlaps, inferred by this data, amongst selected 
clones is illustrated in Figure 2.4.2. It is noteworthy that Sau 3AI was the enzyme utilised 
in the construction of both libraries.
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Clone
identification
Number of 
interpretable 
signals
Signal identification Number of 
signals shared 
with ASM 18
ASM 1 8 I, II, IV, VII, X, XIV, XV, XXI 3
ASM 2 9 I, II, IV, XIII, XVI, XXI, XXV,
xxxm
5
ASM 8 12 i, v, vn, vm, ix, xxi, xxn, xxvi,
XXVIII, XXIX, XXXI, XXXII
10
ASM 11 5 i, vm, xxn, xxvm, xxxh 2
ASM 12 16 I, V, VII, VIII, IX, X, XI, XV, XXI,
xxn, xxvi, xxvii, xxviii, xxix, 
XXXI, xxxn
13
ASM 14 4 i, iv xn, xxvi 3
ASM 15 15 I, II, III, IV, V VII, VIII, IX, XXI,
xxn, xxvi, xxvm, xxix, xxxi,
XXXII
13
ASM 16 7 i, v vn, xxix, xxxi, xxxiii,
XXXV
6
ASM 17 9 I, XII, XIII, (XXII), XXIII, XXIV, 
XXV, XXVI, XXXV
4
ASM 18 2 2 I, II, III, IV, V VII, VIII, IX, X, XI, 
XVI, XVII, XVIII, XXI, XXVI,
xxvii, xxvm, xxix, xxx, xxxi, 
xxxm, xxxv
2 2
ASM 19 2 0 i, ii, hi, iv, v, vi, vn, vm, x, xi,
XVI, XVIII, XXI, XXVI, XXVIII,
xxix, xxx, xxxi, xxxn, xxxm
19
ASM 20 17 I, IV, V, VII, VIII, IX, X, XI, XVI,
xxi, xxn, xxvm, xxix, xxx, 
xxxi, xxxn, xxxv
15
ASM 21 21 I, II, III, IV, V, VI, VII, VIII, X, XI, 
XVI, XVIII, XXI, XXVI, XXVII,
xxvm, xxix, xxx, xxxi, xxxm,
XXXIV
18
Table 2.4.1
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Clone
identification
Number of 
interpretable 
signals
Signal identification Number of 
signals shared 
with ASM 18
ASM 22 10 I, XII, XIII, (XXII), XXIII, XXIV,
xxv, xxvi, xxxn, xxxv
5
ASM 23 8 I, VI, IX, XXII, XXVIII, XXXII, 
XXXV, XXXVI
3
ASM 24 7 i, i i , xn, xvn, xxn, xxvi, xxxn 3
ASM 25 7 i, i i , xn, xvn, xxn, xxvi, xxxn 3
ASM 26 12 i, v, vn, vm, ix, xxi, xxn, xxvi, 
xxvm, xxix, xxxi, xxxn
9
ASM 27 12 I, II, III, IV, V, VI, VII, VIII, IX, X, 
XI, XVI, XVIII, XXI, XXII, XXIII,
xxiv, xxv, xxvi, xxvii, xxvm, 
xxix, xxx, xxxi, xxxn, xxxm, 
XXXIV, xxxv
2
ASM 33 14 i, v, vii, vm, xxi, xxn, xxm, 
xxiv, xxvi, xxvm, xxix, xxxi, 
XXXII, xxxv
9
ASM 35 13 i, v, vii, vm, xxi, xxn, xxv, 
xxvi, xxvm, xxix, xxxi, xxxn, 
xxxv
1 0
ASM 39 21 I, IV, V, VII, VIII, IX, X, XI, XVI, 
XVII, XXI, XXII, XXV, XXVI,
xxvii, xxvm, xxix, xxx, xxxi, 
xxxn, xxxm
18
ASM 40 13 i, iv, v, vn, vm, ix, xxi, xxn, 
xxv, xxvi, xxvm, xxxi, xxxn
8
ASM 41 18 I, IV, V, VII, VIII, IX, X, XI, XVI, 
XVII, XXI, XXII, XXVI, XXVII,
xxvm, xxix, xxx, xxxi, xxxn
16
Table 2.4.1 continued
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Clone
identification
Number of 
interpretable 
signals
Signal identification Number of 
signals shared 
with ASM 18
ASM 42 18 I, IV, V, VII, VIII, IX, X, XI, XVI, 
XVII, XXI, XXII, XXVI, XXVII,
xxvm, xxix, xxx, xxxi, xxxn
16
ASM 45 11 I, V, VII, VIII, IX, XXI, XXII, 
XXVIII, XXIX, XXXI, XXXII
9
ASM 46 11 i, ix, xxn, xxv, xxvm, xxxn 3
Table 2.4.1 Data generated by the DNA fingerprinting assay. The data displayed above 
indicate, in arbitrary units, the degree of overlap between examined clones and the 
selected reference clone ASM 18. Clones ASM 3, 28, 29, 32, 34, 48 and 49 failed to 
provide interpretable results. Signal (XXII) was considered close to but not equal to the 
signal identified as XXII.
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ASM 26
ASM 18 
ASM 22
ASM 17
ASM 35 
ASM 41
0 20 30 40 50 60 Units
Figure 2.4.2 Schematic representation of overlaps between selected cloned DNAs based 
on data generated by the fingerprinting assay, section 2.4.2.1 (Table 2.4.1)
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2A.2.2 Restriction mapping of bacteriophage clones containing Mobp sequences
Restriction mapping of selected clones ([X 2001] ASM 17, 18, 22, 26, 29, 35 and 41; [A-
PS] ASM 50, 55 and 59) was performed using a battery of restriction enzymes including: 
BamHI, EcoRl, Hindlll, Kpn I, Nde I, Sal I, Sst I, Pst I and Xho I. The resulting cleaved 
fragments were separated by electrophoresis in agarose gels (0.5 - 1.5%) as described in 
Chapter 2. Figure 2.4.3 (A and B) illustrates an example of electrophoresis of DNA 
fragments resulting from the restriction enzyme cleavage of cloned DNAs, and list the 
corresponding fragment sizes. Figure 2.4.3 (C) illustrates the corresponding restriction 
maps. Figure 2.4.4 illustrates the restriction maps resulting from this series of assays and 
demonstrates the degree of overlap amongst selected, cloned DNAs. Overlaps are 
elucidated on the basis of the identification of restriction fragments that are shared by two 
or more cloned DNAs. The restriction map is also in close agreement with the map 
(Figure 2.4.2) generated from the DNA fingerprinting assay.
2.4.3 Identification of exonic sequences in cloned genomic fragments
Subsequent to electrophoresis, DNAs were transferred to nylon membrane as described in 
Chapter 2. To locate exonic sequences identified in the studies of Yamamoto et al., 1994; 
Holz et al., 1996 and Montague et al., 1997, a series of oligonucleotide and PCR generated 
probes, designed to published Mobp sequences, were hybridised to these membrane bound 
DNAs as described in Chapter 2. The probes utilised in this study are defined in Table 
2.4.2. Figures 2.4.5 and 2.4.6 A/B show examples of hybridisation experiments 
identifying sequence (defined by PCR oligonucleotides ASM 201 F/R; Chapter 2, Table 
2.3) corresponding to an exonic segment encoding a portion of the 6 8  amino acids shared 
by all MOBP isoforms (ASM501) and to 3'UTR (defined by PCR oligonucleotides ASM 
215 F/R; Table 2.4, Chapter 2) in splice variants Mobp 81A and rOPl (ASM502). Figure 
2.4.4b illustrates the position of the probes utilised, on the restriction map (Figure 2.4.4a) 
generated in section 2.4.2.
Sequences defined by oligonucleotides ASM 242 and ASM 244 (Chapter 2, Table 2.4), 
were not detected amongst the overlapping lambda cloned DNAs (Figure 2.4.4a). 
Oligonucleotides ASM 242 and ASM 244 were designed to sequence within exon 1 and 
exon 2 respectively. These exons provide the majority of the length (4 nt are provided by 
exon 3) of the 5'UTRs identified in rat and mouse Mobp transcripts (rat: Yamamoto et al., 
1994; Holz et al., 1996 and mouse: McCallion, PhD thesis, 1997 [Section 2.5]).
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Hin dill
Xho I
Hin dill Xho I 
Hin dill Sal I 
Hin dill Eco RI
Eco RI
Hin dill Kpn I 
Kpn I
Hin dill Sal I Xho I 
Hin dill Kpn I Xho I
11.5 kb, 11 kb, > 15 kb 
22 kb, 9 kb, 10.8 kb, >5 kb
8.5 kb, 2.9 kb, 2.6 kb, 2.2 kb
2 x >  15 kb
20 kb, 9 kb, 3.9 kb, 2.7 kb, 1.9 kb, 1.3 kb, 1 kb
22 kb, > 11 kb, 3.3 kb, 2.7 kb, 1.3 kb, 1 kb
> 22 kb, 12 kb, 9 kb, 4.2 kb, 1.8 kb
> 13 kb, 10.5 kb, 9 kb, 1.5 kb, 1 kb
> 22 kb, 9 kb, 8.5 kb, 2.9 kb, 2.4 kb, 2.2 kb
> 15 kb, 9 kb, 6.6 kb, 2.9 kb, 2.6 kb, 2.2 kb, 1.8 kb 
Hin dill Kpn I Eco RI> 15 kb, 9 kb, 3.1 kb, 2.7 kb, 2.2 kb, 1.9 kb, 1.8 kb,
1.4 kb, 1.4 kb, 1 kb
Sal  I
X H K
-H 1 V
E X E H X
0  4  k b  8  k b  1 2  k b  1 6  k b  2 0  k b
Figure 2.4.3 Electrophoresis of cleaved DNA fragments from clone ASM 41, subsequent 
to incubation with the restriction enzymes and enzyme combinations indicated above. 
Figure 2.4.3 (A and B [DNA fragments electrophoresed in 0.5 % and 1.5 % agarose gels 
respectively]) illustrates an example of electrophoresis of DNA fragments resulting from 
the restriction enzyme cleavage of cloned DNAs, and list the corresponding fragment 
sizes. Figure 2.4.3 (C) illustrates the corresponding restriction map. Restriction maps 
resulting from this and other restriction mapping experiments are illustrated in Figure 
2.4.4. E, H, K and X represent restriction enzymes Eco RI, Hin dill, Kpn I and Xho I 
respectively.
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Figure 2.4.5 Autoradiograph resulting from hybridisation of the 
radioactively labelled probe ASM 501 (defined in Table 2.4.2) to 
membrane bound cleaved DNA fragments from clones ASM 17 and 
ASM 18 (refer also to Figure 2.4.4 a). This demonstrates the presence 
of Mobp exon 3 within ASM 17 (refer also to Figure 2.4.4 b).
AFigure 2.4.6 Autoradiograph resulting from hybridisation 
of the radioactively labelled probe ASM 502 (defined in 
Table 2.4.2) to membrane bound cleaved DNA fragments 
from clone ASM 35 (refer also to Figure 2.4.6 B). This 
demonstrates the presence of Mobp exon 8 within ASM 35 
(refer also to Figure 2.4.4 A and B). Figure 2.4.6 A 
corresponds to DNA fragments that were electrophoresed in 
0.5% ordinary agarose gels.
BFigure 2.4.6 Autoradiograph resul t ing from 
hybridisation of the radioactively labelled probe ASM 
502 (defined in Table 2.4.2) to membrane bound 
cleaved DNA fragments from clone ASM 35 (refer also 
to Figure 2.4.6 B). This demonstrates the presence of 
Mobp exon 8 within ASM 35 (refer also to Figure 2.4.4 
A and B). Figure 2.4.6 B corresponds to DNA 
fragments that were electrophoresed in 1.5% ordinary 
agarose gels.
Probe identification Origin of 
sequence
Publication Oligonucleotide/s 
defining probe
Gene
region
ASM 501 Rat Yamamoto et al., 
1994
ASM 201 F/R Exon 3
ASM 502 Mouse Savioz and Davies, 
1994
ASM 215 F/R Exon 8 b
ASM 242 Mouse McCallion et a l, 
manuscript submitted
ASM 242 Exon 1
ASM 244 Mouse McCallion et al., 
manuscript submitted
ASM 244 Exon 2
ASM 221 Mouse Montague et al., 
1997
ASM 221 Exon 4
ASM 114 R Rat Holz et al., 1996 ASM 114 R Exon 7 c
Table 2.4.2 Probes utilised Southern blot-hybridisation experiments 2.4.3. 
Oligonucleotides utilised as probes or in the PCR generation of probes are defined in Table 
2.4, Chapter 2. The Mobp gene regions to which these probes are designed are identified 
above. The identification of exons is based on data obtained in the completed studies 
reported in Section 2 (2.4) and Section 2 (2.5).
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2.4.5 Sequence analysis of Mobp
2.4.5.1 Sequence analysis of cloned DNA fragments containing Mobp sequences
Dye-terminator Taq cycle sequencing was performed, as described in Chapter 2, utilising 
double-stranded plasmid DNA as template. Sequence was obtained from cloned DNAs; as
A PS derived plasmids (AS 50, AS 55, AS 59), generated by automatic subcloning
(Chapter 2) or from DNA fragments derived from the Sst I restriction enzyme cleavage of
clones AS 17 and AS26, subcloned in a pBS KS+ plasmid backbone. The first 
oligonucleotides to be synthesised (ASM 101, 102, 103, ASM 201 F/R, ASM 114 R; 
defined in Table 2.3, Chapter 2) for sequencing were designed to sequences within 
reported rat transcripts (Yamamoto et al., 1994; Holz et al., 1996). Subsequently 
oligonucleotides were designed to sequence generated by this study. All oligonucleotides 
utilised in this study are defined in Table 2.3 (Chapter 2). Figure 2.4.7 illustrates how the 
sequence obtained corresponds to the restriction map of the region encompassing Mobp 
and to the genomic organisation of the gene. The combined length of contiguous sequence 
units (contigs) 1, 2 and 3 comprises >10 kb. Overlapping sequences were generated using, 
in most instances, one strand of DNA from any single region. However, all sequencing 
reactions have been performed at least twice with each oligonucleotide. Only 
unambiguously identified bases were used in the generation of contiguous sequence units. 
Contigs 1, 2 and 3 are listed in Appendices VII, VIII and IX respectively. The sequence 
defined as contig 1 (>3 .5  kb) encompasses exons 3-5 (defined in Table 2.4.3). The 
sequence defined as contig 2 (> 5 kb) encompasses exons 6  and 7 (defined in Table 2.4.3). 
The sequence defined as contig 3 (> 2.8 kb) encompasses exon 8 (defined in Table 2.4.3). 
Sequence across intron/exon junctions are reported in section 2.4.5 and in Table 2.4.3.
N.B. All sequencing reaction for study of the M obp  gene were performed with the 
technical support of Dr G. J. Stewart.
160
Gcs
e
g
bn
Hh
X>
CN
£
g
E
o
I>
-*t
<N
43Ui
3
bn
m
bp
’+->
g
o
U
x
00
rl
<
CN
_bn
-t—*
G
O
u
£
Ub
<
_bp
G
O
U
X
m
ro
<
«■
g uoxg
L u o x g
t  => 9 uoxg
W-
X—h
w
w -
w
W “
o b “  
W ■
PQ ”  
PQ
CLh--
c/3e
on
C/3
LI
C l]
S uoxg
t7«oxg
£uoxg Ob
/
CZH
/
zuoxg
Xuoxg
PQ
Ob '
W '
PQ ' 
W 1
X
o
*c3
o
Ob
xM
Tf<N
XM
<N
JOM
00
XIM
m
G 
O
odC/3
•S *G (Dbn G  -GU4 * ^
O  «N co
O SL
0 “ I
! § utin -—\ 
77 43 O  43 0  w
'B  <3 • . Sjfc 
S ’ O ’ ®
■§ § o
1 s s  
f  1 .2oo b£)Td
8  +3 o
£  G  <■>
G1 °  £ g  O  <U
O  0-h 43 
O  O  G
43 2  bn
G  *oo 43O O JS
% |  °
C + - I  G  G
G CO
E 12 bn
G
.2  <N
o -  A
"oo ^<£> bX) - q  n -£3 O 
43 G X O <  
G  bX) 
G  G43 i/3
43 .G C/3C/3
G
&O
C3
G
43
+-< G
^  <13g
(L> G 
O  43 
G G 
43 CT1 
T3 43 G G «3 o
l i t43 ^
fc » s  
o  -a  -S
U  G  M
O C/3
O  O, i-H
k  "d o . G G
^  ®* T J(N Gj G 
1) "S G & £  h
G S  2  bn ^  GG  C+H 43
b  O bn
161
re
str
ict
io
n 
ma
p 
of 
the
 
clo
ne
d 
ge
no
m
ic 
fra
gm
en
ts 
AS
M 
17
, 
18
, 2
2, 
26
, 2
8, 
35 
and
 
41
. 
E,
 B
, H
, K
, 
S 
and
 
X 
re
pr
es
en
t 
re
str
ict
io
n 
en
zy
m
es
 E
co 
RI
, B
am
 
HI
, 
Hi
n 
di
n, 
Kp
n 
I, 
Ss
t 
I a
nd 
Xh
o 
I r
es
pe
ct
iv
el
y.
 
N.
B.
 E
xo
ns
 
1 
and
 
2 
are
 
se
pa
ra
te
d 
fro
m 
eac
h 
oth
er 
and
 
fro
m 
ex
on
 
thr
ee
 
by 
an
, 
as 
ye
t, 
un
de
ter
m
in
ed
 
di
sta
nc
e.
2.4.5.2 Generation of a sequence multi-alignment of coding exon and 3'UTR 
sequences from the mouse and rat genes encoding myelin-associated 
oligodendrocytic basic protein
Sequences were imported to the Genejockey software (Cambridge, Biosoft), from the 
database according to their EMBL accession numbers (defined in Table 2.3.1 and Section 
2, 2.5.1) and aligned by eye within the Genejockey sequence multialignment feature. The 
results of this analysis are illustrated in Appendix X.
Sequence from exons 1 and 2 of the murine gene Mobp demonstrate < 84% identity with 
the 5' UTR sequences within the published rat splice variants (Yamamoto et al, 1994; 
Holz et al., 1996 ). Exon 3 demonstrates 99% identity, at the nucleotide level, with its 
corresponding sequence in rat. These sequences demonstrate 100% identity between the 
amino acids that they encode. Exon 4 demonstrates 98% identity, at the nucleotide level, 
with its corresponding sequence in rat. This corresponds to a 96% similarity at the amino 
acid level. The codon encoding amino acid 69 (Arg) of MOBP 69, encoded by exon 5, is 
conserved between rat and mouse. Exon 6 , which in rat encodes amino acids 69-71 (Arg 
Thr Val) of MOBP 71, in mouse encodes 5 amino acids (Arg Thr Val Arg Lys) resulting in 
a predicted protein of 73 amino acids. Exon 7a encodes amino acids 69-81 of MOBP 81 in 
mouse, and demonstrates 100% identity, at the amino acid level, with amino acids 69-81 
of the isoform MOBP 81. The 3'UTRs provided by exons 7b/c and 8b demonstrate >85% 
sequence identity with their corresponding sequences in rat.
2.4.5.3 Identification of repeated sequence structures within the Mobp gene
The region encompassing the Mobp gene contains a number of repeat structures. These 
are listed in Table 2.4.4.
2.4.6 Linear organisation of Mobp exons
Analysis of isolated clones by restriction mapping, Southern blot hybridisation and DNA 
sequencing indicated that this gene comprises 8 exons encompassing a region in excess of 
15 kb. Exons 7 and 8 also utilise internal splice donor/acceptor sequences and are 
consequently further defined as Exon 7 (7a, 7b and 7c) and exon 8 (8 a and 8 b). The 
sequences across the intron/exon boundaries are shown in Table 2.4.3.
The evidence provided by the presence of an extended exonic 5' donor sequence (C/AAGI, 
where the exon/intron junction is denoted by a vertical line), and the PCR amplification of 
a 1.2 kb genomic fragment (refer to study performed in Section 2, 2.5) using primers ASM
162
242 and ASM 244 (defined; Table 2.3, Chapter 2) supports the hypothesis that the 
identified 5'UTRs (rat: Yamamoto et al., 1994; Holz et al., 1996 and mouse: McCallion, 
PhD thesis, 1997 [Section 2.5]) are interrupted by an intron. Subsequently, the exonic 
segments to which these oligonucleotides were designed have been arbitrarily identified as 
discrete exons. Sequence analysis of cloned cDNA fragments, generated in an endeavour 
to identify the transcriptional start sites associated with Mobp (Oligo-capping; Maruyama 
and Sugano, 1994; Section 2.5), indicated alternative use of the second of these sequence 
units (exon 2) but constitutive use of the first (exon 1). No such alternative splicing in the 
5'UTRs of rat RNAs has been reported (Yamamoto et al., 1994; Holz et al., 1996). Exons 
downstream of the arbitrarily named exons 1 and 2 have been named exons 3-8 in their 
corresponding linear order in the mouse genome.
Exon 3 was found to encode the amino acid residues 1 - 6 8  present in all previously 
reported MOBP isoforms (Yamamoto et al., 1994; Holz et al., 1996 and Montague et al., 
1997). The complex relationship between exons 4 - 8 ,  the six splice variants of the Mobp 
transcript, reported in rat and mouse and the proteins that they encode (Yamamoto et al., 
1994; Holz et al., 1996 and Montague et al., 1997), is illustrated in Figure 2.4.8 and in 
Figure 2.4.9 (refer also to Section 2, 2.3). It is noteworthy that the transcripts Mobp 81A 
and Mobp 8 IB, though identical in their coding regions, are distinguished by their use of 
exons 7b/c and 8 a/b respectively, in the generation of their different 3'UTRs. It has been 
reported that these transcripts demonstrate differing subcellular localisation and are 
expressed at different developmental timepoints (Montague et al., 1997; Montague et al., 
unpublished data).
Exon 4 encodes the 102 amino acids unique to the isoform MOBP 170 ([rOPRPl] 
Yamamoto et al., 1994; Montague et al., 1997). Exon 5 was found to encode amino acid 
69 of the isoform MOBP 69. Exon 6  was found to encode amino acids 69-73 of predicted 
protein MOBP 73. The corresponding sequence unit in rat encodes amino acids 69-71 of 
isoform rOPl [MOBP 71] (Yamamoto et al., 1994). Exon 7a was found to encode amino 
acids 69-81 of isoform MOBP81 and was completely conserved between the rat and 
mouse Mobp genes. However, the same sequence also provides a portion of the 3'UTRs 
corresponding to transcripts rOPl and Mobp 69. Exon 7b provides a 2.6 kb portion of 
3'UTR unique to the transcript Mobp 8 IB. Exon 7c provides a portion of 3'UTR found 
within the transcripts Mobp 69 and Mobp 8 IB. Exon 8 a/b provides a portion of 3'UTR 
found within transcript Mobp 81A and Mobp 73. However exon 8 b, whose corresponding 
sequence in rat encodes amino acids 69-99 of isoform MOBP 99, does not contain an ORF 
reading in frame with that encoding amino acids 1-68. This suggests that no isoform,
163
corresponding to the polypeptide MOBP 99 in rat, is produced from the mouse Mobp gene. 
However, the fact that exon 8 b demonstrates > 8 5 %  sequence identity with its 
corresponding sequence in rat, supports the suggestion that the 3'UTRs of Mobp splice 
variants may be important e.g. in the translocation of RNAs to various parts of the 
oligodendrocyte (Holz et al., 1996; Montague etal., 1997).
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Figure 2.4.9 Schematic representation of exon use in the generation of splice variants, ol 
the murine Mobp gene transcript (Figure 2.4.10). •, Schematic represenation of the genomic 
region encompassing Mobp. The indicated constitutive use of exons 1 and 2, by predicted 
splice variants, is purely arbitrary. The use of exons 1 and 2, within individual splice 
variants has not yet been elucidated. Mobp 71 and Mobp 170 correspond to transcripts 
rOPl and rOPRPl, as defined by Yamamoto et al. (1994). Scale bars are situated 
immediately below their corresponding schematic diagram(s).
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2.4.7 Identification of RNA signals in Mobp gene
The minimum consensus sequences (Mount, 1982; Smith etal., 1989) for splice junctions, 
GT and AG (the intron 5' donor and 3' acceptor sites respectively), were found at the 
appropriate ends of all six introns where intronic sequence is available (Table 2.4.3). An 
exact match to the extended 5' donor site (C/A)AGIGT(G/A)AGT (where the exon/intron 
boundary is denoted by the vertical line) is not found at any of the 5' exon/intron junctions 
in the Mobp gene. The sequence at the 3' end of exon 6 is the most divergent from the 
consensus sequence; only six out of nine bases are in agreement. It is noteworthy that this 
sequence is not highly conserved (Smith et a l, 1989). However, the extended 3' acceptor 
site (C/T)AGIG is found in two of the 3' intron/exon junctions (exon 6 and exon 7c). The 
other 6 intron/exon boundaries, where intronic sequence is available, differ from the 
consensus sequence by only a single nucleotide. Alternative 3' acceptor sites are identified 
in exon 7 (7a and 7c) and in exon 8 (8a and 8b). Exon 7 also contains an internal 5' donor 
site at the exon/exon junction between exon 7a and 7b. Polyadenylation signals are 
indicated by the sequence ATT AAA (exon 4) and AATAAA (exons 7c and 8b).
2.4.7 Discussion
I report here the organisation of the murine gene Mobp encoding myelin-associated 
oligodendrocytic basic protein. Comparison of these data with those for reported 
transcripts generated from the rat and mouse Mobp genes (rat: Yamamoto et al., 1994; 
Holz et al., 1996 and mouse: Montague et al., 1997) provides insight into the complex 
series of splicing events required in their generation (Holz et al., 1996; Montague et al., 
1997). The evident use of alternative 3' splice acceptor sites (exons 7a, 7c, 8a and 8b) and 
5' splice donor sites (exons 7a, 7c) adds to the, now obvious, complexity of the Mobp 
transcriptional unit. Whether intron/exon boundaries are conserved between these species 
will require further study of the rat gene {Mobp).
A knowledge of the organisation of this gene permits the conceptualisation of gene 
disruption strategies that will permit the elimination of expression of all MOBP isoforms 
or of individual isoforms. I have already initiated work to establish a mouse model in 
which the Mobp gene is disrupted, removing expression of all MOBP isoforms. This work 
is reported in Section 2.6.
In summary; the murine Mobp gene encoding myelin-associated oligodendrocytic basic 
protein is a complex transcriptional unit, comprising 8 exons and encompassing a genomic 
region in excess of 15 kb. The relationship between its genomic orginisation and its
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transcriptional complexity may now be deduced, at least in part. Elucidation of the 
genomic orginisation of Mobp provides a platform for functional study through gene 
disruption strategies (refer also to Section 2, 2.6).
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Exon 5' Donor Intron 3' Acceptor Exon
size
Exon 1 CGC 2Q. / / / G GCA Exon 2
Exon 2 CCC PG / / .atqcrtttccacr. T GAG Exon 3
Exon 3 PCT
Thr68
PG
Se4
Ar5
Arg
Sesb
.qtqaqtgcqqq. 0.2 kb . ctctcrcaccacr. C CGC 
r^9 Arg
Exon 4
Exon 4 COT QC . . .ATTAAA.. . 0.3 kb . c t a c t t t a t a q . A69 TAA 
g  OCH
Exon 5
Exon 5 c r c GG . crttaaaccacft. 2.5 kb . t t c c t c c c a q . g 69act
g  Thr
Exon 6
Exon 6 GGA PG .otaaacacrctt. 3.0 kb . c ta ta a a tc a a . A69 TIG 
g  Leu
Exon 7a
Exon 7 a TGG A3 . cftqaqaaqqqcr. 1.2 kb Exon 7b
Exon 7b . g ca ctcc  t a g . GQCCT Exon 7c
Exon 7c ACG TC . . .AATAAA. . . 3.0 kb . tc tccc c tca cr . CATCT Exon 8a
Exon 8 a 
Exon 8b OTA GA . . .AATAAA. . .
. acftaaatqcaa. T69 AIG 
r  Met
Exon 8b
Table 2.4.3 Sequences across the intron / exon boundaries of the murine Mobp gene.
The DNA sequences across the intron / exon boundaries are shown and the encoded amino 
acid sequences are indicated in three-letter code. The last amino acid residue encoded by 
exon three may be Ser or Arg dependent on which downstream exon (4, 5, 6 or 8b) they 
are subsequently spliced to. The exon in question is indicated, in each case, by the 
subscript numbers 4 , 5 , 6 or 8b- The amino acid sequence is numbered (superscript) from
the first residue of the isoform MOBP 81 (Holz et al., 1996). Nucleotides in upper-case 
letters represent exonic sequences, while nucleotides in lower-case letters represent 
intronic sequences. Alternative 3' acceptor sites are identified in exon 7 (7a and 7c) and in 
exon 8 (8a and 8b). Exon 7 contains an internal 5' donor site at the exon/exon junction 
between exon 7a and 7b. The most 3' end of this exon (exon 7c) terminates with the 
polyadenylation signal A AT AAA. Polyadenylation signals are indicated by the sequence 
ATTAAA (exon 4) and AATAAA (exons 7c and 8b). Extended 5' splice donor sites and 
3' acceptor sites are underlined. The extended 3' acceptor site (C/T)AGIG, found in the 3' 
intron/exon junctions of exon 6 and exon 7c respectively, are in bold type.
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Repeat unit Number of Description Location Contig Location 
repeat units within Mobp Number within
Contig
CA 18 Perfect Intron 2 1
GA 26 Perfect Intron 2 1
TTTCAAA 4 Imperfect Intron 5 2
GT/C 12 Imperfect Exon 7b 2
GT/C 19 Imperfect Exon 7b 2
CA 5 Perfect Exon 7b 2
CG/A 27 Imperfect Exon 7b 2
CA 20 Perfect Exon 7b 2
CCACA 5 Imperfect Exon 7b 2
Table 2.4.4 Repeat structures within the Mobp gene
Locations within contigs correspond to nucleotide (nt) positions within contigs 1, 2 and 3 
(Appendices VII, VIII and IX respectively).
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2.5 Promoter region of the murine Mobp gene
2.5.1 Identification of transcriptional start sites
The oligo-capping procedure, first reported by Maruyama and Sugano (1994) was utilised 
in an endeavour to identify the transcriptional start sites of the murine gene Mobp. This 
procedure is made possible by the fact that the 5' end of eukaryotic mRNA has a cap 
structure (Furuichi and Miura, 1975) comprising a 7-methylated GTP attached to the first 
nucleotide of the message via two pyrophosphate linkages (Furuichi and Miura, 1975).
The protocol is described in full in Chapter 2. In brief, poly A+ RNA was 
dephosphorylated in the presence of bacterial alkaline phosphatase (BAP) and the 
methylated cap structure removed by incubation with tobacco acid pyrophosphatase 
(TAP). An oligoribonucleotide (r-oligo) was then ligated to the 5' end of previously 
capped mRNAs. It should be noted that: (a) BAP removes phosphates from 5' uncapped 
RNAs, leaving a hydroxyl at the 5' end; (b) TAP removes the cap structure from capped 
intact RNAs leaving a 5' phosphate whilst leaving internal phosphodiester bonds 
unchanged; (c) RNA ligase requires a 3'-hydroxyl (Acceptor) and a 5'-phosphate (Donor) 
for ligation of substrates. Consequently, where mRNAs are treated first with BAP and 
then with TAP, the RNA ligase can only ligate an r-oligo to previously capped RNAs. The 
5' end of Mobp RNAs were then specifically reverse transcribed and PCR amplified (RT- 
PCR), and cloned into the cloning vector pCR™ 2.1 (defined in Table 2.2, Chapter 2) and 
Taq cycle sequencing, of the resulting clones, performed (as described in Chapter 2).
2.5.2 RT-PCR amplification of the 5' ends of Mobp RNAs
RT was performed using the oligonucleotide ASM 202 (defined in Table 2.3, Chapter 2). 
Subsequent PCR amplification was performed using the oligonucleotides TAG 135 
(defined in Table 2.3, Chapter 2) and ASM 202. A nested PCR amplification was then 
performed, utilising as template product from the primary amplification (1/10 reaction 
volume), using the oligonucleotides TAG 135 and ASM 201 (defined in Table 2.3, 
Chapter 2). The sequence to which ASM 201 was designed is upstream to the sequence to 
which ASM 202 was designed. The amplification products were separated by 
electrophoresis (as described in Chapter 2) in 2% ordinary agarose gels (Figure 2.5.1). 
Four signals were observed, corresponding to DNA fragments in a size range 50-300 bp. 
These fragments were band isolated (as described in Chapter 2) and each was amplified 
using the oligonucleotides TAG 135 and ASM 201. Subsequently, 1 |il of each reaction 
was ligated with the cloning vector pCR™ 2.1 and transformed into the bacterial strain
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INVa F' (defined in Table 2.2, Chapter 2). Taq cycle sequencing was performed using as
template, cDNA clones corresponding to these amplified products. The sequences derived 
from cDNA fragments generated using this RT-PCR combination are illustrated in Figure
2.5.2 and are all prefixed by OC. This RT-PCR combination was repeated using the 
oligonucleotide ASM 203 (defined in Table 2.3, Chapter 2) in the RT step. The 
amplification stages utilised the oligonucleotide TAG 135 in conjunction with the 
oligonucleotides ASM 203 and ASM 204 (defined in Table 2.3, Chapter 2), in the primary 
and secondary PCR steps respectively. The sequence to which oligonucleotide ASM 203 
was designed was downstream of the sequence to which ASM 204 was designed. This 
RT-PCR combination also identified four major signals when products were separated by 
electrophoresis (as described in Chapter 2) in 2% ordinary agarose gels. These four 
signals, corresponded to DNA fragments in a size range 50-350 bp. These fragments were 
band isolated (as described in Chapter 2) and each was amplified using the 
oligonucleotides TAG 135 and ASM 204. PCR products were isolated, cloned and 
sequenced as indicated above (described in Chapter 2). The sequences derived from 
cDNA fragments generated using this RT-PCR combination are illustrated in Figure 2.5.2 
and are all prefixed by OCII. It should be noted that oligonucleotides ASM 201, ASM 
202, ASM 203 and ASM 204 were all designed to sequences within the primary coding 
exon (exon 3) of Mobp. It should be noted that all M obp  exons have been named 
subsequent to the conclusion of all studies contributing to this thesis.
2.5.3 Sequence identification of transcriptional start sites
In total, 70 clones provided interpretable sequence. The corresponding sequences and 
distribution of start sites are illustrated in Figure 2.5.2. Five major transcriptional start 
sites (tsp), or clusters of start sites, are readily observable (Figure 2.5.2) amongst 
sequences derived from cDNA fragments in experiments OC and OCII. The lengths of 
these sequences (28-280 nt) correlate well with the observed fragment sizes (Figure 2.5.1), 
when the lengths of the corresponding oligonucleotide sequences are included. It should 
be noted that amplified cDNA fragments with a product size range of 50-60 bp would be 
indistinguishable from PCR artefacts resulting from primer-dimer formation, in the above 
mentioned agarose gel electrophoresis. A major tsp (>17% of cDNAs sequenced) is 
present at 140 nt upstream of the translation start site (ATGioaq.iosi. where T 1050 is the 
point relative to which all tsp positions are defined and the subscript number 1050 
corresponds to the nucleotide position in Contig 1) (Figure 2.5.3) used in the production of 
all previously identified MOBP isoforms (Yamamoto et al., 1994; Holz et al., 1996; 
Montague et al., 1997). A cluster of tsp are present at 75-68 nt (>7% of cDNAs 
sequenced) upstream of T 1050 (Figure 2.5.3). It is noteworthy that a third tsp, comprising
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>5%  (OC 4.41 inv, OC 3.1, OC 3.19 and OC 13) of sequences in this study, contains 
sequence from exons 1 and 3 in the absence of exon 2 (Figure 2.5.2). These tsp are found 
at a point 60 nt (>5% of cDNAs sequenced) upstream of T 1050 (Figure 2.5.2).
Two further tsp are found clustered at points 25 nt (>35% of cDNAs sequenced) and 
101 nt (>10% of cDNAs sequenced) downstream of T1050 (Figure 2.5.2). As only 
previously capped RNAs are available for ligation of an r-oligo (Maruyama and 
Sugano, 1994; Kurihara et al., 1997), these data would indicate the presence of a 
transcriptional unit whose transcription is initiated within the Mobp gene but utilises a 
translation start point that is downstream of the ATG used in the generation of reported 
isoforms (Yamamoto eta l., 1994; Holz etal., 1996; Montague et al., 1997).
2.5.3.1 Identification of a putative novel transcriptional unit within
Mobp
To assess the possibility of the presence of a downstream transcriptional unit existing 
within Mobp, sequence analysis of intron 3 (separating exons 3 and 4, Figure 2.4.7, Contig 
1) was performed. This analysis identified a putative translation start site (ATG) within 
the intronic sequence. This methionine codon was followed by an open reading frame 
(ORF) encoding a putative protein of some 155 amino acids. Furthermore, this ORF 
extends into exon 4 and reads in frame with the ORF encoding the 102 C-terminal amino 
acids of the isoform MOBP 170 (rOPRP 1, Yamamoto et al., 1994). The sequence across 
intron 3 and exon 4 is shown in Figure 2.5.3. The amino acid sequence of the protein 
encoded by the novel transcript would predict that like MOBP 170, it too is a small (26 
kD) basic hydrophilic positively charged (pi = 12.25 and net charge at pH 7.5 = +26) 
proline rich (35/155 aa residues) protein (Figure 2.5.3).
Oligonucleotides (ASM 245 and ASM 246; defined in Table 2.3, Chapter 2) were 
designed to sequence within intron 3 (within the novel ORF) and exon 4 respectively. 
These oligonucleotides were used in an RT-PCR assay for transcript corresponding to 
sequence within this novel ORF. A preliminary study indicated that a corresponding 
sequence was detectable in cDNA from mouse brain (Postnatal day 43 [P43]). Time 
limitation precluded pursuit of this line of study by this author. However, the study of 
this putative novel transcript has continued in collaboration with the laboratory of Dr I. 
Griffiths (University of Glasgow). Results to date indicate that this transcript is 
detectable at levels equivalent to or slightly lower than Mobp 81A (Montague et al., 
unpublished data). This novel transcript is first detected, by PCR, in concert with or
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just after that of Mobp 73 and Mobp 81 A; first detected in the brain at P5 (Montague et 
a l,  1997). Detection of this putative novel transcript lags behind that of Mobp 170, 
first detected at embryonic day 12 (E l2). Mobp 170 is the only other transcript 
reported to utilise sequence corresponding to exon 4 (Yamamoto et al., 1994; 
Montague et al., 1997). Expression of this putative novel transcript would also appear 
to be oligodendrocyte specific (Montague et al., unpublished data). It is noteworthy 
that this transcript lacks the sequence encoding amino acids 1-68 of all previously 
reported MOBP isoforms (Yamamoto et al, 1994; Holz et al., 1996; Montague et a l, 
1997), including MOBP 170.
2.5.4 Identification of alternative splicing in the 5' untranslated sequence of
Mobp pre-mRNAs
As described above (2.5.3) mRNAs corresponding to tsp at 60 nt upstream of T 1050 
(Figure 2.5.2) contain sequence from exon 1 and exon 3 but lack sequence from exon 2. It 
should be noted that the exon defined as exon 1, possesses a 5' donor splice sequence 
(CAGI; Section 2.4, Table 2.4.3; Figure 2.5.2) at its 3' end. These data indicate that the 
5'UTR sequence of all mRNAs generated by splicing events within the Mobp transcript 
contain sequence from exon 1 and a 4 nt portion of exon 3. Sequence from exon 2 is 
present in < 95% of mRNAs examined in this study. Whether the presence or absence of 
sequence from exon 2 is regulated developmentally or restricted to a subpopulation of 
Mobp splice variants is not known. Exon 2 may be separated from exon 1 by an intronic 
sequence or may be contiguous with exon 1 and demonstrate alternative use of an 
available 5' donor splice site. If the latter is correct, prediction may be made of the size of 
a PCR product amplified using oligonucleotides designed to sequence within exons 1 and 
2. In order to address this question oligonucleotides for PCR were designed to sequence 
within exon 1 and exon 2. In the event that these exons are contiguous, the size of the 
amplified genomic DNA fragment should be no more than 135 bp in length. Figure 2.5.4 
illustrates the results of a sequence alignment of 5'UTR sequences of the published splice 
variants of the rat Mobp gene and a cDNA fragment from the mouse Mobp transcript, 
which contains the predicted exons 1 and 2.
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Figure 2.5.1 PCR
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800 810 820 830 840 850
I I I I I I
Contig# 1 AGCCGTTCCCACATGGCTCTTGTCATAAAACCATGCATAACACACACACACACACACACAC
Big contig 1 AGCCGTTCCCACATGGCTCTTGTCATAAAACCATGCATAACACACACACACACACACACAC
860 870 880 890 900 910
Contig# 1 
Big contig 1 
OCII.15 inverted.
OC 4.34 inv 
OCII.17 inverted. 
OCII.18 
OCII.28 
OCII.9 
OC 4.36 
OC 4.27 
OC 4.47 
OC 4.45
inverted
inv
ACACACACACACACAGAGAGAGAGAGAGAGAGAGAGAGAGAGAGAGAGAGAGAGAAGCTCC
ACACACACACACACAGAGAGAGAGAGAGAGAGAGAGAGAGAGAGAGAGAGAGAGAGAGAGA
AAGCTCC
AAGCTCC
AGCTCC
AGCTCC
AGCTCC
AGCTCC
AGCTCC
AGCTCC
AGCTCC
AGCTCC
920 930 940 950 960 970
Contig# 1 
Big contig 1 
OCII.15 inverted.
OC 4.34 inv 
OCII.17 inverted. 
OCII.18 
OCII.28
OCII.9 inverted 
OC 4.36 inv 
OC 4.27 
OC 4.47 
OC 4.45 
OC 4.46 
OC 3.3 
OC 3.6 
OC 3.14
ACCAGGGCCCGCTATCCACAGGAACCTTTCACAACAGCCATTACTCGCAGGGCAACAAAGA
GAGAGAACCAAGCTCTGCACCTTTGTTCTGCAGAGCAGTGTCACCTGTGGACGCTGAGCAG
ACCAGGGCCCGGTATCCACAGGAACCTTTCACAACAGCCATTACTCGCAGGGCAACAAAGA
ACCAGGGCCCGCTATCCACAGGAACCTTTCACAACAGCCATTACTCGCAGGGCAACAAAGA
ACCAGGGCCCGCTATCCACAGGAACCTTTCACAACAGCCATTACTCGCAGGGCAACAAAGA
ACCAGGGCCCGCTATCCACAGGAACCTTTCACAACAGCCATTACTCGCAGGGCAACAAAGA
ACCAGGGCCCGCTATCCACAGGAACCTTTCACAACAGCCATTACTCGCAGGGCAACAAAGA
ACCAGGGCCCGCTATCCACAGGAACCTTTCACAACAGCCATTACTCGCAGGGCAACAAAGA
ACCAGGGCCCGCTATCCACAGGAACCTTTCACAACAGCCATTACTCGCAGGGCAACAAAGA
ACCAGGGCCCGCTATCCACAGGAACCTTTCACAACAGCCATTACTCGCAGGGCAACAAAGA
ACCAGGGCCCGCTATCCACAGGAACCTTTCACAACAGCCATTACTCGCAGGGCAACAAAGA
ACCAGGGCCCGCTATCCACAGGAACCTTTCACAACAGCCATTACTCGCAGGGCAACAAAGA
ACCAGGGCCCGCTATCCACAGGAACCTTTCACAACAGCCATTACTCGCAGGGCAACAAAGA
GA
GA
A
980 990 1000 1010 1020 1030
inverted
inv
Contig# 1 
Big contig 1 
OCII.15 inverted. 
OC 4.34 inv 
OCII.17 inverted. 
OCII.18 
OCII.28 
OCII.9 
OC 4.36 
OC 4.27 
OC 4.47 
OC 4.45 
OC 4.46 
OC 3.3 
OC 3.6 
OC 3.14 
OC 4.38 
OC 3.10 
OC 2.12 
OC 3.18 
OC 3.13 
OC 4.46
ATCAAATGAGAGCAAGACAAGCGGAGAACAGAGTCCTGGTTGCCAGACCGGCACGGATGAA
AAGGGTTCCTCCCTCACATGCTGTTTTGTGTCTCCCCTCCCCTCCCCTTCTTCATCAATGG
A TC A ^T^G A G C ^^C ^(^C (^G ^^G A G TC C 'K M TT(^C A G A C C G ^A C G ^TC A A
ATCAAGTGAGAGCAAGACAAGCCGAGAACAGAGTCCTGGTTGCCAGACCGGCACGGATGAA
ATCAAATGAGAGCAAGACAAGCGGAGACCAGAGTCCTGGTTGCCAGACCGGCACGGATGAA
ATCAAATGAGAGCAAGACAAGCCGAGAACAGAGTCCTGGTTGCCAGACCGGCACGGATGAA
ATCAAATGAGAGCAAGACAAGCCGAGAACAGAGTCCTGGTTGCCAGACCGGCACGGATGAA
ATCAAATGAGAGCAAGACAAGCGGAGACCAGAGTCCTGGTTGCCAGACCGGCACGGATGAA
ATCAAATGAGAGCAAGACAAGCCGAGAACAGAGTCCTGGTTGCCAGACCGGCACGGATGAA
ATCACATGAGAGCAAGACAAGCCGAGAACAGAGTCCTGGTTGCCAGACCGGCACGGATGAA
ATCAAATGAGAGCAAGACAAGCGGAGAACAGAGTCCTGGTTGCCAGACCGGCACGGATGAA
ATCAAATGAGAGCAAGACAAGCCGAGAACAGAGTCCTGGTTGCCAGACCGGCACGGATGAA
ATCAAATGAGAGCAAGACAAGCCGAGAACAGAGTCCTGGTTGCCAGACCGGCACGGATGAA
ATCAAATGAGAGCAAGACAAGCCGAGAACAGAGTCCTGGTTGCCAGACCGGCACGGATGAA
ATCAAATGAGAGCAAGACAAGAGGAGACCAGAGTCCTGGTTGCCAGACCGGCACGGATGAA
ATCAAATGAGAGCAAGACAAGCGGAGACCAGAGTCCTGGTTGCCAGACCGGCACGGATGAA
ATGAGAGCAAGACAAGCGGAGACCAGAGTCCTGGTTGCCAGACCGGCACGGATGAA
AAGACAAGCCGAGAACAGAGTCCTGGTTGCCAGACCGGCACGGATGAA
TGAA
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980 990 1000 1010 1020 1030
OC 4.41 inv AGCTCCACCAGGGCCCGCTATCCACAGGAACCTTTCACAACAGCCATTA
OC 3.1 AGCTCCACCAGGGCCCGCTATCCACAGGAACCTTTCACAACAGCCATTA
OC 3.19 AGCTCCACCAGGGCCCGCTATCCACAGGAACCTTTCACAACAGCCATTA
OC 13 AGCTCCACCAGGGCCCGCTAGCCACAGGAACCTTTCACAACAGCCATTA
1040 1050 1060 1070 1080 1090
Contig# 1 AACCCAGTGAGATGAGTCAGAAAATGGCCAAGGAGGGCCCCAGGCTCTCCAAGAACCAGAA
Big contig 1 TTTCCAGTGAGATGAGTCAGAAAATGGCCAAGGAGGGCCCCAGGCTCTCCAAGAACCAGAA
OCII.15 inv AACCCAGTGAGATGAGTCAGAAAATGGCCAAGGAGGGCCCCAGGCTCTTCAAGAACCAGAA
OC 4.34 inv AACCCAGTGAGATGAGTCAGAAAATGGCCAAGGAGGGCCCCAGGCTCTCCAAGAACCAGAA
OCII.17 inv AACCCAGTGAGATGAGTCAGAAAATGGCCAAGGAGGGCCCCAGGCTCTCCAAGAACCAGAA
OCII.18 AACCCAGTGAGATGAGTCAGAAAATGGCCAAGGAGGGCCCCAGGCTCTCCAAGAACCAGAA
OCII.28 AACCCAGTGAGATGAGTCAGAAAATGGCCAAGGAGGGCCCCAGGCTCTCCAAGAACCAGAA
OCII.9 inv AACCCAGTGAGATGAGTCAGAAAATGGCCAAGGAGGGCCCCAGGCTCTCCAAGAACCAGAA
OC 4.36 inv AACCCAGTGAGATGAGTCAGAAAATGGCCAAGGAGGGCCCCAGGCTCTCCAAGAACCAGAA
OC 4.27 AACCCAGTGAGATGAGTCAGAAAATGGCCAAGGAGGGCCCCAGGCTCTCCAAGAACCAGAA
OC 4.47 AACCCAGTGAGATGAGTCAGAAAATGGCCAAGGAGGGCCCCAGGCTCTCCAAGAACCAGAA
OC 4.45 AACCCAGTGAGATGAGTCAGAAAATGGCCAAGGAGGGCCCCAGGCTCTCCAAGAACCAGAA
OC 4.46 AACCCAGTGAGATGAGTCAGAAAATGGCCAAGGAGGGCCCCAGGCTCTCCAAGAACCAGAA
OC 3.3 AACCCAGTGAGATGAGTCAGAAAATGGCCAAGGAGGGCCCCAGGCTCTCCAAGAACCAGAA
OC 3.6 AACCCAGTGAGATGAGTCAGAAAATGGCCAAGGAGGGCCCCAGGCTCTCCAAGAACCAGAA
OC 3.14 AACCCAGTGAGATGAGTCAGAAAATGGCCAAGGAGGGCCCCAGGCTCTCCAAGAACCAGAA
OC 4.38 AACCCAGTGAGATGAGTCAGAAAATGGCCAAGGAGGGTCCCAGGCTCTCCAAGAACCAGAA
OC 3.10 AACCCAGTGAGATGAGTCAGAAAATGGCCAAGGAGGGCCCCAGGCTCTCCAAGAACCAGAA
OC 2.12 AACCCAGTGAGATGAGTCAGAAAATGGCCAAGGAGGGCCCCAGGCTCTCCGAGAACCAGAA
OC 3.18 ACCCACTGAGATGAGTCAGAAAATGGCCAAGGAGGGCCCCAGGCTCTCCAAGAACAAGAA
OC 3.13 CCCAGTGAGATGAGTCAGAAAATGGCCAAGGAGGGCCCCAGGCTCTCCAAGAACCAGAA
OC 4.46 CCAGTGAGATGAGTCAGAAAATGGCCAAGGAGGGCCCCAGGCTCTCCAAGAACCAGAA
OC 4.41 inv CTCGCAGTGAGATGAGTCAGAAAATGGCCAAGGAGGGCCCCAGGCTCTCCAAGAACCAGAA
OC 3.1 CTCGCAGTGAGATGAGTCAGAAAATGGCCAAGGAGGGCCCCAGGCTCTCCAAGAACCAGAA
OC 3.19 CTCGCAGTGAGATGAGTCAGAAAATGGCCAAGGAGGGCCCCAGGCTCTCCAAGAACCAGAA
OC 13 CTCGCAGTGAGATCAGTCAGAAAATGGCCAAGGAGGGCCCCAGGCTCTCCAAGAACCAGAA
OC 13 CAGTGAGATGAGTCAGAAAATGGCCAAGGAGGGCCCCAGGCTCTCCAAGAACCAGAA
OC 2.12 CAGTGAGATGAGTCAGAAAATGGCCAAGGAGGGCCCCAGGCTCTCCGAGAACCAGAA
OC 4.43 inv TGAGTCAGAAAATGGCCAAGGAGGGCCCCAGGCTCTCCAAGAACCAGAA
OC 37 inv AAGGAGGGCCCCAGGCTCTCCAAGAACCAGAA
OC 6 CCCCAGGCTCTCCAAGAACCAGAA
OC 15 CCCAGGCTCTCCAAGAACCAGAA
OC 35 CCAGGCTCTCCAAGAACCAGAA
OC 44 CCAGGCTCTCCAAGAACCAGAA
OC 4.48 CCAGGCTCTCCAAGAACCAGAA
OC 4.44 CCAGGCTCTCCAAGAACCAGAA
OC 4.42 CCAGGCTCTCCAAGAACCAGAA
OC 3.8 CCAGGCTCTCCAAGAACCAGAA
OC 3.12 CCAGGCTCTCCAAGAACCAGAA
OC 3.11 CCAGGCTCTCCAAGAACCAGAA
OC 19 CCAGGCTCTCCAAGAACCAGAA
OC 9 CCAGGCTCTCCAAGAACCAGAA
OC 41 CCAGGCTCTCCAAGAACCAGAA
OC 39 inv CCAGGCTCTCCAAGAACCAGAA
OC 32 inv CCAGGCTCTCCAAGAACCAGAA
OC 22 CCAGGCTCTCCAAGAACCAGAA
OC 15 CCAGGCTCTCCAAGAACCAGAA
OC 14 CCAGGCTCTCCAAGAACCAGAA
OC 12 CCAGGCTCTCCAAGAACCAGAA
OC 3.5 CCAGGCTCTCCAAGAACCAGAA
OC 39 inv CCAGGCTCTCCAAGAACCAGAA
OC 41 CCAGGCTCTCCAAGAACCAGAA
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CCAGGCTCTCCAAGAACCAGAA
OC 22 CCAGGCTCTCCAAGAACCAGAA
OC 32 inv CCAGGCTCTCCAAGAACCAGAA
OC 44 CCAGGCTCTCCAAGAACCAGAA
OC 35 CCAGGCTCTCCAAGAACCAGAA
OC 17 CCAGGCACTCCAAGAACCAGAA
OC 12 CCAGGCTCTCCAAGAACCAGAA
OC 14 CCAGGCTCTCCAAGAACCAGAA
OC 10 CCAGGCTCTCCAGGAACCAGAA
OC 19 AGGCTCTCCAAGAACCAGAA
OC 16 inv CAAGAACCAGAA
OC 4.40 AAGAACCAGAA
OC 46 AACCAGAA
OC 47 inv AA
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Contig# 1
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GTTCTCCGAGCACTTCAGCATCCACTGAAGCCCACCCTTCACCTTCCTCAACTCCAAGCGT
Big contig 1 GTTCTCCGAGCACTTCAGCATCCACTGCTGCCCACCCTTCACCTTCCTCAACTCCAAGCGT
OCII.15 inv GTTCTCCGAGCACTTCAGCATCCACTGCTGCCCACCCTTCACCTTCCTCAACTCCAAGCGT
OC 4.34 inv GTTCTCCGAGCACTTCAGCATCCACTGAAGCC
OCII.17 inv GTTCTCCGAGCACTTCAGCATCCACTGCTGCCCACCCTTCACCTTCCTCAACTCCAAGCGT
OCII.18 GTTCTCCGAGCACTTCAGCATCCACTGCTGCCCACCCTTCACCTTCCTCAACTCCAAGCGT
OCII.28 GTTCTCCGAGCACTTCAGCATCCACTGCTGCCCACCCTTCACCTTCCTCAACTCCAAGCGT
OCII.9 inv GTTCTCCGAGCACTTCAGCATCCACTGCTGCCCACCCTTCACCTTCCTCAACTCGAAGCGT
OC 4.36 inv GTTCTCCGAGCACTTCAGCATCCACTGAAGCC
OC 4.27 GTTCTCCGAGCACTTCAGCATCCACTGAAGCC
OC 4.47 GTTCTCCGAGCACTTCAGCATCCACTGCTGCC
OC 4.45 GTTCTCCGAGCACTTCAGCATCCACTGCTGCC
OC 4.46 GTTCTCCGAGCACTTCAGCATCCACTGAAGCC
OC 3.3 GTTCTCCGAGCACTTCAGCATCCACTGAAGCC
OC 3.6 GTTCTCCGAGCACTTCAGCATCCACTGAAGCC
OC 3.14 GTTCTCCGAGCACTTCAGCATCCACTGAAGCC
OC 4.38 GTTCTCCGAGCACTTCAGCATCCACTGAAGCC
OC 3.10 GTTCTCCGAGCACTTCAGCATCCACTGAAGCC
OC 2.12 GTTCTCCGAGCACTTCAGCATCCACTGAAGCC
OC 3.18 GTTCTCCGAGCACTTCAGCATCCACTGAAGCC
OC 3.13 GTTCTCCGAGCACTTCAGCATCCACTGAAGCC
OC 4.46 GTTCTCCGAGCACTTCAGCATCCACTGAAGCC
OC 4.41 inv GTTCTCCGAGCACTTCAGCATCCACTGAAGCC
OC 3.1 GTTCTCCGAGCACTTCAGCATCCACTGAAGCC
OC 3.19 GTTCTCCGAGCACTTCAGCATCCACTGAAGCC
OC 13 GTTCTCCGAGCACTTCAGCATCCACTGAAGCC
OC 13 GTTCTCCGAGCACTTCAGCATCCACTGAAGCC
OC 2.12 GTTCTCCGAGCACTTCAGCATCCACTGAAGCC
OC 4.43 inv GTTCTCCGAGCACTTCAGCATCCACTGAAGCC
OC 37 inv GTTCTCCGAGCACTTCAGCATCCACTGAAGCC
OC 6 GTTCTCCGAGCACTTCAGCATCCACTGAAGCC
OC 15 GTTCTCCGAGCACTTCAGCATCCACTGAAGCC
OC 35 GTTCTCCGAGCACTTCAGCATCCACTGAAGCC
OC 44 GTTCTCCGAGCACTTCAGCATCCACTGAAGCC
OC 4.48 GTTCTCCGAGCACTTCAGCATCCACTGAAGCC
OC 4.44 GTTCTCCGAGCACTTCAGCATCCACTGAAGCC
OC 4.42 GTTCTCCGAGCACTTCAGCATCCACTGAAGCC
OC 3.8 GTTCTCCGAGCACTTCAGCATCCACTGAAGCC
OC 3.12 GTTCTCCGAGCACTTCAGCATCCACTGAAGCC
OC 3.11 GTTCTCCGAGCACTTCAGCATCCACTGAAGCC
OC 19 GTTCTCCGAGCACTTCAGCATCCACTGAAGCC
OC 9 GTTCTCCGAGCACTACAGCATCCACTGAAGCC
OC 41 GTTCTCCGAGCACTTCAGCATCCACTGAAGCC
OC 39 inv GTTCTCCGAGCACTTCAGCATCCACTGAAGCC
OC 32 inv GTTCTCCGAGCACTTCAGCATCCACTGAAGCC
OC 22 GTTCTCCGAGCACTTCAGCATCCACTGAAGCC
Figure 2.5.2
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OC 46 
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OC 38 
OC7
OC 2.2 
OC 2.1
GTTCTCCGAGCACTTCAGCATCCACTGAAGCC
GTTCTCCGAGCACTTCAGCATCCACTGAAGCC
GTTCTCCGAGCACTTCAGCATCCACTGAAGCC
GTTCTCCGAGCACTTCAGCATCCACTGAAGCC
GTTCTCCGAGCACTTCAGCATCCACTGAAGCC
GTTCTCCGAGCACTTCAGCATCCACTGAAGCC
GTTCTCCGAGCACTACAGCATCCACTGAAGCC
GTTCTCCGAGCACTTCAGCATCCACTGAAGCC
GTTCTCCGAGCACTTCAGCATCCACTGAAGCC
GTTCTCCGAGCACTTCAGCATCCACTGAAGCC
GTTCTCCGAGCACTTCAGCATCCACTGAAGCC
GTTCTCCGAGCACTTCATCATCCACTGAACCC
GTTCTCCGAGCACTTCAGCATCCACTGAAGCC
GTTCTCCGAGCACTTCAGCATCCACTGAAGCC
GTTCTCCGAGCACTTCAGCATCCACTGAAGCC
GTTCTCCGAGCACTTCAGCATCCACTGAAGCC
GTTCTCCGAGCACTTCAGCATCCACTGAAGCC
GTTCTCCGAGCACTTCAGCATCCACTGAAGCC
GTTCTCCGAGCACTTCAGCATCCACTGAAGCC
GTTCTCCGAGCACTTCAGCATCCACTGAAGCC
GTTCTCCGAGCACTTCAGCATCCACTGAAGCC
GAGCACTTCAGCATCCACTGAAGCC
GAGCACTTCAGCATCCACTGAAGCC
GAGCACTTCAGCATCCACTGAAGCC
GAGCACTTCAGCATCCACTGAAGCC
1160 1170 1180 1190 1200 1210 1220
Contig# 1 
Big contig 1 
OCII.15 inverted. 
OC 4.34 inv 
OCII.17 inverted. 
OCII.18 
OCII.28
OCII.9 inverted.
GAGATCGTGGACCGCAAGTACAGCATCTGCAAGAGCGGTTGCTAAGCCCAGAAGAAGGAGG
GAGATCGTGGACCGCAAGTACAGCATCTGCAAGAGCGGTTGCTTTTACCAGAAGAAGGAGG
GAGATCGTGGACCGCAAGTACAGCATCTGCAAGAGCGGTTGCTAAGCC
GAGATCGTGGACCGCAAGTACAGCATCTGCAAGAGCGGTTGCTAAGCC
GAGATCGTGGATCGCAAGTACAGCATCTGCAAGAGCGGTTGCTAAGCC
GAGATCGTGGATCGCAAGTACAGCATCTGCAAGAGCGGTTGCTAAGCC
GAGATCGTGGACCGCAAGTACAGCATCTGCAAGAGCGGTTGCTAAGCC
GAGATCGTGGACCGCAAGTACAGCATCTGCAAGAGCGGTTGCTAAGCC
1230 1240 1250 1260 1270 1280
Contig# 1 
Big contig 1
AGGACTGGATCTGCTGTGCCTGCCAGAAGACTAGGTGAGTGCGGGCTCTGGGCCAGGTCTA
AGGACTGGATCTGCTGTGCCTGCCAGAAGACTAGGTGAGTGCGGGCTCTGGGCCAGGTCTA
Figure 2.5.2 Multi-alignment of sequences from generated by oligo-capping assay to 
identify transcription start points (tsp) of the Mobp transcript. Exons 1 and 2 are 
underlined with solid (double) and dotted lines respectively. ATGio49-io51> where T 1050 
is the point relative to which all tsp positions are defined and the subscript number 1050 
corresponds to the nucleotide position in Contig 1. N.B. Nucleotide numbers, listed above 
sequence, are purely arbitrary and bear no relevance to the genomic organisation of the 
gene.
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1030
1
1040
I
1050 1060
1
1070
1
1080
11
ATG ACT 
Met Thr
1
GTC AGC 
Val Ser
TCC
Ser
1
CTG TTA 
Leu Leu
GGA
Gly
AGG
Arg
1
TTC TGG 
Phe Trp
AGG
Arg
1
GCG AGC 
Ala Ser
AGA
Arg
1
AGG TGG 
Arg Trp
GAG
Glu
GGA
Gly
GGG
Gly
1090
I
1100
1
1110
I
1120
1
1130
1
1140
11
CCG GGC 
Pro Gly
1
CTT CCT 
Leu Pro
GCT
Ala
1
GTT TCC 
Val Ser
AGT
Ser
TCC
Ser
1
TGC CAG 
Cys Gin
CAT
His
1
CCC TTA 
Pro Leu
AGC
Ser
1
GAC GGT 
Asp Gly
GGA
Gly
GAG
Glu
CCC
Pro
1150
1
1160
I
1170
1
1180
I
1190
1
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I1
AGG CTG 
Arg Leu
1
CAG CCT 
Gin Pro
CCA
Pro
1
GCT TCT 
Ala Ser
TTT
Phe
GGC
Gly
1
CCT CTC 
Pro Leu
TGC
Cys
1
ACC AGC 
Thr Ser
CGC
Arg
1
CGT GCC 
Arg Ala
ACG
Thr
TCC
Ser
CCT
Pro
1210
1
1220
1
1230
1
1240
1
1250
1
1260
1
1270
1
CAG AGG 
Gin Arg
1
CCC AAG 
Pro Lys
CAC
His
1
CAG CCA 
Gin Pro
GCT
Ala
GCG
Ala
1
TCC CCA 
Ser Pro
GTG
Val
1
GTG GTC 
Val Val
AGA
Arg
1
GCG CCG 
Ala Pro
CCA
Pro
GCC
Ala
AAG
Lys
1270
I
1280
I
1290
I
1300
I
1310
I
1320
I1
CCA AAG 
Pro Lys
1
TCC CCT 
Ser Pro
CTG
Leu
1
ATG CCA 
Met Pro
GCC
Ala
AAG
Lys
1
CCA AGG 
Pro Arg
TCC
Ser
1
CCA CCG 
Pro Pro
AGG
Arg
1
CCA GCC 
Pro Ala
AAG
Lys
CCA
Pro
AGG
Arg
1330
1
1340
1
1350
1
1360
1
1370
1
1380
11
TCC CCT 
Ser Pro
1
TCA AGG 
Ser Arg
ACT
Thr
1
GCT GAT 
Glu Arg
GCC
Gin
AGC
Pro
1
CAA GCC 
Arg Pro
AAG
Arg
1
GTC CCC 
Pro Glu
ACC
Val
1
GAG GCC 
Arg Pro
AGC
Pro
CAA
Pro
GCC
Ala
1390
1
1400
1
1410
1
1420
1
1430
1
1440
11
AAG GTC 
Lys Gin
1
CCC TTC 
Lys Pro
AAG
Pro
1
GAC TGA 
Gin Lys
GCG
Ser
CCA
Lys
1
GCC GCG 
Gin Pro
TCC
Ala
1
CCG CCC 
Arg Ser
AGA
Ser
1
GGT CCG 
Pro Leu
ACC
Arg
ACC
Gly
ACC
Pro
1450
I
1460
1
1470
1
1480
1
1490
1
1500
11
AGC CAA 
Gly Thr
1
GCA GAA 
Ser Arg
GCC
Gly
1
CCC TCA 
Gly Ser
GAA
Pro
ACC
Thr
1
AGA GCT 
Arg Ala
CCT
Pro
1
AGG TTC 
Arg Phe
TGG
Trp
1
TAA CAC C
Figure 2.5.3 Alignment of DNA and amino acid sequences corresponding to the novel 
transcript identified in Section 2, 2.5. The translation start point (ATG) and stop codon 
(TAA), predicted to be utilised by the novel transcript are indicated in bold type. 
Nucleotide (nt) numbers above these sequences correspond to the nucleotide sequence 
within Contig 1 (Appendix VII). The 3' acceptor site corresponding to exon 4 of the Mobp 
gene is at nt 1191.
180
10 20 30 40 50 60
I I I I I I
OC II 15inv 5'UTR AAGCTCCACCAGGGCCCGGTATCCACAGGAACCTTTCACAACAGCCATTACTCGCAGGGCA
MOBP69 5' TATCCACAGGAACCTTTCACAGCAGCCAATACCTGCAGGGCA
MOBP81 B 5' AGGGAACCTTTCACAGCAGCCAATACCTGCAGGGCA
MOBP81A 5' CTTTCACAGCAGCCAATACCTGCAGGGCA
MOBP99 5' GCCAATACCTGCAGGGCA
rOPl 5' 
rOPRPl 5'
70 80 90 100 110 120
OC II 15inv 5'UTR ACAAAGAATCAAATGAGAGCAAGACAAGCCGAGAACAGAGTCCTGGTTGCCAGACCGGCAC
MOBP69 5' 
MOBP81 B 5 
MOBP81A 5' 
MOBP99 5' 
rOPl 5' 
rOPRPl 5'
ACAAAGAATCAAATGAGAGCGAGACAAGCTGGGAATGAAGTCCTGGTTGCCAGA / TGGGA / 
ACAAAGAATCAAATGAGAGCGAGACAAGCTGGGAATGAAGTCCTGGTTGCCAGA/TGGGA/ 
ACAAAGAATCAAATGAGAGCGAGACAAGCTGGGAATGAAGTCCTGGTTGCCAGA/TGGGA/ 
ACAAAGAATCAAATGAGAGCGAGACAAGCTGGGAATGAAGTCCTGGTTGCCAGA/ TGGGA/ 
TGAGAGCGAGACAAGCTGGGAATGAAGTCCTGGTTGCCAGA/TGGGA/ 
TGAGAGCGAGACAAGCTGGGAATGAAGTCCTGGTTGCC AGA / TGGGA/
130
OC II 15inv 5'UTR GGATGAAAACCCAG * * ★
MOBP69 5' GCTTGAAAACACAG ★ ★ *
MOBP81 B 5' GCTTGAAAACACAG ***
MOBP81A 5' GCTTGAAAACACAG ★ * ★
MOBP99 5' GCTTGAAAACACAG •k ■k'k
rOPl 5' GCTTGAAAACACAG ***
rOPRPl 5' GCTTGAAAACACAG * * *
Figure 2.4.4 Sequence multi-alignment of 5' UTR sequences from published (Yamamoto 
et al., 1994; Holz et al., 1996 ) rat splice variants and sequence from a 5' cDNA fragment 
generated in an oligo-capping assay to identify transcriptional start sites (Section 2, 2.5). 
5' donor splice sites are indicated by I***. N.B. Nucleotide numbers, listed above 
sequence, are purely arbitrary and bear no relevance to the genomic organisation of the 
gene. /, symbol arbitrarily introduced into 5'UTR sequence of rat splice variants to 
maintain the alignment of rat and mouse sequences. This does not represent an 
unidentified nucleotides. Exons 1 and 2, of the murine Mobp, gene are underlined with 
solid (double) and dotted lines respectively.
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kb 1.2 kb
Figure 2.5.5 1.2 kb DNA fragment which was PCR
amplified from mouse genomic (M. spretus) template 
DNA using oligonucleotides ASM 242 and ASM 244 
(defined in Chapter 2, Table 2.4). 1 kb ladder,
molecular weight ladder.
2.5.4.1 PCR amplification and sequencing of a mouse genomic fragment using
oligonucleotides specific to the 5'UTR of Mobp
In an endeavour to assess whether the exons defined as exon 1 and exon 2 were interrupted 
by an intron, PCR amplification of the genomic region flanked by these exonic sequences 
was performed. Oligonucleotides ASM 242 and ASM 244 (Table 2.3, Chapter 2) were 
designed to sequence within exon 1 and exon 2 respectively. A 1.2 kb fragment was 
detected upon PCR amplification of mouse (C57BL/6) genomic DNA, using these 
oligonucleotides (Figure 2.5.5). It should be noted that none of the reported Mobp 
transcripts (rat: Yamamoto et al., 1994; Holz et al., 1996 and mouse: Montague et al., 
1997) demonstrate 5'UTRs in excess of 120 nt. Direct sequence analysis of this PCR 
fragment has failed to provide interpretable results. Time limitation precluded pursuit of 
this line of study. However, the study of this DNA fragment, and the 5' region of this 
gene, has continued in collaboration with the laboratory of Dr I. Griffiths (University of 
Glasgow). This work will involve cloning the PCR fragment into the vector pCR™2.1 
(TA cloning vector; defined in Table 2.1, Chapter 2) for subsequent sequence analysis. 
Only upon confirmation of the identity of this DNA fragment, may it be used as a probe 
for hybridisation to cleaved genomic or cloned DNAs, and the genomic structure of the 5' 
region of the gene be fully elucidated.
As discussed in Section 2.4 the evidence, provided by the PCR amplification of a 1.2 
kb genomic fragment using primers ASM 242 and ASM 244 and by the presence of an 
extended exonic 5' donor sequence (C/AAGI) in exon 1, supports the above hypothesis, 
that the identified 5'UTRs (rat: Yamamoto et al., 1994; Holz et al., 1996 and mouse: 
refer also to Section 2.5]) are produced by discrete exons that are interrupted by an 
intron. Subsequently, the exonic segments to which these oligonucleotides were 
designed have been arbitrarily identified as discrete exons. Data arising from this study 
demonstrate that only sequences within exons 1 and a 4 nt portion of exon 3 are present 
in the 5'UTR sequence of all mRNAs generated by splicing events within the Mobp 
transcript. This suggests that alternative splicing, including or excluding sequence 
from exon 2, may be involved in the generation of splice variants of the Mobp 
transcript. To date, the mode of regulation of these alternative splicing events remains 
unknown. As reported in Section 2.4, exons downstream of the arbitrarily named 
exons 1 and 2 have been named exons 3-8 in their corresponding linear order in the 
mouse genome. Appendix XI illustrates a sequence multi-alignment of 5'UTR 
sequences from exons 1 and 2 of the rat and mouse Mobp genes. These sequences 
demonstrate > 90% sequence identity.
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2.5.5 Discussion
Three groups of tsp have been identified (140 nt [> 17%], 75-68 nt [> 7%] and 60 nt [> 
5%]) upstream of Tioso* where ATG 1049-1051 is the translation start site used in the 
production of all previously identified MOBP isoforms (Yamamoto et al., 1994; Holz et 
al., 1996; Montague et al., 1997). These data present the first report of the use of 
alternative splicing in the generation of 5'UTR for Mobp transcripts. It is noteworthy that 
5'UTRs, lacking sequence from exon 2, are present in >5% of the cDNA fragments 
sequenced. The large number of cDNA fragments sequenced in this study is far in excess 
of previous reports (Yamamoto et al., 1994; Holz et al., 1996).
Two further major tsp were identified downstream of T 1050, where ATG.1049-1051 is the 
translation start site used in the production of all previously identified MOBP isoforms 
(Yamamoto et al., 1994; Holz et al., 1996; Montague et al., 1997). These tsp, at 25 nt 
and 101 nt, downstream of Tioso* comprise >35% and >10% of start points 
respectively. The 5' end of previously uncapped RNA should, in theory, be unavailable 
for ligation of an r-oligo. The hypothesis that these sequences represent a portion of a 
previously unidentified transcript is strengthened by the subsequent amplification of a 
cDNA species using an oligonucleotide, specific to sequence within this putative novel 
transcript in conjunction with an oligonucleotide designed to sequence within the 
fourth exon of Mobp. Preliminary study suggests that this putative transcriptional unit 
is indeed transcribed (Montague et al., unpublished data). Further study is required in 
order to assess whether all tsp identified, at points upstream of Tio5o> are associated 
with previously identified Mobp splice variants. In order to address this question 3' 
oligonucleotides, designed to sequence that is unique to the novel transcript i.e. within 
intron 3 of Mobp, will be used in a further oligo-capping experiment. This experiment 
may exclude or include the use of tsp at points upstream of T 1050 in the production of 
the novel transcript. Northern blot analysis, utilising as probe sequence that is unique 
to the putative novel transcript, is presently being performed in an endeavour to 
establish the veracity of the RT-PCR results. Confirmation of the transcription of this 
sequence unit and its translation to protein may yet increase the complexity of the 
question that must be asked in studies designed to elucidate the function of the Mobp 
gene and related transcriptional units.
As yet, the identification of exon sequences 1 and 2, as discrete exons, remains 
incompletely proven. Further analysis of the promoter region of Mobp will require
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elucidation of the locations of exons 1 and 2. In an endeavour to achieve this, study of 
the 5' region of the Mobp gene continues in collaboration with the laboratory of Dr I 
Griffiths (University of Glasgow).
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2.6 Targeted disruption of Mobp in embryonic stem (ES) cells
2.6.1 Gene disruption and assessment of gene function
Gene targeting provides the potential to generate mice of a desired phenotype (Capecchi, 
1989). The discovery that somatic cells possess the ability to mediate homologous 
recombination between non-replicating DNA molecules (Folger et al., 1982) has 
facilitated the development of gene targeting technologies. Gene targeting involves: (1) 
the use of recombinant DNA technology to introduce the desired mutation into a cloned 
DNA of a selected locus; (2) transfer of the mutation to the genome of a pluripotent, 
embryonic stem (ES) cell; (3) microinjection of the mutant cell into blastocysts with the 
aim of generating chimeric mice, containing the targeted allele within the genome of 
germline cells; (4) the mating of heterozygote siblings to generate mice, homozygous for 
the null allele in question (Capecchi, 1989). Homologous recombination between a 
cognate DNA sequence and an endogenous chromosomal locus may now be used in the 
correction, disruption, modification or replacement of mammalian genes (Capecchi, 1989; 
Rothstein, 1991; Bradley, 1993; Scherer and Adair, 1994). A number of recent studies 
(Aguzzi et al., 1994; Higgins and Cordell, 1995; Aguzzi et al., 1996; Lees et al., 1996; 
Price et al., 1996) have indicated the utility of gene targeting and transgenic technologies 
in the study of the mammalian nervous system. In recent years many studies have been 
directed towards gene disruption [Knockout, KO] (refer also to the review article by 
Scherer and Adair, 1994). Such null mutations define the basal function of a gene (Deng 
etal., 1993).
Mutations in genes encoding myelin components have been demonstrated to underlie a 
number of inherited neuropathies in man (Griffiths et al., 1995; Zielasek et al., 1996) 
(refer also to Chapter 1, 1.7) and mouse (Mikoshiba et al., 1991) (refer also to Chapter 1, 
1.7). Loss of function mutations, reported in the genes encoding myelin protein zero [PO] 
(Giese et al., 1992; Martini et al., 1995a; Zielasek et al., 1996) and peripheral myelin 
protein [PMP22] (Adlkofer et a l, 1995), have been suggested to resemble the human 
neuropathies Charcot-Marie-Tooth disease type IB and Dejerne-Sottas and Charcot- 
Marie-Tooth type 1A respectively. It is also known that mutations in the gene encoding 
myelin proteolipid protein [PLP/DM20] are responsible for neuropathies in a number of 
species including man (Pelizaeus Merzbacher disease, X-linked Spastic Paraplegia). 
However, loss of function mutations, in this gene, demonstrate relatively minor clinical 
effects (Griffiths et al., 1995). It has been suggested that MOBP plays a role in stabilising 
the myelin sheath (Yamamoto et al., 1994; Holz et al., 1996; Montague et al., 1997). It
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can therefore reasonably be predicted that the generation of a null mutation in the gene 
encoding MOBP may interfere with the compact nature and appearance of the MDL of
central myelin. Like shiverer, the CNS myelin of an Mobp~^~ mouse may be diffuse and 
lack an MDL.
2.6.2 Design of a targeting construct
One recent report (Deng and Capecchi, 1992) suggested that a number of well defined 
questions must be addressed by any experimenter wishing to undertake a gene targeting 
project. These include: (1) whether to use an insertion or a replacement vector; (2) how 
much homology to use in the generation of the construct; (3) whether there is any 
advantage in the use of isogenic DNA, in preference to non-isogenic DNA; (4) whether it 
is more expedient to use enrichment procedures in cell culture or to screen larger numbers 
of cell lines in the search for targeted cell lines.
I will address these concerns in the order in which they are given above. Firstly, a number 
of studies (Thomas and Capecchi, 1987; Deng et al., 1993) have assessed the utility of 
both vector types. It has been suggested that increased number of cell culture stages, 
required when using insertion vectors, may decrease the ability of a cell line to contribute 
to the germline (Deng et al., 1993). Replacement vectors require fewer culture stages. In 
generating the desired mutation a replacement vector retains structure of the targeting 
construct, between the sites of recombination. This recombinant structure includes the
gene cassette encoding neomycin resistance (neor). This is not a disadvantage in the 
generation of a gene KO. In this instance the investigator desires loss of expression of the
gene in question and may select the insertion site for the neor gene cassette within the 
transcriptional unit. Secondly, it has been demonstrated (Thomas and Capecchi, 1987; 
Hasty et al., 1991) that there is an exponential relationship between the length of 
homologous sequence, in a targeting vector, and the targeting frequency. This exponential 
relationship exists across the range of 2-10 kb. It is further noted that the exponential 
nature of this relationship saturates (plateaus) at approximately 14 kb (Thomas and 
Capecchi, 1987). Thirdly, it has been demonstrated (Letsou and Liskay, 1987) that 
intrachromosomal gene conversion is sensitive to single basepair mismatch. A number of 
recent studies (Waldman and Liskay, 1987; Deng and Capecchi, 1992; Miller, 1992; te 
Reile et al., 1992; van Deursen and Wieringa, 1992) have compared the efficiency of using 
isogenic and non-isogenic DNA in targeting vectors. These suggest that efficient 
recombination requires uninterrupted homology (Waldman and Liskay, 1987) and further 
conclude that even limited heterogeneity can dramatically reduce targeting efficiency
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(Deng and Capecchi, 1992; Miller et al., 1992; te Reile et a l, 1992; van Deursen and 
Weringen, 1992). Finally, the use of positive-negative selection (PNS) is known to enrich 
for cells containing targeted mutations (Mansour et al., 1988; Capecchi, 1989). Positive 
selection utilises the presence of a novel selectable marker in assaying for the integration 
of a targeting vector into the host genome. Negative selection, selects against random 
insertion targeting events (Mansour et al., 1988; Capecchi, 1989). The gene targeting 
vector, for the murine Mobp gene (pM obp-N/TK ), was designed and generated as 
described below.
2.6.3 Generation of a targeting construct
Based on the information given in the studies cited above, I undertook to generate a 
replacement construct, using isogenic DNA. The purpose of this construct was to generate 
a loss of function (KO) mutation in the Mobp gene by deleting a genomic region 
encompassing exons 3, 4 and 5. As discussed in Section 2.4, exon 3 encodes amino acid 
residues 1 - 6 8 ;  present in all MOBP isoforms. The murine gene encoding myelin- 
associated oligodendrocytic basic protein was isolated and characterised as described in 
Section 2 (2.4 and 2.5). The genomic region encompassing exons 3-8 of the Mobp gene is 
illustrated in Figure 2.6.2 A. The genomic libraries used in the isolation of the gene, were 
prepared using DNA from the mouse strain 129/Sv. It should be noted that the ES cells 
used are also derived from this mouse strain. Figure 2.6.1 illustrates the vector backbone 
(pNT) used in the construction of the targeting construct (pMobp-N/TK). Figure 2.6.2 
illustrates the steps involved in its construction. Firstly, a 3.9 kb Bam HI fragment, 
isolated from clone AS 17 which lies approximately 2 kb upstream of the first coding exon 
(exon 3 [Figure 2.6.2 B, Step 1]), was subcloned into the unique Bam HI site of the pNT 
vector. Secondly, a 6.9 kb Xho l-Sal I fragment, isolated from AS 35 (encompassing 
exons 6-8 [Figure 2.6.2 B, Step 2]), was subcloned into the unique Xho I site of the pNT 
vector. It is noteworthy that the Xho I site present in this fragment derives from the
multiple cloning site of the X 2001 bacteriophage vector. The size and orientation of
fragments (illustrated in Figure 2.6.2) were confirmed after subcloning, in each instance, 
by restriction enzyme cleavage with Sst I. Figure 2.6.3 (A, B and C) illustrate the results 
of Sst I restriction enzyme cleavage of the completed construct, indicating the expected 
sizes of fragments. The completed construct is shown linearised, at the unique Not I site in 
the pNT vector (Figure 2.6.2 C), and circularised (Figure 2.6.4). The targeting vector 
pMobp-N/TK comprises 10.8 kb of homology to the Mobp gene locus.
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Not I 0.00
0.01
BstXI 7.23 
Sac I 7.23 0.02
0.54
PGK
pUC Amp (ori)
Neo
J>stl 1.38 
_Pst I 1.45
Xbal
BamHI
Kpnl
SacI
EcoRI
pNT PGK PA
7.24 Kb
PGK
Pst I 2.32
PGK PA
HSVTK
Hind III 4.55
SacI 2.85
Pst I 4.15
Sma I 3.77
Pst I 3.16
Plasmid name: pNT
Plasmid size: 7.24 kb
Figure 2.6.1 Schematic representation of the vector backbone (pNT) used in the 
construction of the targeting construct (ipMobp-N/TK).
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Figure 2.6.3 Identification of cleaved DNA from completed construct pMobp-N/TK 
by electrophoresis of DNAs cleaved with the restriction enzyme Sst I. Restriction 
enzyme cleavage of the completed construct with Sst I yields 7 fragments of 0.75 - 4.5 kb 
in length (Lane *). The three images (A,B and C) illustrate the progress of DNA, with 
time, through a 1% agarose gel. The fragments are, as expected, 0.75 kb, 0.85 kb, 1 kb, 
3 kb, 4 kb, 4.2 kb and 4.5 kb.
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Figure 2.6.4 Schematic representation of the circularised completed construct pMobp- 
N/TK, corresponding to Figure 2.6.2 C in which the completed construct is linearised at 
the unique Not I site therein.
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2.6.4 Embryonic stem (ES) cell culture
The vector pMobp-N/TK was linearised by cleavage with the restriction enzyme Not I 
(Figure 2.6.2 C) and introduced into ES cells via electroporation (as described in Chapter 
2). Aliquots of the resulting cell suspension were distributed evenly between 15 tissue 
culture plates and nutrient medium added (as described in Chapter 2). ES cell culture was 
performed as described in Chapter 2. N.B. one plate was identified as an experimental 
positive control and was incubated with a medium lacking Gancyclovir. When the nutrient 
medium was replaced by medium, containing G418 (0.2 mg/ml) and Gancyclovir (0.55 
jig/ml) two different preparations of media were used. These media, arbitrarily named A 
and B, were prepared individually but utilised the same stock materials (defined in Chapter 
2). Two days after initiating selection, the cells grown in medium A perished. The cells 
were observed to lose their characteristic shape becoming rounded and subsequently 
underwent cell death. The cells incubated in the presence of medium B suffered no such 
reaction. Distinct colonies, resistant to the drugs used in this study, could be observed 
with the naked eye within eight days of electroporation. The average number of colonies, 
demonstrating resistance to G418 (neomycin; positive selection), was found to be 40 per 
experimental plate (total number of colonies = 280). The control plate contained 115 
colonies demonstrating resistance to G418 (neomycin). This indicated that the enrichment 
factor, for correctly targeted events, was approximately 3 fold. Enrichment, for correctly 
targeted events, was achieved by selection against the presence of the Herpes Simplex 
virus (HSV I) gene encoding Thymidine kinase, using the drug Gancyclovir. Gancyclovir 
is cytotoxic to ES cells expressing HSV-TK (Mansour et al., 1988). In total 240 colonies, 
resistant to G418, were identified, picked and grown to confluence in the absence of any 
selection as described in Chapter 2. These cell lines were trypsinised (as described in 
Chapter 2) upon reaching confluence (7-12 days post picking, Chapter 2). 4/10 volume, of 
each trypsinised cell line, were taken for DNA isolation (as described in Chapter 2) and 
6/10 for storage under liquid nitrogen.
2.6.5 Identification of targeted cell lines
DNA was isolated from each cell line (as described in Chapter 2). 1/6 volume of each 
DNA preparation was incubated with the restriction enzyme Eco RI and the resulting 
fragments separated by electrophoresis in 0.5% agarose gels. These DNAs were then 
transferred to nylon membrane (as described in Chapter 2) for hybridisation with selected 
probes. It was believed that any one of a number of DNA fragments would be informative 
in the identification of targeted cell lines. The restriction sites (Sa il - EcoKL, 
corresponding to the 14-18 kb marks on the scale bar and spanning exon 8) permitting the
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generation of these fragments may be observed in Figure 2.4.8. However, hybridisation 
experiments utilising the fragments Hindlll -BamKl(< 1.5 kb), BamHI - Sst I (< 2 kb) and 
Sstl - EcoRl, as probes did not provide interpretable results. These probes hybridised in a 
non-specific manner and did not provide discrete signals. It was known from sequencing 
data (Contigs 1-3) that the genomic region encompassing this gene was rich in repeated 
sequence units (refer also to Section 2.4). Consequently a 1.3 kb genomic DNA fragment 
corresponding to a portion of exon 8b (defined in Table 2.3, Chapter 2) was utilised as a 
probe. The sequence of this DNA fragment is known not to contain repeated sequence 
units (Contig 3 nt 1216-2555, Appendix IX). Time limitation has precluded hybridisation 
experiments, utilising this DNA fragment as a probe, being performed. Figure 2.6.5 
illustrates the homologous recombination event resulting in a correctly targeted allele of 
Mobp. The predicted size of DNA fragment detected by this probe is 16 kb. The 
diagnostic size shift in DNA from a targeted cell line, cleaved by restriction enzyme 
EcoRl, is predicted to be from 16 kb - 13 kb (wild type - targeted respectively). The 
appearance of these bands is illustrated schematically in Figure 2.6.6. It should be noted 
that both band sizes are expected in a targeted cell line. This is because normally only one 
allele will be targeted for an autosomal locus.
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Lanes
1 2 3 4 5
16 kb
13 kb
Figure 2.6.6 Schematic representation of predicted fragment size 
shift between DNA from wild-type ES cell lines and those carrying 
a correctly targeted Mobp allele The bands represent DNAs that 
have been cleaved by the restriction enzyme EcoRl (as described in 
2.6.5) and hybridised with the probe DNA fragment (ASM 600). 
Fragments provided by DNA from wild-type ES cell lines are 
illustrated in lanes 1, 2 and 4. Fragments provided by DNA from 
ES cell lines carrying a correctly targeted Mobp allele are illustrated
2.6.6 Discussion
This study reports the generation of a gene disruption construct (pMobp-N/TK) for the 
murine gene Mobp. pMobp-N/TK was designed to delete the region encompassing exons 
3-5 of the Mobp gene. Deletion of these exons will prohibit expression of all previously 
reported MOBP isoforms (Yamamoto et al., 1994; Holz et al., 1996; Montague et al., 
1997) and the protein predicted to be produced by the novel transcript.
Though time constraint has prevented the completion of this study, it represents the first 
reported attempt to engineer a mutation in the Mobp gene. Time limitation has precluded 
completion of this work. However, evaluation of mice that are homozygous (-/-) for a null 
mutation in the Mobp gene will provide information regarding the basal function of the 
Mobp gene product (Deng et al., 1993). It should be noted that some glia demonstrate a 
sensitivity to the dosage of certain myelin genes (Readhead et al., 1994; Griffiths et al., 
1995; Zielasek et al., 1996; refer also to Chapter 1, 1.7). Consequently, a study of mice
heterozygous (Mobp +/ “) may also provide valuable information concerning the function 
of MOBP and its predicted role in stabilising the myelin sheath (Yamamoto et al., 1994; 
Holz et al., 1996; Montague et al., 1997a). The Mobp gene product is an interesting 
candidate gene for further study in relation to neuropathies affecting the CNS and 
specifically multiple sclerosis (refer also to Section 1, 2.2 and 2.7). By endeavouring to 
generate a loss of function mutation in the Mobp gene, this study provides a solid platform 
from which to begin assessing the function of MOBP. This represents the first steps in 
evaluating the possible role that Mobp may play in known neuropathies.
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2.7 Discussion
2.7.1 Issues raised by experimental work
These studies (Section 2, 2.2-2.6) have raised a number of issues relating to the 
organisation and function of MOBP (refer also to Section 2, 2.3-2.6) and its putative 
association with known neuropathies in man and mouse (refer also to discussion in Section 
2, 2.2). In an endeavour to address the issues raised by this work they are discussed 
below.
2.7.2 Multiple Sclerosis
Multiple Sclerosis (MS) is an autoimmune disorder affecting CNS myelin (Martyn, 1991; 
Allen and Brankin, 1993; Steinman, 1996). It is believed that MS develops when T- 
lymphocytes escape negative selection (deletion) in the thymus (Roder and Hickey, 1996). 
Autoimmunity would then develop because the inciting autoantigen was unavailable and 
thus remained undetected in the thymus. The autoantigen(s) responsible for inciting the 
autoimmune response in MS are, as yet, unknown (Martyn, 1991; Allen and Brankin, 
1993; Steinman, 1996). Myelin proteins are acknowledged to be of particular interest in 
this context. Experimental allergenic encephalomyelitis (EAE) is a progressive 
demyelinating disease similar to MS (Miller and Rodriguez, 1996). It has been reported 
(Brocke et al., 1996) that a single peptide analogue, comprising 13 amino acids (aa), of 
MBP (p87-99) is sufficient to induce EAE in mice. Unlike MBP, expression of MOBP is 
restricted to the CNS. In this context, the Mobp gene product is a strong candidate for 
further study in connection with MS.
2.7.3 Association with known neuropathies
2.7.3.1 Linkage of the Mobp gene locus to known neuropathies
The possible association of Mobp with any locus implicated in a known neuropathy, and in 
particular any locus associated with Multiple Sclerosis, must be among the most 
immediate issues to be addressed. The map position assigned to Mobp by this study 
(Section 2, 2.2) suggests that it is closely linked to a number of known neurological 
mutations in mouse. The published genetic mapping data available for these mutants was 
inadequate to permit exclusion of allelism with Mobp. I suggest that further work is 
required for the evaluation of the possibility that the Mobp gene product may be associated 
with any pathologies in the future. In order to evaluate the possible linkage of the Mobp
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gene locus to any locus associated with MS the human Mobp gene locus must be
identified. This may be readily performed using human x rodent radiation hybrid mapping
panels. The human locus must then be evaluated for possible association with MS by 
comparison with loci previously implicated in the neuropathy. The evaluation of the 
possible association of Mobp with known murine mutants can be performed by genotyping 
a marker adjacent to a disease locus in question, using the same panel of DNAs as Mobp. 
This will permit direct comparison of the loci in question (refer also to discussion in 
Section 2, 2.2).
2.7.3.2 Association of the Mobp locus with a novel transgene insertion mutation
demonstrating demyelination
A recent study (Orian et al., 1994) reported the random insertion of a transgene, in distal 
mouse chromosome 9, resulting in a phenotype demonstrating dysmyelination. Mobp is a 
good candidate locus for this mutational event. Initial evaluation of the involvement of the 
Mobp gene in this pathology may be performed by assaying for the presence of the Mobp 
transcript in affected mice.
2.7.4 Complexity of the Mobp gene encoding myelin-associated oligodendrocytic
basic protein
These studies demonstrate the degree of complexity involved in the generation of splice 
variants from the Mobp gene transcript (Yamamoto et al., 1994; Holz et al., 1996; refer 
also to discussion in Section 2, 2.3). Generation of the previously identified splice variants 
of the Mobp transcript requires a complex range of alternative splicing events (refer also to 
Section 2; 2.3, 2.4 and 2.5). Elucidation of the genomic region encompassing all coding 
and 3' exons of the murine Mobp gene has provided greater insight into these splicing 
events. These studies demonstrate that the complex Mobp transcriptional unit, which 
comprises 8 exons, can also utilise a number of splice donor/acceptor sites within exons 7 
and 8, in the generation of previously identified splice variants (refer also to Section 2; 2.3 
and 2.4). This is the first report of the genomic organisation of the Mobp gene in any 
species. The selection of the mouse, as the species in which to examine this gene, has also 
permitted the initiation of a study to assess MOBP function via gene targeting (refer also 
to Section 2; 2.6).
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2.7.4.1 Further study of the novel transcriptional unit within Mobp
To date it is not known whether the novel transcriptional unit, identified within the murine 
Mobp gene, produces a protein. Further study of this transcriptional unit requires 
confirmation of the production of a transcript e.g. by northern blot analysis, and 
subsequent assay for the presence of a protein corresponding to the predicted amino acid 
sequence. This will require antibodies to be raised against a synthetic peptide, designed to 
a unique portion of the predicted protein, and subsequent performance of a Western blot 
assay.
2.7.4.2 Functional analysis of the murine Mobp gene and the associated novel
transcriptional unit
Assessment of the basal function of the Mobp gene product begins with the generation of 
mice homozygous for a null mutation (-/-) within the Mobp gene (refer also to Section 2, 
2.6). Thus the primary aim of future study of Mobp gene function must be to complete the
generation of Mobp~/~ mice. Secondarily, the functions of the Mobp gene and the novel 
transcriptional unit must be dissected. In order to assess the basal function of the protein 
encoded by the novel transcriptional unit, sequence used exclusively in its production must 
be disrupted. Thus mice homozygous for a null mutation (-/-), specific to the novel 
transcriptional unit, may be generated by deleting the intron 3 of the Mobp gene. 
Sequence within this intron encodes amino acids 1-53 of the protein predicted to be 
encoded by the novel transcript. Elucidation of the genomic organisation of the Mobp 
gene and the complexity of the splicing events required to generate the splice variants 
encoding the family of related myelin-associated oligodendrocytic basic proteins (MOBP) 
has also provided a platform for the establishment of more sophisticated functional assays. 
It has been suggested that the isoform MOBP 170 may have a function alternative or 
additional to involvement in myelination (Montague et al., 1997). This suggestion is 
based primarily on the detection of the Mobp 170 splice variant in the embryo (E12). 
Evaluation of the function of this isoform will require deletion of exon 4 of Mobp. To date 
exon 4 has only been demonstrated to be used in the production of MOBP 170 (refer also 
to Section 2, 2.4). The number of gene targeting strategies which may be envisaged for 
the Mobp gene is multiplied by the elucidation of its structure and complexity. Further 
studies may involve the deletion of exons containing sequences encoding amino acids used 
exclusively in the production of individual MOBP isoforms e.g. exon 6 is used 
exclusively in the production of MOBP 71 and exon 7a is used exclusively in the 
production of MOBP 81. Subsequently, animals lacking expression of specific MOBP
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isoforms may be mated in an endeavour to create animals lacking expression of multiple 
isoforms. Another possible approach to studying the function of MOBP is the generation 
of mice carrying mutations in the Mobp gene which result in the production of an aberrant 
protein. However, such a study requires a greater understanding of the function of MOBP 
before it can be undertaken.
2.7.5 Future analysis of the Mobp promoter region
The organisation of the genomic region encompassing exons 1 and 2 of the Mobp gene is, 
as yet, incompletely understood. However, these studies do provide a solid basis for 
identification and analysis of the Mobp promoter region. Confirmation of the identity of 
the 1.2 kb PCR amplified genomic DNA fragment (refer to Section 2, 2.5) will permit its 
use as a probe to for the presence of sequences corresponding to exons 1 and 2 of the 
Mobp gene. It may be used to screen the bacteriophage clones that have been isolated, or 
the genomic libraries that were utilised, in the course of these studies.
2.7.6 Identification of mRNA localisation signals
It has been demonstrated that the different 3'UTRs of the splice variants Mobp 81A and 
Mobp 8 IB are generated as a consequence of the mutually exclusive use of exons 8 and 7, 
of the murine Mobp gene, respectively. This process of exon selection is reported to 
involve a fine balance between various processing events, including: transcription
termination, cleavage and polyadenylation and splicing (Smith et al., 1989). These splice 
variants have been suggested to localise to different parts of the oligodendrocyte (Holz et 
al., 1996; Montague et al., 1997) and to be present at different developmental stages 
(Montague et al., 1997). It has further been suggested that the corresponding 3'UTRs of 
these splice variants contain as yet unidentified localisation signals (Holz et al., 1996; 
Montague et al., 1997). A number of recent reports (Smith et al., 1989; Chabot, 1996) 
demonstrate a correlation between alternative splicing, molecular interaction e.g. protein 
localisation and biological function. Transgenic technologies may be used, in vitro and in 
vivo in the elucidation of localisation signals present in the corresponding exonic 
sequences (Haas et al., 1994; Griffiths et al., 1995; Ikenaka and Kagawa, 1995).
2.7.8 Concluding remarks
These studies represent a considerable contribution to the understanding of the map 
location, structure and complexity of the murine gene encoding myelin-associated
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oligodendrocytic basic protein. They strengthen the suggestion that Mobp is a gene 
worthy of study in connection with neurodegenerative disease (Yamamoto et a l, 1994; 
Holz et al., 1996; McCallion et al., 1996; Montague et a l, 1997). Furthermore, these 
studies provide the basis for the construction of more complex and detailed hypotheses 
about the function of the Mobp gene product, permitting more incisive questions to be 
asked in the near future. Finally these studies have identified a novel transcriptional unit 
within the Mobp gene, increasing our understanding of the Mobp gene structure and 
adding to an already complex story.
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Appendix I Examples of SSCPs demonstrated, between M.spretus and C57BL/6, 
by PCR amplified sequences from within ESTs utilised in these studies.
Appendix II
Chromos Primers 101 391 421 2 5 8 1 0 12
Chr.1 D1Nds4 7cM B S S B B B B B
Chr.1 D1 Mit24 42,3cM B S B B B B B B
Chr.1 D1 Mit17 111 cM B B B B B B B B
Chr.2 D2Mit1 1cM B B B B B B B B
Chr.2 D2Mit11 41 cM B B S B S B B B
Chr.2 D2Mit55 67cM S B f s S S B B B
Chr.2 D2Mit52 77cM S B B S s B B B
Chr.3 D3Mit54 OcM B B S B B I S S S
Chr.3 D3Mit22 35cM B jp g p - s B B I s ■ s S
Chr.3 D3Mit9 38.6cM B 1 s s B B ) s s s
Chr.3 D3Mit45 75.3cM B B B B B 1 s s s
Chr.3 D3Mit19 81cM B B B B B 5 s s s
Chr.4 D4Mit19 8cM S S B B B B B B
Chr.4 D4Mit38 18.8cM S s :■;! B B B B B B
Chr.4 ORM 1 38cM s s B B B B B B
Chr.4 D4Mit37 47.4cM s B B B B B B B
Chr.4 D4Mit33 67cM s S B B B B B B
Chr. 5 D5Mit48 OcM B Ics,™c - s S B B * S B
Chr. 5 D5Nds2 28cM B B B B B B s
Chr. 5 Gus 63cM B B B B B B B B
Chr.6 D6Mit47 11cM S r s -i B B B B B B
Chr.6 D6Mit8 31 cm s ' s B B B B B B
Chr.6 D6Nds5 41cM s s B B B B B B
Chr.6 D6Mit201 67cM s s B S S B B B
Chr.7 D7Mit21 3cM B B B B B B ! S B
Chr.7 D7Mit54 15cM B B B B B B L B
Chr.7 D7Mit40 51 cM B B B B B B B B
Chr.7 Fflf-3 74cM B B B B B B B B
Chr.8 D8Mit141 4,6cM S B B B B B B B
Chr.8 D8Mit40 35cM B B B B B B B B
Chr.8 D8Mit35 52cM B B B B B B B B
Chr.8 D8Mit13 68,4cM B B B B B B B B
Chr.9 D9Mit160 2,2cM B B B B B B B B
Chr.9 D9Mit2 13,2cM B B B B B B B B
Chr.9 33(Cyp1a2) 31 cM B B B B B B B B
Chr.9 D9Mit137 64,2cM B B B B B B B B
Chr.10 D10Mit77 2,2cM S B B B B S B : - S
Chr.10 D10Mit16 10,2cM S S B B B S B B
Chr.10 D10Mit15 23cM B s . B B S s B B
Chr.10 D10Mit22 38,7cM S B B B S B B B
Chr.10 D10Mit67 46,4cM B B s B B
Chr.10 D10Mit180 64cM S B S B B B B B
Genotyping d a ta  corresponding  to the  anchor m arkers  u sed  in the  typing of DNAs from the  N4
genera tion  of the  breeding  p rogram m e to g en e ra te  consom ic  mice.
Appendix II
Chromos Primers 101 391 421 2 5 8 10 1 2
Chr.11 D11 Mit1 2,2cM B B B B B B B B
Chr.11 D11 Mit31 37cM B B S S S ' B S S
Chr.11 D11M it 159 43,5cM B B S S S S S S
Chr.11 D11 Mit48 82cM B B s B B S s s
Chr.12 MODC 1cM B S B S B B B B
Chr.12 D12Mit65 22cM B S B B B B B B
Chr.12 D12Mit4 33cM B s B B B B B B
Chr.12 D12Mit27 50cM B ■' s B B B B B B
Chr.12 1(lgh-V) 62cM B s B B B B B B
Chr.13 D13Mit80 6.4 S S -5 B B i S B B B
Chr.13 D13 Mit 3 11cM S s B B s  : B B B
Chr.13 D13 Mit 13 30cM s s B B S' B B B
Chr.13 D13 Mit 28 46cM s B B S s B B B
Chr.13 D13 Mit 47 62cM s B B s B B B B
Chr.14 D14 Mit1 2 cM s s B B B B B B
Chr.14 D14 Mit5 15 cM B B B B B B B B
Chr.14 120 26 cM B B B B B B B B
Chr.14 88 42 cM B B B B B B B B
Chr.15 D15Mit11 4,8cM B B ":v S . S B B B
Chr.15 D15Mit29 33.9cM s B I : s B B B B B
Chr.15 D15Mit34 53.7cM s B I S i B B B B B
Chr.15 HOX s B s B B B B B
Chr.16 D16Mit8 3cM s B B B B B B B
Chr.16 D16Mit5 39cM B B B B B B B B
Chr.16 D16Mit5 51cM B B B n r  *.. S :i B B B
Chr.17 D17Mit61 6,1cM B B S s s B B B
Chr.17 D17Mit52 14cM B B s s s B B B
Chr.17 D17Mit9 26cM B B s s s B B B
Chr.17 D17M it 185 35.2 s S B s s B B B
Chr.17 D17Mit39 40cM B S B s s B B B
Chr.18 D18Mit18 OcM S B S B B r B B B
Chr.18 D18Mit53 24cM s B s B B B B S
Chr.18 D18Mit45 37,4cM s B s B B B B B
Chr.18 D18Mit42 45,6cM s B s B B B B
Chr.19 D19Mit32 1cM s B B B B B B B
Chr.19 D19Mit13 20cM s B s B B S B
Chr.19 D19Mit92 56,6cM s B B
Chr.X DXMit53 9,6cM B B B B B B B B
Chr.X DXMit50 22,4cM B B B B B B B B
Chr.X DXMit93 34,2cM B S B B B B B B
Chr.X DXMitl 16 45,7cM B S S B B B B B
Chr.X DXMit34 60cM B B s B B B B B
Chr.X DXMit31 70,7cM B B s B B B B B
G enotyping d a ta  corresponding to the  anchor m arkers  u sed  in the  typing of DNAs from th e  N4
genera tion  of the breeding p rog ram m e to g e n e ra te  consom ic mice.
Appendix II
Chromos Primers 1 5 17 1 8 32 37 38 41 42
Chr.1 D1Nds4 7cM B s S B S B B S
Chr.1 D1 Mit24 42,3cM . ; s B B B B B B B
Chr.1 D1 Mit17 111cM B B B B B B B B
Chr.2 D2Mit1 1cM B B B B B B B S
Chr.2 D2Mit11 41 cM B s S B B B S B
Chr.2 D2Mit55 67cM S B S B S S s B
Chr.2 D2Mit52 77cM S B B B S B B
Chr.3 D3Mit54 OcM B S B B I  S, , B B B
Chr.3 D3Mit22 35cM B B B B B B B B
Chr.3 D3Mit9 38.6cM B B B B B B B B
Chr.3 D3Mit45 75.3cM B B B B B B s S
Chr.3 D3Mit19 81cM B B B B B B s S
Chr.4 D4Mit19 8cM B B B B B B B B
Chr.4 D4Mit38 18.8cM B B B B B B B B
Chr.4 ORM 1 38cM B B B B B B B B
Chr.4 D4Mit37 47.4cM S B B B B B B S
Chr.4 D4Mit33 67cM B B B B S B B S
Chr. 5 D5Mit48 OcM B B * s B S l s  -;J B B
Chr. 5 D5Nds2 28cM B B B B B B S B
Chr. 5 Gus 63cM B B B B B B S s
Chr.6 D6Mit47 11cM s B B B B B B
Chr.6 D6Mit8 31 cm S B B B B B B B
Chr.6 D6Nds5 41 cM s B B B S B B B
Chr.6 D6Mit201 67cM B B B B S S S S
Chr.7 D7Mit21 3cM B B B B B B B S
Chr.7 D7Mit54 15cM B B B B B B B s
Chr.7 D7Mit40 51cM B B B B B B B B
Chr.7 Fgf-3 74cM B B B B B B B B
Chr.8 D8Mit141 4,6cM B B B U  §i,J B B B B
Chr.8 D8Mit40 35cM B B B B B B B S
Chr.8 D8Mit35 52cM B B B B B B B s
Chr.8 D8Mit13 68,4cM B B B B B B B s
Chr.9 D9Mit160 2,2cM B B B B B B B B
Chr.9 D9Mit2 13,2cM B B B B B s B B
Chr.9 33(Cyp1a2) 31 cM B B B B B S B B
Chr.9 D9Mit137 64,2cM B B B B B B B B
Chr.10 D10Mit77 2,2cM B B B B r s B B B
Chr.10 D10Mit16 10,2cM B B B B I s B B B
Chr.10 D10Mit15 23cM B B B s B B B B
Chr.10 D10Mit22 38,7cM B B B s B B B B
Chr.10 D10Mit67 46,4cM B s B B B
Chr.10 D10Mit180 64cM B B B B B B B B
G enotyping d a ta  corresponding  to the  an chor m arkers  u sed  in the  typing of DNAs from th e  N4
genera tion  of the  breeding  p rog ram m e to g e n e ra te  consom ic  mice.
Appendix II
Chromos Primers 1 5 1 7 1 8 32 37 38 41 42
Chr.11 D11 Mit1 2,2cM B B B S B B B B
Chr.11 D11 Mit31 37cM B B S B B B B B
Chr.11 D11 Mit159 43,5cM B S S B B B B B
Chr.11 D11 Mit48 82cM B s s B B B S B
Chr.12 L MODC 1cM B B B B S s B B
Chr.12 D12Mit65 22cM B B B B S s B B
Chr.12 D12Mit4 33cM B B B B s s s B
Chr.12 D12Mit27 50cM B B B B s s s B
Chr.12 1 (Igh-V) 62cM B B B B s s s B
Chr.13 D13Mit80 6.4 S B B B s B s B
Chr.13 D13 Mit 3 11cM S B B B B B s B
Chr.13 D13 Mit 13 30cM s B B B B B s B
Chr.13 D13 Mit 28 46cM B B B B B B B B
Chr.13 D13 Mit 47 62cM B B B B B B B B
Chr.14 D14 Mit1 2 cM B B B B B B s B
Chr.14 D14 Mit5 15 cM B B B B B B s B
Chr.14 120 26 cM B B B B B B s B
Chr.14 88 42 cM B B B B B B s B
Chr.15 D15Mit11 4,8cM B £ ■ S ' > S B B B B S
Chr.15 D15Mit29 33.9cM B . S. - B B B B B
Chr.15 D15Mit34 53.7cM B S B B B B B
Chr.15 HOX B s s B B B B B
Chr.16 D16Mit8 3cM B B B S B B B B
Chr.16 D16Mit5 39cM B B B S B B B B
Chr.16 D16Mit5 51cM B B B s  i B B B B
Chr.17 D17Mit61 6,1cM B B s B B B S S
Chr.17 D17Mit52 14cM B B i ; s v i B B B s S
Chr.17 D17Mit9 26cM B B .. s B B B B B
Chr.17 D17Mit185 35.2 B B B B B B B B
Chr.17 D17Mit39 40cM B B B B B B B B
Chr.18 D18Mit18 OcM s B S B S S B f : - s ^
Chr.18 D18Mit53 24cM S B S B B B B s
Chr.18 D18Mit45 37,4cM s B s B S S B s
Chr.18 D18Mit42 45,6cM s B s B s S B s
Chr.19 D19Mit32 1cM B B B B B B B B
Chr.19 D19Mit 13 20cM B B s B B B B B
Chr.19 D19Mit92 56,6cM B s B
Chr.X DXMit53 9,6cM B B B B B B B B
Chr.X DXMit50 22,4cM B B B B B B B B
Chr.X DXMit93 34,2cM B B B B B B B B
Chr.X DXMitl 16 45,7cM B B B B B B B B
Chr.X DXMit34 60cM B B S B B B B B
Chr.X DXMit31 70,7cM B S s B B B B B
G enotyping d a ta  corresponding  to the  anchor m arkers  u se d  in the  typing of DNAs from th e  N4
genera tion  of th e  breeding  p rogram m e to g en e ra te  consom ic  mice.
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Chromos Primers 44 46 49
Chr.1 D1Nds4 7cM S s B
Chr.1 D1 Mit24 42,3cM S B B
Chr.1 D1 Mit 17 111cM S B S
Chr.2 D2Mit1 1cM S B B
Chr.2 D2Mit11 41 cM S S S
Chr.2 D2Mit55 67cM S B
Chr.2 D2Mit52 77cM B B B
Chr.3 D3Mit54 OcM B B B
Chr.3 D3Mit22 35cM B B B
Chr.3 D3Mit9 38.6cM B B B
Chr.3 D3Mit45 75.3cM B B B
Chr.3 D3Mit19 81cM B B B
Chr.4 D4Mit19 8cM B B
Chr.4 D4Mit38 18.8cM B S B
Chr.4 ORM 1 38cM B S,:J B
Chr.4 D4Mit37 47.4cM S s B
Chr.4 D4Mit33 67cM S s S
Chr. 5 D5Mit48 OcM B s
Chr. 5 D5Nds2 28cM B s S
Chr. 5 Gus 63cM B B !. S •;
Chr.6 D6Mit47 11cM B B B
Chr.6 D6Mit8 31 cm B B B
Chr.6 D6Nds5 41 cM B B B
Chr.6 D6Mit201 67cM B S B
Chr.7 D7Mit21 3cM B B B
Chr.7 D7Mit54 15cM B B B
Chr.7 D7Mit40 51cM s  ^ B B
Chr.7 Fgf-3 74cM B B
Chr.8 D8Mit141 4,6cM B B B
Chr.8 D8Mit40 35cM S S S
Chr.8 D8Mit35 52cM B S B
Chr.8 D8Mit13 68,4cM B s B
Chr.9 D9Mit160 2,2cM B S 1 B
Chr.9 D9Mit2 13,2cM B s B
Chr.9 33(Cyp1a2) 31 cM B B B
Chr.9 D9Mit137 64,2cM B B B
Chr.10 D10Mit77 2,2cM B s B
Chr.10 D1 OMitl 6 10,2cM B s S
Chr.10 D10Mit15 23cM B B B
Chr.10 D10Mit22 38,7cM B B B
Chr.10 D10Mit67 46,4cM B
Chr.10 D1 OMitl 80 64cM B B S
G enotyping d a ta  co r respond ing  to the  anchor m arkers  u sed  in th e  typing of DNAs from th e  N4
generation  of th e  b reed ing  p ro g ram m e to g en e ra te  consom ic mice.
Appendix II
Chromos Primers 4 4 46 49
Chr.11 D11 Mit1 2,2cM B B B
Chr.11 D11 Mit31 37cM B B B
Chr.11 D11 Mit159 43,5cM B B B
Chr.11 D11 Mit48 82cM B B B
Chr.12 MODC 1cM B ! . s B
Chr.12 D12Mit65 22cM B s B
Chr.12 D12Mit4 33cM S s B
Chr.12 D12Mit27 50cM S . . . .  s , B
Chr.12 1(lgh-V) 62cM s s S
Chr.13 D13Mit80 6.4 s s B
Chr.13 D13 Mit 3 11cM s B B
Chr.13 D13 Mit 13 30cM s B B
Chr.13 D13 Mit 28 46cM B B B
Chr.13 D13 Mit 47 62cM B B B
Chr.14 D14 Mit1 2 cM B B S
Chr.14 D14 Mit5 15 cM B B S
Chr.14 120 26 cM B B s
Chr.14 88 42 cM B B f: '; S . i
Chr.15 D15Mit11 4,8cM l; :S, S S
Chr.15 D15Mit29 33.9cM B B B
Chr.15 D15Mit34 53.7cM B B B
Chr.15 HOX B B B
Chr.16 D16Mit8 3cM B B B
Chr.16 D16Mit5 39cM B B B
Chr.16 D16Mit5 51cM B B B
Chr.17 D17Mit61 6,1cM B B B
Chr.17 D17Mit52 14cM B B B
Chr.17 D17Mit9 26cM B B B
Chr.17 D17Mit185 35.2 B B B
Chr.17 D17Mit39 40cM B B B
Chr.18 D18Mit18 OcM S S S
Chr.18 D18Mit53 24cM s S S
Chr.18 D18Mit45 37,4cM s s s
Chr.18 D18Mit42 45,6cM s s s
Chr.19 D19Mit32 1cM B B s
Chr.19 D19Mit13 20cM B B B
Chr.19 D19Mit92 56,6cM B B
Chr.X DXMit53 9,6cM B B B
Chr.X DXMit50 22,4cM B B B
Chr.X DXMit93 34,2cM B B B
Chr.X DXMitl 16 45,7cM B B B
Chr.X DXMit34 60cM B B B
Chr.X DXMit31 70,7cM B B B
Genotyping d a ta  corresponding  to the anchor m arkers  u sed  in the typing of DNAs from th e  N4
generation  of the  breeding  program m e to g en e ra te  consom ic mice.
Appendix HI
Chromosome (SEG/Pas) DNA Backcross Generation
1 59 N7
3 8, 10 N7
4 52 (F) N7
6 87 N7
7 76 N6
12 40 N7
13 78, 80 N6
14 98, 99 N7
15 64, 66 N7
16 18 N7
18 2, 3, 5, 6 (F) N7
DNAs from backcross generation N6/7 containing a single M.spretus (SEG/Pas) 
chromosome in a C57BL/6 genome backgraound (refer also to Section 1,1.1). F, female.
Appendix IV
DNA
(N4)
Genotype
101 1
391 1
421 2
2 /
5 2
8 /
10 1
12 1
15 1
17 1
18 2
32 1
37 2
38 /
41 2
42 2
44 1
46 1
49 1
DNA
(N4)
Genotype DNA
(N4)
Genotype
101 1 101 2
391 1 391 1
421 2 421 1
2 / 2 /
5 2 5 1
8 / 8 /
10 1 10 1
12 1 12 1
15 1 15
17 2 17 1
18 2 18 1
32 1 32 1
37 1 37 1
38 1 38 1
41 2 41 1
42 1 42 2
44 2 44 2
46 2 46 2
49 2 49 2
W36162 W33240 W36235
DNA
(N4)
Genotype
101 1
391 1
421 1
2 1
5 1
8 1
10 2
12 2
15 1
17 1
18 1
32 1
37 1
38 1
41 2
42 1
44 1
46 2
49 2
DNA Genotype DNA Genotype
(N4)______________  (N4)
101 2 101
391 2 391
421 1 421
2 / 2
5 1 5
8 / 8
10 1 10
12 1 12
15 2 15
17 1 17
18 1 18
32 1 32
37 2 37
38 1 38
41 1 41
42 1 42
44 1 44
46 1 46
49 1 49
W39933 W36139 W33210
DNA Genotype
(N4)____________
101 1
391 2
421 1
2 /
5 2
8 2
10 1
12 1
15 1
17 1
18 1
32 1
37 /
38 1
41 1
42 1
44 1
46 1
49 1
DNA Genotype 
(N4)____________
101 1
391 2
421 1
2 1
5 2
8 2
10 1
12 1
15 1
17 1
18 1
32 1
37 1
38 1
41 1
42 1
44 1
46 1
49 1
DNA
(N4)
Genotype
101 2
391 2
421 1
2 1
5 2
8 1
10 1
12 1
15 2
17 1
18 1
32 1
37 1
38 1
41 1
42 1
44 1
46 1
49 1
W39952 W39947 W39956
DNA Genotype
(N4)____________
DNA Genotype 
(N4)____________
DNA Genotype 
(N4)____________
101 2 101 1 101 1
391 1 391 2 391 1
421 2 421 1 421 1
2 1 2 / 2 1
5 1 5 1 5 1
8 1 8 / 8 1
10 1 10 1 10 1
12 / 12 1 12 1
15 2 15 1 15 1
17 1 17 1 17 1
18 2 18 1 18 1
32 1 32 1 32 1
37 2 37 1 37 1
38 2 38 1 38 1
41 1 41 1 41 1
42 2 42 1 42 2
44 2 44 1 44 2
46 2 46 1 46 1
49 2 49 1 49 1
W35449 U58912 Th
DNA
(N2)
Genotype
2 1
3 1
4 1
5 2
6 1
11 1
14 1
15 1
16 2
17 1
18 2
19 2
20 2
21 2
22 1
23 1
24 2
27 1
28 2
W36179
DNA
(N2)
Genotype
2 2
3 2
4 1
5 1
6 1
11 2
14 2
15 2
16 2
17 2
18 2
19 1
20 2
21 1
22 2
23 1
24 1
27 1
28 1
W36213
Appendix IV Allocation of ESTs to chromosomes using DNAs derived from intermediate 
generations of the backcross programme to generate consomic strains (refer also to Section 
1,1.1 and 1.3). a l, a2 and a/ correspond to homozygote, heterozygote and non-informative 
SSCP patterns respectively. N2 and N4 correspond to DNAs derived from the first and 
third backcross generations respectively.
Appendix V
DNA
(EUCIB)
Genotype DNA
(EUCIB)
Genotype DNA
(EUCIB)
Genotype
LB 138 al LB 064 1 PB171 1
LB 157 a2 LB 142 2 PB160 2
LB 167 2 LB 163 2 PB187 2
LB 161 1 LB 161 2 PB179 1
LB 139 2 LB 145 1 PB191 1
LB 290 1 LB111 2 PB201 2
LB 234 2 LB 158 1 PB230 1
LB 23 8 2 LB 23 8 2 PB186 2
W36162 W33240 W36235
DNA
(EUCIB)
Genotype DNA
(EUCIB)
Genotype DNA
(EUCIB)
Genotype
PB066 1 LB410 1 PB048 1
PB065 2 LB 348 2 PB204 2
PB081 2 LB 520 2 PB026 1
PB070 1 LB391 1 PB078 2
LB417 2 LB352 2 PB074 2
LB 242 2 LB401 2 PB054 1
LB237 1 LB 408 1 PB067 2
LB 254 2 LB399 a/ PB053 1
LB 060 1 PB083 2
LB 305 2 PB066 1
W39933 W36139 W33210
DNA
(EUCIB)
Genotype DNA
(EUCIB)
Genotype DNA
(EUCIB)
Genotype
LS217 1 LB 165 1 LS455 1
LS191 2 LB 167 2 LS468 2
LSI 86 2 LB 246 1 LS572 2
LSI 98 1 LB 304 2 LS321 1
LS226 1 LB 169 1 LS379 1
LS223 1 LB 299 2 LS549 2
LSI 82 2 LB 25 3 1 LS576 1
LB237 2 LS362 2
W39952 W39947 W39956
DNA
(EUCIB)
Genotype DNA
(EUCIB)
Genotype DNA
(EUCIB)
Genotype
LB 345 1 PB021 1 LSI 54 1
LB355 2 PB041 2 LS261 2
LB 301 2 PB043 2 LSI 86 2
LB 293 1 PB047 1 LS272 1
LB357 2 PB050 2 LSI 92 2
LB 300 1 PB062 1 LS260 1
LB 245 2 PB078 2 LS274 2
LB256 1 PB056 2 LS220 1
W35449 U58912 Th
DNA Genotype
(EUCIB)___________
DNA Genotype 
(EUCIB)__________
DNA Genotype 
(EUCIB)___________
LB 175 1 LB 300 1 LS175 1
LB 162 2 LB 309 2 LS176 2
LB 168 1 LB 257 2 LSI 90 1
LB 160 2 LB 303 1 LSI 86 2
LB 164 1 LB 295 2 LS192 1
LB 200 2 LB254 1 LS174 2
LB 201 1 LB 301 2 LS191 2
LB 240 2 LB 249 1 LS193 2
LB252 2
W36221 W36213 W36259
Appendix V Allocation of ESTs to a position between anchor markers, on mouse 
chromosomes, using subset panels of EUCIB DNAs (refer also to Section 1, 1.1 and 1.3). 
a l, a2 and a/ correspond to homozygote, heterozygote and non-informative SSCP patterns 
respectively.
Appendix VI
EUCIB
DNA
Genotype X-over EUCIB
DNA
Genotype X-over EUCIB
DNA
Genotype X-over
LB 158 1 aNo LB 393 2 aYes LB 213 / a/
LB 166 1 No LS 453 1 No LB 347 2 No
LS 336 1 No LS 539 1 No LB 355 1 Yes
LB242 1 No LS 246 1 No LB 407 1 Yes
LB 251 1 No LS 159 1 Yes LS 464 1 Yes
LB 309 2 Yes LS 318 1 Yes LS 488 / /
LB 384 1 No LB 201 1 Yes LB 441 1 Yes
LB 386 2 Yes LS 379 / / LB 508 1 Yes
Localisation of W36179 between EUCIB anchor markers D19Ndsl and D19Mitl. The 
data displayed above are for the PCR-SSCP* typing of W36179 on DNAs demonstrating 
recombination events in the interval D19Ndsl and D19Mitl. a l, a2 and a/ correspond to 
homozygote, heterozygote and non-informative SSCP patterns respectively. X-over, 
recombination event.
EUCIB
DNA
Genotype X-over EUCIB
DNA
Genotype X-over EUCIB
DNA
Genotype X-over
LB232 1 No LB445 1 No LB399 2 No
LB257 1 No LB 247 2 No LB406 2 No
LB301 1 No LB251 2 No LB407 2 No
LB307 1 No LB255 2 No LB422 2 No
LB 349 1 No LB 290 2 No
LB396 1 No LB293 2 No
LB398 1 No LB384 2 No
LB408 1 No LB386 2 No
Localisation of W36221 between EUCIB anchor markers D18MU20 and D18Mit24. The 
data displayed above are for the PCR-SSCP* typing of W36221 on DNAs demonstrating 
recombination events in the interval D18Mit20 and D18Mit24. a l, a2 and a/ correspond 
to homozygote, heterozygote and non-informative SSCP patterns respectively. X-over, 
recombination event.
EUCIB
DNA
Genotype X-over EUCIB
DNA
Genotype X-over EUCIB
DNA
Genotype X-over
LB233 1 No LB441 1 No LB 254 2 No
LB 245 2 Yes LB500 1 No LB256 1 Yes
LB 302 1 No LB531 1 No LB 309 1 Yes
LB 344 1 No LB 136 1 Yes LB 339 2 No
LB 346 2 Yes LB 139 1 Yes LB341 1 Yes
LB432 1 No LB 170 1 Yes LB438 2 No
LB433 2 Yes LB 240 2 No LB528 2 No
Localisation of W35449 between EUCIB anchor markers D18Mit8 and D18Mit25. The 
data displayed above are for the PCR-SSCP* typing of W35449 on DNAs demonstrating 
recombination events in the interval D18Mit8 and D18MU25. a l, a2 and a/ correspond to 
homozygote, heterozygote and non-informative SSCP patterns respectively. X-over, 
recombination event.
EUCIB Genotype X-over EUCIB Genotype X-over EUCIB Genotype X-over 
DNA DNA DNA
LSI 75 LS331 LS329
LSI 97 LS336 LS330
LS230 LS361 LS376
LS321 LS418 LS455
LS322 LSI 27 LS481
LS326 LSI 52 LS556
LS327 LS323 LS582
LS 587
Localisation of W36213 between EUCIB anchor markers D17Mit39 and D17M itl23. The 
data displayed above are for the PCR-SSCP* typing of W36213 on DNAs demonstrating 
recombination events in the interval D17Mit39 and D17Mitl23.. a l , a2 and a/ correspond 
to homozygote, heterozygote and non-informative SSCP patterns respectively. X-over, 
recombination event.
EUCIB
DNA
Genotype X-over EUCIB
DNA
Genotype X-over EUCIB
DNA
Genotype X-over
LSI 86 2 Yes LS469 1 No LS326 2 No
LS269 2 Yes LS553 1 No LS336 1 Yes
LS272 1 No LS566 1 No LS451 1 Yes
LS280 1 No LSI 55 1 Yes LS452 1 Yes
LS318 1 No LSI 98 2 No LS459 1 Yes
LS325 1 No LS219 2 No LS484 1 Yes
LS334 2 Yes LS230 2 No
LS404 2 Yes LS321 2 No
Localisation of W39956 between EUCIB anchor markers D13Mitl7 and D13MU61. The 
data displayed above are for the PCR-SSCP* typing of W39956 on DNAs demonstrating 
recombination events in the interval D13MU17 and D13Mit61. a l, a2 and a/ correspond to 
homozygote, heterozygote and non-informative SSCP patterns respectively. X-over, 
recombination event.
EUCIB
DNA
Genotype X-over EUCIB
DNA
Genotype X-over EUCIB
DNA
Genotype X-over
LB 140 1 No LB 292 1 No LB357 1 Yes
LB 202 1 No LB 302 2 Yes LB 3 84 1 Yes
LB232 1 No LB 307 1 No LB 3 87 1 Yes
LB 242 1 No LB350 2 Yes LB 3 89 1 Yes
LB 246 1 No LB 247 2 No LB392 1 Yes
LB 257 2 Yes LB 304 1 Yes LB411 1 Yes
LB 291 1 No LB 341 2 No LB 345 1 Yes
Localisation of W39947 between EUCIB anchor markers D10Mitl6 and D10Mit20. The 
data displayed above are for the PCR-SSCP* typing of W39947 on DNAs demonstrating 
recombination events in the interval D1 OMitl6 and D10MU20 a l , a2 and a/ correspond to 
homozygote, heterozygote and non-informative SSCP patterns respectively. X-over, 
recombination event.
EUCIB
DNA
Genotype X-over EUCIB
DNA
Genotype X-over EUCIB
DNA
Genotype X-over
LS087 / / LS583 2 Yes LS223 1 No
LSI 92 2 Yes LS587 2 Yes LS319 2 Yes
LS226 2 Yes LS739 2 Yes LS692 2 Yes
LS230 2 Yes LS088 / / LS697 2 Yes
LS269 2 Yes LS152 2 No LS777 2 Yes
LS334 2 Yes LS173 2 No LS791 2 Yes
LS455 2 Yes LSI 83 1 Yes
LS487 / / LSI 84 2 No
Localisation of W39952 between EUCIB anchor markers D10MU20 and D10Mit7. The 
data displayed above are for the PCR-SSCP* typing of W39952 on DNAs demonstrating 
recombination events in the interval D10Mit20 and D10Mit7. a l, a2 and a/ correspond to 
homozygote, heterozygote and non-informative SSCP patterns respectively. X-over, 
recombination event.
EUCIB
DNA
Genotype X-over EUCIB
DNA
Genotype X-over EUCIB
DNA
Genotype X-over
PB030 / / PB113 / / PB137 1 Yes
PB034 2 Yes PB125 2 Yes PB138 1 Yes
PB036 2 Yes PB134 1 No PB145 1 Yes
PB044 2 Yes PB109 1 Yes PB155 1 Yes
PB064 2 Yes PB123 2 No PB181 1 Yes
PB066 2 Yes PB124 1 Yes PB190 1 Yes
PB087 2 Yes PB127 1 Yes
PB104 2 Yes PB130 1 Yes
Localisation of W36139 between EUCIB anchor markers D6Nds4 and D6Mit5. The data 
displayed above are for the PCR-SSCP* typing of W36139 on DNAs demonstrating 
recombination events in the interval D6Nds4 and D6Mit. a l , a2 and a/ correspond to 
homozygote, heterozygote and non-informative SSCP patterns respectively. X-over, 
recombination event.
EUCIB Genotype X-over EUCIB Genotype X-over EUCIB Genotype X-over
DNA DNA DNA
PB029 1 No PB060 1 No PB051 1 Yes
PB030 1 No PB063 / / PB064 2 No
PB035 1 No PB072 1 No PB070 2 No
PB040 1 No PB039 2 No PB102 1 Yes
PB050 1 No PB041 2 No PB113 1 Yes
PB053 2 Yes PB042 2 No PB183 2 No
PB055 1 No PB047 2 No
PB056 1 No PB049 / /
Localisation of W39933 between EUCIB anchor markers D5Nds8 and D5Nds2. The data
displayed above are for the PCR-SSCP* typing of W39933 on DNAs demonstrating
recombination events in the interval D5Nds8 and D5Nds. a l, a2 and a/ correspond to
homozygote, heterozygote and non­informative SSCP patterns respectively. X-over,
recombination event.
EUCIB
DNA
Genotype X-over EUCIB
DNA
Genotype X-over EUCIB
DNA
Genotype X-over
LS094 2 Yes LS258 2 Yes LS338 2 No
LSI 86 1 No LS460 2 Yes LS362 2 No
LSI 93 1 No LS483 2 Yes LS367 2 No
LS214 1 No LSI 00 1 Yes LS495 2 No
LS217 1 No LSI 84 2 No LS548 1 Yes
LS220 2 Yes LS221 2 No LS731 1 Yes
LS224 2 Yes LS327 1 Yes LS733 2 No
Localisation of W36135 between EUCIB anchor markers Trypl and D4Mit52. The data 
displayed above are for the PCR-SSCP* typing of W36135 on DNAs demonstrating 
recombination events in the interval Trypl and D4Mit52. a l, a2 and a/ correspond to 
homozygote, heterozygote and non-informative SSCP patterns respectively. X-over, 
recombination event.
EUCIB
DNA
Genotype X-ovei EUCIB
DNA
Genotype X-over EUCIB
DNA
Genotype X-over
LSI 88 2 Yes LS324 2 Yes LS272 2 No
LSI 89 2 Yes LS325 2 Yes LS333 1 Yes
LSI 92 / LS328 2 Yes LS334 1 Yes
LSI 93 1 No LS181 1 Yes LS465 1 Yes
LS229 / LSI 83 2 No LS376 1 Yes
LS230 2 Yes LS191 1 Yes LS404 1 Yes
LS265 2 Yes LSI 94 1 Yes
LS279 2 Yes LS219 1 Yes
Localisation of W33240 between EUCIB anchor markers D2Mitl and D2M itll. The data
displayed above are for the PCR-SSCP* typing of W33240 on DNAs demonstrating
recombination events in the interval D2Mitl and D2M itll. a l, a2 and a/ correspond to
homozygote, heterozygote and non­informative SSCP patterns respectively. X-over,
recombination event.
EUCIB
DNA
Genotype X-over EUCIB
DNA
Genotype X-over EUCIB
DNA
Genotype X-over
PB021 2 Yes PB053 1 No PB153 2 No
PB041 2 Yes PB056 1 No PB186 1 Yes
PB043 1 No PB062 1 No PB203 2 No
PB044 2 Yes PB031 1 Yes PB225 1 Yes
PB045 2 Yes PB078 1 Yes PB246 2 No
PB047 1 No PB139 1 Yes LB 062 1 Yes
PB049 / / PB142 1 Yes
PB050 2 Yes PB148 2 No
Localisation of W36162 between EUCIB anchor markers D 2M itll and D2Nds3. The data 
displayed above are for the PCR-SSCP* typing of W36162 on DNAs demonstrating 
recombination events in the interval D 2M itll andD2Nds3. a l, a2 and a/ correspond to 
homozygote, heterozygote and non-informative SSCP patterns respectively. X-over, 
recombination event.
EUCIB
DNA
Genotype X-over EUCIB
DNA
Genotype X-over EUCIB
DNA
Genotype X-over
LSI 22 1 No LS230 1 No LS215 2 No
LSI 25 1 No LS265 1 No LS222 2 No
LSI 53 1 No LS273 1 No LS316 2 No
LSI 54 1 No LS121 2 No LS329 2 No
LSI 55 1 No LS173 2 No LS372 2 No
LSI 83 1 No LSI 84 2 No LS404 2 No
LSI 90 1 No LSI 85 2 No
LS226 2 Yes LSI 86 2 No
Localisation of W36259 between EUCIB anchor markers Col3al and D1MU12. The data 
displayed above are for the PCR-SSCP* typing of W36259 on DNAs demonstrating 
recombination events in the interval Col3al and DlM itl2. a l, a2 and a/ correspond to 
homozygote, heterozygote and non-informative SSCP patterns respectively. X-over, 
recombination event.
Appendix VII
1 ACTAGTCAAT CATTTATTTT CTGTCCTTGC ACCTACAATA ATTTGTCCAT TCCCAATGTA
61 TGATCTTTAG TTACTGAGAC AGTGGCCTCA TTCCTAATTA GAAGGAATGT TTCCTTGATC
121 AAAAATTTGT TCCAACCCTG TTTTATTTTC CTAGTGGAAT TAGCCTGTGA CACATGAAGG
181 CTCTATTTGC AGCTTTTATT CTATAGGGGG CATGGATTTA CTTTTCTTAA TTCAGGAGTT
241 CTATAAAATC ACTATCAGGA ATTAGGAAGT CATCAATTTG TTTAAACTGC ACTATTTCAT
301 GAAAGTTCAT CTTCATATTG GTTCTGTAGA AGATGTGCCC AATAGGGTGG GCTGATACAC
361 AGAAATCATT AGGCTATGTA ACAGAGGCAG GAAAGGCAGG TCAGCAGCGA GAAGCAATCT
421 TAGGATCAAG TCTCTTTGGA TATTGCCTCT CAGAGTGCAC CCACTGCAGC CATGCAAAAC
481 GGTGGGTCAT CTCCAGGAAA CTCACTTACT TGCCATAGCC GTTCCCACAT GGCTCTTGTC
541 ATAAAACCAT GCATAACACA CACACACACA CACACACACA CACACACACA CAGAGAGAGA
601 GAGAGAGAGA GAGAGAGAGA GAGAGAGAGA GAGAGAGAGA GAGAACCAAG CTCTGCACCT
661 TTGTTCTGCA GAGGAGTGTC ACCTGTGGAC GCTGAGCAGA AGGGTTCCTC CCTCACATGC
721 TGTTTTGTGT CTCCCCTCCC CTCCCCTTCT TCATCAATGG TTTCCAGTGA GATGAGTCAA
781 AAAGTGGCCA AGGAGGGCCC CAGGCTCTCC AAGAACCAGA AGTTCTCCGA GCACTTCAGC
841 ATCCACTGCT GCCCACCCTT CACCTTCCTC AACTCCAAGC GTGAGATCGT GGACCGCAAG
901 TACAGCATCT GCAAGAGCGG TTGCTTTTAC CAGAAGAAGG AGGAGGACTG GATCTGCTGT
961 GCCTGCCAGA AGACTAGGTG AGTGCGGGCT CTGGGCCAGG TCTACACCAC ATTCCCTTTG
1021 CTCCATCCAT GACTGTCAGC TCCCTGTTAG GAAGGTTCTG GAGGGCGAGC AGAAGGTGGG
1081 AGGGAGGGCC GGGCCTTCCT GCTGTTTCCA GTTCCTGCCA GCATCCCTTA AGCGACGGTG
1141 GAGAGCCCAG GCTGCAGCCT CCAGCTTCTT TTGGCCCTCT CTGCACCAGC CGCCGTGCCA
1201 CGTCCCCTCA GAGGCCCAAG CACCAGCCAG CTGCKTCCCC AGTGGTGGTC AGAGCGCCGC
1261 CAGCCAAGCC AAGTCCCCTC TGATGCCAGC CAAGCCAAGG TCCCCACCGA GGCCAGCCAA
1321 GCCAAGTCCC CTTCAAGGAC TGAGCGCCAG CCGCGTCCCC GCCCAGAGGT CCGACCACCA
1381 CCAGCCAAGC AGAAGCCCCC TCAGAAGTCT AAGCAGCCAG CACGCAGCAG CCCCCTCAGA
1441 GGGCCAGGCA CCAGCCGCGG GGGGTCTCCC ACCAGAGCTC CTAGGTTCTG GTAACACCAT
1501 CTCTTGCCTT TTGTCCCCTC TAGCCTAAGG TCAGTAGCTG CTCTCTGCAA GTACTAACAT
1561 GGGGGATCTG TCCACAGTAC CAAGCCTGTG TAATCCACTC CCTGCATTAA ACCCCCTCTG
1621 TTTGAAAGAC CTGGCGTGGC TTCTGTTTTT CCAGATGTTA CCGGTCCTCA CTTTAGATGG
1681 CTGTGTCTGT GCCAATCCAT AGGACTGGAA GTCACTAATT TACCAGCATA GTATTGGCCA
1741 CAGTGGCAGG CTGAGTGTAT GAGCCTCCTT AACCACCTTG TGCCTCAGAG AGACATAGTG
1801 GTAACTGATG AGTTGTATCT GTGCATGTGT GATGGGAGGA CCCGATGCTC GATTTGCTGA
1861 CCCTCCTGAC GGATCTCATC AGATATCTGT TTGCTCATAC AGCCACTCAG CAAACTCTAC
1921 TGCTTTATAG ATAATAAGGT TCATATGCTG TACTGGGGAG AGGAAAATAA TTTGTGATTT
1981 CTGAGTACCA AAAAGAGACA AGCTGGCCCT GATGTACTGT AATCACTCCA GTACTGCCAT
2041 GCTCAGGGTG TTTATGCCCA TGGGAGCCCC AACTGGGAAC TTTCCAGCTC TGCCGTGGGA
2101 ACCTGAGGCT TCACAGAGAA AATTAGGTTG GAGTGAGCAA ACTGGAGAAG GATGGCCAGA
2161 GAGGAACTTA CCCATCTGCT CTACCTCGGG TTAGACCAGT TTCCTTTCTT CTTTTTGAGA
2221 CAGACACTCC CACTGTAGTT CATGCTATCC CATATCTTAC TCCGTATCTA ATGTTTACTT
2281 CAAACTTATA AATATCTTAC TGCTTTAAAT TCCCAAATGC TTGGATTAAA CGTGTTAACT
2341 GCAATGCTTG GTGGTGACTT CCTCTTCTTT CTCTTCCTCC TCCTCTCCCT CCTTCCCCCC
2401 TCTGTCTCCC CCCCTCTTCT TCTTTATAGA CTTTATTTTT TGGTTCAGTT TTAGGTCCAC
2461 AGAGAAACTG AGGGAAAGAT AGAAACTTCT ATTCCCTGCC CCGCACACAG AGTAGGCAGC
2521 ATTTTACTCC TCGGAGGTAG ATCTGTGTAG TGGGTCCACA GCGAGCACTG GTTCACATCC
2581 TTTTCACTCT GCCACTCAGC CCCTGCGCAG CTTTAGAGAA CCCCCGTGAG AATCTCACGC
2641 ATGGTTCTTT CAGACAGCAA AGATGCAAGA ACAATTGATT TACCCAGCCA AGAACTAACT
2701 GGCTGCTGCT CACTAGACCT CAGTACCTTA GAGAGGTGTA TCCAGGCTGA CTGATCACTA
2761 AGTCCCTCCA AGGGACTGGA GTAAAAAAGC TGGCTCAGCT GGCTAACTTC TGACATACAG
2821 AAGTGCCCAG AAAATGGAGG GGGCTGAGGA TATTCATTTT GTACAGAAGA GGCAGTCCTT
2881 CATAGGAAGC TAAGCGATCG GCTGGGGTGG TTAGGTTCAA GCTGTAACTG GACGTTCTCT
2941 CAGTCACTCT TTGGGTATCA GCTAAGGTGT TTCCGCTGGC TGTGCCCTAT GTCCCTGGGA
3001 ACGTAGGACC AGCTTCCTAC CAGCCTGCAC CTCTCATGCA CCCCGAGTCC CACCCAATAC
3061 ACAAGCTCCC TTCTCAGAAT CTCAGAGGTC CTAAGGTAAT ATACTAGAAT AGATATTTTA
3121 CCACTGCATC GTTTATTTCG TTTATTGATC TGACTATTTC AAATCAGAGG CGTAGGAGGC
3181 ACATTAATGG GAGCAGTTTA ATCAGGGCAG CTAGTCAGAC ATTTAGAAAG GGTTAAAAAG
3241 GTTTTCAGAA GCTGCCCGAA GTCAGATCTG ACGCTGTTCC TCAGGTATTG TGTTTGACGA
3301 ATCAAACGGT TCAGACAAAG GTCTTTTTTT TGGATCAATA ATAACTCCTT AGAAAAGGCC
3361 CTCTTCCTGG ACCGGAGAAT ATCTGTCTTA GAAATGAATG GGCTTGGTTT TCAGCATCCC
3421 AGTGGA
Appendix VII Contiguous sequence 1 
This sequence encompasses exons 3, 4 and 5 of the Mobp gene.
VIII
1 ATTTAGGGCG CTTGTTTTTT CCAAGCCTTA ACAACAGTCT TAGGGCTGTT TTGTTTCTTT
61 CCGATTTCCT AGGGGGGAAA TTTTTGTAAA TTTCAAAACT TTCAAAAGCT AACTTTCAAA
121 AGGAGTGAGA TCAGGGTGGA TTACAAGATG ATTGAACCCT CGTGGGCTTC CATCCTTTCA
181 AACCCTCCTG TTCGGTTAGG ACAATGGTGT TTGATATCTT CCTGGAAGCC AAACCTTCTT
241 CTCTTGCATC TAAGGAGTTG CCATTATCCT CAGTTTAGGG AGTTCTGCTC CCTAAACTGT
301 GCTAGCTGAC CCCACATTTC TTTCTGAGCA GGTGCTGCCC TCTGCTGGGC ACGGATTAAT
361 AGACCTGTTT GTCTTCCTCC CAGGACTGTG CGTAAATAAG GCTCAGGCAA TCTCACACCC
421 ATCTCTCTAG CTTACACTCA GCTCAGGGCT TGACTGATGT TGATGGCTGA ATGGGACCAA
481 ACAATTTACC TCACAGTCTG ACTCAGCAGG AAGGTGGACG GCTTCAGCAT CGGGTTTGAG
541 TCCACACTTT TTGATAAACT TGTAACCAGT GCGTGTCTGG GCCCACCTAT TAGTAATACA
601 TTTACTAAAT ATTGCTTATC TTTTTAAATG TAGTTCATTC CCTAACAAAT TAGAGACATG
661 TCAACCTGGT CAGGATTTTA TAAGAGTTCA TATATACAGA TGTGCGCACG GTTGCATTTA
721 AGTCTGCGGT ATCAGTCACT GCTCTCACTG ATGTGACGGG CTATCTGGGC AAACACGTTA
781 GGAAGGCTCA TTCTGTTTAA TGTATACAGG AGCTCTGTTT TTATGCATAC CAGACGAGGG
841 AATCAGATTC TATTACAGAT GGTTGTGAGA CACCATGTGG CTGTTGGGAA TTGAACTCAG
901 GACCTCTGGA AGAGCAGTAG GTGTCCCTAA CCACTGAGCC ATCTCTCCAG TCCTGGAAGG
961 ATCATTTTGA CTCACAGTTT GAAGGGACAC AGGCCACCAT GGTGAGCAAA GAGTGGTGGC
1021 AAGAACCTGA GGTGGCAGGT GATATGGCAC CCGCAGTCAG GCAGCAGAGA GGTGACCGCT
1081 GGTGCTCAGC TAGCTTTCTC CTTCCTATTC AGTCCCTGGC CCTGAGACCA GGGTCTGTTG
1141 TCCCTCACAT TCCAGCCGAG TCTTCTCCGC TCACTTAAAC CTTTCTGCGA ACTTGTCCAC
1201 AAACACAGAG ATGTGTTTCC TTGGTGACCC TAAATCCAGG CAAGTTGACA ATAAAGAGCA
1261 AGAGAAAGTG AGCTGAACAC CAGCGCTTAC CTCTCTGCTG CCTGACTGTG GATGGCATGT
1321 GACCTGCAGA GCCTCAGGTC CTTGTCACAA GTAATAAAAT GTTTTTGTTT CTGTTCTAAG
1381 AGCAGGATAT ACTTATGCTA GCTTTGTGTT CTTCTGGGTC CCTTACCACC AGTAGCCAGA
1441 AAACCAAATA TTATTATGCA TGGAAACAGG GATATATATA TATATATATC TCCTTTCCTA
1501 TGCTCAGTTC AGGAAAAAAA GAAATCAACA TATCAGTTTT GCCCAGAGAT TAAAAGGAGT
1561 TGAGAAAGCT GGATTTCTAA GGAGAAAAAA CAAAACAAAA AAACAAAACA AAACAAAAAA
1621 ATCATCTCAA GTGGTTCACT CAGAGCTCAG CAGTTAAAAG CCCTTCTTGC TCTTGTAGGA
1681 CCTGAGTTCA GTTCCCAGCA CCTACATGGT GGCTTACAAC TCTATAACTT TAGTTTTAGC
1741 GCCCTCTTCT GGAACCTGTG AGAACTGCAT GCACATGGTG CACATAGACA CACACAGACA
1801 CACAGACACA CACAGACACA CAGACACACA CAGACACACA GACACACACA GACACAGACA
1861 CACACACACA CACACACACA CACACACACA CACACACACA CACACACACA CACACACACA
1921 GAGTAAACAC ATCTTTTTAA AATGCCCGTG AAGTCACTGT TGTTCTAAGT GCTCTGCAGG
1981 AAGTGGACAC CACCTACCAA TTCATAAATC TTTCTTTTTC TCTCTATAAA TCAGATTGAG
2041 GAGGAGGAGC AGGTCAAACC CCAAGGAAGA AGTGACCGAG AAGGGACTTC TTGTGAATGG
2101 ACAGCCTCTG CCTGTGGACT CACTGCTTCC CGCAACCCAT CTGCTCTCAG ACGAATTATC
2161 TGACCTCAAG TATGATGCAG GAGTGGACGC CTGCTGATGT AACAACCACA GATGCCCTCA
2221 GTCCCCATGG TGTGGGAGCC TTAGGGCAGC CTTCCTGGAG GTGAGAAGGG GGCTCTTCGT
2281 GTCGTACTCT AGCCACGGAG TCCTGGAAGG ATCTCTTGTG CTCCAGAGCT CAGGGAACGG
2341 GTCTTTTGGT TTCATCTGGA GCCCCTTTCT CTCTGGCAGG TGCACGCTTC CTCAGGGTCT
2401 TTGGCAAAGG TGATTGCAGA GCTAATCCAC ACACATTCCT CCTTCTTCCT CTCCCCTCCC
2461 TCCCTGCATC TGGTCAGCAA ACATGACTCT TGATACTTTT TTTTCTCTTC CTGGCTCTCT
2521 GTCCGGCCTC TCTTGCTCGC ACACCATTTG CTTCCCATTC ACCTCTTAGC CAGCAGTACT
2581 CAGAGCCAGA GTCGAGTCTG GTGAAAGGGC CATGGAATTG TAAGATACTA AGTTGTTGTA
2641 TGATCCTTAA ATGCGGCGAT GTTCCGATAA GTTAGGGGAT CGCGCTAAAT TCCCATGTGA
2701 ACTGTAGGTA ACTTGTGTCA GAAACAGAGG AAATGGAGGC ATCCTCCTTC CTCCCCCTCC
2761 GCGGGCCCAG TCTCCAGCCT CACACAGGGC TTTGAGAGAA TCAGTTCCTG CCCCAGTCTG
2821 GGGAGAACCA CCCTCTAAAG CCTTGCCTTT GAGCTTGTCA CCTGCACAGG CGCCCGGCGC
2881 AGCTCTGACT GCTTTCAAAT GATATCATTT AGGAAGGTCA TATGGCTTCA GCCCTGTCCC
2941 CCAACCCTCC CAATCACTTC CCTCGCAGCA TCCTGGACAA GTCCCCATGC GCACTTGTAT
3001 AGGTCTAGAA AGAGTGCCAG GAGCGTTTCT GTCTCCAAAT CAAAACCCCT CAAATTCCTG
3061 AGAGGCCTGA TGCTCCAGTG CTTCCCCTGG CTGGCCCTCC GCGGCTATGT CTGTGGCAAG
3121 GAGAGGTGAA GGAAAACAGG AAGGGAACTT GGCCTTCTGG AAAGGAAGGC AAAGTGCGTG
3181 TGTGTGTGCG TGTGTGTGTT TGCGCGTGCG CGTACGCGTG CGCGTGTGAT GTGTGCGTGT
3241 GTTAGAGAGT TATCAGTCCA AGATCCCATC CCTGAGTAGG AGGCCTTCCA CGGGATGAAG
3301 GGGTCTGTGC TCACTGTGGA GGTGGAGTAG CGCGGGGCTG AGTTTCCGTC TCCTCGCTCT
3361 GGTCTGCCTC CACAGTCCGT AGCCTCCAGA CTCCCGGGGA AGAATGAGCC CGAGCATGGG
3421 CTCTTTTTGT TCTAGACCAC AGGAGCCAGC CCTCCCCCAT GGCGTGGCAC TTGCTTGTAC
3481 CCATCTGTAC ACTTGCTGTG GGGACAGAGA TTGGGCCAGA TGGAAGCGCC TCGTACTGCC
3541 TTGTACTCGT GTGGACTGCT GTGTGGGTGT TGGCCTTGGG AGTAGCTTGG GGAGAATATG
3601 TGCCAGCTCT CAGTTTTCTT GCCCAAGTGC AAATGCTAGA GGCCCTTCCA AGTCCCAGGT
3661 TCATTCTTGT CCCCCAAAGG CCTCAACTGC AGGAGGTCGT CATGAACTGC AGGAGGTCGT
3721 CATGAAAAGG CCACAACGGT ACATGCAACA CTTCAGAGTC CCAAAGCCTT CTCAGCAGGG
3781 GGCACATGGT GATCGGCTTG GGCCTCTTTT CCCTAGTCAG CCCAGATGGG CGGGGGCGGA
3841 GGGTGGAAGG AGAGGAGTTG GATAGATCCA TCTCTAGTCA GGCTCCATCT GGGTCGGCCC
3901 CACAACTTCA GCTTGCTTTG AGCCCAAACT TTGGTAAGTT ATAAACACAA AGAATAGAGA
3961 AAGAGAGATA GAGAGAGACA CACACAAACA CATACACATT ACACAGATAT ATACACACAC
4021 ACATATACCA GACACACGCA CGCACGCACG CACGCACACG CACACGCGCA CACACACACA
4081 CACAAACCTT GTCACTCCTC ACCCCTCCTA ACACTTTTCT CCTTAGGAGG CCAGTGGACG
4141 GGAAGGAGGC CATGTCTCTA TTCACAAGGA AACCAGGCTC AGGGCCTGAC TCAGTGGTTA
4201 AAAAATTCTT GCCTTGCAAG CATGAGAGCT AGAGTTCAAA TCCCCATGAC CCACACGAAT
4261 GCTGGGTAGG CCTGACAACG TACCTCTAAA TCCAAACTGA GAAGCTGGTG ACAGGAGATC
4321 CCAGAGCAAG CAAGAGTGGC CATATCTGTG TGCTTTGGGA CTGAGTGGGA AACCCTTCTT
4381 CTGTGACTAT GGTAGAAGAT ATAGGACTGA CTCCCAATGT CTAACTCTGG GACTCCATGC
4441 ACATGCACCC CTGTATGCTT GTGCACATAC ACTTGCACAC ACACACACAC ACACACACAC
4501 ACACACACAC ACACCACACC ACACCACACC ACACACCACA CATCCACATG GAAATGGGGA
4561 AAAAGGAAAC AAGAGAGTAC CAGACTCATG GTTCTTCGAG GATGGGTGCA TCCTAGCCAG
4621 GACTTAGAAG CCTTTCCCCA CCCAGGAAGA CCTCACCATT TCTTCCTCCT GTTCCCTCTC
4681 TTGTACGTGT GAGCTGCTAA TGGGGTGCTT CATTCACCAT GGGGCTGTGT GCATGCTCCT
4741 CAGAGCCTGT CACGCTCTGG CCTACGGCTC CTACACAGGT GCCCTGAGCG CAGATATCTT
4801 CTCAGAGATT CCTCCACGGT CACCAGACTC CATCATTGTC TTCCAGGATC ATCTGCTCAC
4861 TTATTT
Appendix VIII Contiguous sequence 2 
This sequence encompasses exons 6 and 7 of the Mobp gene.
Appendix IX
1 TGGATCTCCT TTGGGAAACT TTTTTTTGGT TTATTCTAGG AATAGGTTTT TTTTGGGAGG
61 TAGAAAAAGA TTCAGAACAA CAAACAAGGT ACATTCCGCA GGGCGGGAGA GGGGCCCTTC
121 CAGCTTACTG ACCGGAGTTG TTGGTTGAGC TGGTTTCAGG GGTGTGGCGT TCCATGGGTC
181 TTGCCCCTCT CTGCCCTCCC TATCCTCAGG GCCAAGTGTG TGACCAGAGC TCGGTGTGTG
241 CTTCCCTTCA CAGATATGTC TTCTTCTTCA TGAGAGCGGG TACCTGCTTC TGAAGGATGT
301 AGGAGGCCAA CGGGAACGCA GGGGTCCAAC CGCCAGGAGA ACCAGGGGAG GAACAGCCCC
361 ATTTAGTTCT GATGTTTTTT CTCTCCCCTC AGCATGTGGA CGATGCCATT CCATCACCTC
421 CCTCTATAAC TGCCAGCGAG ATATCTCTGT CAACTGTCTC GACTCTCCGA GGTAAGATTC
481 TTTTTCACTT TCTGTTATTT TTTAACAAGG TTTTTCCTCT CTGTCACTGA CATTCCAAAT
541 GCTGGCTGTG ATGTCACTAA GTACAGATTA TATGTGCTTG TTCCGCCCAG GATTCGGGTT
601 CTTCAGGCTG AAGATTCTTG TGTCTTCTCG GATGTGCAAA ACAAGGTCAT GGTGCACAAC
661 CATGCAAACC GCAAATGCAA AAGAGAAATT GTCAAGGTTG GCGGTGACGT GAGAAAAATC
721 CTAAGCAGCT ACCGATGGGA GTCTAACATT GTCACCACTG AGCTGTACTC TGGGGACACT
781 GTCAAAGGCA AAATATCTTA AAACCTCTAA TCAAGTGACT GCAATTTTAG GAATCCATCC
841 TGGAGAAAAC TCACACCCCT TTAGAGAAGG AGAAATGCGC AGATTTGTCT AAAAGATCGT
901 GGTTTGTAGT TAAGAGAAGT GGAATGAAAC TAGCCAAAAT GTCTGTCCAA GGGAATGAGA
961 GAATCAATTT TGGGACGTTC ACAAATAAAG TCCTAACAGC GGTTAAAAGC CAATCTGTCA
1021 GATAGACCAT GTCATGTAGG TAAATCTAGA AAGCAAACTG AGAACTATAA AAATCAAGTA
1081 CCGGGCAGTA AATGCAGTAT GACGTTCTGG GCCTGAATAT TGACATCCCA CAGTCCTGTA
1141 TTGGTTATTG CTTAATAAGG AGAAGCCACA AGATCTCACA CTTTTTCTAT AATGCAATAG
1201 GATTTAAAAA TGACAGCAGA ACACAAAGAC ACTAGAAATT GTCCTGTCAG AAATAAAAGT
1261 ATAAGAAATA ATTCCTGGCT TGAGGAAATA ACCCAGACTA AAAGCTAGAT AGAAACGGCT
1321 TAACAGTACT GGCAGGGCAT ATATTTGTTT GGAGAGGGTC GATGTGAAGT CTGTGAATAG
1381 TCTGGGATGT TTACAAGGTC GCATAAATTT TAAACACCAA AAATATTTGT TTTGAATCAA
1441 TTTTGGGTCT GGGCTATAGA GTCTGCCTTG TGATGGTTCC TGACACGAGA GAAAAGGGAA
1501 GAAATGTTAA TACAGCTCTC GAATTTTCCC TTTAAAGACC AGGTAGGTAG GAAAGGACAA
1561 CAGGATGTTG GGGAATGTGG AGGGATGTAA AACAGACAGT ATTACGGTGG CGAAAACTCA
1621 GTGTAGGGCG ATAAGAACAT CAGATGGCCT TGTGCTGGGA GCCGGGGTGG CCAAGCACAG
1681 GCGGATGCTT GAAGACCCCA AAGGTCACCA TGGCGTCCTC ACAGCCAGAC CCGGCAAAGT
1741 TCAGATCAAG TGCACGGATG GGGGCCATGT TAGTGGAAAC TGTCCAAGGT GTGCGGAGGG
1801 GGTGAGGAAG ACAGCCAGGA GGAAGAGATG GCTCAGAATG CTGCACTACA GCAAAGAAGA
1861 AGCAGGCCAA ATATCGTCCT AAGGCAGCCG AGGGGTCCCG GCTTCCTCTC CCGAGGGCAC
1921 TGTGGCTCCG TGGAAGTGCC GAGGCAGAGG CAGGGGAATT TAACTGCACA AAAACTACAC
1981 GCAGAAACTC AGGTGCTAAA ATGGACATGT ATGTGACCAC CTTTCTGAGG ACCAGTTCCA
2041 GTGAGTGCCC AGGATGTTTC CTTCTCGACT ACGGTTACTG AGCTTAGAAG AATGGGAACG
2101 GGTTTAGGAG CACACAGTTA GCCCCATTGG TGAGACAAAT TTCCAGGCTA GCTTCATCCA
2161 ATCCATTAAG GAGACTTTAG GCTTTTTCAT CTGGTTTTCA TTGGGGCAAA GCAAAGCATA
2221 TCCTGAGTGT TGGTTTGTTT CCGCCCTCCA CGCCACCCCT GAGACACCGA GCATGCGCAT
2281 TAACCCAGAG CGCGCTAACC CATGCGCAGC GTTGGACGTT AGCTCATTAA TGTGATTAAC
2341 CAGAAACCAC TAAATTTTGT TTGTTGTAGA AATAAAACCT GGGGATGGAT CAAACTATAT
2401 CTGGAGATTG CTTGAAGCTG ATGGGTTACT AAGCCAAATG TGCTTTGGAA TTCCTCACTG
2461 AGTCGCGTTG TAATCACCAC GTACTGTTTT TCTACTTAAC ATCGACTCTC AGGAACATTC
2521 CCAAGTTAAT ACCGGAGACA TTTCATAAAA CTCCCAAAGC TGTTCTTCAT ACATTTCTTG
2581 AATTAGCAAT CCAAGCCCCC ATGTTCTGAC ATTATTCCCG AATGTTTAAT TAATCCTTAC
2641 ATTTTGGGGA AAAAACGGAA GGC
Appendix IX Contiguous sequence 3 
This sequence encompasses exon 8 of the Mobp gene
Appendix X 10 20 30 40 50 60
Contig# 2 
Gen.contig 1
ACTAGTCAATCATTTATTTTCTGTCCTTGCACCTACAATAATTTGTCCATTCCCAATGTATGAT
ACTAGTCAATCATTTATTTTCTGTCCTTGCACCTACAATAATTTGTCCATTCCCAATGTATGAT
70 80 90 100 110 120
Contig# 2 
Gen.contig 1
CTTTAGTTACTGAGACAGTGGCCTCATTCCTAATTAGAAGGAATGTTTCCTTGATCAAAAATTT
CTTTAGTTACTGAGACAGTGGCCTCATTCCTAATTAGAAGGAATGTTTCCTTGATCAAAAATTT
130 140 150 160 170 180 190
Contig# 2 
Gen.contig 1
GTTCCAACCCTGTTTTATTTTCCTAGTGGAATTAGCCTGTGACACATGAAGGCTCTATTTGCAG
GTTCCAACCCTGTTTTATTTTCCTAGTGGAATTAGCCTGTGACACATGAAGGCTCTATTTGCAG
200 210 220 230 240 250
Contig# 2 
Gen.contig 1
CTTTTATTCTATAGGGGGCATGGATTTACTTTTCTTAATTCAGGAGTTCTATAAAATCACTATC
CTTTTATTCTATAGGGGGCATGGATTTACTTTTCTTAATTCAGGAGTTCTATAAAATCACTATC
260 270 280 290 300 310 320
Contig# 2 
Gen.contigl
AGGAATTAGGAAGTCATCAATTTGTTTAAACTGCACTATTTCATGAAAGTTCATCTTCATATTG
AGGAATTAGGAAGTCATCAATTTGTTTAAACTGCACTATTTCATGAAAGTTCATCTTCATATTG
330 340 350 360 370 380
Contig# 2 
Big contig 1
GTTCTGTAGAAGATGTGCCCAATAGGGTGGGCTGATACACAGAAATCATTAGGCTATGTAACAG
GTTCTGTAGAAGATGTGCCCAATAGGGTGGGCTGATACACAGAAATCATTAGGCTATGTAACAG
390 400 410 420 430 440
Contig# 2 
Big contig 1
AGGCAGGAAAGGCAGGTCAGCAGCGAGAAGCAATCTTAGGATCAAGTCTCTTTGGATATTGCCT
AGGCAGGAAAGGCAGGTCAGCAGCGAGAAGCAATCTTAGGATCAAGTCTCTTTGGATATTGCCT
450 460 470 480 490 500 510
Contig# 2 
Big contig 1
CTCAGAGTGCACCCACTGCAGCCATGCAAAACGGTGGGTCATCTCCAGGAAACTCACTTACTTG
CTCAGAGTGCACCCACTGCAGCCATGCAAAACGGTGGGTCATCTCCAGGAAACTCACTTACTTG
520 530 540 550 560 570
Contig# 2 
Gen.contig 1
CCATAGCCGTTCCCACATGGCTCTTGTCATAAAACCATGCATAACACACACACACACACACACA
CCATAGCCGTTCCCACATGGCTCTTGTCATAAAACCATGCATAACACACACACACACACACACA
580 590 600 610 620 630 640
Contig# 2
Gen.contig 1
MOBP69
MOBP81B
MOBP81A
MOBP99
rOPRPl
rOPl
Big contig 2 
Untitled 1 
Big contig 3+4
CACACACACACACACAGAGAGAGAGAGAGAGAGAGAGAGAGAGAGAGAGAGAGAGAGAGAGAGA
CACACACACACACACAGAGAGAGAGAGAGAGAGAGAGAGAGAGAGAGAGAGAGAGAGAGAGAGA
Contig# 2
Gen.contig 1
MOBP69
M0BP81B
M0BP81A
MOBP99
rOPRPl
rOPl
Big contig2a 
Gen.contig2b 
Gen contig 3+4
GAGAACCAAGCTCTGCACCTTTGTTCTGCAGAGCAGTGTCACCTGTGGACGCTGAGCAGAAGGG 
GAGAACCAAGCTCTGCACCTTTGTTCTGCAGAGCAGTGTCACCTGTGGACGCTGAGCAGAAGGG 
TATCCACA GGAACCTTTCACAGCAGCCAATACCTGCAGGGCAACAAAGAATCAAATGAGAGC 
GGAACCTTTCACAGCAGCCAATACCTGCAGGGCAACAAAGAATCAAATGAGAGC 
CTTTCACAGCAGCCAATACCTGCAGGGCAACAAAGAATCAAATGAGAGC 
GCCAATACCTGCAGGGCAACAAAGAATCAAATGAGAGC
TGAGAGC
TGAGAGC
710 720 730 740 750 760
Contig# 2
Big contig 1
MOBP69
MOBP81B
MOBP81A
MOBP99
rOPRPl
rOPl
Big contig2a 
Gen.contig2b 
Gen contig 3+4
TTCCTCCCTCACATGCTGTTTTGTGTCTCCCCTCCCCTCCCCTTCTTCATCAATGGTTTCCAGT
TTCCTCCCTCACATGCTGTTTTGTGTCTCCCCTCCCCTCCCCTTCTTCATCAATGGTTTCCAGT
GAGACAAGCTGGGAATGAAGTCCTGGTTGCCAGATGGGAGCTTGAAAACACAG
GAGACAAGCTGGGAATGAAGTCCTGGTTGCCAGATGGGAGCTTGAAAACACAG
GAGACAAGCTGGGAATGAAGTCCTGGTTGCCAGATGGGAGCTTGAAAACACAG
GAGACAAGCTGGGAATGAAGTCCTGGTTGCCAGATGGGAGCTTGAAAACACAG
GAGACAAGCTGGGAATGAAGTCCTGGTTGCCAGATGGGAGCTTGAAAACACAG
GAGACAAGCTGGGAATGAAGTCCTGGTTGCCAGATGGGAGCTTGAAAACACAG
770 780 790 800 810 820 830
Contig# 2
Gen contig 1
MOBP69
MOBP81B
MOBP81A
MOBP99
rOPRPl
rOPl
Gen contig2a 
Gen.contig2b 
Gen contig 3+4
GAGATGAGTCAAAAAGTGGCCAAGGAGGGCCCCAGGCTCTCCAAGAACCAGAAGTTCTCCGAGC
GAGATGAGTCAAAAAGTGGCCAAGGAGGGCCCCAGGCTCTCCAAGAACCAGAAGTTCTCCGAGC
AAGATGAGTCAAAAAGTGGCCAAGGAGGGCCCCAGGCTCTCCAAGAACCAGAAGTTCTCAGAGC
AAGATGAGTCAAAAAGTGGCCAAGGAGGGCCCCAGGCTCTCCAAGAACCAGAAGTTCTCAGAGC
AAGATGAGTCAAAAAGTGGCCAAGGAGGGCCCCAGGCTCTCCAAGAACCAGAAGTTCTCAGAGC
AAGATGAGTCAAAAAGTGGCCAAGGAGGGCCCCAGGCTCTCCAAGAACCAGAAGTTCTCAGAGC
AAGATGAGTCAAAAAGTGGCCAAGGAGGGCCCCAGGCTCTCCAAGAACCAGAAGTTCTCAGAGC
AAGATGAGTCAAAAAGTGGCCAAGGAGGGCCCCAGGCTCTCCAAGAACCAGAAGTTCTCAGAGC
840 850 860 870 880 890
Contig# 2
Gen contig 1
MOBP69
MOBP81B
MOBP81A
MOBP99
rOPRPl
rOPl
Gen contig2a 
Gen.contig2b 
Gen contig 3+4
ACTTCAGCATCCACTGCTGCCCACCCTTCACCTTCCTCAACTCCAAGCGTGAGATCGTGGACCG
ACTTCAGCATCCACTGCTGCCCACCCTTCACCTTCCTCAACTCCAAGCGTGAGATCGTGGACCG
ACTTCAGCATCCACTGCTGCCCACCCTTCACCTTCCTCAACTCCAAGCGTGAGATCGTGGACCG
ACTTCAGCATCCACTGCTGCCCACCCTTCACCTTCCTCAACTCCAAGCGTGAGATCGTGGACCG
ACTTCAGCATCCACTGCTGCCCACCCTTCACCTTCCTCAACTCCAAGCGTGAGATCGTGGACCG
ACTTCAGCATCCACTGCTGCCCACCCTTCACCTTCCTCAACTCCAAGCGTGAGATCGTGGACCG
ACTTCAGCATCCACTGCTGCCCACCCTTCACCTTCCTCAACTCCAAGCGTGAGATCGTGGACCG
ACTTCAGCATCCACTGCTGCCCACCCTTCACCTTCCTCAACTCCAAGCGTGAGATCGTGGACCG
900 910 920 930 940 950 960
Contig# 2 CAAGTACAGCATCTGCAAGAGCGGTTGCTTTTACCAGAAGAAGGAGGAGGACTGGATCTGCTGT
Gen contig 1 CAAGTACAGCATCTGCAAGAGCGGTTGCTTTTACCAGAAGAAGGAGGAGGACTGGATCTGCTGT 
MOBP6 9 CAAGTACAGCATCTGCAAGAGCGGTTGCTTTTACCAGAAGAAGGAGGAGGACTGGATCTGCTGT
MOBP8 IB CAAGTACAGCATCTGCAAGAGCGGTTGCTTTTACCAGAAGAAGGAGGAGGACTGGATCTGCTGT
MOBP81A CAAGTACAGCATCTGCAAGAGCGGTTGCTTTTACCAGAAGAAGGAGGAGGACTGGATCTGCTGT
MOBP9 9 CAAGTACAGCATCTGCAAGAGCGGTTGCTTTTACCAGAAGAAGGAGGAGGACTGGATCTGCTGT
rOPRPl CAAGTACAGCATCTGCAAGAGCGGTTGCTTTTACCAGAAGAAGGAGGAGGACTGGATCTGCTGT
rOPl CAAGTACAGCATCTGCAAGAGCGGTTGCTTTTACCAGAAGAAGGAGGAGGACTGGATCTGCTGT
Gen contig2a
970 980 990 1000 1010 1020
Contig# 2 
Gen contig 1 
MOBP69 
MOBP81B 
MOBP81A 
MOBP99 
rOPRPl 
rOPl 
Gen contig2a 
Gen.contig2b 
Gen contig 3+4
GCCTGCCAGAAGACTAG
GCCTGCCAGAAGACTAG
GCCTGCCAGAAGACCAG
GCCTGCCAGAAGACCAG
GCCTGCCAGAAGACCAG
GCCTGCCAGAAGACCAG
GCCTGCCAGAAGACCAG
GCCTGCCAGAAGACCAG
GTGAGTGCGGGCTCTGGGCCAGGTCTACACCACATTCCCTTTGCTCC
GTGAGTGCGGGCTCTGGGCCAGGTCTACACCACATTCCCTTTGCTCC
1030 1040 1050 1060 1070 1080
I I I I I I
Contig# 2 ATCCATGACTGTCAGCTCCCTGTTAGGAAGGTTCTGGAGGGCGAGCAGAAGGTGGGAGGGAGGG
Gen contig 1 ATCCATGACTGTCAGCTCCCTGTTAGGAAGGTTCTGGAGGGCGAGCAGAAGGTGGGAGGGAGGG
MOBP69
MOBP81B
MOBP81A
MOBP99
rOPRPl
rOPl
Gen contig2a 
Gen.contig2b 
Gen contig 3+4
1090 1100 1110 1120 1130 1140 1150
I I I I I I I
Contig# 2 CCGGGCCTTCCTGCTGTTTCCAGTTCCTGCCAGCATCCCTTAAGCGACGGTGGAGAGCCCAGGC
Gen contig 1 CCGGGCCTTCCTGCTGTTTCCAGTTCCTGCCAGCATCCCTTAAGCGACGGTGGAGAGCCCAGGC
MOBP69
MOBP81B
MOBP81A
MOBP99
rOPRPl
rOPl
Gen contig2a 
Gen contig2b 
Gen contig 3+4
1160 1170 1180 1190 1200 1210
I I I I I I
Contig# 2 TGCAGCCTCCAGCTTCTTTTGGCCCTCTCTGCACCAG|CCGCCGTGCCACGTCCCCTCAGAGGCC
Gen contig 1 TGCAGCCTCCAGCTTCTTTTGGCCCTCTCTGCACCAG j CCGCCGTGCCACGTCCCCTCAGAGGCC
MOBP69
MOBP81B
MOBP81A
MOBP99
rOPRPl |CCGCCGTGCCACATCCCCTCAGAAGCC
rOPl
Gen contig2a 
Gen contig2b 
Gen contig 3+4
1220 1230 1240 1250 1260 1270 1280
I I I I I I I
Contig# 2 CAAGCACCAGCCAGCTGCKTCCCCAGTGGTGGTCAGAGCGCCGCCAGCCAAGCCAAAGTCCCCT
Gen contig 1 CAAGCACCAGCCAGCTGCKTCCCCAGTGGTGGTCAGAGCGCCGCCAGCCAAGCCAAAGTCCCCT
MOBP69
MOBP81B
MOBP81A
MOBP99
rOPRPl CAAGCACCAGCCAGCTGCATCCCCTGTGGTGGTCAGAGCGCCGCCAGCCAAGCCAAAGTCCCCT
rOPl
Gen contig2a 
Gen contig2b 
Gen contig 3+4
1290 1300 1310 1320 1330 1340
Contig# 2
Gen contig 1
MOBP69
MOBP81B
MOBP81A
MOBP99
rOPRPl
rOPl
Gen contig2a 
Gen contig2b 
Gen contig 3+4
CTGATGCCAGCCAAGCCAAGGTCCCCACCGAGGCCAGCCAAGCCAAGGTCCCCTTCAAGGACTG
CTGATGCCAGCCAAGCCAAGGTCCCCACCGAGGCCAGCCAAGCCAAGGTCCCCTTCAAGGACTG
CCGAGGCCAGCCAAGCCAAGGTCCCCTCCGATTCCAGCCAAGCCAAGGTCCCCTTCAAGGACTG
1350 1360 1370 1380 1390 1400
Contig# 2
Gen contig 1
MOBP69
MOBP81B
MOBP81A
MOBP99
rOPRPl
rOPl
Gen contig2a 
Gen contig2b 
Gen contig 3+4
AGCGCCAGCCGCGTCCCCGCCCAGAGGTCCGACCACCACCAGCCAAGCAGAAGCCCCCTCAGAA
AGCGCCAGCCGCGTCCCCGCCCAGAGGTCCGACCACCACCAGCCAAGCAGAAGCCCCCTCAGAA
AGCGCCAGCCGCGTCCCCGCCCAGAGGTCCGACCACCACCAGCCAAGCAGAAGCCCCCTCAGAA
1410 1420 1430 1440 1450 1460 1470
Contig# 2 
Gen contig 1 
MOBP69 
MOBP81B 
MOBP81A 
MOBP99 
rOPRPl 
rOPl 
Gen contig2a 
Gen contig2b 
Big contig 3+4
GTCTAAGCAGCCAGCACGCAGCAGCCCCCTCAGAGGGCCAGGCACCAGCCGCGGGGGGTCTCCC
GTCTAAGCAGCCAGCACGCAGCAGCCCCCTCAGAGGGCCAGGCACCAGCCGCGGGGGGTCTCCC
GTCTAAACAGCCAGCACGAAGCAGCCCCCTCAGAGGGCCAGGCACCAGCCGCGGGGGGTCTCCC
1480 1490 1500 1510 1520 1530
Contig# 2
Gen contig 1
MOBP69
MOBP81B
MOBP81A
MOBP99
rOPRPl
rOPl
Gen contig2a 
Gen contig2b 
Gen contig 3+4
ACCAGAGCTCCTAGGTTCTGGTAACACCATCTCTTGCCTTTTGTCCCCTCTAGCCTAAGGTCAG
ACCAGAGCTCCTAGGTTCTGGTAACACCATCTCTTGCCTTTTGTCCCCTCTAGCCTAAGGTCAG
ACCAGAGCTCCTAGGTTCTGGTAACACCATCTCTTGCCTTTTGTCCCCCCTAGCCTAAGGTCAG
1540 1550 1560 1570 1580 1590 1600
Contig# 2
Gen contig 1
MOBP69
MOBP81B
MOBP81A
MOBP99
rOPRPl
rOPl
Gen contig2a 
Gen contig2b 
Gen contig 3+4
TAGCTGCTCTCTGCAAGTACTAACATGGGGGATCTGTCCACAGTACCAAGCCTGTGTAATCCAC
TAGCTGCTCTCTGCAAGTACTAACATGGGGGATCTGTCCACAGTACCAAGCCTGTGTAATCCAC
TAGCTGCTCTCTGCAAGTACTAACATGGGGGATCTCTCCACAGTACCAAGC TGTGTAATCTAC
Contig# 2 TCCCTGCATTAAACCCCCTCTGTTTGAAAGACCTGGCGTGGCTTCTGTTTTTCCAGATGTTACC
Gen contig 1 TCCCTGCATTAAACCCCCTCTGTTTGAAAGACCTGGCGTGGCTTCTGTTTTTCCAGATGTTACC
MOBP69
M0BP81B
M0BP81A
MOBP99
rOPRPl TCC TGCATTAAACCCCCTCTGTTTG
rOPl
Gen contig2a 
Gen contig2b 
Gen contig 3+4
1670 1680 1690 1700 1710 1720
I I I I I I
Contig# 2 GGTCCTCACTTTAGATGGCTGTGTCTGTGCCAATCCATAGGACTGGAAGTCACTAATTTACCAG
Gen contig 1 GGTCCTCACTTTAGATGGCTGTGTCTGTGCCAATCCATAGGACTGGAAGTCACTAATTTACCAG
MOBP69
MOBP81B
MOBP81A
MOBP99
rOPRPl
rOPl
Gen contig2a 
Gen contig2b 
Gen contig 3+4
1730 1740 1750 1760 1770 1780 1790
I I I I I I I
Contig# 2 CATAGTATTGGCCACAGTGGCAGGCTGAGTGTATGAGCCTCCTTAACCACCTTGTGCCTCAGAG
Gen contig 1 CATAGTATTGGCCACAGTGGCAGGCTGAGTGTATGAGCCTCCTTAACCACCTTGTGCCTCAGAG
MOBP69
MOBP81B
MOBP81A
MOBP99
rOPRPl
rOPl
Gen contig2a 
Gen contig2b 
Gen contig 3+4
1800 1810 1820 1830 1840 1850
I I I I I I
Contig# 2 AGACATAGTGGTAACTGATGAGTTGTATCTGTGCATGTGTGATGGGAGGACCCGATGCTCGATT
Gen contig 1 AGACATAGTGGTAACTGATGAGTTGTATCTGTGCATGTGTGATGGGAGGACCCGATGCTCGATT
MOBP69
MOBP81B
MOBP81A
MOBP99
rOPRPl
rOPl
Gen contig2a 
Gen contig2b 
Gen contig 3+4
1860 1870 1880 1890 1900 1910 1920
I I I I I I I
Contig# 2 TGCTGACCCTCCTGACGCATCTCATCAGATATCTGTTTGCTCATACAGCCACTCAGCAAACTCT
Gen contig 1 TGCTGACCCTCCTGACGCATCTCATCAGATATCTGTTTGCTCATACAGCCACTCAGCAAACTCT
MOBP69
MOBP81B
MOBP81A
MOBP99
rOPRPl
rOPl
Gen contig2a 
Gen contig2b 
Gen contig 3+4
1930 1940 1950 1960 1970 1980
I I I I I I
Contig# 2 ACTGCTTTATAG | ATAATAAGGTTCATATGCTGTACTGGGGAGAGGAAAATAATTTGTGATTTCT
Gen contig 1 ACTGCTTTATAG j ATAATAAGGTTCATATGCTGTACTGGGGAGAGGAAAATAATTTGTGATTTCT
MOBP6 9 | ATAATAAGGTTCTATTCACTGTACTGGGGAGAGGAATATGATTTGTGATTCC
MOBP81B
MOBP81A
MOBP99
rOPRPl
rOPl
Gen contig2a 
Gen contig2b 
Gen contig 3+4
1990 2000 2010 2020 2030 2040
I I I I I I
Contig# 2 GAGTACCAAAAAGAGACAAGCTGGCCCTGATGTACTGTAATCACTCCAGTACTGCCATGCTCAG
Gen contig 1 GAGTACCAAAAAGAGACAAGCTGGCCCTGATGTACTGTAATCACTCCAGTACTGCCATGCTCAG
MOBP6 9 CGAGGACCAAGAAGAGAGAAGCTGGCCCTGGTGTACACAGTAATCACTCCAATACTGCCGTGCC
MOBP81B
MOBP81A
MOBP99
rOPRPl
rOPl
Gen contig2a 
Gen contig2b 
Gen contig 3+4
2050 2060 2070 2080 2090 2100 2110
I I I I I I I
GGTGTTTATGCCCATGGGAGCCCCAACTGGGAACTTTCCAGCTCTGCCGTGGGAACCTGAGGCT 
GGTGTTTATGCCCATGGGAGCCCCAACTGGGAACTTTCCAGCTCTGCCGTGGGAACCTGAGGCT 
AGGATGTATGACCAAAGGAGCCCTGAATGGCGATTGTCCAGCTCTGCCATGGGAGCCTGAGGCT
MOBP81A
MOBP99
rOPRPl
rOPl
Big contig 2 
Untitled 1 
Big contig 3+4
Contig# 2 
Big contig 1 
MOBP69 
MOBP81B
2120 2130 2140 2150 2160 2170
Contig# 2
Gen contig 1
MOBP69
MOBP81B
MOBP81A
MOBP99
rOPRPl
rOPl
Gen contig2a 
Gen contig2b 
Gen contig 3+4
TCACAGAGAAAATTAGGTTGGAGTGAGCAAACTGGAGAAGGATGGCCAGAGAGGAACTTACCCA 
TCACAGAGAAAATTAGGTTGGAGTGAGCAAACTGGAGAAGGATGGCCAGAGAGGAACTTACCCA 
TCACAGAGAAAATTAGGTTGGAGCGGCGTA CAGGAGAAGGATAGACAGAGAGGCACTTACCAA
2240
I★ ★ ★
* * *
MOBP81B
MOBP81A
MOBP99
rOPRPl
rOPl
Gen contig2a 
Gen contig2b
2180 2190 220 0 2210 2220 2230
Contig# 2 TCTGCTCTACCTCGGGTTAG|
Gen contig 1 TCTGCTCTACCTCGGGTTAG j ACCAGTTTCCTTTCTTCTTTTTGAGACAGACACTCCC
MOBP6 9 TCTGCTCTGCCTTAGI
2250 2260 2270 2280 2290 2300
I I I I I I
Contig# 2 ATTTAGGGCGCTTGTTTTTTCCAAGCCTTAACAACAGTCTTAGGGCTGTTTTGTTTCTTTC
Gen contig 1
MOBP69
MOBP81B
MOBP81A
MOBP99
rOPRPl
rOPl
Gen contig2a ATTTAGGGCGCTTGTTTTTTCCAAGCCTTAACAACAGTCTTAGGGCTGTTTTGTTTCTTTC
Gen contig2b 
Gen contig 3+4
2310 2320 2330 2340 2350 2360
I I I I I I
Contig# 2 CGATTTCCTAGGGGGGAAATTTTTGTAAATTTCAAAACTTTCAAAAGCTAACTTTCAAAAGGAG
Gen contig 1
MOBP69
MOBP81B
MOBP81A
MOBP99
rOPRPl
rOPl
Gen contig2a CGATTTCCTAGGGGGGAAATTTTTGTAAATTTCAAAACTTTCAAAAGCTAACTTTCAAAAGGAG
Gen contig2b 
Gen contig 3+4
2370 2380 2390 2400 2410 2420 2430
Contig# 2
Big contig 1
MOBP69
MOBP81B
MOBP81A
MOBP99
rOPRPl
rOPl
Big contig2a 
Gen contig2b 
Big contig 3+4
TGAGATCAGGGTGGATTACAAGATGATTGAACCCTCGTGGGCTTCCATCCTTTCAAACCCTCCT
TGAGATCAGGGTGGATTACAAGATGATTGAACCCTCGTGGGCTTCCATCCTTTCAAACCCTCCT
2440 2450 2460 2470 2480 2490
I I I I I I
Contig# 2 GTTCGGTTAGGACAATGGTGTTTGATATCTTCCTGGAAGCCAAACCTTCTTCTCTTGCATCTAA
Gen contig 1
MOBP69
MOBP81B
MOBP81A
MOBP99
rOPRPl
rOPl
Gen contig2a GTTCGGTTAGGACAATGGTGTTTGATATCTTCCTGGAAGCCAAACCTTCTTCTCTTGCATCTAA
Gen contig2b 
Gen contig 3+4
2500 2510 2520 2530 2540 2550 2560
Contig# 2
Gen contig 1
MOBP69
MOBP81B
MOBP81A
MOBP99
rOPRPl
rOPl
Gen contig2a 
Gen contig2b 
Gen contig 3+4
GGAGTTGCCATTATCCTCAGTTTAGGGAGTTCTGCTCCCTAAACTGTGCTAGCTGACCCCACAT
GGAGTTGCCATTATCCTCAGTTTAGGGAGTTCTGCTCCCTAAACTGTGCTAGCTGACCCCACAT
2570 2580 2590 2600 2610 2620
I I I I I I
Contig# 2 TTCTTTCTGAGCAGGTGCTGCCCTCTGCTGGGCACGGATTAATAGACCTGTTTGTCTTCCTCCC
Gen contig 1
MOBP69
MOBP81B
MOBP81A
MOBP99
rOPRPl
rOPl
Gen contig2a TTCTTTCTGAGCAGGTGCTGCCCTCTGCTGGGCACGGATTAATAGACCTGTTTGTCTTCCTCCC
Gen contig2b 
Gen contig 3+4
2630 2640 2650 2660 2670 2680
I I I I I I
Contig# 2 AGGACTGTGCGTAAATAAGGCTCAGGCAATCTCACACCCATCTCTCTAGCTTACACTCAGCTCA
Gen contig 1
MOBP69
MOBP81B
MOBP81A
MOBP99
rOPRPl
rOPl | GACTGTGTGAATCAGGCTCAGGCAATCTTACACTCATCTCTCTAGAGCCCAGCTCAGGGTTT
Gen contig2a AG j GACTGTGCGTAAATAAGGCTCAGGCAATCTCACACCCATCTCTCTAGCTTACACTCAGCTCA
Gen contig2b 
Gen contig 3+4
2690 2700 2710 2720 2730 2740 2750
I I I I I I I
Contig# 2 GGCTGACGTCGGCGACTGAATGAGACCAGATAATTTACCTCACAGTCTGACCCAGCAAGAAAGT
Gen contig 1
MOBP69
MOBP81B
MOBP81A
MOBP99
rOPRPl
rOPl GGCTGACGTCGGCGACTGAATGAGACCAGATAATTTACCTCACAGTCTGACCCAGCAAGAAAGT
Gen contig2a GGGCTTGACTGATGTTGATGGCTGAATGGGACCAAACAATTTACCTCACAGTCTGACTCAGCAG
Gen contig2b 
Gen contig 3+4
2760 2770 2780 2790
Contig# 2
Gen contig 1
MOBP69
MOBP81B
MOBP81A
MOBP99
rOPRPl
rOPl
Gen contig2a 
Gen contig2b 
Gen contig 3+4
GAAGGTGGACGGCTTCAGCATCGGGTTTGAGTCC
CAG
GAAGGTGGACGGCTTCAGCATCGGGTTTGAGTCC
2800 2810
I I
AATCAG|ATTGAGAAGGA
|ATTGAGAAGGA 
|ATTGAGAAGGA 
ATTGAGAAGGA
|ATTGAGAAGGA 
AATCAG j ATTGAGGAGGA
2820 2830 2840 2850 2860 2870 2880
Contig# 2
Gen contig 1
MOBP69
MOBP81B
MOBP81A
MOBP99
rOPRPl
rOPl
Gen contig2a 
Gen contig2b
GGAGCAGGTCAACCCCAAGAAAAAAGTGACCGAGAAGGGACTTCTCGTGAATGGACAGCCTCTG
GGAGCAGGTCAACCCCAAGAAAAAAGTGACCGAGAAGGGACTTCTCGTGAATGGACAGCCTCTG
GGAGCAGGTCAACCCCAAGAAAAAAGTGACCGAGAAGGGACTTCTCGTGAATGGACAGCCTCTG
GGAGCAGGTCAACCCCAAGAAAAAAGTGACCGAGAAGGGACTTCTCGTGAATGGACAGCCTCTG
GGAGCAGGTCAACCCCAAGAAAAAAGTGACCGAGAAGGGACTTCTCGTGAATGGACAGCCTCTG
GGAGCAGGTCAACCCCAAGGAAGAAGTGACCGAGAAGGGACTTCTTGTGAATGGACAGCCTCTG
2890 2900 2910 2920 2930 2940
Contig# 2
Gen contig 1
MOBP69
MOBP81B
MOBP81A
MOBP99
rOPRPl
rOPl
Gen contig2a 
Gen contig2b 
Gen contig 3+4
CCTGTGGACTCACTGCTTCCCGCAACCCATCTGCTCTCAGACGAATTATCTGACCTCAAGTATG
CTTGTGGATTTACTGCTTCACCGCAACCCATCTGCCCTCAGACTTATCTGGCCTCGAGTATGAC
CTTGTGGATTTACTGCTTCACCGCAACCCATCTGCCCTCAGACTTATCTGGCCTCGAGTATGAC
CTTGTGGATTTACTGCTTCACCGCAACCCATCTGCCCTCAGACTTATCTGGCCTCGAGTATGAC
CTTGTGGATTTACTGCTTCACCGCAACCCATCTGCCCTCAGACTTATCTGGCCTCGAGTATGAC
CCTGTGGACTCACTGCTTCCCGCAACCCATCTGCTCTCAGACGAATTATCTGACCTCAAGTATG
2950 2960 2970 2980 2990 3000
Contig# 2
Gen contig 1
MOBP69
MOBP81B
MOBP81A
MOBP99
rOPRPl
rOPl
Gen contig2a 
Gen contig2b 
Big contig 3+4
ATGCAGGAGTGGACGCCTGCTGATGTAACAACCACAGATGCCCTCAGTCCCCATGGTGTGGGAG
GCAGGGGTGGACACCTGCTGATGTAACAACTACAGATGCCCTCAGTCCCCATGGTGTGGGAGCC
GCAGGGGTGGACACCTGCTGATGTAACAACTACAGATGCCCTCAGTCCCCATGGTGTGGGAGCC
GCAGGGGTGGACACCTGCTGATGTAACAACTACAGATGCCCTCAGTCCCCATGGTGTGGGAGCC
GCAGGGGTGGACACCTGCTGATATAACAACTACAGATGCCCTCAGTCCCCATGGTGTGGGAGCC
ATGCAGGAGTGGACGCCTGCTGATGTAACAACCACAGATGCCCTCAGTCCCCATGGTGTGGGAG
3010 3020 3030 3040 3050 3060 3070
Contig# 2
Big contig 1
MOBP69
MOBP81B
MOBP81A
MOBP99
rOPRPl
rOPl
Gen contig2a 
Gen contig2b 
Gen contig 3+4
CCTTAGGGCAGCCTTCCTGGAG | GTGAGAAGGGGGCTCTTCGTGTCGTACTCTAGCCACGGAGTC 
TTAGGGCAGCCTGCCTGGAG|
TTAGGGCAGCCTGCCTGGAGGTGAGGAGGGAGCTCTTCATGCCTTACTCTAGCCACAGAGTCCT 
TTAGGGCAGCCTGCCTGGAGI
TTAGGGCAGCCTGCCTGGAG|
CCTTAGGGCAGCCTTCCTGGAG IGTGAGAAGGGGGCTCTTCGTGTCGTACTCTAGCCACGGAGTC
3080 3090 3100 3110 3120 3130
Contig# 2
Gen contig 1
MOBP69
MOBP81B
MOBP81A
MOBP99
rOPRPl
rOPl
Gen contig2a 
Gen contig2b 
Gen contig 3+4
CTGGAAGGATCTCTTGTGCTCCAGAGCTCAGGGAACGGGTCTTTTGGTTTCATCTGGAGCCCCT
GGAAGGACCCCTCGGGCTCCAGAGCTCAGGGAATGGGTCTTTTGGTTTCATCTGGAGCCCTTTT
CTGGAAGGATCTCTTGTGCTCCAGAGCTCAGGGAACGGGTCTTTTGGTTTCATCTGGAGCCCCT
3140 3150 3160 3170 3180 3190 3200
Contig# 2
Gen contig 1
MOBP69
MOBP81B
MOBP81A
MOBP99
rOPRPl
rOPl
Gen contig2a 
Gen contig2b 
Gen contig 3+4
TTCTCTCTGGCAGGTGCACGCTTCCTCAGGGTCTTTGGCAAAGGTGATTGCAGAGCTAATCCAC
CTCTCTGGCAGGTGCACAGTTCCTCAGGGTCTTTGGCAAAGGTGATTACAGAGTCAATCCACAC
TTCTCTCTGGCAGGTGCACGCTTCCTCAGGGTCTTTGGCAAAGGTGATTGCAGAGCTAATCCAC
3210 3220 3230 3240 3250 3260
I I I I I I
Contig# 2 ACACATTCCTCCTTCTTCCTCTCCCCTCCCTCCCTGCATCTGGTCAGCAAACATGACTCTTGAT
Gen contig 1
MOBP69
MOBP8 IB ACATTCCTCCTCCTTCCAATTCCCCTCTCTCCCTGGGTCAGGTTGACAACCTGGCTCTTTTTCC
MOBP81A
MOBP99
rOPRPl
rOPl
Gen contig2a ACACATTCCTCCTTCTTCCTCTCCCCTCCCTCCCTGCATCTGGTCAGCAAACATGACTCTTGAT
Gen contig2b 
Gen contig 3+4
3270 3280 3290 3300 3310 3320
Contig# 2
Gen contig 1
MOBP69
MOBP81B
MOBP81A
MOBP99
rOPRPl
rOPl
Gen contig2a 
Gen contig2b 
Gen contig 3+4
ACTTTTTTTTCTCTTCCTGGCTCTCTGTCCGGCCTCTCTTGCTCGCACACCATTTGCTTCCCAT
TTTCCTTCCTAATTCTCTGCCTGGCCTCTCTTGATCACGTGACATCTGTCTCCCATTGACCTTC
ACTTTTTTTTCTCTTCCTGGCTCTCTGTCCGGCCTCTCTTGCTCGCACACCATTTGCTTCCCAT
3330 3340 3350 3360 3370 3380 3390
Contig# 2
Gen contig 1
MOBP69
MOBP81B
MOBP81A
MOBP99
rOPRPl
rOPl
Gen contig2a 
Gen contig2b 
Gen contig 3+4
TCACCTCTTAGCCAGCAGTACTCAGAGCCAGAGTCGARTCTGGTGAAAGGGCCATGGAATTGTA
TTAATCAGGAGTGGTCAGAGCCAACGTCCACACTGGTGAAGGCTCAGGTTATTTTTGGAGTAAG
TCACCTCTTAGCCAGCAGTACTCAGAGCCAGAGTCGARTCTGGTGAAAGGGCCATGGAATTGTA
3400 3410 3420 3430 3440 3450
I I I I I I
Contig# 2 AGATACTAAGTTGTTGTATGATCCTTAAATGCGGCGATGTTCCGATAAGTTAGGGGATCGCGCT
Gen contig 1
MOBP69
MOBP8 IB ATACAGAGTTGCTGTATGATCCTTAAATGCAGCAATGTTCTCATAAGAATGGGATCCCGTTAAA
MOBP81A
MOBP99
rOPRPl
rOPl
Gen contig2a AGATACTAAGTTGTTGTATGATCCTTAAATGCGGCGATGTTCCGATAAGTTAGGGGATCGCGCT
Gen contig2b 
Gen contig 3+4
3460 3470 3480 3490 3500 3510 3520
I I I I I I I
Contig# 2 AAATTCCCATGTGAACTGTAGGTAACTTGTGTCAGAAACAGAGGAAATGGAGGCATCCTCCTTC
Gen contig 1
MOBP69
MOBP8 IB TCTTCACGTCAACTGTAGGTAACTTGTGTCAGAAACAGAGAAAAGGGGGCATCTTCCTCCCTCC
MOBP81A
MOBP99
rOPRPl
rOPl
Big contig2a AAATTCCCATGTGAACTGTAGGTAACTTGTGTCAGAAACAGAGGAAATGGAGGCATCCTCCTTC
Gen contig2b 
Big contig 3+4
3530 3540 3550 3560 3570 3580
I I I I I I
Contig# 2 CTCCCCCTCCGCGGGCCCAGTCTCCAGCCTCACACAGGGCTTTGAGAGAATCAGTTCCTGCCCC
Gen contig 1
MOBP69
MOBP8 IB CCCTCTGCAGGCCCAGTCTCCAGCGTTACACAGGGCTTTGTGAGCACCAGCTCCTGCCCCAGTC
MOBP81A
MOBP99
rOPRPl
rOPl
Gen contig2a CTCCCCCTCCGCGGGCCCAGTCTCCAGCCTCACACAGGGCTTTGAGAGAATCAGTTCCTGCCCC
Gen contig2b 
Gen contig 3+4
3590 3600 3610 3620 3630 3640
I I I I I I
Contig# 2 AGTCTGGGGAGAACCACCCTCTAAAGCCTTGCCTTTGAGCTTGTCACCTGCACAGGCGCCCGGC
Gen contig 1
MOBP69
MOBP8 IB TGGGGATAACAACCCTCTAAACACTGACTTTGACTTGTCCCCAGTGCAGTTGGCACTCAGCCTC
MOBP81A
MOBP99
rOPRPl
rOPl
Gen contig2a AGTCTGGGGAGAACCACCCTCTAAAGCCTTGCCTTTGAGCTTGTCACCTGCACAGGCGCCCGGC
Gen contig2b 
Gen contig 3+4
3650 3660 3670 3680 3690 3700 3710
Contig# 2
Gen contig 1
MOBP69
MOBP81B
MOBP81A
MOBP99
rOPRPl
rOPl
Gen contig2a 
Gen contig2b 
Gen contig 3+4
GCAGCTCTGACTGCTTTCAAATGATATCATTTAGGAAGGTCATATGGCTTCAGCCCTGTCCCCC
ACAGACTCTCAGTGCAGCTCTGACTGCTCTCAATTATATAATTTAGGAAGGTCATGTGGCTTCA
GCAGCTCTGACTGCTTTCAAATGATATCATTTAGGAAGGTCATATGGCTTCAGCCCTGTCCCCC
3720 3730 3740 3750 3760 3770
I I I I I I
Contig# 2 AACCCTCCCAATCACTTCCCTCGCAGCATCCTGGACAAGTCCCCATGCGCACTTGTATAGGTCT
Gen contig 1
MOBP69
MOBP8IB GCCCTGTCCCCCATTCCCCATCACCTCCCTTGAGGCATCCTGGACAAGTCCCATGTGCACTTGT
MOBP81A
MOBP99
rOPRPl
rOPl
Gen contig2a AACCCTCCCAATCACTTCCCTCGCAGCATCCTGGACAAGTCCCCATGCGCACTTGTATAGGTCT
Gen contig2b 
Gen contig 3+4
3780 3790 3800 3810 3820 3830 3840
I I I I I I I
Contig# 2 AGAAAGAGTGCCAGGAGCGTTTCTGTCTCCAAATCAAAACCCCTCAAATTCCTGAGAGGCCTGA
Gen contig 1
MOBP69
MOBP8 IB ATAGGTCTAGAAAGAATGCTTGGAGAGTTTCTGTCTCCAGGTCAAAATTCCTCAAATTCCTGGG
MOBP81A
MOBP99
rOPRPl
rOPl
Gen contig2a AGAAAGAGTGCCAGGAGCGTTTCTGTCTCCAAATCAAAACCCCTCAAATTCCTGAGAGGCCTGA
Gen contig2b 
Gen contig 3+4
3850 3860 3870 3880 3890 3900
I I I I I I
Contig# 2 TGCTCCAGTGCTTCCCCTGGCTGGCCCTCCGCGGCTATGTCTGTGGCAAGGAGAGGTGAAGGAA
Gen contig 1
MOBP69
M OBP8IB AAGGGCAGAGGCTTGATGCTCCAGTGTTTTCCGTGGCTGACCCTCCACATCTGGGTCTGTGGTA
MOBP81A
MOBP99
rOPRPl
rOPl
Gen contig2a TGCTCCAGTGCTTCCCCTGGCTGGCCCTCCGCGGCTATGTCTGTGGCAAGGAGAGGTGAAGGAA
Gen contig2b 
Gen contig 3+4
3910 3920 3930 3940 3950 3960
I I I I I I
Contig# 2 AACAGGAAGGGAACTTGGCCTTCTGGAAAGGAAGGCAAAGTGCGTGTGTGTGTGCGTGTGTGTG
Gen contig 1
MOBP69
MOBP8 IB AGGGAGAAGTCAAGAAAAAGGGGAAAGGAACTTGACTTTCTATAAAGGAAGGTAGTGTGTGTGT
MOBP81A
MOBP99
rOPRPl
rOPl
Gen contig2a AACAGGAAGGGAACTTGGCCTTCTGGAAAGGAAGGCAAAGTGCGTGTGTGTGTGCGTGTGTGTG
Gen contig2b 
Gen contig 3+4
3970 3980 3990 4000 4010 4020 4030
I I I I I I I
Contig# 2 TTTGCGCGTGCGCGTACGCGTGCGCGTGTGATGTGTGCGTGTGTTAGAGAGTTATCAGTCCAAG
Gen contig 1
MOBP69
MOBP8IB GTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTACGTGTGCACATGTGTGTGTTAGA
MOBP81A
MOBP99
rOPRPl
rOPl
Gen contig2a TTTGCGCGTGCGCGTACGCGTGCGCGTGTGATGTGTGCGTGTGTTAGAGAGTTATCAGTCCAAG
Gen contig2b 
Gen contig 3+4
4040 4050 4060 4070 4080 4090
I I I I I I
Contig# 2 ATCCCATCCCTGAGTAGGAGGCCTTCCACGGGATGAAGGGGTCTGTGCTCACTGTGGAGGTGGA
Gen contig 1
MOBP69
MOBP8 IB GAGCTAGCAATCCAAGAGTCCTTCCCAGACTAGGAGGCCAATCCATGGTATGAAGGAGTTTGTG
MOBP81A
MOBP99
rOPRPl
rOPl
Gen contig2a ATCCCATCCCTGAGTAGGAGGCCTTCCACGGGATGAAGGGGTCTGTGCTCACTGTGGAGGTGGA
Gen contig2b 
Gen contig 3+4
4100 4110 4120 4130 4140 4150 4160
I I I I I I I
Contig# 2 GTAGCGCGGGGCTGAGTTTCCGTCTCCTCGCTCTGGTCTGCCTCCACAGTCCGTAGCCTCCAGA
Gen contig 1
MOBP69
MOBP8IB CTCAACTGTCTATGTGGAGCAGGGTTGGGCTGAGTTTCTGTCTCCTTGCTCTAGTTTGCCTCCA
MOBP81A
MOBP99
rOPRPl
rOPl
Gen contig2a GTAGCGCGGGGCTGAGTTTCCGTCTCCTCGCTCTGGTCTGCCTCCACAGTCCGTAGCCTCCAGA
Gen contig2b 
Gen contig 3+4
4170 4180 4190 4200 4210 4220
I I I I I I
Contig# 2 CTCCCGGGGAAGAATGAGCCCGAGCATGGGCTCTTTTTGTTCTAGACCACAGGAGCCAGCCCTC
Gen contig 1
MOBP69
MOBP8IB CGATCTGTAGCTCAGACTCTTGGGAAAGAATGAGCTTCGGTATGGACACTTGTTCTAGACCATA
MOBP81A
MOBP99
rOPRPl
rOPl
Gen contig2a CTCCCGGGGAAGAATGAGCCCGAGCATGGGCTCTTTTTGTTCTAGACCACAGGAGCCAGCCCTC
Gen contig2b 
Gen contig 3+4
4230 4240 4250 4260 4270 4280
I I I I I I
Contig# 2 CCCCATGGCGTGGCACTTGCTTGTACCCACCTGTACACTTGCTGTGGGGACAGAGATGGGGCCA
Gen contig 1
MOBP69
MOBP8IB GGAGCCAACCCTCCCCCATGGCACTTGCTTGTACCTCATCTGCACTCTTGCTGTGAGGACAGAG
MOBP81A
MOBP99
rOPRPl
rOPl
Gen contig2a CCCCATGGCGTGGCACTTGCTTGTACCCACCTGTACACTTGCTGTGGGGACAGAGATGGGGCCA
Gen contig2b 
Gen contig 3+4
4290 4300 4310 4320 4330 4340 4350
Contig# 2
Gen contig 1
MOBP69
MOBP81B
MOBP81A
MOBP99
rOPRPl
Gen contig2a 
Gen contig2b 
Gen contig 3+4
ATGGAAACGCCTCCTACTGCCTTGTACTCCTGTAGAATACGTTGTAGGTGTTGGCCCCTGGGAA
ATTGGGCCAGATGTAACCGCCTTGTACTGCCTTGTACTCGTGTGGACTGGCGTGTGGGTGTCGG
ATGGAAACGCCTCCTACTGCCTTGTACTCCTGTAGAATACGTTGTAGGTGTTGGCCCCTGGGAA
4360 4370 4380 4390 4400 4410
I I I I I I
Contig# 2 TACCTCGGGAGAATAGT
Gen contig 1
MOBP69
MOBP8IB CGTTGGGATTAGCTTGGGGAGATATTTGCCAGCTCTCGGTTTTCTTGCCCAAGTGCAGATGCTA
MOBP81A
MOBP99
rOPRPl
rOPl
Gen contig2a TACCTCGGGAGAATAGT
Gen contig2b 
Gen contig 3+4
4420 4430 4440 4450 4460 4470 4480
I I I I I I I
Contig# 2 
Gen contig 1 
MOBP69
MOBP8IB GAGAGCCCCTCCAAGTCCCAACTTAATTCTTGCCTCCCTGAAGACCTCAACCGTAGAAGGTCAT
MOBP81A
MOBP99
rOPRPl
rOPl
Gen contig2a 
Gen contig2b 
Gen contig 3+4
4490 4500 4510 4520 4530 4540
I I I I I I
Contig# 2 
Gen contig 1 
MOBP69
MOBP8 IB CATGAAAAGGCCACCACTTCAGAGTCCTGGCCTAAACTCAGAGTCCACATGCCTTCCCAGCAGG
MOBP81A
MOBP99
rOPRPl
rOPl
Gen contig2a 
Gen contig2b 
Gen contig 3+4
4550 4560 4570 4580 4590 4600
I I I I I I
Contig# 2 
Gen contig 1 
MOBP69
MOBP8 IB GGCCACAGAGGTGATCCACTTGGGCCTCTTTCCCCACTCAGCCCAGATGGGTGGGGGTGGAGGG
MOBP81A
MOBP99
rOPRPl
rOPl
Gen contig2a 
Gen contig2b 
Gen contig 3+4
4610 4620 4630 4640 4650 4660 4670
I I I I I I I
Contig# 2 
Gen contig 1 
MOBP69
MOBP8 IB TGGAGGGTGGAAGGAGAGGAGTTGGAGAAAATCCATGTCTATTCAGGCTCCGTCTGGGTCTGCT
MOBP81A
MOBP99
rOPRPl
rOPl
Gen contig2a 
Gen contig2b 
Gen contig 3+4
4680 4690 4700 4710 4720 4730
Contig# 2
Gen contig 1
MOBP69
MOBP81B
MOBP81A
MOBP99
rOPRPl
rOPl
Gen contig2a 
Gen contig2b 
Gen contig 3+4
GCACAACAACTTCAGCTTGTTTGAGCCCAAACTTACATAAGTTATAATCACAAAGCTGGAACTA
GCCCC
4740 4750 4760 4770 4780 4790 4800
I I I I I I I
Contig# 2 AAAAATTTAGGTTGTTTGGGGCCCAAAATTGGTAAGTTTTAAACACAAGGATTGGGGAAGGGGG
Gen contig 1
MOBP69
MOBP8 IB GAGAAAGAGAGAAGGACACACACACACACACACACACACACACACACACATACACACACACTCA
MOBP81A
MOBP99
rOPRPl
rOPl
Gen contig2a
Gen contig2b AAAAATTTAGGTTGTTTGGGGCCCAAAATTGGTAAGTTTTAAACACAAGGATTGGGGAAGGGGG
Gen contig 3+4
4810 4820 4830 4840 4850 4860
I I I I I I
Contig# 2 TGGGGGGGGACACACACCAACACTACACACTACACGGGTACTAACACACACACATATACCAACA
Gen contig 1
MOBP69
MOBP8 IB TATATACACATACACACATATACACATATATACACATACACACGCATACACACATACACACATA
MOBP81A
MOBP99
rOPRPl
rOPl
Gen contig 2
Gen contig2b TGGGGGGGGACACACACCAACACTACACACTACACGGGTACTAACACACACACATATACCAACA
Gen contig 3+4
4870 4880 4890 4900 4910 4920
I I I I I I
Contig# 2 CACACGCACGCACGCACGCACGCACACGCACACGCACAACAACACACACACAAACCTTGTCACT
Gen contig 1
MOBP69
MOBP8 IB TACACACATACATAACACACATACACATGCATACACACACTCATATATACACATACACACATAT
MOBP81A
MOBP99
rOPRPl
rOPl
Gen contig2a
Gen contig2b CACACGCACGCACGCACGCACGCACACGCACACGCACAACAACACACACACAAACCTTGTCACT
Gen contig 3+4
4930 4940 4950 4960 4970 4980 4990
Contig# 2
Gen contig 1
MOBP69
MOBP81B
MOBP81A
MOBP99
rOPRPl
rOPl
Gen contig2a 
Gen contig2b 
Gen contig 3+4
CCTCACCCCTCCTAACACTTTTCTCCTTAGGAGGCCAGTGGACGGGAAGGAGGCCATGTCTCTA
ACACATATATATACGCATACACACATACACACATATACACACATACATAACACACATACACATG
CCTCACCCCTCCTAACACTTTTCTCCTTAGGAGGCCAGTGGACGGGAAGGAGGCCATGTCTCTA
5000 5010 5020 5030 5040 5050
I I I I I I
Contig# 2 TTCACAAGGAAACCAGGCTCAGGGCCTGACTCAGTGGTTAAAAAATTCTTGCCTTGCAAGCATG
Big contig 1
MOBP69
MOBP8 IB CATACACACACACACACACACACACACACACACACACACACACACACCCTCGTCACTCCTCATC
MOBP81A
MOBP99
rOPRPl
rOPl
Gen contig2a
Gen contig2b TTCACAAGGAAACCAGGCTCAGGGCCTGACTCAGTGGTTAAAAAATTCTTGCCTTGCAAGCATG
Gen contig 3+4
5060 5070 5080 5090 5100 5110 5120
I I I I I I I
Contig# 2 AGAGCTAGAGTTCAAATCCCCATGACCCACACGAATGCTGGGTAGGCCTGACAACGTACCTCTA
Gen contig 1
MOBP69
MOBP8IB CCTCCTAACATTTTCTCCTTAGGAGGCTAGTAGAAGGGAAGGAAGCCGTTTCTATTTACAAGGA
MOBP81A
MOBP99
rOPRPl
rOPl
Gen contig2a
Gen contig2b AGAGCTAGAGTTCAAATCCCCATGACCCACACGAATGCTGGGTAGGCCTGACAACGTACCTCTA
Gen contig 3+4
5130 5140 5150 5160 5170 5180
I I I I I I
Contig# 2 AATCCAAACTGAGAAGCTGGTGACAGGAGATCCCAGAGCAAGCAAGAGTGGCCATATCTGTGTG
Gen contig 1
MOBP69
MOBP8IB AGTCCGGCTCACGGCCCGGGAGATGACTGCCTTGCAGGCATGGGGGATAGAGTTCGGATCCCCG
MOBP81A
MOBP99
rOPRPl
rOPl
Big contig2a
Gen contig2b AATCCAAACTGAGAAGCTGGTGACAGGAGATCCCAGAGCAAGCAAGAGTGGCCATATCTGTGTG
Big contig 3+4
5190 5200 5210 5220 5230 5240
I I I I I I
Contig# 2 CTTTGGGACTGAGTGGGAAACCCTTCTTCTGTGACTATGGTAGAAGATATAGGACTGACTCCCA
Gen contig 1
MOBP69
MOBP8IB TGACCCACGTGAAGGCTGGGTAGGCCTGGCAGTGGACCTCTAAATCCAAACTCAGAAAGTGGAG
MOBP81A
MOBP99
rOPRPl
rOPl
Gen contig2a
Gen contig2b CTTTGGGACTGAGTGGGAAACCCTTCTTCTGTGACTATGGTAGAAGATATAGGACTGACTCCCA
Gen contig 3+4
5250 5260 5270 5280 5290 5300 5310
Contig# 2
Gen contig 1
MOBP69
MOBP81B
MOBP81A
MOBP99
rOPRPl
rOPl
Gen contig2a 
Gen contig2b 
Gen contig 3+4
ATGTCTAACTCTGGGACTCCATGCACATGCACCCCTGTATGCTTGTGCACATACACTTGCACAC
ACAGGAGATGCCAGAGCAAGTCAAGAGGCCATATCCATGAACTCTGGGACTGATGGAGAAACCC
ATGTCTAACTCTGGGACTCCATGCACATGCACCCCTGTATGCTTGTGCACATACACTTGCACAC
5320 5330 5340 5350 5360 5370
I I I I I I
Contig# 2 ACACACACACACACACACACACACACACACACACCACACCACACCACACCACACACCACACATC
Gen contig 1
MOBP69
MOBP8IB TTCCTTCCTCCAGTGAATATGATTAGAAGACATAGGCTGACTCCCAGTGTCAAACTCAGGGACT
MOBP81A
MOBP99
rOPRPl
rOPl
Gen contig 2
Gen contig2b ACACACACACACACACACACACACACACACACACCACACCACACCACACCACACACCACACATC
Gen contig 3+4
5380 5390 5400 5410 5420 5430 5440
I I I I I I I
Contig# 2 CACATGGAAATGGGGAAAAAGGAAACAAGAGAGTACCAGACTCATGGTTCTTCGAGGATGGGTG
Gen contig 1
MOBP69
MOBP8IB CCATGCACACACACCCCTGCATGCTCCTGCACATACACTTGCAAACATGAGCACACACACTTCA
MOBP81A
MOBP99
rOPRPl
rOPl
Gen contig 2
Gen contig2b CACATGGAAATGGGGAAAAAGGAAACAAGAGAGTACCAGACTCATGGTTCTTCGAGGATGGGTG
Gen contig 3+4
5450 5460 5470 5480 5490 5500
Contig# 2
Gen contig 1
MOBP69
MOBP81B
MOBP81A
MOBP99
rOPRPl
rOPl
Gen contig2a 
Gen contig2b 
Gen contig 3+4
CATCCTAGCCAGGACTTAGAAGCCTTTCCCCACCCAGGAAGACCTCACCATTTCTTCCTCCTGT
TACATCCACATGGAAATGGGGGTAAGAGAAACGAGAGAGTACCTGGCTCATGGTTCCTCTAGGA
CATCCTAGCCAGGACTTAGAAGCCTTTCCCCACCCAGGAAGACCTCACCATTTCTTCCTCCTGT
5510 5520 5530 5540 5550 5560
Contig# 2
Gen contig 1
MOBP69
MOBP81B
MOBP81A
MOBP99
rOPRPl
rOPl
Gen contig2a 
Gen contig2b 
Gen contig 3+4
TCCCTCTCTTGTACGTGTGAGCTGCTAATGGGGTGCTTCATTCACCATGGGGCTGTGTGCATGC
TGGGCCCACCCTGCCCAGGACTTAGAAGCCCTTTCCACACCTAGCAGGACCACACGATTTCTTC
TCCCTCTCTTGTACGTGTGAGCTGCTAATGGGGTGCTTCATTCACCATGGGGCTGTGTGCATGC
5570 5580 5590 5600 5610 5620 5630
Contig# 2
Gen contig 1
MOBP69
MOBP81B
MOBP81A
MOBP99
rOPRPl
rOPl
Gen contig2a 
Gen contig2b 
Gen contig 3+4
TCCTCAG AGCCTGTCACGCTCTGGCCTACGGCTCCTACACAGGTGCCCTGAGCGCAGATATCTT
TGCCTGTTCTCTCTCTTGTACGTGTGAACAAACGGGATGTGTCATCCACCATGGGGCTGTGTGC
TCCTCAG AGCCTGTCACGCTCTGGCCTACGGCTCCTACACAGGTGCCCTGAGCGCAGATATCTT
5640 5650 5660 5670 5680 5690
Contig# 2
Gen contig 1
MOBP69
MOBP81B
MOBP81A
MOBP99
rOPRPl
rOPl
Gen contig2a 
Gen contig2b 
Gen contig 3+4
CTCAGAGATTCCTCCACGGTCACCAGACTCCATCATTGTCTTCCAGGATCATCTGCTCACTTAT
|g g c c t c t t g t g c t ct g a c ct c c c t gt c c t ac a t g ga t g c c ct c g g ct c a a at a t
GCACTCCTAG GGCCTCTTGTGCTCTGACCTCCCTGTCCTACATGGATGCCCTCGGCTCAAATAT
CTCAGAGATTCCTCCACGGTCACCAGACTCCATCATTGTCTTCCAGGATCATCTGCTCACTTAT
5700 5710 5720 5730 5740 5750 5760
Contig# 2
Gen contig 1
MOBP69
MOBP81B
MOBP81A
MOBP99
rOPRPl
rOPl
Gen contig2a 
Gen contig2b 
Gen contig 3+4
CACCCCAGAGATTCTTCCACGGTCACCGACTCCGTCATTCTAGTTTGTCTTCAGGAATCATCAC
CACCCCAGAGATTCTTCCACGGTCACCGACTCCGTCATTCTAGTTTGTCTTCAGGAATCATCAC
5770 5780 5790 5800 5810 5820
I I I I I I
Contig# 2 
Gen contig 1
MOBP6 9 TCACTTGTTTAATTATTGTTTAATTCTCGCTCCAATGCTTTGCTTAATGTAAATCCCATGGCTG
MOBP8IB TCACTTGTTTAATTATTGTTTAATTCTCGCTCCAATGCTTTGCTTAATGTAAATCCCATGGCTG
MOBP81A
MOBP99
rOPRPl
rOPl
Gen contig2a 
Gen contig2b 
Gen contig 3+4
5830 5840 5850 5860 5870 5880
I I I I I I
Contig# 2 
Gen contig 1
MOBP69 CCCCTTTGATTT
MOBP8IB CCCCTTTGATTTCTCCTGTCTTCCCTTGTCTGGCACTAACAAGACGTCAATAAATTCTTGCCGA
MOBP81A
MOBP99
rOPRPl
rOPl
Gen contig2a 
Gen contig2b 
Gen contig 3+4
5890 5900 5910 5920 5930 5940 5950
Contig# 2
Gen contig 1
MOBP69
MOBP81B
MOBP81A
MOBP99
rOPRPl
rOPl
Gen contig2a 
Gen contig2b 
Gen contig 3+4
TGGATCTCCTTTGGGAAACTTTTTTTTGGTTTATTCTAGGAATAGGTTTT
CTGAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA
TGGATCTCCTTTGGGAAACTTTTTTTTGGTTTATTCTAGGAATAGGTTTT
5960 5970 5980 5990 6000 6010
Contig# 2
Gen contig 1
MOBP69
MOBP81B
MOBP81A
MOBP99
rOPRPl
rOPl
Gen contig2a 
Gen contig2b 
Gen contig 3+4
TTTTGGGAGGTAGAAAAAGATTCAGAACAACAAACAAGGTACATTCCGCAGGGCGGGAGAGGGG
TTTTGGGAGGTAGAAAAAGATTCAGAACAACAAACAAGGTACATTCCGCAGGGCGGGAGAGGGG
6020 6030 6040 6050 6060 6070 6080
Contig# 2
Gen contig 1
MOBP69
MOBP81B
MOBP81A
MOBP99
rOPRPl
rOPl
Gen contig2a 
Gen contig2b 
Gen contig 3+4
CCCTTCCAGCTTACTGACCGGAGTTGTTGGTTGAGCTGGTTTCAGGGGTGTGGCGTTCCATGGG
CCCTTCCAGCTTACTGACCGGAGTTGTTGGTTGAGCTGGTTTCAGGGGTGTGGCGTTCCATGGG
6090 6100 6110 6120 6130 6140
I I I I I I
Contig# 2 TCTTGCCCCTCTCTGCCCTCCCTATCCTCAGGGCCAAGTGTGTGACCAGAGCTCGGTGTGTGCT
Gen contig 1
MOBP69
MOBP81B
MOBP81A
MOBP99
rOPRPl
rOPl
Gen contig2a 
Gen contig2b
Gen contig 3+4 TCTTGCCCCTCTCTGCCCTCCCTATCCTCAGGGCCAAGTGTGTGACCAGAGCTCGGTGTGTGCT
6150 6160 6170 6180 6190 6200
I I I I I I
Contig# 2 TCCCTTCACAGATATGTCTTCTTCTTCATGAGAGCGGGTACCTGCTTCTGAAGGATGTAGGAGG
Gen contig 1
MOBP69
MOBP81B
MOBP81A
MOBP99
rOPRPl
rOPl
Gen contig2a 
Gen contig2b
Gen contig 3+4 TCCCTTCACAGATATGTCTTCTTCTTCATGAGAGCGGGTACCTGCTTCTGAAGGATGTAGGAGG
6210 6220 6230 6240 6250 6260 6270
I I I I I I I
Contig# 2 CCAACGGGAACGCAGGGGTCCAACCGCCAGGAGAACCAGGGGAGGAACAGCCCCATTTAGTTCT
Gen contig 1
MOBP69
MOBP81B
MOBP81A
MOBP99
rOPRPl
rOPl
Gen contig2a 
Gen contig2b
Gen contig 3+4 CCAACGGGAACGCAGGGGTCCAACCGCCAGGAGAACCAGGGGAGGAACAGCCCCATTTAGTTCT
6280 6290 6300 6310 6320 6330
Contig# 2
Gen contig 1
MOBP69
MOBP81B
MOBP81A
MOBP99
rOPRPl
rOPl
Gen contig2a 
Gen contig2b 
Gen contig 3+4
GATGTTTTTTCTCTCCCCTCAG CATGTGGACGATGCCATTCCATCACCTCCCTCTATAACTGCC
CACTTGGACGATGCCACTCCATCACCTCCCTCTATAACCGCC
CACTTGGACGATGCCACTCCATCACCTCCCTCTATAACCGCC
GATGTTTTTTCTCTCCCCTCAG CATGTGGACGATGCCATTCCATCACCTCCCTCTATAACTGCC
6340 6350 6360 6370 6380 6390 6400
Contig# 2
Gen contig 1
MOBP69
MOBP81B
MOBP81A
MOBP99
rOPRPl
rOPl
Gen contig2a 
Gen contig2b 
Gen contig 3+4
AGCGAGATATCTCTGTCAACTGTCTCGACTCTCCGAGGTAAGATTCTTTTTCACTTTCTGTTAT
GAAGAGGCATCTCTGTCCACCTTCTGACCCTCCATGGTTGTTCAGTCTGAAGATTCCTGTGTCT
GAAGAGGCATCTCTGTCCACCTTCTGACCCTCCATGGTTGTTCAGTCTGAAGATTCCTGTGTCT
AGCGAGATATCTCTGTCAACTGTCTCGACTCTCCGAGGTAAGATTCTTTTTCACTTTCTGTTAT
6410 6420 6430 6440 6450 6460
I I I I I I
Contig# 2 TTTTTAACAAGGTTTTTCCTCTCTGTCACTGACATTCCAAATGCTGGCTGTGATGTCACTAAGT
Gen contig 1
MOBP69
MOBP81B
MOBP81A TCAGGGATGTGCAAAACAAGGTCATGGTGTGCGACCATCCAAATGGCAAATATAAAAAAGAAAT
MOBP99
rOPRPl
rOPl TCAGGGATGTGCAAAACAAGGTCATGGTGTGCGACCATCCAAATGGCAAATATAAAAAAGAAAT
Gen contig2a 
Gen contig2b
Gen contig 3+4 TTTTTAACAAGGTTTTTCCTCTCTGTCACTGACATTCCAAATGCTGGCTGTGATGTCACTAAGT
6470 6480 6490 6500 6510 6520
I ! I I I I
Contig# 2 ACAGATTATATGTGCTTGTTCCGCCCAGGATTCGGGTTCTTCAGGCTGAAGATTCTTGTGTCTT
Gen contig 1
MOBP69
MOBP81B
MOBP81A TGTCAAGTGTTGGCGGTGACGCAAGAAAAATCCTAGAAGCCACAGATGGGGATTTATACACTGT
MOBP99
rOPRPl
rOPl TGTCAAGTGTTGGCGGTGACGCAAGAAAAATCCTAGAAGCCACAGATGGGGATTTATACACTGT
Gen contig2a 
Gen contig2b
Gen contig 3+4 ACAGATTATATGTGCTTGTTCCGCCCAGGATTCGGGTTCTTCAGGCTGAAGATTCTTGTGTCTT
6530 6540 6550 6560 6570 6580 6590
Contig# 2
Gen contig 1
MOBP69
MOBP81B
MOBP81A
MOBP99
rOPRPl
rOPl
Gen contig2a 
Gen contig2b 
Gen contig 3+4
CTCGGATGTGCAAAACAAGGTCATGGTGCACAACCATGCAAACCGCAAATGCAAAAGAGAAATT
CGCAACACCGTTGAGATGTACTCTGGGGACACTATCAAGGCAAAGTATCTTAAAACCTCTAATC
CGCAACACCGTTGAGATGTACTCTGGGGACACTATCAAGGCAAAGTATCTTAAAACCTCTAATC
CTCGGATGTGCAAAACAAGGTCATGGTGCACAACCATGCAAACCGCAAATGCAAAAGAGAAATT
6600 6610 6620 6630 6640 6650
I I I I I I
Contig# 2 GTCAAGGTTGGCGGTGACGTGAGAAAAATCCTAAGCAGCTACCGATGGGAGTCTAACATTGTCA
Gen contig 1
MOBP69
MOBP81B
MOBP81A AAGCGACTGTAATTTTAGGCATCCATCCTGGGGAAAACTCACACCCTTTTAGAGAAAGGAGAAA
MOBP99
rOPRPl
rOPl AAGCGACTGTAATTTTAGGCATCCATCCTGGGGAAAACTCACACCCTTTTAGAGAAAGGAGAAA
Gen contig2a 
Gen contig2b
Gen contig 3+4 GTCAAGGTTGGCGGTGACGTGAGAAAAATCCTAAGCAGCTACCGATGGGAGTCTAACATTGTCA
6660 6670 6680 6690 6700 6710 6720
I I I I I I I
Contig# 2 CCACTGAGCTGTACTCTGGGGACACTGTCAAAGGCAAAATATCTTAAAACCTCTAATCAAGTGA
Gen contig 1
MOBP69
MOBP81B
MOBP81A TGCCCAAATTTGTTTAAAAGATCGTGGTTTGTAGTTAAGAGAGGTAGAATGAGATTAACCAAAA
MOBP99
rOPRPl
rOPl TGCCCAAATTTGTTTAAAAGATCGTGGTTTGTAGTTAAGAGAGGTAGAATGAGATTAACCAAAA
Gen contig2a 
Gen contig2b
Gen contig 3+4 CCACTGAGCTGTACTCTGGGGACACTGTCAAAGGCAAAATATCTTAAAACCTCTAATCAAGTGA
6730 6740 6750 6760 6770 6780
Contig# 2
Gen contig 1
MOBP69
MOBP81B
MOBP81A
MOBP99
rOPRPl
rOPl
Gen contig2a 
Gen contig2b 
Gen contig 3+4
CTGCAATTTTAGGAATCCATCCTGGAGAAAACTCACACCCCTTTAGAGAAGGAGAAATGCGCAG
TGTCGGTCCACGGGAGAGCAAGAGAGTCAATCTTGGTATGTCCACAAAGTCCTAAGAGCAGTTA
TGTCGGTCCACGGGAGAGCAAGAGAGTCAATCTTGGTATGTCCACAAAGTCCTAAGAGCAGTTA
CTGCAATTTTAGGAATCCATCCTGGAGAAAACTCACACCCCTTTAGAGAAGGAGAAATGCGCAG
6790 6800 6810 6820 6830 6840
I I I I I I
Contig# 2 ATTTGTCTAAAAGATCGTGGTTTGTAGTTAAGAGAAGTGGAATGAAACTAGCCAAAATGTCTGT
Gen contig 1
MOBP69
MOBP81B
MOBP81A AAAGCCAATCTGTCAGACAGACCCATGCCGAGCAGGTAAATCTAGAAAGCAAACCAAGGACTAT
MOBP99
rOPRPl
rOPl AAAGCCAATCTGTCAGACAGACCCATGCCGAGCAGGTAAATCTAGAAAGCAAACCAAGGACTAT
Gen contig2a 
Gen contig2b
Gen contig 3+4 ATTTGTCTAAAAGATCGTGGTTTGTAGTTAAGAGAAGTGGAATGAAACTAGCCAAAATGTCTGT
6850 6860 6870 6880 6890 6900 6910
Contig# 2
Gen contig 1
MOBP69
MOBP81B
MOBP81A
MOBP99
rOPRPl
rOPl
Gen contig2a 
Gen contig2b 
Gen contig 3+4
CCAAGGGAATGAGAGAATCAATTTTGGGACGTTCACAAATAAAGTCCTAACAGCGGTTAAAAGC
AAAAGTCAAGCACCAGGCAGTAAATCCAG | AATAAGAGCCTATGCATACATATTGACAGCTCACA
|AATAAGAGCCTATGCATACATATTGACAGCTCACA
AAAAGTCAAGCACCAGGCAGTAAATCCAG IAATAAGAGCCTATGCATACATATTGACAGCT ACA
CCAAGGGAATGAGAGAATCAATTTTGGGACGTTCACAAATAAAGTCCTAACAGCGGTTAAAAGC
6920 6930 6940 6950 6960 6970
Contig# 2
Big contig 1
MOBP69
MOBP81B
MOBP81A
MOBP99
rOPRPl
rOPl
Gen contig2a 
Gen contig2b 
Gen contig 3+4
CAATCTGTCAGATAGACCATGTCATGTAGGTAAATCTAGAAAGCAAACTGAGAACTATAAAAAT
ATCCTGTACTGGTTATTGCTTACATAAGGAGAAGCCACAGATCTCATTCTTTCTTCTAGAATGC
ATCCTGTACTGGTTATTGCTTACATAAGGAGAAGCCACAGATCTCATTCTTTCTTCTAGAATGC
ATCCTGTACTGGTTATTGCTTACATAAGGAGAAGCCACAGATCT ATTCTTTCTTCTAGAATGC
CAATCTGTCAGATAGACCATGTCATGTAGGTAAATCTAGAAAGCAAACTGAGAACTATAAAAAT
6980 6990 7000 7010 7020 7030 7040
I I I I I I I
Contig# 2 CAAGTACCGGGCAGTAAATGCAG | TATGACGTTCTGGGCCTGAATATTGACATCCCACAGTCCTG
Gen contig 1
MOBP69
MOBP81B
MOBP81A AATAGAATTTAAAAATGACAGCAGAACAAAAGGACACTAGAAATTATCCTCTCAGAAATAAAAG
MOBP9 9 AATAGAATTTAAAAATGACAGCAGAACAAAAGGACACTAGAAATTATCCTCTCAGAAATAAAAG
rOPRPl
rOPl AATAGAATTTAAAAATGACAGCAGAACAAAAGGACACTAGAAATTATCCTCTCAGAAATAAAAG
Gen contig2a 
Gen contig2b
Gen contig 3+4 CAAGTACCGGGCAGTAAATGCAG|TATGACGTTCTGGGCCTGAATATTGACATCCCACAGTCCTG
7050 7060 7070 7080 7090 7100
Contig# 2
Big contig 1
MOBP69
MOBP81B
MOBP81A
MOBP99
rOPRPl
rOPl
Gen contig2a 
Gen contig2b 
Gen contig 3+4
TATTGGTTATTGCTTAATAAGGAGAAGCCACAAGATCTCACACTTTTTCTATAATGCAATAGGA
TATAAGAAATAATTTCTGGCTTGAGGAAATAACCCAGGCTAAAAGCTACACAGGCCTGGCTTAA
TATAAGAAATAATTTCTGGCTTGAGGAAATAACCCAGGCTAAAAGCTACACAGGCCTGGCTTAA
TATAAGAAATAATTTCTGGCTTGAGGAAATAACCCAGGCTAAAAGCTACACAGGCCTGGCTTAA
TATTGGTTATTGCTTAATAAGGAGAAGCCACAAGATCTCACACTTTTTCTATAATGCAATAGGA
7110 7120 7130 7140 7150 7160
Contig# 2
Gen contig 1
MOBP69
MOBP81B
MOBP81A
MOBP99
rOPRPl
rOPl
Gen contig2a 
Gen contig2b 
Gen contig 3+4
TTTAAAAATGACAGCAGAACACAAAGACACTAGAAATTGTCCTGTCAGAAATAAAAGTATAAGA
CCATACCAGCAGGGCATACCTTTGTTAGGAGAGGGTCAATTCGAAGTTTGTGAACAGCCTGGGC
CCATACCAGCAGGGCATACCTTTGTTAGGAGAGGGTCAATTCGAAGTTTGTGAACAGCCTGGGC
CCATACCAGCAGGGCATACCTTTGTTAGGAGAGGGTCAATTCGAAGTTTGTGAACAGCCTGGGC
TTTAAAAATGACAGCAGAACACAAAGACACTAGAAATTGTCCTGTCAGAAATAAAAGTATAAGA
7170 7180 7190 7200 7210 7220 7230
Contig# 2
Gen contig 1
MOBP69
MOBP81B
MOBP81A
MOBP99
rOPRPl
rOPl
Gen contig2a 
Gen contig2b 
Gen contig 3+4
Contig# 2
Gen contig 1
MOBP69
MOBP81B
MOBP81A
MOBP99
rOPRPl
rOPl
Gen contig2a 
Gen contig2b 
Gen contig 3+4
AATAATTCCTGGCTTGAGGAAATAACCCAGACTAAAAGCTACATAGAAACGGCTTAACAGTACT
TGTTTCCGAGGCTGCATAAATCTTAAACACCAAAAATGTGTGTTTTGAATTAACTTTGGGTCTG
TGTTTCCGAGGCTGCATAAATCTTAAACACCAAAAATGTGTGTTTTGAATTAACTTTGGGTCTG
TGTTTCCGAGGCTGCATAAATCTTAAACACCAAAAATGTGTGTTTTGAATTAACTTTGGGTCTG
AATAATTCCTGGCTTGAGGAAATAACCCAGACTAAAAGCTACATAGAAACGGCTTAACAGTACT
7240 7250 7260 7270 7280 7290
GGCAGGGCATATATTTGTTTGGAGAGGGTCGATGTGAAGTCTGTGAATAGTCTGGGATGTTTAC
GTCTACAGAGTCCGGCTTGTGATGGCTCCTGACACGGGAGAAAAGGGGATAAGTTAATATAAGG
GTCTACAGAGTCCGGCTTGTGATGGCTCCTGACACGGGAGAAAAGGGGATAAGTTAATATAAGG
GTCTACAGAGTCCGGCTTGTGATGGCTCCTGACACGGGAGAAAAGGGGATAAGTTAATATAAGG
GGCAGGGCATATATTTGTTTGGAGAGGGTCGATGTGAAGTCTGTGAATAGTCTGGGATGTTTAC
7300 7310 7320 7330 7340 7350 7360
Contig# 2
Gen contig 1
MOBP69
MOBP81B
MOBP81A
MOBP99
rOPRPl
rOPl
Gen contig2a 
Gen contig2b 
Gen contig 3+4
AAGGTCGCATAAATTTTAAACACCAAAAATATTTGTTTTGAATCAATTTTGGGTCTGGGCTATA
CTCTGGGATTTTCCTTTGAGGAACAGGCAGGTAGGAAAGGACACTAGAATGTTGGGGAATGTGG
CTCTGGGATTTTCCTTTGAGGAACAGGCAGGTAGGAAAGGACACTAGAATGTTGGGGAATGTGG
CTCTGGGATTTTCCTTTGAGGAACAGGCAGGTAGGAAAGGACACTAGAATGTTGGGGAATGTGG
AAGGTCGCATAAATTTTAAACACCAAAAATATTTGTTTTGAATCAATTTTGGGTCTGGGCTATA
7370 7380 7390 7400 7410 7420
Contig# 2
Gen contig 1
MOBP69
MOBP81B
MOBP81A
MOBP99
rOPRPl
rOPl
Gen contig2a 
Gen contig2b 
Gen contig 3+4
Contig# 2
Gen contig 1
MOBP69
MOBP81B
MOBP81A
MOBP99
rOPRPl
rOPl
Gen contig2a 
Gen contig2b 
Gen contig 3+4
GAGTCTGCCTTGTGATGGTTCCTGACACGAGAGAAAAGGGAAGAAATGTTAATACAGCTCTCGA
AGGGATGTAAAACAGACAGTATTATGATGGGGGGAACTCAGGAAGGAACGGTAAGGACACCAGA
AGGGATGTAAAACAGACAGTATTATGATGGGGGGAACTCAGGAAGGAACGGTAAGGACACCAGA
AGGGATGTAAAACAGACAGTATTATGATGGGGGGAACTCAGGAAGGAACGGTAAGGACACCAGA
GAGTCTGCCTTGTGATGGTTCCTGACACGAGAGAAAAGGGAAGAAATGTTAATACAGCTCTCGA
7430 7440 7450 7460 7470 7480
ATTTTCCCTTTAAAGACCAGGTAGGTAGGAAAGGACAACAGGATGTTGGGGAATGTGGAGGGAT
ATGGCCTCGTGCTGGGAGCCAGGGTGGCCAAGCCCAGGCAGATGCACAAAGACCCCAAAGGCCA
ATGGCCTCGTGCTGGGAGCCAGGGTGGCCAAGCCCAGGCAGATGCACAAAGACCCCAAAGGCCA
ATGGCCTCGTGCTGGGAGCCAGGGTGGCCAAGCCCAGGCAGATGCACAAAGACCCCAAAGGCCA
ATTTTCCCTTTAAAGACCAGGTAGGTAGGAAAGGACAACAGGATGTTGGGGAATGTGGAGGGAT
7490 7500 7510 7520 7530 7540 7550
Contig# 2 
Gen contig 1 
MOBP69 
MOBP81B 
MOBP81A 
MOBP99 
rOPRPl 
rOPl
Gen contig2a 
Gen contig2b 
Gen contig 3+4
GTAAAACAGACAGTATTACGGTGGCGAAAACTCAGTGTAGGGCGATAAGAACATCAGATGGCCT
CCATTGCCTCACAACCAGACCCAGCAAAGTTCAGATCAAGTGCATAAATGGGGGTCACGTCAGT
CCATTGCCTCACAACCAGACCCAGCAAAGTTCAGATCAAGTGCATAAATGGGGGTCACGTCAGT
CCATTGCCTCACAACCAGACCCAGCAAAGTTCAGATCAAGTGCATAAATGGGGGTCACGTCAGT
GTAAAACAGACAGTATTACGGTGGCGAAAACTCAGTGTAGGGCGATAAGAACATCAGATGGCCT
7560 7570 7580 7590 7600 7610
Contig# 2
Gen contig 1
MOBP69
MOBP81B
MOBP81A
MOBP99
rOPRPl
rOPl
Gen contig2a 
Gen contig2b 
Gen contig 3+4
TGTGCTGGGAGCCGGGGTGGCCAAGCACAGGCGGATGCTTGAAGACCCCAAAGGTCACCATGGC
GGAAACTGTCCGGAGCATGGAGCAGGGGGTGAGGAAGACAGTCAGAAGGAAGCAAGAGATGGCT
GGAAACTGTCCGGAGCATGGAGCAGGGGGTGAGGAAGACAGTCAGAAGGAAGCAAGAGATGGCT
GGAAACTGTCCGGAGCATGGAGCAGGGGGTGAGGAAGACAGTCAGAAGGAAGCAAGAGATGGCT
TGTGCTGGGAGCCGGGGTGGCCAAGCACAGGCGGATGCTTGAAGACCCCAAAGGTCACCATGGC
7620 7630 7640 7650 7660 7670 7680
Contig# 2
Gen contig 1
MOBP69
MOBP81B
MOBP81A
MOBP99
rOPRPl
rOPl
Gen contig2a 
Gen contig2b 
Gen contig 3+4
GTCCTCACAGCCAGACCCGGCAAAGTTCAGATCAAGTGCACGGATGGGGGCCATGTTAGTGGAA
TAGAGTGTTGCATGGCAGCAAGAAGAAGCAGTCCAAATATCATCCCAAGGCAGCCATGGCTTCC
TAGAGTGTTGCATGGCAGCAAGAAGAAGCAGTCCAAATATCATCCCAAGGCAGCCATGGCTTCC
TAGAGTGTTGCATGGCAGCAAGAAGAAGCAGTCCAAATATCATCCCAAGGCAGCCATGGCTTCC
GTCCTCACAGCCAGACCCGGCAAAGTTCAGATCAAGTGCACGGATGGGGGCCATGTTAGTGGAA
7690 7700 7710 7720 7730 7740
Contig# 2
Gen contig 1
MOBP69
MOBP81B
MOBP81A
MOBP99
rOPRPl
rOPl
Gen contig2a 
Gen contig2b 
Gen contig 3+4
ACTGTCCAAGGTGTGCGGAGGGGGTGAGGAAGACAGCCAGGAGGAAGAGATGGCTCAGAATGCT
TCTCCCGAGGACACTGTGGCCCTGTGGAAGTGCCAAGGCAGAGGCAGAGGAATTTAACCGCACA
TCTCCCGAGGACACTGTGGCCCTGTGGAAGTGCCAAGGCAGAGGCAGAGGAATTTAACCGCACA
TCTCCCGAGGACACTGTGGCCCTGTGGAAGTGCCAAGGCAGAGGCAGAGGAATTTAACCGCACA
ACTGTCCAAGGTGTGCGGAGGGGGTGAGGAAGACAGCCAGGAGGAAGAGATGGCTCAGAATGCT
7750 7760 7770 7780 7790 7800
Contig# 2
Gen contig 1
MOBP69
MOBP81B
MOBP81A
MOBP99
rOPRPl
rOPl
Gen contig2a 
Gen contig2b 
Gen contig 3+4
GCACTACAGCAAAGAAGAAGCAGGCCAAATATCGTCCTAAGGCAGCCGAGGGGTCCCGGCTTCC
CAAACTACATGCAGAAACTAAGGTGCTAAATGAACATCTACGTGACAACCTTTCTGAGGACCAG
CAAACTACATGCAGAAACTAAGGTGCTAAATGAACATCTACGTGACAACCTTTCTGAGGACCAG
CAAACTACATGCAGAAACTAAGGTGCTAAATGAACATCTACGTGACAACCTTTCTGAGGACCAG
GCACTACAGCAAAGAAGAAGCAGGCCAAATATCGTCCTAAGGCAGCCGAGGGGTCCCGGCTTCC
7810 7820 7830 7840 7850 7860 7870
Contig# 2
Gen contig 1
MOBP69
MOBP81B
MOBP81A
MOBP99
rOPRPl
rOPl
Gen contig2a 
Gen contig2b 
Gen contig 3+4
TCTCCCGAGGGCACTGTGGCTCCGTGGAAGTGCCGAGGCAGAGGCAGGGGAATTTAACTGCACA
GTTCCAGTGAGCGGCCCAGGGCCGTTATCTTCGCGATGGTAACTGAGCTGAGAAGAATGGGAAC
GTTCCAGTGAGCGGCCCAGGGCCGTTATCTTCGCGATGGTAACTGAGCTGAGAAGAATGGGAAC
GTTCCAGTGAGCGGCCCAGGGCCGTTATCTTCGCGATGGTAACTGAGCTGAGAAGAATGGGAAC
TCTCCCGAGGGCACTGTGGCTCCGTGGAAGTGCCGAGGCAGAGGCAGGGGAATTTAACTGCACA
7880 7890 7900 7910 7920 7930
Contig# 2
Gen contig 1
MOBP69
MOBP81B
MOBP81A
MOBP99
rOPRPl
rOPl
Gen contig2a 
Gen contig2b 
Gen contig 3+4
AAAACTACACGCAGAAACTCAGGTGCTAAAATGGACATGTATGTGACCACCTTTCTGAGGACCA
CGGATAGGAGCACACAGTAGCCCACTGGTGAGACAAATCCACGGGCGAGCCTCAACCAACCCAC
CGGATAGGAGCACACAGTAGCCCACTGGTGAGACAAATCCACGGGCGAGCCTCAACCAACCCAC
CGGATAGGAGCACACAGTAGCCCACTGGTGAGACAAATCCACGGGCGAGCCTCAACCAACCCAC
AAAACTACACGCAGAAACTCAGGTGCTAAAATGGACATGTATGTGACCACCTTTCTGAGGACCA
7940 7950 7960 7970 7980 7990 8000
Contig# 2
Gen contig 1
MOBP69
MOBP81B
MOBP81A
MOBP99
rOPRPl
rOPl
Gen contig2a 
Gen contig2b 
Gen contig 3+4
GTTCCAGTGAGTGCCCAGGATGTTTCCTTCTCGACTACGGTTACTGAGCTTAGAAGAATGGGAA
TAAGGAAACTTCACGCCTTTTCATCTAGTTTTCATTTTGGCAAAGCAAAGCCATCCTGAGTGCT
TAAGGAAACTTCACGCCTTTTCATCTAGTTTTCATTTTGGCAAAGCAAAGCCATCCTGAGTGCT
TAAGGAAACTTCACGCCTTTTCATCTAGTTTTCATTTTGGCAAAGCAAAGCCATCCTGAGTGCT
GTTCCAGTGAGTGCCCAGGATGTTTCCTTCTCGACTACGGTTACTGAGCTTAGAAGAATGGGAA
8010 8020 8030 8040 8050 8060
Contig# 2
Gen contig 1
MOBP69
MOBP81B
MOBP81A
MOBP99
rOPRPl
rOPl
Gen contig2a 
Gen contig2b 
Gen contig 3+4
CGGGTTTAGGAGCACACAGTTAGCCCCATTGGTGAGACAAATTTCCAGGCTAGCTTCATCCAAT
TGCTTGTCTCCGCCCTCCACGCCACCCCCGAGACACAGAGCATGCGCATTAACCCAGAGCGCGC
TGCTTGTCTCCGCCCTCCACGCCACCCCCGAGACACAGAGCATGCGCATTAACCCAGAGCGCGC
TGCTTGTCTCCGCCCTCCACGCCACCCCCGAGACACAGAGCATGCGCATTAACCCAGAGCGCGC
CGGGTTTAGGAGCACACAGTTAGCCCCATTGGTGAGACAAATTTCCAGGCTAGCTTCATCCAAT
8070 8080 8090 8100 8110 8120
I I I I I I
Contig# 2 CCATTAAGGAGACTTTAGGCTTTTTCATCTGGTTTTCATTGGGGCAAAGCAAAGCATATCCTGA
Gen contig 1
MOBP69
MOBP81B
MOBP81A TAACACATGCACAGCGTTGGACATTAGCCTATTAATGGGAATAACCAGAAACTACTAAATTTTG
MOBP9 9 TAACACATGCACAGCGTTGGACATTAGCCTATTAATGGGAATAACCAGAAACTACTAAATT
rOPRPl
rOPl TAACACATGCACAGCGTTGGACATTAGCCTATTAATGGGAATAACCAGAAACTACTAAATTTTG
Gen contig2a 
Gen contig2b
Gen contig 3+4 CCATTAAGGAGACTTTAGGCTTTTTCATCTGGTTTTCATTGGGGCAAAGCAAAGCATATCCTGA
8130 8140 8150 8160 8170 8180 8190
Contig# 2
Gen contig 1
MOBP69
MOBP81B
MOBP81A
MOBP99
rOPRPl
rOPl
Gen contig2a 
Gen contig2b 
Gen contig 3+4
GTGTTGGTTTGTTTCCGCCCTCCACGCCACCCCTGAGACACCGAGCATGCGCATTAACCCAGAG
TTTGTTGTAGAAATAAAACCTGGGGATGGATCAAAA
TTTGTTGTAGAAATAAAACCTGGGGATGGATC
GTGTTGGTTTGTTTCCGCCCTCCACGCCACCCCTGAGACACCGAGCATGCGCATTAACCCAGAG
8200 8210 8220 8230 8240 8250
I I I I I I
Contig# 2 CGCGCTAACCCATGCGCAGCGTTGGACGTTAGCTCATTAATGTGATTAACCAGAAACCACTAAA
Gen contig 1
MOBP69
MOBP81B
MOBP81A
MOBP99
rOPRPl
rOPl
Gen contig2a 
Gen contig2b
Gen contig 3+4 CGCGCTAACCCATGCGCAGCGTTGGACGTTAGCTCATTAATGTGATTAACCAGAAACCACTAAA
8260 8270 8280 8290 8300 8310 8320
I I I I I I I
Contig# 2 TTTTGTTTGTTGTAGAAATAAAACCTGGGGATGGATCAAACTATATCTGGAGATTGCTTGAAGC
Gen contig 1
MOBP69
MOBP81B
MOBP81A
MOBP99
rOPRPl
rOPl
Big contig2a 
Gen contig2b
Gen contig 3+4 TTTTGTTTGTTGTAGAAATAAAACCTGGGGATGGATCAAACTATATCTGGAGATTGCTTGAAGC
8330 8340 8350 8360 8370 8380
Contig# 2
Gen contig 1
MOBP69
MOBP81B
MOBP81A
MOBP99
rOPRPl
rOPl
Gen contig2a 
Gen contig2b 
Gen contig 3+4
TGATGGGTTACTAAGCCAAATGTGCTTTGGAATTCCTCACTGAGTCGCGTTGTAATCACCACGT
TGATGGGTTACTAAGCCAAATGTGCTTTGGAATTCCTCACTGAGTCGCGTTGTAATCACCACGT
8390 8400 8410 8420 8430 8440
Contig# 2
Gen contig 1
MOBP69
MOBP81B
MOBP81A
MOBP99
rOPRPl
rOPl
Big contig2a 
Gen contig2b 
Gen contig 3+4
ACTGTTTTTCTACTTAACATCGACTCTCAGGAACATTCCCAAGTTAATACCGGAGACATTTCAT
ACTGTTTTTCTACTTAACATCGACTCTCAGGAACATTCCCAAGTTAATACCGGAGACATTTCAT
8450 8460 8470 8480 8490 8500 8510
Contig# 2
Gen contig 1
MOBP69
MOBP81B
MOBP81A
MOBP99
rOPRPl
rOPl
Gen contig2a 
Gen contig2b 
Gen contig 3+4
AAAACTCCCAAAGCTGTTCTTCATACATTTCTTGAATTAGCAATCCAAGCCCCCATGTTCTGAC
AAAACTCCCAAAGCTGTTCTTCATACATTTCTTGAATTAGCAATCCAAGCCCCCATGTTCTGAC
8520 8530 8540 8550 8560
Contig# 2
Gen contig 1
MOBP69
MOBP81B
MOBP81A
MOBP99
rOPRPl
rOPl
Gen contig2a 
Gen contig2b 
Gen contig 3+4
ATTATTCCCGAATGTTTAATTAATCCTTACATTTTGGGGAAAAAACGGAAGGC
ATTATTCCCGAATGTTTAATTAATCCTTACATTTTGGGGAAAAAACGGAAGGC
Appendix X Sequence multi alignment of contigs 1, 2 and 3, and published sequence 
data. Sequences were imported to the Genejockey software (Cambridge, Biosoft), from 
the database according to their EMBL accession numbers (defined in Table 2.3.1 and 
Section 2, 2.5.1) and aligned by eye within the Genejockey.
OC II 15inv 5'UTR 
MOBP69 5'
MOBP81 B 5' 
MOBP81A 5'
MOBP99 5' 
rOPl 5' 
rOPRPl 5'
AAGCTCCACCAGGGCCCGGTATCCACAGGAACCTTTCACAACAGCCATTACTCGCAGGGCA
TATCCACAGGAACCTTTCACAGCAGCCAATACCTGCAGGGCA
AGGGAACCTTTCACAGCAGCCAATACCTGCAGGGCA
CTTTCACAGCAGCCAATACCTGCAGGGCA
GCCAATACCTGCAGGGCA
70 80 90 100 110 120
I I I I I I
OC II 15inv 5'UTR ACAAAGAATCAAATGAGAGCAAGACAAGCCGAGAACAGAGTCCTGGTTGCCAGACCGGCAC 
MOBP69 5' ACAAAGAATCAAATGAGAGCGAGACAAGCTGGGAATGAAGTCCTGGTTGCCAGA/TGGGA/
MOBP81 B 5' ACAAAGAATCAAATGAGAGCGAGACAAGCTGGGAATGAAGTCCTGGTTGCCAGA/TGGGA/
MOBP81A 5' ACAAAGAATCAAATGAGAGCGAGACAAGCTGGGAATGAAGTCCTGGTTGCCAGA/TGGGA/
MOBP99 5' ACAAAGAATCAAATGAGAGCGAGACAAGCTGGGAATGAAGTCCTGGTTGCCAGA/TGGGA/
rOPl 5 ' TGAGAGCGAGACAAGCTGGGAATGAAGTCCTGGTTGCCAGA/TGGGA/
rOPRPl 5 ' TGAGAGCGAGACAAGCTGGGAATGAAGTCCTGGTTGCCAGA/TGGGA/
130
OC II 15inv 5'UTR GGATGAAAACCCAG ★ ★ ★
MOBP69 5' GCTTGAAAACACAG ***
MOBP81 B 5' GCTTGAAAACACAG ***
MOBP81A 5' GCTTGAAAACACAG * ★ *
MOBP99 5' GCTTGAAAACACAG ***
rOPl 5' GCTTGAAAACACAG ***
rOPRPl 5' GCTTGAAAACACAG * * ★
Appendix XI Sequence multi-alignment of 5' UTR sequences from published (Yamamoto 
et al., 1994; Holz et al., 1996 ) rat splice variants and sequence from a 5' cDNA fragment 
generated in an oligo-capping assay to identify transcriptional start sites (Section 2, 2.5). 
5' donor splice sites are indicated by I***. N.B. Nucleotide numbers, listed above 
sequence, are purely arbitrary and bear no relevance to the genomic organisation of the 
gene. /, introduced into 5'UTR sequence of rat splice variants to maintain the alignment 
of rat and mouse sequences. These do not represent unidentified nucleotides.
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